<SEC-DOCUMENT>0001193125-22-136867.txt : 20220502
<SEC-HEADER>0001193125-22-136867.hdr.sgml : 20220502
<ACCEPTANCE-DATETIME>20220502163656
ACCESSION NUMBER:		0001193125-22-136867
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20220621
FILED AS OF DATE:		20220502
DATE AS OF CHANGE:		20220502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		22882557

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d296110ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
INFORMATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only&nbsp;(as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to &#167; <FONT STYLE="white-space:nowrap">240.14a-12</FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH COMPANIES INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement if Other Than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g296110g16f81.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May&nbsp;2, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dear Fellow Shareholders: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On behalf of the Board of Directors of Bausch Health Companies Inc., it is my pleasure to invite you to attend our Annual
Meeting of Shareholders (the &#147;Meeting&#148;) on Tuesday, June&nbsp;21, 2022 at 9:00 a.m., Eastern Daylight Time. Due to the continuing public health concerns relating to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the Board
has determined to conduct the Meeting in an exclusively virtual format via a live internet webcast. There will be no physical meeting. We believe the virtual Meeting will facilitate shareholder attendance and participation by enabling shareholders
to participate in the Meeting at no cost, while safeguarding the health and well-being of our shareholders, employees, and Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At the Meeting, shareholders will vote on the proposals listed in the Notice of Annual Meeting (the &#147;Notice&#148;) and
the accompanying Proxy Statement (as defined below), as well as receive a report on the progress of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are
providing access to our proxy materials, including our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, in a fast and efficient manner via the internet. On May&nbsp;2, 2022, we will
begin mailing the proxy materials to all shareholders of record as of April&nbsp;28, 2022 and will post our proxy materials on the website (<U>www.proxyvote.com). </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Your vote is important. Whether or not you plan to attend the virtual Meeting, we hope you will vote as soon as possible. You
will find voting instructions in the Notice, on the proxy card or your voting instruction form. You may vote via the internet or by telephone. Alternatively, if you requested a printed copy of the proxy materials by mail, you may mark, date, sign
and mail the proxy card in the envelope provided. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We appreciate your continued ownership of Bausch Health shares and your
support. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em">


<IMG SRC="g296110g10v55.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board and Chief Executive Officer</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH COMPANIES INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2150 Saint Elz&eacute;ar Blvd. West </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Laval, Qu&eacute;bec H7L 4A8 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NOTICE OF ANNUAL
MEETING OF SHAREHOLDERS </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TO BE HELD ON JUNE&nbsp;21, 2022 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Shareholders of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Bausch Health Companies Inc.: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">NOTICE IS HEREBY GIVEN that the 2022 Annual Meeting of Shareholders (the &#147;Meeting&#148;) of Bausch Health Companies Inc.,
a British Columbia corporation (the &#147;Company,&#148; &#147;Bausch Health,&#148; &#147;we&#148; or &#147;our&#148;), will be conducted in an exclusively virtual formal via a live internet webcast at
<U>www.virtualshareholdermeeting.com/BHC2022</U> at 9:00 a.m., Eastern Daylight Time, on Tuesday, June&nbsp;21, 2022, for the following purposes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1.&nbsp;&nbsp;to elect twelve directors to serve on the Company&#146;s board of directors (the
&#147;Board&#148;) until the close of the 2023 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director&#146;s earlier resignation or removal; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2.&nbsp;&nbsp;to approve, in an advisory vote, the compensation of our named executive officers; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3.&nbsp;&nbsp;to approve an amendment and restatement of the Company&#146;s Amended and Restated 2014 Omnibus
Incentive Plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4.&nbsp;&nbsp;to appoint PricewaterhouseCoopers LLP to serve as the Company&#146;s auditor
until the close of the 2023 Annual Meeting of Shareholders and to authorize the Board to fix the auditor&#146;s remuneration; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5.&nbsp;&nbsp;to receive the audited consolidated financial statements of the Company for the year ended
December&nbsp;31, 2021, and the auditor&#146;s report thereon; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6.&nbsp;&nbsp;to transact such other
business as may properly come before the Meeting or any adjournments or postponements thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The record date for the
Meeting is April&nbsp;28, 2022. Only shareholders at the close of business on April&nbsp;28, 2022 will be entitled to notice of, and to vote at, the Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are providing access to our proxy materials, including our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, to each shareholder in a fast and efficient manner via the internet. On May&nbsp;2, 2022, we will begin mailing the proxy materials to all shareholders as
of the record date of April&nbsp;28, 2022 and will post our proxy materials at <U>www.proxyvote.com</U>. The management proxy circular and proxy statement that accompanies this Notice of Annual Meeting of Shareholders contains additional information
regarding the proposals to be considered at the Meeting, and shareholders are encouraged to read it in its entirety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We
encourage shareholders to vote as soon as possible. Shareholders can vote via the internet, by going to <U>www.proxyvote.com</U> and following the instructions on the website. Record shareholders can also call toll free <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> on a touch tone telephone and following the instructions provided by &#147;Vote Voice.&#148; You will need to refer to
the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number provided on your proxy card. You may also vote by proxy by completing, dating and signing the proxy card provided with those materials and sending it in the envelope provided to
Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, New York 11717, United States. <I><FONT STYLE="white-space:nowrap">Non-record</FONT> shareholders</I> (beneficial holders) who receive these materials through their broker or other
intermediary should follow the instructions provided by their broker or intermediary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For your vote to be effective, your
voting instructions, if mailed in, must be received by Broadridge Financial Solutions, Inc. (&#147;Broadridge&#148;) not later than <B>11:59 p.m. (Eastern Daylight Time) on Thursday, June</B><B></B><B>&nbsp;16, 2022</B>,<B></B> or, in the case of
any adjournment of the Meeting, not less than 48 hours, excluding Saturdays, Sundays and applicable holidays, prior to the time of the rescheduled meeting. The Board, or the chairperson of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Meeting may, at their discretion, accept late proxies or waive the time limit for deposit of proxies, but are under no obligation to accept or reject any late proxy. <B>If you have voted by
proxy via the internet or by telephone or mail, any subsequent vote by proxy through any of these methods or during the Meeting will cancel any other proxy you may have previously submitted in connection with the Meeting, and only the latest dated
proxy received prior to the deadline will be counted. </B>A proxy received after this deadline may only be effective to revoke any prior proxy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors,</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:25.00em; text-indent:-1.00em">


<IMG SRC="g296110g69b62.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General Counsel</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May&nbsp;2, 2022 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_1">MANAGEMENT PROXY CIRCULAR AND PROXY STATEMENT</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_2">ELECTRONIC DELIVERY OF BAUSCH HEALTH SHAREHOLDER COMMUNICATIONS</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_3">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE MEETING
 OF SHAREHOLDERS TO BE HELD ON JUNE&nbsp;21, 2022</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_4">ATTENDING THE MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_5">QUESTIONS ABOUT VOTING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_6">PROPOSAL NO. 1 ELECTION OF DIRECTORS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>9</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_7">BACKGROUND</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_8">NOMINATION OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_9">NOMINEES FOR ELECTION TO THE BOARD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_10">STATEMENT OF CORPORATE GOVERNANCE PRACTICES</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>26</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_11">COMPENSATION COMMITTEE INTERLOCKS AND INSIDER
PARTICIPATION</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>40</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_12">EXECUTIVE OFFICERS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>41</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_13">OWNERSHIP OF THE COMPANY&#146;S SECURITIES</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>43</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_14">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_15">OWNERSHIP OF MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_16">DELINQUENT SECTION 16(a) REPORTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_17">EXECUTIVE COMPENSATION AND RELATED MATTERS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>48</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_18">COMPENSATION DISCUSSION AND ANALYSIS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_19">COMPENSATION COMMITTEE REPORT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_20">SUMMARY COMPENSATION TABLE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_21">POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_22">DIRECTOR COMPENSATION TABLE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_23">EQUITY COMPENSATION PLAN INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_24">AUDIT COMMITTEE REPORT</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>86</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_25">CERTAIN TRANSACTIONS</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>87</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_26">PROPOSAL NO. 2 ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>89</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_27">PROPOSAL NO. 3 APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY&#146;S
 AMENDED AND RESTATED 2014 OMNIBUS INCENTIVE PLAN</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>90</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_28">PROPOSAL NO. 4 APPOINTMENT OF AUDITOR</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>103</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_29">AUDITOR FEES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><A HREF="#tx296110_30">OTHER</A></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>105</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_31">SHAREHOLDER PROPOSALS AND DIRECTOR NOMINATIONS FOR THE 2022 ANNUAL MEETING OF
 SHAREHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_32">COMMUNICATION WITH THE BOARD OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_33">ANNUAL REPORT AND ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_34">PROXY SOLICITATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_35">HOUSEHOLDING OF PROXY MATERIALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_36">MISCELLANEOUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_37">EXHIBIT A &#151; Charter of the Board of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_38">EXHIBIT B &#151; Amended and Restated 2014 Omnibus Incentive
Plan</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">B-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx296110_39">APPENDIX 1</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">E-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH COMPANIES INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2150 Saint Elz&eacute;ar Blvd. West </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Laval, Qu&eacute;bec H7L 4A8 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;
</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_1"></A>MANAGEMENT PROXY CIRCULAR AND PROXY STATEMENT </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2022 ANNUAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON JUNE&nbsp;21, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">INFORMATION ABOUT THE ANNUAL MEETING AND VOTING </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Management Proxy Circular and Proxy Statement (&#147;Proxy Statement&#148;) contains information about the 2022 Annual
Meeting of Shareholders of Bausch Health Companies Inc., which will be conducted in an exclusively virtual format via a live internet webcast at <U>www.virtualshareholdermeeting.com/BHC2022</U> at 9:00 a.m., Eastern Daylight Time, on June&nbsp;21,
2022, and at any adjournments or postponements thereof (the &#147;Meeting&#148;), for the purposes set forth in this Proxy Statement and in the accompanying Notice of Annual Meeting of Shareholders. In this document, the words &#147;Bausch
Health,&#148; &#147;we,&#148; &#147;our,&#148; &#147;ours&#148; &#147;us&#148; and similar terms refer only to Bausch Health Companies Inc. and not to any other person or entity. References to &#147;US$&#148; or &#147;$&#148; are to United States
dollars. Unless otherwise indicated, the statistical and financial data contained in this Proxy Statement are as of May&nbsp;2, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are providing you with this Proxy Statement and related materials in connection with the solicitation of proxies by our
management. See the section titled &#147;Questions About Voting &#151; Who is soliciting my proxy?&#148; on page 8 for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are providing access to our proxy materials, including our Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, in a fast and efficient manner via the internet. On May&nbsp;2, 2022, we will begin mailing the proxy materials to all shareholders as of the record date
of April&nbsp;28, 2022 and post our proxy materials on the website referenced in the Notice (<U>www.proxyvote.com</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All properly executed written proxies, and all properly completed proxies submitted via the internet or by telephone or mail,
which are delivered pursuant to, and which appoint Joseph C.&nbsp;Papa and Christina&nbsp;M.&nbsp;Ackermann, or each of them, each with the power to appoint his or her substitute, as proxyholders in accordance with, this solicitation will be voted
at the Annual Meeting in accordance with the directions given in the proxy, unless the proxy is revoked prior to completion of voting at the Annual Meeting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_2"></A>ELECTRONIC DELIVERY OF BAUSCH HEALTH SHAREHOLDER COMMUNICATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are pleased to offer to our shareholders the benefits and convenience of electronic delivery of Meeting materials,
including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">email delivery of the Proxy Statement, Annual Report and any related materials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shareholder voting <FONT STYLE="white-space:nowrap">on-line;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduction of the number of bulky documents shareholders receive; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduction of our printing and mailing costs associated with more traditional methods. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We encourage you to conserve natural resources and to reduce printing and mailing costs by signing up for electronic delivery
of Bausch Health shareholder communications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a registered shareholder or a beneficial owner of common shares,
no par value, of the Company (&#147;Common Shares&#148;), or if a broker or other intermediary holds your Common Shares, and you would like to sign up for electronic delivery, please visit <U>www.proxyvote.com</U> and enter the information requested
to enroll. Your electronic delivery enrollment will be effective until you cancel it. If you have questions about electronic&nbsp;delivery, please call Bausch Health Investor Relations at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">514-856-3855</FONT></FONT> or send an email to <U>ir@bauschhealth.com.</U> </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_3"></A>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE&nbsp;21, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021 (the
&#147;Annual Report&#148;) is available on the internet at our website at <U>www.bauschhealth.com</U>, through the System for Electronic Document Analysis and Retrieval (&#147;SEDAR&#148;) at <U>www.sedar.com</U> or through the U.S. Securities and
Exchange Commission&#146;s electronic data system, EDGAR, at <U>www.sec.gov</U>. <B>To request a printed copy of our Annual Report, which we will provide to you without charge, either write to Bausch Health Investor Relations at Bausch Health
Companies Inc., 2150 Saint Elz&eacute;ar</B> <B>Blvd. West, Laval, Qu&eacute;bec</B> <B>H7L 4A8, Canada, or send an email to Bausch Health Investor Relations at </B><B><U>ir@bauschhealth.com</U></B><B>.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>This Proxy Statement and the Annual Report are available at: <U>www.proxyvote.com</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Proxy Statement contains information regarding, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date and time of the Meeting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">instructions for accessing the live internet webcast of the Meeting; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a list of the proposals being submitted to shareholders for approval; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">information concerning voting. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Whether or not you plan to attend the Meeting, please promptly provide your voting instructions.</B> Your promptness in
voting will assist in the expeditious and orderly processing of the proxies and in ensuring that a quorum is present at the Meeting. If you vote your proxy or follow the instructions for voting from the voting instruction from, you may nevertheless
attend, and vote your Common Shares during, the live webcast of the Meeting by using the 16-digit control number on the Notice, proxy card or voting instruction form. If you want to revoke your instructions at a later time prior to the vote for any
reason, you may do so in the manner described in this Proxy Statement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_4"></A>ATTENDING THE MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Meeting will be conducted exclusively via live internet webcast. The Board, certain members of management, and
representatives of PricewaterhouseCoopers, our auditor, will dial into the webcast from remote locations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What do I need to do if I wish to attend the
Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Meeting will be conducted in an exclusively virtual format via live internet webcast available at
<U>www.virtualshareholdermeeting.com/BHC2022</U>. You will be able to access the Meeting using an internet connected device such as a laptop, computer, tablet or mobile phone, and the meeting platform will be supported across browsers and devices
that are running the most updated version of the applicable software plugins. You will need your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number located on the Notice, proxy card or voting instruction form to enter the virtual
Meeting as a shareholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Shareholders as of the record date can access and vote at the Meeting during
the live webcast as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1.&nbsp;&nbsp;Log into <U>www.virtualshareholdermeeting.com/BHC2022</U> at
least 15 minutes before the Meeting starts. You should allow ample time to check into the virtual Meeting and to complete the related procedures. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2.&nbsp;&nbsp;Enter your <FONT STYLE="white-space:nowrap">16-digit</FONT> control number into the Shareholder
Login section (your control number is located on your proxy card, voting instruction form or Notice) and click on &#147;Enter Here.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3.&nbsp;&nbsp;Follow the instructions to access the Meeting and vote when prompted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even if you currently plan to participate in the virtual Meeting, you should consider voting your shares in advance so that
your vote will be counted in the event that you later decide not to attend, or are unable to access, the virtual Meeting. If you access and vote on any matter at the Meeting during the live webcast, then you will revoke any previously submitted
proxy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Those accessing and voting at the virtual Meeting must remain connected to the internet at all times during the
Meeting in order to vote when balloting commences. It is your responsibility to ensure internet connectivity for the duration of the Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There will be technical support phone numbers available on the virtual meeting website at
<U>www.virtualshareholdermeeting.com/BHC2022</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I ask a question at the Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe that the ability to allow for shareholders or their proxyholders to participate in the Meeting in a meaningful way,
including asking questions, remains important despite the virtual format of the Meeting. At the Meeting, shareholders and proxyholders will have an opportunity to ask questions at the meeting in writing by sending a message to the chair of the
Meeting online through the virtual meeting platform. Questions received from shareholders or proxyholders which relate to the business of the Meeting are expected to be addressed in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">question-and-answer</FONT></FONT> session that will follow the Meeting. Such questions will be read by the chair of the Meeting or a designee of the chair and responded to by a
representative of the Company as they would be at a shareholders meeting that was being held in person. As at an <FONT STYLE="white-space:nowrap">in-person</FONT> meeting, to ensure fairness for all attendees, the chair of the Meeting will decide on
the amount of time allocated to each question and will have the right to limit or consolidate questions and to reject questions that do not relate to the business of the Meeting or which are determined to be inappropriate or otherwise out of order.
It is anticipated that shareholders and proxyholders will have substantially the same opportunity to ask questions on matters of business at the meeting as in past years when the annual meeting of shareholders was held in person. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_5"></A>QUESTIONS ABOUT VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What decisions will the shareholders be making at the Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You will be asked to vote on each of the following proposals: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to elect twelve directors to serve on the Company&#146;s board of directors (the &#147;Board&#148;) until the
close of the 2023 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director&#146;s earlier resignation or removal (&#147;Proposal No.&nbsp;1&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to approve, in an advisory vote, the compensation of our named executive officers (&#147;Proposal
No.&nbsp;2&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to approve an amendment and restatement of the Company&#146;s Amended and Restated 2014 Omnibus Incentive Plan
(&#147;Proposal No.&nbsp;3&#148;); and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to appoint PricewaterhouseCoopers LLP (&#147;PwC&#148;) to serve as the Company&#146;s auditor until the close
of the 2022 Annual Meeting of Shareholders, and the authorization of the Board to fix the auditor&#146;s remuneration (&#147;Proposal No.&nbsp;4&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board recommends that you vote: (i)<U>&nbsp;FOR</U> each of the director nominees proposed by the Board in this Proxy
Statement, to serve on the Board until the close of the 2023 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director&#146;s earlier resignation or removal; (ii)<U>&nbsp;FOR</U> the approval, in an advisory
vote, of the compensation of our named executive officers; (iii)<U>&nbsp;FOR</U> the approval of an amendment and restatement of the Company&#146;s Amended and Restated 2014 Omnibus Incentive Plan; and (iv)<U>&nbsp;FOR</U> the appointment of PwC as
our auditor until the close of the 2023 Annual Meeting of Shareholders and the authorization of the Board to fix the auditor&#146;s remuneration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, you may be asked to vote in respect of any other matters that may properly be brought before the Meeting. As of
the date of this Proxy Statement, the Board is not aware of any such other matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A simple majority of votes cast at
the Meeting, whether virtually, by proxy or otherwise, in favor of Proposal No.&nbsp;2, Proposal No.&nbsp;3 and Proposal No.&nbsp;4 will constitute approval of any such proposal submitted to a vote. With respect to Proposal No.&nbsp;1, the election
of directors will be subject to the Company&#146;s majority vote policy described in &#147;Proposal No.&nbsp;1 &#151; Election of Directors &#151; Background&#148; on page 9. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What impact does a Withhold or Abstain vote have? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposal No.</B><B></B><B>&nbsp;1</B>: With respect to each director nominee, you may either vote
&#147;For&#148; the election of such nominee or &#147;Withhold&#148; your vote with respect to the election of such nominee. If you vote &#147;For&#148; the election of a nominee, your Common Shares will be voted accordingly. If you select
&#147;Withhold&#148; with respect to the election of a nominee, your vote will not be counted as a vote cast for the purposes of electing such nominee but will be considered in the application of the majority vote policy described in &#147;Proposal
No.&nbsp;1 &#151; Election of Directors &#151; Background&#148; on page&nbsp;9. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposal No.</B><B></B><B>&nbsp;2:</B> Proposal No.&nbsp;2 is a
<FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote. You may select &#147;For,&#148; &#147;Against&#148; or &#147;Abstain&#148; with respect to such proposal. Abstentions will have no effect and will not be counted as votes cast on
Proposal No.&nbsp;2. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposal No.</B><B></B><B>&nbsp;3:</B> With respect to the approval of an amendment and restatement of the
2014 Plan, you may vote &#147;For&#148;, &#147;Against,&#148; or &#147;Abstain&#148; with respect to such proposal. Abstentions will have the effect of a vote &#147;Against&#148; Proposal No.&nbsp;3. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Proposal No.</B><B></B><B>&nbsp;4:</B> With respect to the appointment of the proposed auditor, you may
either vote &#147;For&#148; such appointment or &#147;Withhold&#148; your vote with respect to such appointment. If you vote &#147;For&#148; the appointment of the proposed auditor, your Common Shares will be voted accordingly. If you select
&#147;Withhold&#148; with respect to the appointment of the proposed auditor, your vote will not be counted as a vote cast for the purposes of appointing the proposed auditor. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the effect if I do not cast my vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a record shareholder does not cast its vote by proxy or in any other permitted fashion, no votes will be cast on its behalf
on any of the items of business at the Meeting. If a <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder does not instruct its intermediary on how to vote on any of the items of business at the Meeting and the intermediary does not have
discretionary authority to vote the <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder&#146;s Common Shares on the matter, or elects not to vote in the absence of instructions from the <FONT STYLE="white-space:nowrap">non-record</FONT>
shareholder, no votes will be cast on behalf of such <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder with respect to such item (a &#147;broker <FONT STYLE="white-space:nowrap">non-vote&#148;).</FONT> If you are a beneficial owner
whose Common Shares are held of record by a broker authorized to trade on the New York Stock Exchange (&#147;NYSE&#148;), NYSE rules permit your broker to exercise discretionary voting authority to vote your Common Shares on Proposal
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
No.&nbsp;4, the appointment of PwC as our auditor, even if the broker does not receive voting instructions from you. However, NYSE rules do not permit your broker to exercise discretionary
authority to vote on Proposal No.&nbsp;1, the election of directors, Proposal No.&nbsp;2, the advisory vote to approve the compensation of our named executive officers or Proposal No. 3, the approval of an amendment and restatement of the 2014 Plan.
If you have further questions on this issue, please contact your intermediary bank or broker or Bausch Health Investor Relations at <U>ir@bauschhealth.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What constitutes a quorum for the Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A minimum of two persons who either are, or represent by proxy, shareholders holding, in the aggregate, at least 25% of the
outstanding Common Shares entitled to vote at the Meeting will constitute a quorum for the transaction of business at the Meeting. Votes withheld, abstentions, and broker <FONT STYLE="white-space:nowrap">non-votes</FONT> will be counted for purposes
of determining the presence of a quorum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is entitled to vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each shareholder is entitled to one vote for each Common Share registered in his or her name as of the close of business on
April&nbsp;28, 2022, the record date for the purpose of determining holders of Common Shares entitled to receive notice of and to vote at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of April&nbsp;28, 2022, 361,446,847 Common Shares were issued and outstanding and entitled to be voted at the Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
voting process is different depending on whether you are a record (registered) or <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You are a <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder if your Common Shares are held on
your behalf by a bank, trust company, securities broker, trustee or other intermediary. This means the Common Shares are registered in your intermediary&#146;s name, and you are the beneficial owner. Most shareholders are <FONT
STYLE="white-space:nowrap">non-record</FONT> shareholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">You are a record shareholder if your name appears in our share register. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-record</FONT> shareholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder, you should receive voting instructions from your
broker or other intermediary holding your shares. You should carefully follow the instructions provided by the broker or intermediary in order to instruct them how to vote your Common Shares. The availability of voting by telephone or internet, and
the deadline for providing your broker or nominee with your voting instructions, will depend on the voting process of your broker or intermediary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Your intermediary must receive your voting instructions in sufficient time for your intermediary to act on them prior to the
deadline for the deposit of proxies of 11:59 p.m. (Eastern Daylight Time) on Monday, June&nbsp;20, 2022, or, in the case of any adjournment of the Meeting, not less than 48 hours (excluding Saturdays, Sundays and applicable holidays) prior to the
rescheduled Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you wish to vote your Common Shares online during the Meeting, you may do so by following the
instructions provided during the webcast of the Meeting. Even if you plan to attend the virtual Meeting, we recommend that you vote before the Meeting by following the instructions provided by your broker or intermediary, so that your vote will be
counted if you later decide not to, or are unable to, attend the Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Record shareholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a record shareholder, there are several ways for you to vote your Common Shares or submit your proxy: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Via the internet:</I>&nbsp;&nbsp;&nbsp;&nbsp;Go to <U>www.proxyvote.com</U> and follow the instructions on
the website. You will be prompted to provide the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number printed on your proxy card. The internet voting service will be available until 11:59 p.m. (Eastern Daylight Time) on Monday,
June&nbsp;20, 2022. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>By telephone:</I>&nbsp;&nbsp;&nbsp;&nbsp;You may vote via telephone by calling toll
free <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903.</FONT></FONT></FONT> You will be prompted to provide the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number printed
on your proxy card). The telephone voting service will be available until 11:59 p.m. (Eastern Daylight Time) on Monday, June&nbsp;20, 2022. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>By mail:</I>&nbsp;&nbsp;&nbsp;&nbsp;Complete, sign and date each proxy card you received, and return it in
the prepaid envelope to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, New York 11717, United States. Broadridge must receive your proxy card not later than 11:59&nbsp;p.m. (Eastern Daylight Time) on Thursday, June&nbsp;16, 2022 in
order for your vote to be counted if sent in by mail. If the Meeting is adjourned or postponed, Broadridge must receive your proxy card at least 48 hours, excluding Saturdays, Sundays and applicable holidays, before the rescheduled Meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>During the Meeting:</I> &nbsp;&nbsp;&nbsp;&nbsp;You may vote your Common Shares online during the Meeting by
following the instructions provided during the webcast of the Meeting. Even if you plan to attend the virtual Meeting, we recommend that you submit your proxy card or vote by telephone or internet by the above deadlines so that your vote will be
counted if you later decide not to, or are unable to, attend the Meeting. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>We provide internet proxy voting to allow you to vote your Common Shares via the internet, with procedures designed to
ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board, or the Chairperson of the Meeting may, at their discretion, accept late proxies or waive the time limit
for deposit of proxies, but are under no obligation to accept or reject any late proxy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you receive more than one set
of proxy materials, your Common Shares are registered in more than one name or are registered in different accounts. Please follow the voting instructions on each Notice and/or proxy card to ensure that all of your Common Shares are voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I appoint a proxyholder? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Your proxyholder is the person you appoint to cast your votes on your behalf at the Meeting.<B>&nbsp;You can choose anyone you
want to be your proxyholder; it does not have to be either of the persons we have designated on your proxy card or voting instruction form, nor does it have to be a shareholder</B>. Please ensure that the person you have appointed will be attending
the virtual Meeting and has your Control Number and other information required in order to vote your Common Shares. Since the Meeting will take place virtually, the process for appointing another person as your proxyholder other than the persons we
have designated, is different than it would be for an in person meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you wish to appoint such a person as your
proxyholder and you are a record shareholder, you must follow the instructions on your proxy card. <FONT STYLE="white-space:nowrap">Non-record</FONT> shareholders wishing to appoint such a person as their proxyholder must contact their intermediary
for instructions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How will my Common Shares be voted if I give my proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you sign and return a proxy card or voting instruction form and do not appoint a third-party proxyholder, or if you vote via
the internet or by telephone in advance of the Meeting, you appoint Mr.&nbsp;Papa and Ms.&nbsp;Ackermann as your proxyholders (with full power of substitution), either of whom will be authorized to vote and otherwise act for you at the Meeting,
including any continuation after adjournment of the Meeting. <B>Unless you specify voting instructions, Mr.</B><B></B><B>&nbsp;Papa and Ms.</B><B></B><B>&nbsp;Ackermann, as your proxyholders, will vote your Common Shares as follows: </B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>FOR each of the director nominees proposed by the Board in this Proxy Statement, to serve on the Board
until the close of the 2023 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director&#146;s earlier resignation or removal; </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>FOR the approval, in an advisory vote, of the compensation of our named executive officers;
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>FOR the approval of an amendment and restatement of the Company&#146;s Amended and Restated 2014 Omnibus
Incentive Plan; and </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>FOR the appointment of PwC as the auditor for the Company to hold office until the close of the 2022 Annual
Meeting of Shareholders and the authorization of the Board to fix the auditor&#146;s remuneration. </B></P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If I change my mind, can I
revoke my proxy once I have given it? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a <FONT STYLE="white-space:nowrap">non-record</FONT> shareholder, you
can revoke your prior voting instructions by contacting your broker to revoke your proxy or change your voting instructions, by providing new instructions to your broker or intermediary on a later date (if you provide your voting instructions by
mail) or at a later time (if you provide your voting instructions by telephone or via the internet), or by voting at the Meeting.<SUP STYLE="font-size:85%; vertical-align:top">.</SUP> Any new voting instructions given to brokers or other
intermediaries in connection with the revocation of proxies must be received in sufficient time to allow them to act on such instructions prior to the deadline for the deposit of proxies of 11:59 p.m. (Eastern Daylight Time) on Monday, June&nbsp;20,
2022, or at least 48 hours (excluding Saturdays, Sundays and applicable holidays) prior to the time of the Meeting if it is rescheduled. If you choose to provide voting instructions multiple times, only the latest one which is not revoked and is
received prior to such deadline will be counted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you are a record shareholder, you may revoke any proxy that you have
given until the time of the Meeting by voting again by telephone or via the internet as instructed above, by signing and dating a new proxy card and submitting it as instructed above, or by voting at the Meeting. If you choose to submit a proxy
multiple times before the Meeting via the internet or by telephone or mail, or a combination thereof, only your latest vote, which is not revoked and is received prior to 11:59 p.m. (Eastern Daylight Time) on Monday, June&nbsp;20, 2022 (or 48 hours,
excluding Saturdays, Sundays and applicable holidays, before the Meeting if it is rescheduled) will be counted. A record shareholder who votes during the Meeting will automatically revoke any proxy previously given by that shareholder regarding
business considered by that vote. However, mere attendance at the Meeting by a record shareholder who has voted by proxy does not revoke such proxy. If your proxy is delivered following the proxy <FONT STYLE="white-space:nowrap">cut-off</FONT> time
it will revoke your previous proxy; however, it will not be valid for voting except at the discretion of the Board or the chairperson of the Meeting, who are under no obligation to accept or reject any late proxy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if amendments are made to these proposals or if other matters are brought before the Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The proxy card also gives discretionary authority to proxyholders to vote as the proxyholders see fit with respect to
amendments or variations to proposals identified in the Notice of Meeting or other matters that may come before the Meeting whether or not the amendment, variation or other matter that comes before the Meeting is or is not routine and whether or not
the amendment, variation or other matter that comes before the Meeting is contested. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of the date of this Proxy Statement, the Board is not aware of any such
amendments, variations or other matters to come before the Meeting. However, if any such changes that are not currently known to the Board should properly come before the Meeting, the Common Shares represented by your proxyholders will be voted in
accordance with the best judgment of the proxyholders, and in accordance with the rules of the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is soliciting my proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Management of the Company is soliciting your proxy for use at the Meeting.</B> All associated costs of solicitation will be
borne by the Company. It is expected that the solicitation will be primarily by mail, but proxies may also be solicited personally, by advertisement, by telephone, internet, telegraph, courier service, telecopies or other electronic means by
directors, officers or employees of the Company without special compensation or by the Company&#146;s proxy solicitor, D.F. King Co., Inc. (&#147;D.F. King&#148;) for a fee of $10,000 plus reimbursement of reasonable
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses. The Company will bear the entire cost of solicitation, including the preparation, assembly, internet hosting, maintaining a dedicated call line,
and printing and mailing the Proxy Statement and form of proxy card. The Company will pay those entities holding Common Shares in the names of their beneficial owners, such as brokers, nominees, fiduciaries and other custodians, for their reasonable
fees and expenses in forwarding solicitation materials to their beneficial owners and for obtaining their instructions. We anticipate that the Proxy Statement and accompanying proxy card will be distributed to shareholders on or about May&nbsp;2,
2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I contact the independent directors and/or the Chairman of the Board? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You may contact the independent directors and/or the Chairman of the Board with the assistance of the Company&#146;s Investor
Relations Department. Shareholders or other interested persons can call or send a letter or email to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Bausch Health Companies Inc.
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2150 Saint Elz&eacute;ar Blvd. West </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Laval, Qu&eacute;bec H7L 4A8 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Canada </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Phone: <B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">514-856-3855</FONT></FONT> </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Email: <U>ir@bauschhealth.com</U> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Whom should I contact if I have questions concerning the Proxy Statement or the proxy card? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you have questions concerning the information contained in this Proxy Statement or require assistance in completing the
proxy card, you may contact Bausch Health Investor Relations as provided above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I contact the Company&#146;s transfer agent? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You may contact the Company&#146;s transfer agent by mail or by telephone (within Canada and the United States): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">TSX Trust Company</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">P.O. Box 700 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Station B </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Montreal, QC H3B 3K3 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Canada </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Email:&nbsp;<U>shareholderinquiries@tmx.com</U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">888-249-6189</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Phone (for all security transfer inquiries): <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-800-387-0825</FONT></FONT></FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">416-682-3860</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Website:&nbsp;<U>www.tsxtrust.com</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_6"></A>ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_7"></A>BACKGROUND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bausch + Lomb Separation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On August 6, 2020, we announced our plan to separate our eye-health business into an independent publicly traded entity, Bausch
+ Lomb Corporation (&#147;Bausch + Lomb&#148;) from the remainder of Bausch Health Companies Inc. On April 28, 2022, we launched the roadshow for the initial public offering of Bausch + Lomb (the &#147;B+L IPO&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On April 26, 2022, each of John A. Paulson and Andrew von Eschenbach, M.D. gave notice of his intended resignation from the
Board, effective and conditional upon the closing of the B+L IPO (such date, the &#147;IPO Closing Date&#148;). The IPO Closing Date is expected to occur before the Annual Meeting, and therefore neither director is being nominated for election. The
decision of each of Mr. Paulson and Dr. Von Eschenbach to resign from the Board was not due to any dispute or disagreement with the Company or the Board on any matter relating to the Company&#146;s operations, policies or practices. Effective and
conditional upon the IPO Closing Date, the Board has resolved to appoint Richard C. Mulligan and Thomas J. Appio, both of whom are nominated for election at this Meeting, to fill the vacancies that will be created by the departures of Mr. Paulson
and Dr. Von Eschenbach. There are no arrangements or understandings between either Dr. Mulligan or Mr. Appio and any other persons pursuant to which he was selected as a director, and there have been no transactions since the beginning of the
Company&#146;s last fiscal year, or are currently proposed, regarding Dr. Mulligan or Mr. Appio that are required to be disclosed pursuant to Item 404(a) of Regulation S-K other than the Amended and Restated Employment Agreement, dated February 18,
2022, between us and Mr. Appio, filed as an exhibit to our Annual Report on Form 10-K on February 23, 2022, or unless otherwise disclosed elsewhere in this Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As previously announced, Mr. Appio will also replace Mr. Papa as CEO effective as of the IPO Closing Date. Mr. Papa will
continue to serve as Chairman of the Board if elected. In addition, certain other changes in management will occur effective as of the IPO Closing Date. See &#147;Executive Officers &#150; Certain Changes Upon Completion of the B+L IPO.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The twelve director nominees standing for election at the Meeting are therefore based on the members of the Board that we
expect to be in place at the time of the Meeting (assuming the IPO Closing Date has already occurred). However, there can be no assurance as to when the B+L IPO will be completed, if at all. If the B+L IPO is not completed prior to the Meeting, the
resignations of Mr. Paulson and Dr. von Eschenbach will not be effective, Dr. Mulligan and Mr. Appio will not be appointed to the Board, and we may amend this proxy statement to update the nominees standing for election at the Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Director Nominees </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have twelve director nominees standing for election at the Meeting. Under the Company&#146;s Articles, directors are elected
annually. Directors elected at the Meeting will hold office until the close of the 2023 Annual Meeting of Shareholders of the Company, their successors are duly elected or appointed, or such director&#146;s earlier resignation or removal. In an
uncontested election, any director nominee who receives a greater number of votes &#147;withheld&#148; from his or her election than votes &#147;for&#148; such election is required to tender his or her resignation promptly following the vote, which
resignation must state that it will become effective upon acceptance by the Board. The Nominating and Corporate Governance Committee of the Board shall then consider the offered resignation and make a recommendation to the Board as to whether it
should accept such resignation. The Nominating and Corporate Governance Committee is expected to accept such resignation, except in exceptional circumstances. Within 90 days of the applicable vote, the Board must decide whether to accept such
resignation, and promptly disclose its decision via press release. Full details of this policy are set forth in our Corporate Governance Guidelines, available on our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and
under the subtab &#147;Corporate Governance &#150; Governance Documents&#148;). Our website is not part of this Proxy Statement; references to our website address in this Proxy Statement are intended to be inactive textual references only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the twelve director nominees has established his or her eligibility
and willingness to serve on the Board. Set forth in the section titled &#147;Nominees for Election to the Board&#148; beginning on page 12 are the names of the director nominees together with details about their backgrounds and experience. Also
indicated is the number of the Company&#146;s securities beneficially owned, controlled or directed, directly or indirectly, by each of the director nominees as of April&nbsp;28, 2022, as well as the aggregate value based on the $19.74 per share
closing price of our Common Shares as reported on the NYSE on April&nbsp;28, 2022. For each director nominee, you will find a record of attendance at meetings of the Board and the committees of the Board on which such director nominee served during
2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has determined that ten of the twelve director nominees are independent within the meaning of all
applicable securities regulatory and stock exchange requirements in Canada and the United States. In addition, in accordance with the applicable stock exchange requirements and Board committee charters, the Board has determined that all members of
the Board&#146;s Audit and Risk Committee, Talent and Compensation Committee and Nominating and Corporate Governance Committee are independent directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Unless otherwise instructed, the designated proxyholders intend to vote FOR the election of the twelve director nominees
proposed by the Board in this Proxy Statement. If, for any reason, at the time of the Meeting any of these director nominees are unable or unwilling to serve, unless otherwise specified in the signed proxy card, it is intended that the designated
proxyholders will vote in their discretion for a substitute nominee or nominees. </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_8"></A>NOMINATION OF DIRECTORS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board is responsible for nominating director candidates for election to the Board, and for appointing directors
to the Board to fill any vacancies that may occur in between annual elections of directors. The Nominating and Corporate Governance Committee is responsible for identifying individuals qualified to become directors and recommending to the Board
director candidates for nomination either for election by shareholders or for appointment by the Board. In fulfilling this responsibility, the Nominating and Corporate Governance Committee considers, among other things, (i)the independence, skills,
qualifications and experience of director candidates in a manner consistent with the selection criteria approved by the Board from time to time; (ii)&nbsp;the composition, competencies and skills of the Board as a whole, and the needs of the
individual Board committees; (iii)&nbsp;the wide range of attributes, competencies, characteristics, experiences and backgrounds contemplated by the Company&#146;s Board Diversity Policy, as described below; and (iv)&nbsp;in evaluating incumbent
directors for <FONT STYLE="white-space:nowrap">re-nomination,</FONT> the performance of such directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company does
not have a director retirement policy or set term limits for independent directors, because the Board does not believe either is necessary to provide for adequate Board renewal. The Company believes that the director nomination process described
above has resulted in a reasonable level of Board renewal in recent years, and the Nominating and Corporate Governance Committee actively considers this issue in recommending to the Board director candidates for nomination for election by
shareholders. Our current Board is comprised of directors who have served on our Board, including, as applicable, the board of a predecessor of the Company, from less than one year to more than fourteen years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the recommendation of the Nominating and Corporate Governance Committee, the Board has adopted a formal written Board
Diversity Policy. The objective of the Board Diversity Policy is to require the Board and the Nominating and Corporate Governance Committee to consider of a wide range of attributes, competencies, characteristics, experiences and backgrounds,
including specifically considering the number of women and minorities on the Board, when reviewing the composition of the Board in the director nomination and <FONT STYLE="white-space:nowrap">re-nomination</FONT> process. The key provisions of the
Board Diversity Policy emphasize the Company&#146;s view on the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">benefits of diverse backgrounds and the need to consider diversity in
evaluating the needs of the Board. The Nominating and Corporate Governance Committee oversees and annually evaluates the implementation and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
effectiveness, both as measured annually and cumulatively, of the Board Diversity Policy in conjunction with its director evaluation and nomination process. The Nominating and Corporate
Governance Committee assesses the effectiveness of the Board Diversity Policy by reference to, among other things, the extent to which the current Board and the nominees for election to the Board reflect the stated objectives of the Board Diversity
Policy. The recently approved Board Diversity Policy provides for a target of 30% women and/or minority representation on the Board by the end of 2024. The Board Diversity Policy provides that any search firm engaged to assist in identifying
candidates for appointment to the Board will be directed to consider the desire of the Company to have its Board reflect diversity as contemplated by the policy, including the number of women directors. If all of our director nominees are elected by
shareholders at this Meeting, two directors, representing 17% of our directors, will be women. For a discussion of the Company&#146;s policy regarding the level of women in executive officer positions, see &#147;Statement of Corporate Governance
Practices &#151; Talent and Compensation Committee &#151; Succession Planning&#148; on page 38. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In considering an
individual&#146;s experience, the following additional criteria are also considered with respect to the composition of the Board as a whole: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Healthcare and Healthcare Industry Expertise:</I>&nbsp;&nbsp;&nbsp;&nbsp;The Board values directors with
experience in healthcare and the healthcare industry, including the pharmaceutical, consumer and life science industries, who can draw on their functional expertise and industry relationships to assist the Board and management in executing the
Company&#146;s strategy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>International Business Experience:</I>&nbsp;&nbsp;&nbsp;&nbsp;To complement
the Company&#146;s multinational and cross-border operations, the Board seeks to have directors with a global business perspective who can assist the Board and management in successfully navigating the business, political, legal and regulatory
environments in the countries in which the Company conducts, or seeks to conduct, its business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Financial Literacy:</I>&nbsp;&nbsp;&nbsp;&nbsp;The Board believes that it is important for its directors to
possess significant financial reporting, compliance and accounting expertise. Among other functions, the Board and the Audit and Risk Committee have oversight responsibility with respect to the quality and integrity of the Company&#146;s financial
statements, the internal and external audit functions, and internal control over financial reporting and disclosure controls and procedures. It is therefore important that its directors are financially knowledgeable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Corporate Governance Experience:</I>&nbsp;&nbsp;&nbsp;&nbsp;The Board is responsible for the stewardship of
the Company and supervising its management, business and affairs, in addition to being responsible for adopting and monitoring the Company&#146;s corporate governance guidelines and policies. In order to carry out these responsibilities, it is
important that the Board be comprised of individuals who understand corporate governance issues, the various constituencies interested in such issues, and have a proven track record of sound business judgment, integrity and high ethical standards.
Many of the Company&#146;s director nominees have experience serving on public company boards in multiple jurisdictions, including in the United States and Canada. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Executive Leadership:</I>&nbsp;&nbsp;&nbsp;&nbsp;The Board believes that it is important for its directors
to possess strong management experience at senior corporate levels. It is important that the Board be comprised of individuals who have held senior management positions with companies or business entities who have experience with mergers,
acquisitions and strategic business transactions and who have a strong background in implementing, managing and overseeing strategic planning and business development initiatives. A number of the Company&#146;s director nominees possess extensive
leadership experience and have held a number of senior management and leadership positions with global organizations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Submitting Director Recommendations to the Nominating and Corporate Governance Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee will also consider director recommendations submitted by the Company&#146;s
shareholders. Shareholders who wish to have the Nominating and Corporate Governance Committee consider their recommendations should submit their recommendation in writing to the Nominating and Corporate Governance Committee, attention: Chairperson,
Bausch Health Companies Inc., 2150 Saint Elz&eacute;ar Blvd. West, Laval, Qu&eacute;bec, H7L 4A8, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Director
recommendations made by shareholders in such manner will undergo the same evaluation by the Nominating and Corporate Governance Committee and the Board as all other director nominees. For more detailed information on this evaluation process, please
refer to the charter of the Nominating and Corporate Governance Committee, which is available on the Company&#146;s website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance &#150;
Corporate Governance Documents&#148;). For additional information regarding our director standards, please refer to our Corporate Governance Guidelines, which are available on the Company&#146;s website at <U>www.bauschhealth.com</U> (under the tab
&#147;Investors&#148; and under the subtab &#147;Corporate Governance &#151; Governance Documents&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order for a
director candidate nominated by a shareholder to be included as a nominee in the management proxy circular and proxy statement for an Annual Meeting of Shareholders, such shareholder&#146;s nomination must satisfy the criteria and procedures
prescribed under the <I>British Columbia Business Corporations Act </I>(&#147;BCBCA&#148;) and in the Company&#146;s Articles. For additional information regarding the deadlines and procedures for submitting such nominations for the 2023 Annual
Meeting of Shareholders, please see the discussion on page 105 under &#147;Shareholder Proposals and Director Nominations for the 2023 Annual Meeting of Shareholders.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_9"></A>NOMINEES FOR ELECTION TO THE BOARD </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the proposed director nominees will be an incumbent director (assuming that the B+L IPO has closed prior to the date
of the Meeting, at which time the appointment of Dr. Mulligan and Mr. Appio to fill the vacancies created by the resignations of Mr. Paulson and Dr. von Eschenbach will be effective). Prior to the IPO Closing Date, neither Dr. Mulligan nor Mr. Appio
was a member of the Board. See &#147;Proposal No. 1 Election of Directors &#150; Background &#150; Bausch + Lomb Separation.&#148; Dr. Mulligan was recommended by the Board in light of his extensive experience in the biotechnology and life sciences
industries and international reputation in academia, and Mr. Appio was recommended by the Board in light of his role as CEO following the completion of the B+L IPO. Each director nominee elected at the 2022 Annual Meeting will hold office until the
close of the 2023 Annual Meeting of Shareholders, his or her successor is duly elected or appointed, or such director&#146;s earlier resignation or removal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The results from the 2021 election of directors are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Withheld</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Broker&nbsp;Non-Votes</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard U. De Schutter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,369,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,768,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D. Robert Hale<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196,356,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,781,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brett Icahn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196,491,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,646,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Argeris (Jerry) N. Karabelas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,928,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,209,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sarah B. Kavanagh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">203,110,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,027,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Miller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,857,243</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,280,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,455,884</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,682,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John A. Paulson<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,191,567</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">946,528</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert N. Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,088,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,049,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Russel C. Robertson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">197,810,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,327,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas W. Ross, Sr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,746,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,391,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew C. von Eschenbach, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">205,016,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,121,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amy B. Wechsler, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,266,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,871,607</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,380,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Mr. Hale resigned from his role as an independent director of the Board, effective as of June 19, 2021. Mr.
Hale&#146;s decision to resign from the Board was not due to any dispute or disagreement with the Company or the Board on any matter relating to the Company&#146;s operations, policies or practices. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Mr. Paulson and Dr. Von Eschenbach have notified us of their intention to resign from the Board , and Mr.
Papa will be replaced by Mr. Appio as CEO, in each case effective upon the completion of the B+L IPO. See &#147;Proposal No. 1 Election of Directors &#150; Background &#150; Bausch + Lomb Separation.&#148; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following narratives provide details about each of the director nominees&#146; background and experience, and summarizes
the specific attributes, competencies and characteristics that led to the determination of the Nominating and Corporate Governance Committee and the Board to nominate such individual as a director for election by the shareholders at the Meeting. In
addition, the narrative lists the number of meetings of the Board and any applicable committee each director nominee attended during 2021 and any public company directorships, other than with the Company, held by the nominees during the past five
years. The narrative also sets out (i)&nbsp;the number of securities of the Company each director nominee beneficially owned, controlled or directed, directly or indirectly, as of April&nbsp;28, 2022; (ii) the aggregate value of such securities
based on the $19.74 per share closing price of our Common Shares on April&nbsp;28, 2022, as reported on the NYSE; and (iii)&nbsp;the progress of each director nominee toward the director share ownership requirement established by the Board. For
further detail regarding the share ownership requirement for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors, see the discussion in the section titled &#147;Statement of Corporate Governance Practices &#151; Directors&#146; Share
Ownership&#148; on page 30. For further detail regarding the share ownership requirement for Mr.&nbsp;Papa and Mr. Appio, see the discussion in the section titled &#147;Compensation Discussion and Analysis &#151; Other Compensation Governance
Practices &#151; Share Ownership Guidelines&#148; on page 63. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Appio </B>will serve as CEO and a director of the Company effective
upon the completion of the B+L IPO. He has served as the Company&#146;s President&nbsp;&amp; <FONT STYLE="white-space:nowrap">Co-Head</FONT> Bausch + Lomb/International since August 2018, and was previously Executive Vice President, Company Group
Chairman, International from August 2016 until July 2018. Prior to joining Bausch Health in 2013, Mr.&nbsp;Appio served in several positions with Bausch + Lomb, including as Vice President, North Asia/Japan and as Managing Director, Greater China
and Japan. Prior to joining Bausch + Lomb, Mr.&nbsp;Appio served 23 years with Schering-Plough in a wide range of leadership and operations responsibilities. Mr.&nbsp;Appio holds a Bachelor of Science in Accounting from Arizona State University,
W.P. Carey School of Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has determined that Mr.&nbsp;Appio&#146;s extensive management experience and demonstrated leadership with the Company is a valuable
contribution to the Board. </P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr.&nbsp;Thomas&nbsp;J. Appio </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New Jersey, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 60 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">204,083 Common Shares &#151; $4,028,598 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">271,454 RSUs (comprised of 271,454 unvested RSUs &#151;$5,358,502) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">876,005 Stock Options </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $4,028,598 based on the value of the Common Shares beneficially owned by
Mr.&nbsp;Appio (but excluding all options and unvested RSUs). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Appio is subject to share ownership guidelines
under the terms of his employment agreement with the Company, as further described in the section titled &#147;Compensation Discussion and Analysis &#150; Other Compensation Governance Practices &#150; Share Ownership Guidelines&#148; on page 63.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Not applicable.
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;De Schutter</B> has served on the Board since January 2017.
Mr.&nbsp;De Schutter is the owner of asset management firm L.B. Gemini, Inc., where he has served as President and director since 2000. He previously served as the Chairman and CEO of DuPont Pharmaceuticals Company from July 2000 until its
acquisition by Bristol-Myers Squibb in October 2001. Mr.&nbsp;De Schutter was also a director and Chief Administrative Officer of Pharmacia Corporation, which was created through the merger of Monsanto Company and Pharmacia&nbsp;&amp; Upjohn in
2000. Prior to this merger, Mr.&nbsp;De Schutter was a director, Vice Chairman and Chief Administrative Officer for Monsanto. From 1995 to 1999, he served as Chairman and CEO of G.D. Searle&nbsp;&amp; Co., Monsanto&#146;s wholly owned pharmaceutical
subsidiary. Mr.&nbsp;De Schutter earned a Bachelor of Science degree in 1963, and a Master of Science Degree in Chemical Engineering in 1965 from the University of Arizona. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;De Schutter has served as a director of AuVen Therapeutics, a private equity company focused on the healthcare industry, since 2007,
and as a director of Sermonix Pharmaceuticals Inc., a private biotechnology company, since April 2019. He previously served as Chairman of publicly traded pharmaceutical companies Incyte Corporation, from 2003 to 2015, and Durata Therapeutics, Inc.,
from 2012 to 2014. Mr.&nbsp;De Schutter also served as a director of Smith&nbsp;&amp; Nephew plc, a publicly traded medical device company, from 2001 to 2014, during which time he also served as the Lead Independent Director from 2011 to 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Mr.&nbsp;De Schutter&#146;s many years of experience in senior management and board positions of publicly traded companies, as well as his extensive insight and knowledge of the pharmaceutical industry and healthcare-related issues
qualify him to serve as a member of the Board and the committees on which he serves.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mr. Richard U. De Schutter </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Arizona, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Age 81 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">280,657 Common Shares &#151; $5,540,169 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">40,235 Restricted Share Units (&#147;RSUs&#148;) (comprised of 32,590 vested RSUs &#151; $643,327, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>: $6,183,496, representing
1,237% of the Company&#146;s current aggregate amount of $500,000 required under the share ownership guidelines for non-employee Directors and 6,183% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Talent and Compensation Committee &#151; 9/9 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Finance and Transactions Committee &#151; 4/4 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Special Transactions Committee &#151; 5/5 </P></TD></TR></TABLE>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Total Equity Value at Risk calculation for each director includes only Common Shares and vested RSUs
held by the relevant director. It does not include the value of any options (as applicable) or unvested RSUs. </P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Icahn </B>was appointed to the Board on March&nbsp;17, 2021 pursuant
to the Appointment and Nomination Agreement described under &#147;Certain Transactions&#148; beginning on page 87 (the &#147;Nomination Agreement&#148;). Since October 2020, he has been a portfolio manager for Icahn Capital LP, a subsidiary of Icahn
Enterprises L.P., a diversified holding company engaged in a variety of businesses, including investment, automotive, energy, food packaging, metals, real estate and home fashion. Mr.&nbsp;Icahn has held a variety of investment advisory roles at
Icahn Enterprises L.P. since 2002, including as an investment strategy consultant from 2017 to October 2020, and as portfolio manager of the Sargon Portfolio from 2010 to 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Icahn has served on the board of Icahn Enterprises L.P., a private entity since October 2020. He has also been a director of Newell
Brands Inc., a publicly traded global marketer of consumer and commercial products, since March 2018 and Dana Inc., a supplier of automotive products and services, since January 2022. Mr. Icahn was previously a director of Nuance Communications,
Inc., a provider of voice and language solutions, from October 2013 to March 2016. Mr.&nbsp;Icahn also previously served on the boards of American Railcar Industries, Inc., <FONT STYLE="white-space:nowrap">Take-Two</FONT> Interactive Software Inc.,
The Hain Celestial Group, Inc. and Voltari Corporation. Mr.&nbsp;Carl&nbsp;C. Icahn, the founder and controlling shareholder of Icahn Enterprises L.P., has or previously <FONT STYLE="white-space:nowrap">had&nbsp;non-controlling&nbsp;interests</FONT>
in Nuance Communications, Inc., Hain Celestial Group, Inc. <FONT STYLE="white-space:nowrap">and&nbsp;Take-Two&nbsp;Interactive</FONT> Software Inc. Mr.&nbsp;Icahn received a B.A. from Princeton University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Mr.&nbsp;Icahn&#146;s experience at the Icahn entities, and his service as a director of multiple public company boards, and his tenure as a Portfolio Manager provide him with expertise in investing and capital allocation, which
qualifies him to serve as a member of the Board and the committees on which he serves.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Brett Icahn </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Florida, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 42 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">744 Common Shares &#151; $14,687 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">12,363 Restricted Share Units (&#147;RSUs&#148;) (comprised of 4,718 vested RSUs &#151; $93,133, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $107,820 representing 22% of both the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 108% of the annual Board retainer. Mr.&nbsp;Icahn has until March&nbsp;17, 2026 to achieve the expected minimum equity
ownership under such share ownership guidelines. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting
Attendance:<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 6/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Finance and Transactions Committee &#151; 3/4 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Special Transactions Committee &#151; 5/5 </P></TD></TR></TABLE>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr. Icahn was appointed to the Board on March&nbsp;17, 2021 and his Board and committee meeting attendance
is based on meetings held after that date. </P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Dr.</B><B></B><B>&nbsp;Karabelas </B>has served on the Board since June 2016. Since January
2021, he has been a Venture Partner at Apple Tree Partners, a life sciences venture firm. From December 2001 until December 2020, he was a Partner at Care Capital, LLC, a life sciences venture firm. Dr.&nbsp;Karabelas was previously the founder and
Chairman at Novartis BioVenture Fund, and served as Head of Healthcare and CEO of Worldwide Pharmaceuticals for Novartis Pharma AG. Prior to joining Novartis, Dr.&nbsp;Karabelas was Executive Vice President of SmithKline Beecham, where he was
responsible for U.S. and European operations, regulatory and strategic marketing. Dr.&nbsp;Karabelas received a B.S. from the University of New Hampshire and a Ph.D. from the Massachusetts College of Pharmacy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dr.&nbsp;Karabelas has been a director of REGENXBIO Inc., a publicly held clinical-stage biotechnology company, since May 2015, and since July
2020 has also served as Lead Independent Director. He has also served on the board of Braeburn Pharmaceuticals, Inc., a privately held specialty pharmaceuticals company, since September 2015. Dr.&nbsp;Karabelas previously served as Chairman of the
board of Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company (which merged with Rocket Pharmaceuticals, Inc. in 2017), from July 2012 until June 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Dr.&nbsp;Karabelas&#146;s many years of experience in senior management positions, his strong knowledge of strategic and regulatory issues, his insight into international operations and his international perspective on the
pharmaceutical industry and healthcare related issues qualify him to serve as a member of the Board and the committees on which he serves.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dr.&nbsp;Argeris (Jerry) N. Karabelas </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New Hampshire, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 69 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,000 Common Shares &#151; $78,960 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">85,328 Restricted Share Units (&#147;RSUs&#148;) (comprised of 77,683 vested RSUs &#151; $1,533,462, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $1,612,422, representing 322% of the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 1,612% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Talent and Compensation Committee &#151; 9/9 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Science and Technology Committee &#151; 5/5 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Special Transactions Committee &#151; 5/5
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Ms.</B><B></B><B>&nbsp;Kavanagh </B>has served on the Board since July 2016. She is currently
a corporate director. From 2011 through May 2016, Ms.&nbsp;Kavanagh served as a Commissioner of the Ontario Securities Commission, where she also served as chairperson of the audit committee starting in 2014. Between 1999 and 2010, Ms.&nbsp;Kavanagh
served in various senior investment banking roles at Scotia Capital Inc., including Vice-Chair and <FONT STYLE="white-space:nowrap">Co-Head</FONT> of Diversified Industries Group, Head of Equity Capital Markets, and Head of Investment Banking. Prior
to Scotia Capital, she held several senior financial positions with operating companies. She started her career as an investment banker with a bulge bracket firm in New York. Ms.&nbsp;Kavanagh graduated from Harvard Business School with a Master of
Business Administration and received a Bachelor of Arts degree in Economics from Williams College. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since 2013, Ms.&nbsp;Kavanagh has been
a director of Hudbay Minerals Inc., a publicly traded Canadian mining corporation, and a member of the board of trustees of WPT Industrial REIT, a publicly traded open-ended real estate investment trust. In addition to her public company
directorships, she is a director of AST and Cymax Technology Group and also serves as a director of Sustainable Development Technology Canada. She completed the Directors Education Program at the Institute of Corporate Directors in 2011. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Ms.&nbsp;Kavanagh&#146;s extensive experience of complex financial and capital market issues at various banking institutions, and her <FONT STYLE="white-space:nowrap">in-depth</FONT> knowledge of financial and operational matters
qualify her to serve as a member of the Board and the committees on which she serves.<B> </B>
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sarah B. Kavanagh </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ontario, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 65 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">0 Common Shares &#151; $0 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">83,060 Restricted Share Units (&#147;RSUs&#148;) (comprised of 75,415 vested RSUs &#151; $1,488,692, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $1,488,692, representing 298% of the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 1,489% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Audit and Risk Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominating and Corporate Governance Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Finance and Transactions Committee &#151; 4/4 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Special Transactions Committee &#151; 5/5
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Miller </B>was appointed to the Board on March&nbsp;17, 2021 pursuant
to the Nomination Agreement described under &#147;Certain Transactions&#148; beginning on page&nbsp;87. Since October 2020, Mr.&nbsp;Miller has been a portfolio manager for Icahn Capital LP, a subsidiary of Icahn Enterprises L.P., a diversified
holding company engaged in a variety of businesses. Prior to joining Icahn Capital L.P., Mr.&nbsp;Miller was an analyst in the Distressed and Special Situations investment group in the New York office of BlueMountain Capital Management, LLC from
2013 to 2019. Mr.&nbsp;Miller represented BlueMountain on the Ad Hoc Group of Puerto Rico Electric Power Authority Bondholders from 2014 to 2019, and from 2011 to 2013 he was an analyst in the Distressed Products Group in the New York office of
Goldman, Sachs&nbsp;&amp; Co. Mr.&nbsp;Miller received a B.S. summa cum laude from Duke University in 2011. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Miller has been a
director of Conduent Incorporated, a publicly traded business process services company, since February 2021, and a director of Xerox Holdings Corporation, an office equipment company, since May 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Mr.&nbsp;Miller&#146;s experience as a portfolio manager and securities analyst has provided him with experience in investing and finance and complex debt matters, respectively, which qualifies him to serve as a member of the Board
and the committees on which he serves. </P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Steven D. Miller </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Florida, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 33 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">50,844 Common Shares &#151; $1,003,661 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">12,385 Restricted Share Units (&#147;RSUs&#148;) (comprised of 4,740 vested RSUs &#151; $93,568, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $1,097,229 representing 219% of both the Company&#146;s current aggregate amount
of $500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 1,097% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance:<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 6/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Finance and Transactions Committee &#151; 4/4 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Special Transactions Committee &#151; 5/5 </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr. Miller was appointed to the Board on March&nbsp;17, 2021 and his Board and committee meeting attendance
is based on meetings held after that date. </P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Dr.</B><B></B><B>&nbsp;Mulligan </B>will serve as a director of the Company and the
Chairperson of the Science and Technology Committee, effective upon the completion of the B+L IPO. Dr.&nbsp;Mulligan is currently the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, after serving as the Mallinckrodt
Professor of Genetics and Director of the Harvard Gene Therapy Initiative from 1996 to 2013. Dr. Mulligan also currently serves as Executive Vice Chairman of the Board of Sana Biotechnology, Inc. a public biotechnology company, and a director of
Biogen Inc., a public biotechnology company. Prior to Harvard, Dr. Mulligan was a professor of Molecular Biology at the Massachusetts Institute of Technology, a member of the Whitehead Institute for Biomedical Research and chief scientific officer
of Somatix Therapy Corporation, a drug discovery and development company that he founded. Dr.&nbsp;Mulligan was a founding partner of Sarissa Capital Management LP from 2013 to 2016 and from March 2017 to October 2018 served as Portfolio Manager at
Icahn Capital LP. He was named a MacArthur Foundation Fellow in 1981. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has determined that Dr.&nbsp;Mulligan&#146;s extensive experience in the biotechnology and life sciences industries and international
reputation in academia qualifies him to serve as a member of the Board and the committees on which he serves.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Richard C. Mulligan </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New Jersey, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 67 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">0 Common Shares &#151; $0 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">0 RSUs &#151; $0 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $0 representing 0% of the Company&#146;s current aggregate amount of $500,000
required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 0% of the annual Board retainer. Dr.&nbsp;Mulligan has until the fifth anniversary of his appointment to the Board to achieve the
expected minimum equity ownership under such share ownership guidelines. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Not applicable
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Papa</B> has been Chairman of the Board and Chief Executive Officer of
the Company since May 2016. Mr. Papa will step down as Chief Executive Officer of the Company effective upon the completion of the B+L IPO, and will continue as Chairman of the Board. Mr.&nbsp;Papa has more than 35 years of experience in the
pharmaceutical, healthcare and specialty pharmaceutical industries, including 20 years of branded prescription drug experience. He served as the CEO of Perrigo Company plc (&#147;Perrigo&#148;) from 2006 to April 2016, where he also served as
Chairman from 2007 to April 2016. Prior to joining Perrigo, Mr.&nbsp;Papa served from 2004 to 2006 as Chairman and CEO of the Pharmaceutical and Technologies Services segment of Cardinal Health, Inc. From 2001 to 2004, he served as President and
Chief Operating Officer of Watson Pharmaceuticals, Inc. (&#147;Watson&#148;). Prior to joining Watson, Mr.&nbsp;Papa held management positions at DuPont Pharmaceuticals, Pharmacia/Searle and Novartis AG. Mr.&nbsp;Papa holds a BS in pharmacy from the
University of Connecticut and an MBA from Northwestern University&#146;s Kellogg Graduate School of Management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Papa joined the
board of directors of Prometheus Biosciences, Inc., a privately held biopharmaceutical company, in August 2020, and previously served as a director of Smith&nbsp;&amp; Nephew plc, a publicly traded medical device company, from 2008 to April 2018.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board
has determined that Mr.&nbsp;Papa&#146;s extensive experience as a chief executive officer of a public company, where he demonstrated leadership capability and extensive knowledge of complex financial and operational issues facing large
organizations, and his understanding of operations and financial strategy in challenging environments, qualify him to serve as a member of the Board. Additionally, Mr.&nbsp;Papa&#146;s knowledge of the pharmaceutical industry and business, combined
with his drive for innovation and excellence, position him well to serve as the Chairman of the Board.<B> </B>
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Joseph C. Papa </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New Jersey, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 66 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,011,622 Common Shares &#151; $19,969,418 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">83,530 RSUs (comprised of 83,530 unvested RSUs &#151;$1,648,882) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,794,471 Stock Options </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $19,969,418, based on the value of the Common Shares beneficially owned by
Mr.&nbsp;Papa (but excluding all options and unvested RSUs). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Papa is subject to share ownership guidelines
under the terms of his employment agreement with the Company, as further described in the section titled &#147;Compensation Discussion and Analysis &#150; Other Compensation Governance Practices &#150; Share Ownership Guidelines&#148; on
page&nbsp;63. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Power </B>has served on the Board since August 2008. He is currently a
corporate director. From 2009 to 2011, Mr.&nbsp;Power was a faculty member at The Wharton School of Business, University of Pennsylvania, where he taught multinational marketing. Mr.&nbsp;Power has over 25 years&#146; experience working in the
pharmaceutical and biotechnology industry, which he gained serving in a number of leadership positions with Wyeth from 1985 through 2007, including Director &#151; New Product Development, Managing Director &#151; U.K./Ireland, Vice President &#151;
Global Marketing, President &#151; Europe, Middle East, Africa, President &#151; International and Executive Vice President &#151; Global Business Operations. Mr.&nbsp;Power also has completed the Director Professionalism course offered by the
National Association of Corporate Directors. Mr.&nbsp;Power has a B.S. in statistics from the State University of New York and an M.S. in biostatistics from the Medical College of Virginia- Virginia Commonwealth University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Mr.&nbsp;Power&#146;s extensive experience in the pharmaceutical industry and international business is a valuable contribution to the Board. In addition, his experience in general management, strategic planning, working with
Research and Development organizations, business development, product marketing, merging and streamlining of organizations and his demonstrated leadership in a multi-billion-dollar business qualify Mr.&nbsp;Power as a member of the Board and the
committees on which he serves. </P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Robert N. Power </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pennsylvania, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 65 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,601 Common Shares &#151; $130,304 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">94,823 Restricted Share Units (&#147;RSUs&#148;) (comprised of 87,178 vested RSUs &#151; $1,720,894, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $1,851,198, representing 370% of the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 1,851% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Audit and Risk Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominating and Corporate Governance Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Science and Technology Committee &#151; 5/5
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Robertson </B>has served on the Board since June 2016. He is currently
a corporate director. From 2013 through August 2016, Mr.&nbsp;Robertson served as Executive Vice President and Head, Anti-Money Laundering, at BMO Financial Group (&#147;BMO&#148;), a diversified financial services organization. Prior to that role,
he served as Executive Vice President, Business Integration, at BMO Financial Group, and as Vice Chair at BMO Financial Corp. from 2011. He joined BMO as interim Chief Financial Officer, BMO Financial Group in 2008 and was appointed Chief Financial
Officer, BMO Financial Group in 2009. Before joining BMO, Mr.&nbsp;Robertson spent over 35 years as a Chartered Public Accountant. In this capacity, he held various senior positions with a number of major accounting firms, including Vice Chair,
Deloitte&nbsp;&amp; Touche LLP in Toronto, Canada, from 2002 to 2008, and Canadian Managing Partner, Arthur Andersen LLP, from 1994 to 2002. Mr.&nbsp;Robertson holds a Bachelor of Arts degree (Honours) from the Ivey School of Business at the
University of Western Ontario. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Robertson has served on the board of Hydro One Limited, a publicly traded electricity
transmission and distribution utility serving the Canadian province of Ontario, since August 2018, and since 2012 has served on the board of Turquoise Hill Resources, a publicly traded Canadian mineral exploration and development company.
Mr.&nbsp;Robertson previously served on the board of Virtus Investment Partners, Inc., a multi-manager asset management business, from 2013 to August 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Mr.&nbsp;Robertson&#146;s extensive experience of complex financial matters at Deloitte&nbsp;&amp; Touche LLP and Arthur Andersen LLP, <FONT STYLE="white-space:nowrap">in-depth</FONT> knowledge of financial and accounting matters and
leadership capabilities in senior finance positions qualify him to serve as a member of the Board and as Chairman of the Audit and Risk Committee.<B> </B>
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Russel C. Robertson </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ontario, Canada </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 74 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">0 Common Shares &#151; $0 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">128,253 Restricted Share Units (&#147;RSUs&#148;) (comprised of 120,608 vested RSUs &#151; $2,380,802, and
7,645 unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $2,380,802, representing 476% of the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 2,381% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Audit and Risk Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominating and Corporate Governance Committee &#151; 10/10
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Mr.</B><B></B><B>&nbsp;Ross</B> has served on the Board since March 2016 and was appointed
our Lead Independent Director in June 2016. He served as president of the Volcker Alliance from July 2016 until December 2021. He continues to serve as a Senior Advisor to the Volcker Alliance as well as a director on the Alliance board. He is
President Emeritus of the University of North Carolina (&#147;UNC&#148;), having served as President from 2011 to January 2016. Mr.&nbsp;Ross was named the Sanford Distinguished Fellow in Public Policy at the Duke University Sanford School of Public
Policy in 2016. Prior to becoming President of the UNC system, Mr.&nbsp;Ross served as President of Davidson College, Executive Director of the Z. Smith Reynolds Foundation, director of the North Carolina Administrative Office of the Courts, a
Superior Court judge, chief of staff to U.S. Congressman Robin Britt, a member of the Greensboro, NC law firm Smith, Patterson, Follin, Curtis, James&nbsp;&amp; Harkavy, and Assistant Professor of Public Law and Government at UNC Chapel Hill&#146;s
School of Government. Mr.&nbsp;Ross holds a B.A. in Political Science from Davidson College and a J.D. from University of North Carolina School of Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Mr.&nbsp;Ross&#146;s demonstrated leadership in senior management positions, extensive experience with corporate governance responsibilities and complex knowledge of legal, compliance and operational issues qualify him to serve as a
member of the Board and the committees on which he serves.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thomas W. Ross, Sr. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">North Carolina, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 71 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">11,500 Common Shares &#151; $227,010 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">86,424 Restricted Share Units (&#147;RSUs&#148;) (comprised of 78,779 vested RSUs &#151; $1,555,097, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $1,782,107, representing 356% of the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 1,782% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 8/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Audit and Risk Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominating and Corporate Governance Committee &#151; 10/10 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Special Transactions Committee &#151; 5/5
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Dr.</B><B></B><B>&nbsp;Wechsler </B>has served on the Board since June 2016. She has been a
practicing dermatologist in New York City since 2005. Dr.&nbsp;Wechsler is the author of The Mind-Beauty Connection, published by Simon&nbsp;&amp; Schuster in 2008. She is board certified in both dermatology and psychiatry and is also an Adjunct
Clinical Professor in Psychiatry at the Weill Cornell Medical College. As an expert on skin health, Dr.&nbsp;Wechsler serves as an advisor for Chanel Skin Care and is also a certified trainer and well-known KOL Speaker, qualified to teach physicians
and other medical professionals in the use of various dermatological products. Dr.&nbsp;Wechsler is an active member of several medical professional organizations, including the American Academy of Dermatology, the American Psychiatric Association,
the American Academy of Child and Adolescent Psychiatry, the Independent Doctors of New York, The Physicians Scientific Society, and The Skin Cancer Foundation. Dr.&nbsp;Wechsler completed her residency in psychiatry and a fellowship in child and
adolescent psychiatry at New York Presbyterian Hospital&#146;s Payne Whitney Clinic, and completed a residency in dermatology at SUNY Downstate Medical Center. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Qualifications: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has
determined that Dr.&nbsp;Wechsler&#146;s many years of experience as a board-certified dermatologist and psychiatrist, her strong knowledge of medical products to assist patients with their medical needs and her insight into the medical field and
pharmaceutical industry and healthcare related issues qualify her to serve as a member of the Board and on the committees on which she serves.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amy B. Wechsler, M.D. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, USA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Age 52 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock Ownership: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">0 Common Shares &#151; $0 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">99,354 Restricted Share Units (&#147;RSUs&#148;) (comprised of 91,709 vested RSUs &#151; $1,810,336, and 7,645
unvested RSUs &#151; $150,912) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Total Equity Value at Risk: $1,810,336, representing 362% of the Company&#146;s current aggregate amount of
$500,000 required under the share ownership guidelines for <FONT STYLE="white-space:nowrap">non-employee</FONT> Directors and 1,810% of the annual Board retainer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2021 Meeting Attendance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Board &#151; 6/8 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Talent and Compensation Committee &#151; 7/9 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6">&nbsp;</TD>
<TD WIDTH="20" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Science and Technology Committee &#151; 5/5
</P></TD></TR></TABLE></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Messrs. Icahn and Miller were appointed to the Board on March&nbsp;17, 2021
pursuant to the Nomination Agreement described under &#147;Certain Transactions&#148; beginning on page 87. No other directors or director nominees of the Company were selected for nomination at the Meeting pursuant to any arrangement or
understanding. None of the directors or director nominees are related by blood, marriage or adoption to one another or to any executive officer of the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_10"></A>STATEMENT OF CORPORATE GOVERNANCE PRACTICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board is committed to sound and effective corporate governance practices with the goal of ensuring the Company&#146;s
financial strength and overall business success. Our governance practices are periodically assessed against those practices suggested by recognized governance authorities and are designed to maintain alignment with shareholder interests and key
governance best practices. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board believes that, in order to be effective, our Board must be able to operate independently of management. As described
in our Corporate Governance Guidelines, available on our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance &#151; Corporate Governance Documents&#148;), a sufficient number of
directors must satisfy the applicable tests of independence, such that the Board complies with all independence requirements under corporate and securities laws and stock exchange requirements applicable to the Company. The Corporate Governance
Guidelines further provide that the Nominating and Corporate Governance Committee, as well as the Board, reviews the relationships that each director has with the Company in order to satisfy itself that these independence criteria have been met. On
an annual basis, as part of our disclosure procedures, all directors complete a questionnaire pertaining to, among other things, share ownership, family and business relationships, and director independence standards. The Board must then disclose in
the Company&#146;s annual management proxy circular and proxy statement the identity of each of the independent directors and the basis for the Board&#146;s determination for each of the directors who are not independent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board is currently comprised of twelve members. The Board has determined that eleven of our twelve current directors (or
92%) are &#147;independent directors&#148; within the meaning of applicable regulatory and stock exchange requirements in Canada and the United States, as none of them have a material relationship with the Company that could be reasonably expected
to interfere with their exercise of independent judgment. The eleven independent directors currently on the board are: Mr. Ross (Lead Independent Director), Mr. De Schutter, Mr. Icahn, Dr. Karabelas, Ms. Kavanagh, Mr. Miller, Mr. Paulson, Mr. Power,
Mr. Robertson, Dr.&nbsp;von Eschenbach, and Dr. Wechsler. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">None of our current directors (all of whom are director
nominees, except for Mr. Paulson and Dr. von Eschenbach) have entered into employment, service or similar contracts with us, with the exception of Mr.&nbsp;Papa and Mr. Appio. On April&nbsp;25, 2016, Mr.&nbsp;Papa entered into an employment
agreement with the Company as its Chairman of the Board and Chief Executive Officer (&#147;CEO&#148;). In addition, Mr. Appio, a director nominee who has been appointed to fill one of the vacancies created by the departures of Mr. Paulson and Dr.
Von Eschenbach effective upon the IPO Closing Date, has entered into an employment agreement with the Company to serve as CEO effective as of the IPO Closing Date (at which time Mr. Papa will step down as CEO). For this reason, the Board has
determined that neither Mr. Papa nor Mr. Appio is an independent director and will not be eligible to serve on the Audit and Risk Committee, the Talent and Compensation Committee, or the Nominating and Corporate Governance Committee. The Board has
also determined that Dr. Mulligan, a director nominee who will be appointed to the Board upon the IPO Closing Date, is independent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership
Structure </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Corporate Governance Guidelines provide that our Board may determine from time to time the most
effective leadership structure for the Company, including whether the same individual should serve both as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Chairman of the Board and the CEO. Mr.&nbsp;Papa, our CEO, also serves as Chairman of the Board. Due to the <FONT STYLE="white-space:nowrap">in-depth</FONT> knowledge of the Company&#146;s
operations gained by serving as CEO, Mr.&nbsp;Papa is well positioned to identify and lead Board deliberations regarding important matters relating to the Company&#146;s operations, strategic priorities, and overall development. The Board believes
that serving as both CEO and Chairman of the Board enables Mr.&nbsp;Papa to facilitate effective communication between Company management and the Board and to ensure key issues and recommendations are brought to the attention of the Board. The Board
believes that this leadership structure, in conjunction with the appointment of a Lead Independent Director, is the most effective for the Company at this time, and that the existing corporate governance practices effectively achieve independent
oversight and management accountability. Effective on the IPO Closing Date, Mr. Papa will continue as Chairman of the Board and Mr. Appio will act as CEO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Corporate Governance Guidelines also provide that, if the same individual serves as Chairman of the Board and CEO, or if
the Chairman of the Board is otherwise not independent, our Board shall appoint a Lead Independent Director. Our independent directors annually appoint a Lead Independent Director. Mr.&nbsp;Ross has been appointed to serve as Lead Independent
Director each year since June 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The responsibilities of the Lead Independent Director are set forth in the
Company&#146;s Position Description for the Lead Independent Director, which is posted on the Company&#146;s website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance &#151; Corporate
Governance Documents&#148;). These responsibilities include: (i)&nbsp;fostering processes that allow the Board to function independently of management and encouraging open and effective communication between the Board and management of the Company;
(ii)&nbsp;providing input to the Chairman on behalf of the independent directors with respect to Board agendas; (iii)&nbsp;presiding at all meetings of the Board at which the Chairman is not present, as well as regularly scheduled executive sessions
of independent directors; (iv)&nbsp;in the case of a conflict of interest involving a director, if appropriate, asking the conflicted director to leave the room during discussion concerning such matter and, if appropriate, asking such director to
recuse him or herself from voting on the relevant matter; (v)&nbsp;communicating with the Chairman and the CEO, as appropriate, regarding meetings of the independent directors and resources and information necessary for the Board to effectively
carry out its duties and responsibilities; (vi)&nbsp;serving as liaison between the Chairman and the independent directors; (vii)&nbsp;being available to directors who have concerns that cannot be addressed through the Chairman; (viii)&nbsp;calling
meetings of the independent directors, as needed or when appropriate; and (ix)&nbsp;performing other functions as may reasonably be requested by the Board or the Chairman. In the event the Company appoints an independent Chairman of the Board, the
responsibilities of the Lead Independent Director will be assumed by the independent Chairman of the Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meetings of Independent Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Corporate Governance Guidelines provide that the independent directors of the Board may meet in executive session at any
meeting of the Board, and that an opportunity shall be provided during the meeting for any member of the Board to make such a request. The independent directors generally meet in executive sessions without management present during their regularly
scheduled board and committee meetings, and on an <FONT STYLE="white-space:nowrap">as-needed</FONT> basis during ad hoc meetings. Mr.&nbsp;Ross, our Lead Independent Director, presides over executive sessions of the Board, and the committee chairs,
all of whom are independent, preside over executive sessions of the Committees. During 2021, our independent directors held executive sessions at each of the four regularly scheduled Board meetings and at one ad hoc meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meetings of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board meets regularly, at least four times per year, including at least once annually to review our strategic plan.
Additional meetings can be called when necessary. From January&nbsp;1, 2021 to December&nbsp;31, 2021, the Board had four regularly scheduled meetings and seven ad hoc meetings to review specific matters. All agendas for Board and Board committee
meetings are set by the Chairman of the Board in consultation with the Board committee Chairpersons, as necessary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As required by the Company&#146;s Articles, at least 50% of the directors
then in office must be present in order to transact business at any Board meeting. All incumbent directors attended at least 75% of the total Board and Committee meetings on which he or she served in 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During 2021, the Board had five standing committees: the Audit and Risk Committee, the Talent and Compensation Committee, the
Nominating and Corporate Governance Committee, the Finance and Transactions Committee, and the Science and Technology Committee. In addition, on June&nbsp;3, 2020, the Board established an ad hoc Special Transactions Committee to assist with
evaluating strategic alternatives, including the proposed separation of the Company&#146;s eye health business into an independent, publicly traded entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Directors are expected to attend and participate in substantially all meetings of the Board and of all committees on which
they serve. The Board and Board committee attendance records for all directors who served on the Board during 2021 are set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Board<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Audit<BR>and&nbsp;Risk<BR>Committee<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Talent&nbsp;and<BR>Compensation<BR>Committee<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nominating<BR>and<BR>Corporate<BR>Governance<BR>Committee<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Finance&nbsp;and<BR>Transactions<BR>Committee<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Science&nbsp;and<BR>Technology<BR>Committee<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Special<BR>Transactions<BR>Committee<BR>Meetings</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Overall</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Director</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Richard U. De Schutter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">D. Robert Hale<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Brett Icahn<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Dr.&nbsp;Argeris (Jerry) N.&nbsp;Karabelas</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Sarah B. Kavanagh</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Steven D. Miller<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Joseph C. Papa</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">John A. Paulson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Robert N. Power</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Russel C. Robertson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Thomas W. Ross, Sr.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Andrew C. von Eschenbach</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Amy B. Wechsler, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr. Hale resigned from his role as an independent director of the Board, effective as of June 19, 2021.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr. Icahn and Mr. Miller were appointed to the Board on March 17, 2021. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although we do not have a formal policy requiring our directors to attend our Annual Meetings of Shareholders, we expect all
directors to attend the Meeting absent exceptional circumstances. The 2021 Annual Meeting of Shareholders was attended by all directors who were serving on the Board at that time and we anticipate that our directors will attend this year&#146;s
virtual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Charter of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board is responsible for the overall stewardship of the Company and its business, including supervising the management of
the Company&#146;s business and affairs. The Board discharges this responsibility directly and through delegation of specific responsibilities to committees of the Board and to our officers. Under the charter of the Board (the &#147;Board
Charter&#148;), the Board has established committees to assist with its responsibilities. Our current standing Board committees are: the Audit and Risk Committee, the Talent and Compensation Committee, the Nominating and Corporate Governance
Committee, the Finance and Transactions Committee, and the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Science and Technology Committee. The Board has also established an ad hoc
Special Transactions Committee to assist with evaluating strategic alternatives, including the proposed separation of the Company&#146;s eye health business into an independent, publicly traded entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Board Charter, the Board is responsible for, among other things,
the following corporate governance-related matters: (i)&nbsp;overseeing the Company&#146;s performance and the quality, depth and continuity of management needed to meet the Company&#146;s strategic objectives; (ii)&nbsp;developing and approving the
Company&#146;s approach to and practices regarding corporate governance; (iii)&nbsp;succession planning; (iv)&nbsp;overseeing orientation and education programs for new directors and ongoing education opportunities for continuing directors;
(v)&nbsp;reviewing, discussing and approving the Company&#146;s strategic planning and organizational structure and supervising management to oversee that the strategic planning and organizational structure preserve and enhance the business of the
Company and the Company&#146;s underlying value; (vi)&nbsp;approving and assessing compliance with all significant policies and procedures by which the Company is operating, including the Bausch Health Code of Conduct (as described below); (vii)
reviewing the Company&#146;s principal risks and assessing whether appropriate systems are in place to manage such risks; and (viii)&nbsp;ensuring the integrity and adequacy of the Company&#146;s internal controls. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board Charter is attached to this Proxy Statement as Exhibit A and is available on our website at
<U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance &#150; Corporate Governance Documents&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Position Descriptions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board has developed written position descriptions for the Chairman of the Board, the CEO, the Lead Independent Director,
and the Chairpersons of each of the Audit and Risk Committee, the Nominating and Corporate Governance Committee, the Talent and Compensation Committee, the Finance and Transactions Committee, and the Science and Technology Committee. The position
descriptions are reviewed annually and are posted on our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance &#151; Corporate Governance Documents&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Orientation and Continuing Education </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee oversees the Board&#146;s continuing education program, which was developed
to assist directors in maintaining or enhancing their skills and abilities as directors and updating their knowledge and understanding of the Company and the pharmaceutical industry. New directors are oriented to the roles of the Board and
individual directors and the business and affairs of the Company through discussions with the incumbent directors and the Company&#146;s management by periodic presentations from senior management on major business, industry and competitive issues.
Management and outside advisors provide information and education sessions to the Board and its committees as necessary to keep the directors <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">up-to-date</FONT></FONT> with, among
other things, (i)&nbsp;disclosure and corporate governance requirements and best practices; (ii)&nbsp;the Company, its business and the environment in which it operates; and (iii)&nbsp;developments in the responsibilities of directors. The Board may
invite representatives of various business units to Board meetings to discuss business strategy and market analysis, as well as make <FONT STYLE="white-space:nowrap">on-site</FONT> visits of the operations of the Company at the various facilities of
the Company. Directors may also attend outside conferences and seminars that are relevant to their roles at the Company&#146;s expense, with the approval of the Chairman of the Board. In 2021, our directors participated in outside seminars and
conferences on educational topics that included financial reporting and audit matters, human capital management, environmental, social and governance (&#147;ESG&#148;), board committee effectiveness, executive compensation and cybersecurity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ethical Business Conduct </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Bausch
Health Code of Conduct </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have a written code of business conduct and ethics, (the &#147;Code of Conduct), that
applies to all employees (including our officers) and directors of the Company and its worldwide subsidiaries. Among other things, the Code of Conduct is designed to deter wrongdoing and promote honest and ethical conduct, including (i)&nbsp;the
ethical handling of actual or apparent conflicts of interest; (ii)&nbsp;full, fair, accurate, timely and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
understandable public disclosure; (iii)&nbsp;compliance with applicable laws and regulations; (iv)&nbsp;protection of the Company&#146;s assets; and (v)&nbsp;maintaining a harassment-free work
environment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our employees and directors are required to maintain an understanding of, and ensure their compliance with,
the Code of Conduct, which we review annually. Supervisors are responsible for maintaining awareness of the Code of Conduct, and for reporting any deviations from the Code of Conduct. The Code of Conduct also require the Company to conduct regular
audits to test compliance with the Code of Conduct. Subject to Board approval, responsibility for the establishment and periodic review and update of the Code of Conduct falls within the mandate of the Audit and Risk Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All individuals subject to the Code of Conduct are obligated to promptly report violations and potential violations of law,
the Code of Conduct, or policies of the Company referenced in the Code of Conduct. Such violations or suspected violations may be reported to the appropriate Company representative, or anonymously and confidentially through the Company&#146;s
business ethics hotline. All potential violations must in turn be reported to the Company&#146;s General Counsel or Chief Compliance&nbsp;&amp; Ethics Officer. The Board has established reporting procedures in order to encourage employees and
directors to raise concerns regarding matters addressed by the Code of Conduct on a confidential basis free from discrimination, retaliation or harassment. Employees of the Company who violate the Code of Conduct may face disciplinary actions,
including dismissal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Code of Ethics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also maintain a Code of Ethics for the CEO and Senior Finance Executives (the &#147;Code of Ethics&#148;), which is designed
to deter wrongdoing and promote (i)&nbsp;honest and ethical conduct in the practice of financial management; (ii)&nbsp;full, fair, accurate, timely and understandable disclosure; and (iii)&nbsp;compliance with all applicable laws and regulations.
Violations of the Code of Ethics are reported to the General Counsel or Chief Compliance&nbsp;&amp; Ethics Officer. Failure to observe the terms of the Code of Ethics may result in disciplinary action, including dismissal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The foregoing description of the Code of Conduct and the Code of Ethics is intended as a summary only, and does not purport to
be complete. It is subject to, and qualified in its entirety by, reference to all of the provisions of the Code of Conduct, a copy of which is available on our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the
subtab &#147;Corporate Governance &#150; Governance Documents&#148;). These documents are also available in print to shareholders upon request. Shareholders may submit their request to Investor Relations, Bausch Health Companies Inc., 2150 Saint
Elz&eacute;ar Blvd. West, Laval, Qu&eacute;bec H7L 4A8, Canada. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We intend to satisfy any disclosure requirements
regarding amendments to, or waivers of, any provision of the Code of Conduct or the Code of Ethics, by posting such information on the Company&#146;s website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab
&#147;Corporate Governance &#150; Governance Documents&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors&#146; Share Ownership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To support the alignment of directors&#146; interests with our interests and those of our shareholders, the Board has adopted
share ownership guidelines for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. The directors&#146; share ownership guidelines, which are set forth in our Corporate Governance Guidelines, provide that each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director is expected to hold or control Common Shares, vested restricted or deferred share units, or a combination thereof, valued at five (5)&nbsp;times the annual Board cash retainer not later than
the fifth anniversary of his or her first election or appointment to the Board. Based on the current annual cash retainer of the Board of $100,000, the minimum value of equity each of our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors are required to hold is $500,000. Messrs. Icahn and Miller, who were appointed to the Board on March&nbsp;17, 2021, will have until March&nbsp;17, 2026 to meet the director share ownership requirements described in this paragraph. If Dr.
Mulligan is appointed to the Board prior to this Meeting, he will have until the fifth anniversary of the IPO Closing Date to meet the director share ownership </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
requirements described in this paragraph. All of our other <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as of April&nbsp;28, 2022 have satisfied the minimum equity ownership
requirement based on the $19.74 per share closing price of our Common Shares on April&nbsp;28, 2022, as reported on the NYSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Papa and Mr. Appio are excluded from the share ownership guidelines for
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors. They are subject to share ownership guidelines established by our Talent and Compensation Committee, as further discussed in the section titled &#147;Compensation Discussion and
Analysis &#150; Other Compensation Governance Practices &#150; Share Ownership Guidelines&#148; on page 63. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Board recognizes the importance of effective risk oversight in the achievement of organizational objectives, including
strategic objectives, improving long-term organizational performance and enhancing shareholder value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our management is
responsible for identifying, assessing and managing our exposure to various risks. The global Enterprise Risk Management (&#147;ERM&#148;) office, which reports to our Executive Vice President, General Counsel and Head of Commercial Operations, was
established to assist with this process. Our ERM office routinely meets with the Company&#146;s Executive Committee and members of senior leadership to (i)&nbsp;identify emerging risks across the Company&#146;s operations; (ii)&nbsp;review, assess
and prioritize identified risks; and (iii)&nbsp;develop risk mitigation plans, and each quarter provides the Audit and Risk Committee with updates on these activities. Risks identified through this process include those related to our R&amp;D
pipeline, strategic planning, debt and finance, human capital, IT and cybersecurity, business disruption, and legal and compliance. During 2020, the ERM office expanded this process to include risks across all risk categories arising from the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">While our executive officers and members of our senior leadership
team are responsible for our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> risk management, including identifying risks and implementing risk mitigation plans, our Board is responsible for promoting a
culture of risk management within the Company and overseeing the Company&#146;s principal risks and assessing whether appropriate systems are in place to manage such risks. The Board exercises its risk oversight responsibilities both directly as
well as through its standing committees. The Board committees regularly review and discuss risk topics that fall under the duties and responsibilities described in their committee charters, as summarized below, and report to the Board any
significant risks identified during their review. The Board discusses those risks, and also receives regular reports regarding material legal, IT and cybersecurity, commercial, finance and business development matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee, in addition to its oversight of the ERM office as described above, oversees risks relating to
(i)&nbsp;financial statements, reporting and internal controls; (ii)&nbsp;technology, information security and cybersecurity; (iii)&nbsp;compliance and ethics programs, including receipt and handling of business ethics reports received through the
reporting program; and (iv)&nbsp;legal and regulatory issues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee oversees risks
related to human capital and compensation, including (i)&nbsp;the Company&#146;s compensation policies and practices; (ii)&nbsp;the Company&#146;s incentive and equity compensation plans; (iii)&nbsp;workforce staffing; and (iv)&nbsp;executive and
senior leadership succession. For additional information regarding the Talent and Compensation Committee&#146;s oversight of risk relating to compensation policies and practices, see &#147;Talent and Compensation Committee &#151; Compensation Risk
Determination&#148; on page 64. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee provides oversight with respect to
risks related to the Company&#146;s corporate governance, including: (i)&nbsp;the composition, size, structure, and effectiveness of the Board and its committees; (ii)&nbsp;director succession; (iii)&nbsp;director independence; and (iv)&nbsp;the
Company&#146;s corporate governance policies and practices. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Finance and Transactions Committee oversees risks relating to the
Company&#146;s (i)&nbsp;debt; (ii)&nbsp;credit and liquidity; (iii)&nbsp;capital structure; and (iv)&nbsp;business development activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Science and Technology Committee oversees risks relating to (i)&nbsp;the Company&#146;s product pipeline;
(ii)&nbsp;R&amp;D initiatives; and (iii)&nbsp;regulatory matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ESG and Sustainability; Board Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our vision is to continue to be a trusted health care partner, and our mission is improving people&#146;s lives with our health
care products. Bausch Health&#146;s mission is supported by the following five guiding principles that are foundational to our success and future growth, and provide direction for the company: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">customer focus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">people; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">innovation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">quality health care outcomes; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">efficiency. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our mission and five guiding principles define how we approach ESG matters. Based on them, we have framed our ESG work around
five key ESG commitment areas: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">operate with integrity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">respect the environment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">advance global health and patient care; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">improve our communities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">support employee growth and well-being. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe that focusing on these commitment areas are integral to the success of the Company and the health of the
communities we operate in and serve. We publish a corporate social responsibility (&#147;CSR&#148;) report that highlights our corporate responsibility commitments. The CSR report provides an overview of our ESG practices and programs. Our 2021 CSR
report is available on our website at www.bauschhealth.com (under the tab &#147;Responsibility&#148; and under the subtab &#147;CSR Report&#148;). Neither the CSR report nor our website are incorporated by reference to this Proxy Statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Board Oversight of ESG Matters </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Board, the Audit and Risk Committee, the Nominating and Corporate Governance Committee, and the Talent and
Compensation Committee shares responsibility for oversight of various aspects of our ESG practices and programs. Our Talent and Compensation Committee oversees our human capital management programs, and the processes, policies and governance related
to our executive compensation practices. Our Audit and Risk Committee oversees our compliance and ethics program. Finally, our Nominating and Corporate Governance Committee oversees our Board governance practices, environmental and sustainability
programs, and corporate governance policies. In its oversight role, the Board receives periodic updates from each of these standing committees and from management, and a complete ESG status update is provided to the Nominating and Corporate
Governance Committee quarterly, including on the Company&#146;s environmental and sustainability efforts and programs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Key Areas of Focus and Progress </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Below are a few examples of initiatives we have undertaken with respect to each of our five ESG commitment areas: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>I. Operate with Integrity </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">1. Corporate Governance </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>We have implemented a broad system of internal controls and policies. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We provide annual corporate governance training for employees. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Board provides independent leadership of the Company, and our Lead Independent Director provides
independent leadership of the Board. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Audit and Risk Committee oversees our compliance and ethics programs. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2. Patient Access and Pricing </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Our management-level Patient Access and Pricing Committee works to enable patients to have access to the Company&#146;s products at cost consistent with their ability to pay. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>We have pledged that the average annual price increase for our branded prescription products will be set at no greater than single digits. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">3. Commitment to Diversity and Inclusion </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Our Diversity and Inclusion (&#147;D&amp;I&#148;) Council provides oversight of D&amp;I initiatives and has set 2022 objectives and intiatives for the Company. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Our Supplier Diversity Program works with various organizations to strengthen our outreach and engagement with the diverse business community, including: Women&#146;s Business Enterprise National Council, National Minority Supplier Development
Council, Diversity Alliance for Science, HUBZone Contractors National Council, National LGBT Chamber of Commerce, and Elite Service-Disabled Veteran Owned Business. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Our Women&#146;s Leadership Network has facilitated discussions and hosted events addressing leadership, building resilience and managing stress. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>II. Respect the Environment </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">1. EHS+S Organization </P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our global Environment, Health, Safety + Sustainability (&#147;EHS+S&#148;) organization provides the leadership and infrastructure to
enable our regional sites around the world to achieve a more sustainable and regenerative state, while reducing the adverse environmental impact of our products. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2. Energy and Water Usage </P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Energy Efficiency Group helps us continue to make progress to reduce overall energy usage at our global manufacturing and supply
chain sites by assessing and investigating our energy use and energy reduction efforts. Some of our recent activities include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We installed a solar farm in our manufacturing site in France, which will support approximately 10% of the
site&#146;s total energy needs. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We conducted energy audits in Poland and Italy to identify and design energy reduction projects.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We installed reverse osmosis-powered equipment and a wastewater monitoring system in our facility in Milan,
Italy to, respectively, reduce waste water generation and evaluate water conservation strategies. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We upgraded the cooling system in our Berlin, Germany facility to reduce energy consumption and wastewater
disposal. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">3. Carbon Emissions </P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We monitor and continue to make progress to reduce our global carbon emissions. For example: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We consider the environmental impact of vehicles we use for our
<FONT STYLE="white-space:nowrap">in-field</FONT> sales and support teams, and recently launched our Scope 3 Emissions Tracking Initiative to track the environmental impact of these vehicles. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We reduced our global carbon dioxide emissions by nearly 23,000 metric tons in 2021 as compared to 2018
levels. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our new nitrogen-generating plant at our Waterford, Ireland facility reduces carbon dioxide emissions by
almost 200 tons per year. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">4. Waste Management </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Bausch + Lomb&#146;s ONE by ONE Recycling Program, the first contact lens recycling program of its kind, continues to expand its efforts to reduce the environmental impact of contact lens materials. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>For six years we have collaborated with TerraCycle to offer contact lens wearers a free and convenient way to recycle their used contact lenses and packaging materials. ONE by ONE and
Biotrue<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Eye Care Recycling programs have recycled a total of 48,235,850 million units, or 290,145 pounds, of used contact lenses, eye care and lens care materials. Both programs are made
possible through a collaboration with TerraCycle<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a world leader in the collection and repurposing of hard-to-recycle post-consumer waste. Building upon the success of the ONE by ONE program,
we created the Biotrue<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Eye Care Recycling program in 2021, which allows consumers to also recycle their used eye care and lens care materials, such as lens cases and lens solution bottle
caps. Together, these programs are helping us keep recyclable plastic and aluminum eye health materials out of landfills and oceans so we can help preserve our environment for future generations. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Zero Waste to Landfill initiative yielded a 94% landfill diversion rate in our Rochester, NY site.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>III. Advance Global Health&nbsp;&amp; Patient Care </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">1. Philanthropy &#150; Bausch Foundation </P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We established the Bausch Foundation in 2017 to support initiatives aimed at disease prevention, improving patient outcomes and lives,
and education related to our core businesses. As of 2020 and into 2022, the Bausch Foundation has: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Contributed millions of dollars&#146; worth of financial and product donations to charitable health
organizations, including, but not limited to: (i)&nbsp;National Society to Prevent Blindness; (ii)&nbsp;Children&#146;s Skin Disease Foundation; (iii)&nbsp;the National Psoriasis Foundation; (iv)&nbsp;Eye Bank Association of America;
(v)&nbsp;American Association for the Study of Liver Disease; and (vi)&nbsp;Feeding America. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Funded scholarship programs for students with dermatological and gastrointestinal conditions.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In response to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> donated hand sanitizers to first responders
and volunteers, contact lenses to frontline medical workers in China, and ARTELAC<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Splash<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> eye drops to health care providers in
hospitals in Spain. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Partnered with Global Giving, a non-profit organization, to match employee contributions in support of Ukraine
citizens impacted by the Russia conflict. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In honor of Juneteenth, donated to The International Center for Professional Development&#146;s (ICPD)
Scientist Mentoring and Diversity Program for Medical Technology a one-year career mentoring program that pairs ethnically diverse students and early career researchers with mentors who work at companies in the medical technology, biotech and
consumer healthcare industries; also provided two mentors from the company for the programs. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Through our Employee Resource Groups (ERGs) established connections with charities whose missions align with
those of our individual ERGs and made donations to them. The charities included the Asian Health Foundation, the National Civil Rights Museum, OutRight Action International, Community Hope and Dress for Success. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2. Patient Safety and Health Advocacy </P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We invest millions of dollars each year to support provider education, research grants and charitable organizations devoted to improving
patient care and quality of life and advancing the safety and effectiveness of health care products. </P></TD></TR></TABLE> <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>IV. Improve our Communities
</I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">1. Community Enrichment </P></TD>
<TD> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We believe the Company&#146;s long-term success is linked directly to our ability to make a positive difference in our communities. As
such, we support community enrichment activities, such as volunteering, investing in scholarship programs, and donating to local charities. Examples include: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In collaboration with TerraCycle<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, we donated custom
training modules to the Guide Dog Foundation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We supported Camp Wonder and Camp Discovery, week-long free programs for children with chronic skin
conditions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Employees throughout the world led volunteering and fundraising efforts in their communities.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We supported World Sight Day Challenge fundraising efforts. </P></TD></TR></TABLE>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>V. Employee Growth and Well-Being </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">1. Health and Safety </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>In 2021, we exceeded our Days Away Rate (&#147;DAR&#148;) annual goal. Our DAR measures days that employees are unable to work due to workplace injury or illness. With a &#147;Not to Exceed&#148; DAR Goal of less than 12 days per 100 employees,
our Global Manufacturing and Supply Chain achieved an actual DAR of 6 days per 100 employees, surpassing both our annual goal and the industry&#146;s average a DAR of 24 days per 100 employees. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In 2021, with the COVID-19 outbreak, we continued to focus on supporting our employees by continuing to make
available our remote work policies, which had been broadened in 2020 to enable our global employees to work from home whenever possible, and continuing to implement safety measures in circumstances where remote work was not possible (such as at our
manufacturing and distribution facilities). </P></TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">2. Diversity, Equity &amp; Inclusion </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>In 2021, we continued to expand our (&#147;ERGs&#148;), providing opportunities for professional growth, development and informal networking. These ERGs have helped strengthen our focus on Diversity, Equity &amp; Inclusion by providing forums to
voice concerns and multiple perspectives, as well as to establish connections with charities whose missions align with those of our individual ERGs to give back to these communities. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">3. Employee Health and Wellness </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Our holistic approach to supporting employee health and wellness is centered around three pillars of well-being: physical, emotional, and financial. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>Across each of these pillars, we offer a range of benefits and support resources to help our employees be healthy and feel successful in both their professional and personal lives. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="25%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">4. Talent Development </P></TD>
<TD WIDTH="1%" VALIGN="Top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&#149;</P></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD>We are committed to the development of our employees and believe that our success coincides with our employees&#146; achievements of personal and professional goals. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Through our Employee Development Framework, we endeavor to support our employees&#146; interests to grow to
their full potential, achieve career goals, and contribute to the success of our Company. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We provide a variety of development programs to support our employees at every stage of their career and
incorporate individual development plans that aim to help our employees reach their career goals. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During 2021, the Board had five standing committees: the Audit and Risk Committee, the Talent and Compensation Committee, the
Nominating and Corporate Governance Committee, the Finance and Transactions Committee, and the Science and Technology Committee. In addition, on June&nbsp;3, 2020, the Board established an ad hoc Special Transactions Committee to assist with
evaluating strategic alternatives, including the proposed separation of the Company&#146;s eye health business into an independent, publicly traded entity. No member of any committee is an employee of the Company or its subsidiaries. The specific
responsibilities of each of the Audit and Risk Committee, the Talent and Compensation Committee, the Nominating and Corporate Governance Committee, the Finance and Transactions Committee, and the Science and Technology Committee are identified in
the respective committee&#146;s charter. Copies of the charters for each of the foregoing committees are available on our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance
&#151; Corporate Governance Documents&#148;) and are also available in print to shareholders upon request submitted to Investor Relations, Bausch Health Companies Inc., 2150 Saint Elz&eacute;ar Blvd. West, Laval, Qu&eacute;bec H7L 4A8, Canada. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Chairman of the Board and the Chairperson of each of the Audit and Risk Committee, the Talent and Compensation Committee
and the Nominating and Corporate Governance Committee are expected to be available to respond to questions from shareholders at the Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The table below sets forth each current director&#146;s membership on our Board committees. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Audit&nbsp;and&nbsp;Risk<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Talent&nbsp;and<BR>Compensation<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nominating&nbsp;and<BR>Corporate<BR>Governance<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Finance&nbsp;and<BR>Transactions<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Science&nbsp;and<BR>Technology<BR>Committee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Special<BR>Transactions<BR>Committee</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Richard&nbsp;U.&nbsp;De&nbsp;Schutter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Brett Icahn</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Dr.&nbsp;Argeris&nbsp;(Jerry)&nbsp;N.&nbsp;Karabelas</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairperson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Sarah B. Kavanagh</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairperson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Steven D. Miller</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Joseph C. Papa<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">John A. Paulson<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Robert N. Power</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairperson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Russel C. Robertson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairperson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Thomas W. Ross, Sr.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairperson</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Andrew&nbsp;C.&nbsp;von&nbsp;Eschenbach,&nbsp;M.D.
<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Chairperson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Amy B. Wechsler, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#10003;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Chairman of the Board </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Lead Independent Director </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr. Paulson and Dr. Von Eschenbach have notified us of their intention to resign from the Board effective
upon the completion of the B+L IPO. See &#147;Proposal No. 1 Election of Directors &#150; Background &#150; Bausch + Lomb Separation.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit and Risk Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee is comprised of four independent directors: Mr.&nbsp;Robertson (Chairperson), Ms.&nbsp;Kavanagh,
Mr.&nbsp;Power and Mr.&nbsp;Ross. The responsibilities, powers and operation of the Audit and Risk Committee are set out in the written charter of the Audit and Risk Committee. Pursuant to the Audit and Risk Committee Charter, each member of the
Audit and Risk Committee is an independent director as defined and required by applicable regulatory and stock exchange rules. The Board has concluded that each member of the Audit and Risk Committee is &#147;financially literate&#148; as defined
under National Instrument <FONT STYLE="white-space:nowrap">52-110</FONT> &#151;<I> Audit Committees </I>and as required under NYSE rules, and each of Mr.&nbsp;Robertson and Ms.&nbsp;Kavanagh qualify as an &#147;audit committee financial expert&#148;
under the regulations promulgated by the U.S. Securities and Exchange Commission (the &#147;SEC&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and
Risk Committee operates pursuant to the Audit and Risk Committee Charter. Its responsibilities include, among other things, responsibility for reviewing and recommending to the Board our annual financial statements and management&#146;s discussion
and analysis of results of operation and financial condition (&#147;MD&amp;A&#148;) and reviewing and approving our interim financial statements and MD&amp;A. As contemplated in the Audit and Risk Committee Charter, the Audit and Risk Committee
periodically meets with our internal auditor and with our external auditor without management being present. The Audit and Risk Committee also recommends to the Board the external auditor to be nominated for approval by the Company&#146;s
shareholders, as well as the compensation of the external auditor. The Audit and Risk Committee Charter provides that the Audit and Risk Committee must establish procedures for the receipt, retention and treatment of complaints received by the
Company regarding accounting, internal accounting controls, or auditing matters and the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with the Audit and Risk Committee Charter, the Audit and Risk Committee also provides assistance to the Board in
fulfilling its oversight function, including with respect to: (i)&nbsp;the quality and integrity of our financial statements; (ii)&nbsp;compliance with our Bausch Health Code of Conduct, and legal and regulatory requirements, including with respect
to disclosure of financial information; (iii)&nbsp;the qualifications, performance and independence of our external auditor; (iv)&nbsp;the performance of our senior finance employees and internal audit function; (v)&nbsp;internal controls and
certifications; (vi)&nbsp;monitoring the appropriateness and effectiveness of the Company&#146;s risk management systems and policies, including evaluating on a regular basis the effectiveness and prudence of senior management in managing the
Company&#146;s operations and the risks to which it is exposed; and (vii)&nbsp;overseeing the Company&#146;s compliance programs, policies and procedures, and investigating compliance matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee Charter provides that no member of the Audit and Risk Committee may hold 10% or more of the
Company&#146;s outstanding Common Shares or serve simultaneously on the audit committee of more than two other public companies, unless the Board determines that such simultaneous service would not impair his or her ability to serve effectively on
the Audit and Risk Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Talent and Compensation Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee is comprised of three independent directors: Dr.&nbsp;Karabelas (Chairperson),
Mr.&nbsp;De Schutter and Dr.&nbsp;Wechsler. The responsibilities, powers and operation of the Talent and Compensation Committee are set out in the written charter of the Talent and Compensation Committee. In accordance with the Talent and
Compensation Committee Charter, each member of the Talent and Compensation Committee is an independent director as defined and required by applicable regulatory and stock exchange rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As described in the Talent and Compensation Committee Charter, the key responsibilities of the Talent and Compensation
Committee include: (i)&nbsp;reviewing and approving corporate goals and objectives in connection with the compensation of our CEO, evaluating the CEO&#146;s performance in light of those goals and objectives, and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(either as a committee or together with the other independent directors who satisfy the independence, <FONT STYLE="white-space:nowrap">&#147;non-employee&#148;</FONT> and &#147;outside
director&#148; requirements under the Talent and Compensation Committee Charter) determining and approving the compensation of the CEO based on such evaluation; (ii)&nbsp;reviewing and approving each element of total compensation for all officers
(as such term is defined in Rule <FONT STYLE="white-space:nowrap">16a-1(f)</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)); (iii) reviewing and approving arrangements with executive officers relating to
their employment relationships with us; (iv)&nbsp;reviewing talent management and succession planning materials for key roles; (v)&nbsp;providing strategic supervision of our benefit plans, programs and policies; and (vi)&nbsp;reviewing and
recommending to the Board for approval the Compensation Discussion&nbsp;&amp; Analysis to be included in the Company&#146;s annual management proxy circular and proxy statement and/or annual report on Form
<FONT STYLE="white-space:nowrap">10-K,</FONT> and preparing the Talent and Compensation Committee Report. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For details on the philosophy and approach adopted by the Talent and Compensation Committee with respect to compensation of our
officers, please see &#147;Compensation Discussion and Analysis&#148; beginning on page&nbsp;48. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and
Compensation Committee has the authority to retain and compensate any consultants and advisors it considers necessary to fulfill its mandate. It shall, annually or on an <FONT STYLE="white-space:nowrap">as-needed</FONT> basis, specify the work to be
performed by, and agree on the associated fees to be paid to the compensation consultants. It shall also review annually the work performed and fees paid. In addition, the Talent and Compensation Committee Charter provides that the Talent and
Compensation Committee shall report to the Board, on an annual basis, the nature of any additional work or <FONT STYLE="white-space:nowrap">non-Board</FONT> based services conducted by any such compensation consultant and associated fees paid, if
approved by the Chairperson of the Talent and Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Periodically, and at least annually, the Talent and
Compensation Committee selects and retains independent consultants to conduct comprehensive reviews and assessments of our policies, procedures and internal controls for setting compensation of the CEO and other members of senior management. The
consultant prepares and submits relevant information and analyses to the Talent and Compensation Committee. As discussed below under &#147;Compensation Discussion and Analysis,&#148; in 2021, the Talent and Compensation Committee retained Pay
Governance LLC (&#147;Pay Governance&#148;), as its independent consultant to provide advice on compensation matters. Pay Governance&#146;s services included the following: (i)&nbsp;periodically reviewing our executive compensation programs,
including base salary, short-term incentives, equity-based incentives, total cash compensation levels and total direct compensation of certain senior positions, against those of a peer group; (ii)&nbsp;advising the Talent and Compensation Committee
with regard to the compensation packages of the CEO and other members of senior management; (iii)&nbsp;reviewing the proxy and specifically the Compensation Discussion and Analysis; and (iv)&nbsp;preparing materials for and attending select Talent
and Compensation Committee Meetings. Pay Governance did not provide any additional services to the Company during the fiscal year 2021. The Talent and Compensation Committee has assessed, at the relevant times, the independence of Pay Governance and
concluded that its engagement of Pay Governance did not raise any conflict of interest with the Company or any of the Company&#146;s directors or executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee considers the advice and analysis of the independent compensation consultants, together
with other factors the Talent and Compensation Committee considers appropriate (including feedback from shareholders and corporate governance groups, market data, knowledge of the comparator group and personal knowledge and experience of the Talent
and Compensation Committee members), in reaching its decisions and making compensation determinations for the CEO and executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Succession Planning </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board regularly undertakes a thorough review of succession planning for the members of the Company&#146;s Executive
Committee, including our CEO, over the course of the year, led by the efforts of the Talent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
and Compensation Committee. The Talent and Compensation Committee continuously reviews the Executive Committee and key positions within the Company to ensure the continuity and comprehensiveness
of succession planning company-wide. Among other factors, the Talent and Compensation Committee considers the level of representation of women in executive officer and managerial positions when making appointments and during succession planning by
taking into account the overall number of women currently serving in such roles at the Company and by actively considering women candidates for such positions when they become available; however, the Company does not have a specific target number or
date by which to achieve a specific level of representation of women in executive officer and managerial positions, as it considers a multitude of factors in determining the best person for any position. Women currently lead a substantial portion of
our businesses and global functions, in the following roles: Executive Vice President, General Counsel, President Ophthalmic Pharmaceuticals (who also serves as an executive officer of the Company); SVP and Chief Human Resources Officer; SVP, Head
of Legal International; SVP, Global Head of Ethics and Compliance; SVP, Vision Care; SVP, U.S. Ophthalmic Pharmaceuticals, Market Access, and Generics and VPs of Marketing and/or Sales for various lines of business. Currently, one (representing 14%)
of the Company&#146;s executive officers is a woman. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board regularly receives exposure to executives, managers and
other personnel in the organization by having the executives and managers participate in Board meetings and present on the Company&#146;s business and strategy. The Board&#146;s participation in these events provides significant exposure to the
Company&#146;s leadership team and strategic focus, which greatly enhances the Board&#146;s ability to conduct succession planning, as well as to gain insight as it oversees organization risk and strategy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominating and Corporate Governance Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee is comprised of four independent directors: Mr.&nbsp;Power (Chairperson),
Ms.&nbsp;Kavanagh, Mr.&nbsp;Robertson and Mr.&nbsp;Ross. The responsibilities, powers and operation of the Nominating and Corporate Governance Committee are set out in the committee&#146;s written charter. As required by the Nominating and Corporate
Governance Committee Charter, each member of the Nominating and Corporate Governance Committee is an independent director as defined and required by applicable regulatory and stock exchange rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As described in the Nominating and Corporate Governance Committee Charter, the key responsibilities of the Nominating and
Corporate Governance Committee include: (i)&nbsp;identifying individuals qualified to become directors and recommending to the Board new nominees for election by shareholders or for appointment by the Board, and engaging the services of third party
search firms to assist in identifying such individuals; (ii)&nbsp;providing recommendations to the Board regarding the competencies and skills the Board should possess, and the qualifications of its directors; (iii)&nbsp;recommending for Board
approval, if appropriate, revisions to our corporate governance practices and procedures; (iv)&nbsp;developing new charters for any new committees established by the Board, if not otherwise mandated by the Board; (v)&nbsp;monitoring relationships
and communication between management and the Board and monitoring emerging best practices in corporate governance; (vi)&nbsp;reviewing the composition and mandate of the Board and each committee of the Board annually and, if appropriate,
recommending to the Board any changes it considers desirable with respect thereto; and (vii)&nbsp;overseeing our orientation process for new directors and our continuing education program for all directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nominating and Corporate Governance Committee annually develops and recommends processes for assessing the performance and
effectiveness of the Board and the committees of the Board and reports the results of such assessments to the Board on an annual basis. Pursuant to these processes established by the Nominating and Corporate Governance Committee and adopted by the
Board, the Board and each committee conduct annual self-assessments of their performance and effectiveness. The self-assessments include a review of the compliance of the Board and each committee with their respective charters, the adequacy of
information provided, the skills and experience of the members, and other matters. The results of the individual directors&#146; surveys are compiled by the Chairperson of the Nominating and Corporate Governance Committee and presented to the Lead
Independent director and Chairman of the Board for discussion. Following these discussions, the Chairperson of the Nominating and Corporate Governance Committee provides a report to the full Board identifying the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
opportunities for improvement identified in the self-assessment process. The Board has previously conducted periodic peer reviews of the directors to supplement the annual Board and committee
self-assessments and will do so again when the Board determines peer reviews will add value to these annual self-assessments. The Nominating and Corporate Governance Committee also makes recommendations to the Board regarding director compensation
and may retain advisors to assist with evaluating and making these recommendations. For additional information regarding the compensation of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, and the role of the Nominating and
Corporate Governance Committee in reviewing and recommending changes to <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation, please see &#147;Director Compensation&#148; beginning on page&nbsp;81. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Finance and Transactions Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Finance and Transactions Committee is currently comprised of five independent directors: Ms.&nbsp;Kavanagh (Chairperson),
Mr.&nbsp;De Schutter, Mr.&nbsp;Paulson, and Messrs. Icahn and Miller, who joined this Committee upon their appointment to the Board on March&nbsp;17, 2021. It was established to assist the Board in providing fiduciary oversight and strategic advice
with respect to the Company&#146;s significant transactional and financing activities, and monitoring the overall financial condition of the Company, including the impact of these activities on the Company&#146;s financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Science and Technology Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Science and Technology Committee is comprised of four independent directors: Dr.&nbsp;von Eschenbach (Chairperson),
Dr.&nbsp;Karabelas, Mr.&nbsp;Power, and Dr.&nbsp;Wechsler. The Science and Technology Committee was established to provide oversight and strategic advice with respect to the Company&#146;s research and development programs and pipeline, and the
Company&#146;s strategic direction and development in research and development and technology. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Special Transactions Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Special Transactions Committee is currently comprised of seven independent directors: Mr.&nbsp;Ross (Chairperson),
Mr.&nbsp;De Schutter, Dr.&nbsp;Karabelas, Ms.&nbsp;Kavanagh, Mr.&nbsp;Paulson, and Messrs. Icahn and Miller, who joined this Committee upon their appointment to the Board on March&nbsp;17, 2021. The Special Transactions Committee was established on
June&nbsp;3, 2020 to assist the Company with evaluating strategic alternatives, including the proposed separation of the Company&#146;s eye health business into an independent, publicly traded entity. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_11"></A>COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of Dr.&nbsp;Karabelas, Mr.&nbsp;De Schutter, Mr.&nbsp;Hale, and Dr.&nbsp;Wechsler, representing all of the directors who
served on the Talent and Compensation Committee during 2021, is (i)&nbsp;a <FONT STYLE="white-space:nowrap">non-employee</FONT> director for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act, as amended, (ii)&nbsp;an
&#147;outside director&#148; under Section 162(m) of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), to the extent applicable; and (iii) an independent director. None of the members of the Talent and Compensation Committee is a
current or former officer of the Company. There were no compensation committee interlocks with other companies in 2021 within the meaning of Item&nbsp;407(e)(4)(iii) of Regulation <FONT STYLE="white-space:nowrap">S-K.</FONT> See &#147;Certain
Transactions &#151; Certain Related-Party Transactions&#148; on page&nbsp;87 for a description of related-party transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_12"></A>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The executive officers of the Company are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Age</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">66</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chairman of the Board and Chief Executive Officer</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Executive Vice President, General Counsel</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">and Head of Commercial Operations</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer, Pharma Business</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph F. Gordon</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">58</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President&nbsp;&amp; <FONT STYLE="white-space:nowrap">Co-Head</FONT> Bausch&nbsp;+ Lomb/International</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">U.S. President, Pharma Business</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam Eldessouky</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">49</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President and Chief Financial Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Below is a description of each executive officer who is not also a director nominee of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">CHRISTINA M. ACKERMANN has been our Executive Vice President and General Counsel since August 2016, and from
July 2020 has also served as Head of Commercial Operations. In 2022, Ms.&nbsp;Ackermann&#146;s role expanded to include President, Ophthalmic Pharmaceuticals of the Company&#146;s eye healthcare business. Prior to joining Bausch Health,
Ms.&nbsp;Ackermann was part of the Novartis group of companies for the 14 years, most recently serving as Senior Vice President, General Counsel for Alcon, where she was responsible for the Legal, Intellectual Property and Compliance functions. She
previously served as Global Head, Legal and General Counsel at Sandoz, the generics division of Novartis, from 2007 to 2012. She joined Novartis Pharma in 2002 as Head, Legal Technical Operations and Ophthalmics and assumed the role of Head Legal
General Medicine in July 2005. Before Novartis, Ms.&nbsp;Ackermann served in Associate General Counsel roles with Bristol Myers Squibb and DuPont Pharmaceuticals, as well as in private practice, where she focused on securities and mergers&nbsp;&amp;
acquisitions. Ms.&nbsp;Ackermann has been a director of Graybug Vision, Inc., a publicly traded biopharmaceutical company, since August 2020. Ms.&nbsp;Ackermann has a Post Graduate Diploma in EC Competition Law from King&#146;s College, the
University of London, U.K., a Bachelor of Laws from Queen&#146;s University, Kingston, Canada, and attended York University, Toronto, Ontario, for her undergraduate studies in Math, Political Sciences and Fine Arts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">JOSEPH F. GORDON has been our President&nbsp;&amp; <FONT STYLE="white-space:nowrap">Co-Head</FONT> Bausch + Lomb/International
since August 2018. He previously served as our President, Consumer and Vision Care from December 2016 through July 2018 and as General Manager of U.S. Consumer from August 2013 to November 2016. Prior to joining Bausch Health in 2013,
Mr.&nbsp;Gordon served in various positions with Bausch + Lomb, where he most recently served as Vice President, Sales and Marketing, Global Consumer from January 2011 to July 2013. Earlier in his career, he led sales and marketing organizations
within Pfizer Inc., and Wyeth, a pharmaceutical company purchased by Pfizer Inc. in 2009. Mr.&nbsp;Gordon holds a Bachelor of Science in Economics from Rutgers University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ROBERT A. SPURR currently serves as our U.S. President, Pharma Business, and has previously served as President, Salix, since
May 2020, and was previously our Senior Vice President, Market Access and Commercial Operations from August 2018 to May 2020. Before joining Bausch Health, Mr.&nbsp;Spurr was the Vice President Market Access and Commercial Operations for Novartis
Pharmaceuticals from August 2012 to August 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">SAM A. ELDESSOUKY joined us in 2016 as senior vice president and
corporate controller and was appointed Chief Financial Officer effective June&nbsp;1, 2021. He has been responsible for overseeing the global controllership functions, including financial reporting, regional finance and global policies. Previously,
he served as senior vice president, controller and chief accounting officer for Tyco International plc from 2012 to 2016. During his tenure at Tyco, Mr.&nbsp;Eldessouky led the efforts to redesign the controller&#146;s organization and the
implementation of Enterprise Performance Management framework, and he played a significant role in the wholesale turnaround of Tyco&#146;s business. He also played a key role in executing the spinoffs of Covidien and Tyco Electronics in 2006 and ADT
NA and Flow Control in 2012. Prior to that, Mr.&nbsp;Eldessouky spent ten years at PricewaterhouseCoopers (PwC), where he held several roles of increasing responsibility and served in PwC&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
National Office providing technical accounting guidance on complex accounting matters. Mr.&nbsp;Eldessouky holds a Bachelor of Science in Accountancy from Ain Shams University and a master&#146;s
degree in Accounting and Finance from the University of Liverpool. He is a Certified Public Accountant and Chartered Global Management Accountant. He served as a member of the Board of Trustees of Financial Executives Research Foundation and
Financial Executives International. Additionally, Mr.&nbsp;Eldessouky served as a member of the Global Preparers Forum, an external advisory body to the International Accounting Standards Board, from 2007 to 2013. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">None of the executive officers of the Company were selected pursuant to any arrangement or understanding, other than their
respective employment agreements with the Company. None of the executive officers are related by blood, marriage or adoption to one another or to any director or nominee for director of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain Changes Upon Completion of the B+L IPO </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As previously disclosed, Mr. Eldessouky will serve as the Chief Financial Officer of Bausch + Lomb effective as of the IPO
Closing Date. On January 3, 2022, Tom Vadaketh joined Bausch Health from eResearch Technology Inc., and will serve as the Chief Financial Officer of the Company effective as of the IPO Closing Date. In addition, as previously disclosed, Ms.
Ackermann will become General Counsel of Bausch + Lomb and lead the ophthalmology pharmaceutical business, with specific responsibility for the United States, Canada, Latin America, and Asia Pacific markets effective as of the IPO Closing Date.
Seana Carson, Senior Vice President of Legal, will be appointed General Counsel of Bausch Health effective as of the IPO Closing Date. As previously disclosed, Mr. Gordon will also transfer with Bausch + Lomb, effective as of the IPO Closing Date,
where he will lead Bausch + Lomb&#146;s global consumer, vision care and surgical businesses as well as the EMEA ophthalmology pharmaceutical business. In addition, effective as of the IPO Closing Date, Mr. Papa will step down as CEO to be replaced
by Mr. Appio and continue as Chairman of the Board. See &#147;Proposal No. 1 Election of Directors &#151; Background &#151; Bausch + Lomb Separation.&#148; However, there can be no assurance as to when the B+L IPO will be completed, if at all. If
the IPO Closing Date does not occur when it is expected then none of Mr. Vadaketh, Mr. Appio or Ms.&nbsp;Carson will be appointed, and each of Mr. Eldessouky, Mr. Papa and Ms. Ackermann are expected to remain in their current roles with the Company.
If the IPO Closing Date does not occur prior to the Meeting, the resignations of Mr. Paulson and Dr. von Eschenbach will not be effective, and we may amend this proxy statement to update the nominees standing for election at the Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr. Vadaketh, 59, joined Bausch Health on January 3, 2022. Prior to joining Bausch Health Mr. Vadaketh served as Executive
Vice President and Chief Financial Officer of eResearch Technology, Inc. from September&nbsp;2018 to December 2021 where he was responsible for leading the Finance function including controllership, treasury, taxation and financial planning, and
prior to that was Executive Vice President and Chief Financial Officer of Cambrex Corporation. Mr. Vadaketh spent over 20 years at Procter &amp; Gamble and Tyco International, where he held several roles at both companies of increasing
responsibility. Mr. Vadaketh received his degree from the Institute of Chartered Accountants in England and Wales (ACA) and an M.B.A from Manchester Business School. He is a Certified Public Accountant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Seana Carson, 50, joined Bausch Health in November of 2006 as Senior Legal Counsel. In her current role, she is responsible
for the legal function for the international businesses of Bausch Health, and prior to that was Chief Compliance Officer. Ms.&nbsp;Carson received her law degree from Queens University in Ontario and an Honors Bachelor of Arts degree from the
University of Western Ontario. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither Mr. Vadaketh nor Ms. Carson was selected pursuant to any arrangement or
understanding, other than their respective employment agreements with the Company. Neither Mr. Vadaketh nor Ms. Carson is related by blood, marriage or adoption to one another or to any director or nominee for director of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_13"></A>OWNERSHIP OF THE COMPANY&#146;S SECURITIES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_14"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth certain information regarding the beneficial ownership of our Common Shares and the percentage
of Common Shares owned beneficially by holders of more than 5% of our outstanding Common Shares as of April&nbsp;28, 2022 (unless otherwise noted). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Identity&nbsp;of&nbsp;Owner&nbsp;or&nbsp;Group</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>and Nature&nbsp;of<BR>Beneficial<BR>Ownership</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of<BR>Class<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Carl&nbsp;C. Icahn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,109,152</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">c/o Icahn Associates Holding LLC, 16690 Collins Ave., Suite
<FONT STYLE="white-space:nowrap">PH-1,</FONT> Sunny Isles Beach, FL 33160</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulson&nbsp;&amp; Co. Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,839,035</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.15</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1251 Avenue of the Americas, New York, NY 10020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nomura Global Financial Products, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,515,079</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Worldwide Plaza, 309 West 49th Street, New York, NY 10019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This table is based upon information supplied by the principal shareholders, Schedules 13D and
13G filed with the SEC and &#147;early warning reports&#148; and similar regulatory filings filed on SEDAR and on the Canadian System for the Electronic Disclosure by Insiders. Unless otherwise indicated in the footnotes to this table, we believe
that the shareholders named in the table have sole voting and investment power with respect to the Common Shares indicated as beneficially owned. </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Based on 361,446,847 Common Shares outstanding on April&nbsp;28, 2022. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Based on information contained in a Schedule 13D/A filed by Mr.&nbsp;Carl&nbsp;C. Icahn with the SEC on
March&nbsp;11, 2021, Mr.&nbsp;Icahn and the following entities associated with Mr.&nbsp;Icahn may be deemed to beneficially own, in the aggregate, 34,109,152 Common Shares (including 29,076,005 Common Shares underlying forward contracts): Icahn
Partners Master Fund LP (&#147;Icahn Master&#148;), Icahn Offshore LP (&#147;Icahn Offshore&#148;), Icahn Partners LP (&#147;Icahn Partners&#148;), Icahn Onshore LP (&#147;Icahn Onshore&#148;), Icahn Capital LP (&#147;Icahn Capital&#148;), IPH GP
LLC (&#147;IPH&#148;), Icahn Enterprises Holdings L.P. (&#147;Icahn Enterprises Holdings&#148;), Icahn Enterprises G.P. Inc. (&#147;Icahn Enterprises GP&#148;), and Beckton Corp. (&#147;Beckton&#148;). According to this Schedule 13D/A, Icahn Master
has sole voting and dispositive power with respect to 14,169,189 Common Shares; Icahn Offshore has shared voting and dispositive power with respect to 14,169,189 Common Shares; Icahn Partners has sole voting and dispositive power with respect
to&nbsp;19,939,963 Common Shares; Icahn Onshore has shared voting and dispositive power with respect to&nbsp;19,939,963 Common Shares; and Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Becton and Mr.&nbsp;Icahn each have
shared voting and dispositive power with respect to 34,109,152 Common Shares. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of Icahn Offshore,
Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr.&nbsp;Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Securities
Exchange Act of 1934, as amended, the &#147;Act&#148;) the Common Shares which Icahn Master directly beneficially owns. Each of Icahn Offshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Enterprises GP, Beckton and Mr.&nbsp;Icahn disclaims beneficial ownership of such Common Shares for all other purposes. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings,
Icahn Enterprises GP, Beckton and Mr.&nbsp;Icahn may be deemed to indirectly beneficially own (as that term is defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Act) the Common Shares which Icahn Partners directly beneficially
owns. Each of Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises Holdings, Icahn Enterprises GP, Beckton and Mr.&nbsp;Icahn disclaims beneficial ownership of such Common Shares for all other purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The address for each of Icahn Master, Icahn Offshore, Icahn Partners, Icahn Onshore, Icahn Capital, IPH, Icahn Enterprises
Holdings, Icahn Enterprises GP, and Beckton is 16690 Collins Avenue, Sunny Isles Beach, FL 33160. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">According to information provided to the Company by Paulson&nbsp;&amp; Co., Inc. on April 29, 2022, it has
sole voting and dispositive power with respect to 25,839,035 Common Shares. Mr.&nbsp;Paulson may be deemed an indirect beneficial owner of these Common Shares, which are directly owned by investment funds which he manages. Mr.&nbsp;Paulson disclaims
beneficial ownership of these Common Shares, except to the extent he has a pecuniary interest therein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Based on information contained in a Schedule 13G filed jointly by Nomura Global Financial Products, Inc. and
Nomura Holdings, Inc. with the SEC on February&nbsp;14, 2022. Nomura Global Financial Products, Inc. may be deemed to beneficially own 19,515,079 Common Shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_15"></A>OWNERSHIP OF MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth, as of April&nbsp;28, 2022 (unless otherwise noted below), certain information regarding the
beneficial ownership of our Common Shares and the percentage of Common Shares beneficially owned by (i)&nbsp;each director and each director nominee; (ii)&nbsp;each executive officer named in the Summary Compensation Table on page 67 (together, the
&#147;named executive officers,&#148; or &#147;NEOs&#148;); and (iii)&nbsp;all directors and current executive officers as a group. None of the shares held by directors and executive officers included in the table are pledged as security. Unless
otherwise indicated, the address of each beneficial owner listed in the following table is c/o Bausch Health Companies Inc., 2150 St. Elz&#233;ar Blvd. West, Laval, Qu&#233;bec, Canada H7L 4A8. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Identity of Owner or Group</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>and&nbsp;Nature&nbsp;of<BR>Beneficial<BR>Ownership<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>percentage is<BR>subject to change<BR>based on total<BR>number&nbsp;of&nbsp;shares<BR>outstanding<BR>Percentage<BR>of&nbsp;Class <SUP
STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers, Directors and Director Nominees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">284,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard U. De Schutter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">320,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam A. Eldessouky**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D. Robert Hale<SUP STYLE="font-size:85%; vertical-align:top">(5) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,627,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.97</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul S. Herendeen<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,660,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brett Icahn</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Argeris (Jerry) N. Karabelas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sarah B. Kavanagh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Miller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard C. Mulligan**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,561,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John A. Paulson<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,839,053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.17</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert N. Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Russel C. Robertson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas W. Ross, Sr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew C. von Eschenbach, M.D.**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amy B. Wechsler, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,354</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors, director nominees and current executive officers of the Company as a group (18
persons)**</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,659,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.32</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Less than 1% of the outstanding Common Shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Upon completion of the B+L IPO, Ms. Ackermann, Mr. Eldessouky and Mr. Papa will cease to be executive
officers of Bausch Health. In addition, at such time Mr. Mulligan and Mr. Appio will be appointed as members of the Board to fill the vacancies created by the departures of Mr. Paulson and Dr. Von Eschenbach (which are conditioned upon the closing
of the B+L IPO). See &#147;Proposal No. 1 Election of Directors &#151; Background &#151; Bausch + Lomb Separation&#148; and &#147;Executive Officers &#151; Certain Changes Upon Completion of the B+L IPO.&#148; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This table is based on information supplied by the individuals identified above. We believe that Common
Shares shown as beneficially owned are those as to which the named persons possess sole voting and investment power. However, under the laws of California and certain other states, personal property owned by a married person may be community
property, which either spouse may manage and control, and we have no information as to whether any Common Shares shown in this table are subject to community property laws. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amounts reported include the following vested RSUs which are payable in Common Shares following the
applicable director&#146;s separation of service from the Company: Mr. De Schutter, 32,590; Mr. Icahn, 4,718; Dr. Karabelas, 85,328; Ms. Kavanagh, 83,060; Mr. Miller, 4,740; Mr. Paulson, 86,629; Mr. Power, 94,823; Mr. Robertson, 128,253; Mr. Ross,
86,424; Dr. von Eschenbach, 35,147; Dr. Wechsler, 91,709. These vested RSUs represent either or both of the following: (i) director fees paid in RSUs, pursuant to the election of the applicable director to defer such fees; and (ii) annual grants of
RSUs, for which delivery of Common Shares underlying the RSUs was deferred pursuant to the election of the applicable director. For further information regarding director compensation, see the section titled &#147;Director Compensation&#148;
beginning on page 81. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amounts reported include (i) the following stock options that are exercisable currently or will become
exercisable within 60 days of April 28, 2022: Ms. Ackermann, 173,519; Mr. Appio, 250,750; Mr.&nbsp;Herendeen, 1,438,173; Mr. Eldessouky, 150,495, Mr. Papa, 1,549,790, Mr. Spurr, 142,739; and all current executive officers as a group (and excluding
our directors and director nominees, who do not receive stock options), 3,705,466; and (ii) the following unvested RSUs that will vest within 60 days of April 28, 2022: Mr. Eldessouky, 11,224; Mr. De Schutter, 7,645; Mr. Hale, 7,645; Mr. Icahn,
7,645; Dr. Karabelas, 7,645; Ms. Kavanagh, 7,645; Mr. Miller, 7,645; Mr. Paulson, 7,645; Mr. Power, 7,645; Mr. Robertson, 7,645; Mr. Ross, 7,645; Dr. von Eschenbach, 7,645; Dr. Wechsler, 7,645; and all directors and current executive officers as a
group, 102,964. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Applicable percentage ownership is based on 361,446,847 Common Shares outstanding on April&nbsp;28, 2022. In
computing the number of Common Shares beneficially owned by a person and the percentage ownership of that person, we deemed outstanding all Common Shares subject to options, warrants, rights or conversion privileges held by that person that are
currently exercisable or exercisable within 60 days of April&nbsp;28, 2022. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. Under Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> of the SEC, certain Common Shares may be deemed to be beneficially owned by more than one person (if, for example, a person shares the power to vote or the power to dispose of the Common Shares).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">According to information provided to the Company by VA Partners I, LLC on April 29, 2022, as of December 31,
2021, 15,616,761 shares were beneficially owned by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital
Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of
VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi)
ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings II, L.P. Mr. Hale is a partner at ValueAct Holdings GP, LLC. 11,037 shares of previously awarded restricted share units held by Mr. Hale and all board
compensation accrue to the benefit of the investors in ValueAct Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, Mr. Hale is deemed to hold the shares for the benefit of the limited partners of ValueAct
Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital
Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v) ValueAct Holdings II, L.P. as the sole owner of the membership
interests of ValueAct Capital Management, LLC and as the majority owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. and ValueAct Holdings
II, L.P. Each person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by such person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Effective June 1, 2021, Mr. Herendeen stepped down from his role as the Company&#146;s CFO and was appointed
Advisor to the Chairman and CEO. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">According to information provided to the Company by Paulson&nbsp;&amp; Co., Inc. on April 29, 2022, it has
the sole power to vote and sole power to dispose of 25,839,053 of our Common Shares. Mr.&nbsp;Paulson may be deemed an indirect beneficial owner of these Common Shares, which are directly owned by investment funds which he manages. Mr.&nbsp;Paulson
disclaims beneficial ownership of these Common Shares, except to the extent he has a pecuniary interest therein. This number also includes 220 Common Shares owned indirectly as a Uniform Gift to Minors Act custodian for minor children.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_16"></A>DELINQUENT SECTION 16(a) REPORTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;16(a) of the Exchange Act requires the Company&#146;s executive officers and directors, and persons who own more
than 10% of a registered class of the Company&#146;s equity securities, to file reports of ownership and changes in ownership with the SEC and the NYSE. Such executive officers, directors and shareholders are required by SEC regulation to furnish
the Company with copies of all Section&nbsp;16(a) forms they file. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based solely upon its review of the copies of such
forms it received, or written representations from certain reporting persons for whom no such forms were required, the Company believes that during fiscal year 2021, all executive officers, directors and 10% beneficial owners of the Company timely
filed all forms required by Section&nbsp;16(a) except for the following: Mr.&nbsp;Appio filed one late Form 4 relating to a single transaction due to a clerical error. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_17"></A>EXECUTIVE COMPENSATION AND RELATED MATTERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_18"></A>COMPENSATION DISCUSSION AND ANALYSIS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Executive Summary </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Compensation Discussion and Analysis (&#147;CD&amp;A&#148;) section describes our compensation approach and programs for
our NEOs for 2021. Our NEOs for 2021 are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Joseph C. Papa, Chairman of the Board and Chief Executive Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sam A. Eldessouky, Executive Vice President and Chief Financial Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Christina M. Ackermann, Executive Vice President, General Counsel and Head of Commercial Operations
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Thomas J. Appio, CEO, Pharma Business </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Robert A. Spurr, U.S. President, Pharma Business </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Paul S. Herendeen, Former Executive Vice President and Chief Financial Officer<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP> </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2021 Business Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In 2021, our reported revenues grew by five percent, and several of our key products gained market share. We also delivered on
near-term R&amp;D catalysts, with four new product launches. We achieved the following financial results for 2021: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">GAAP Revenues of $8,434M </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">GAAP Net Loss of ($948M) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT> of $3,472M<SUP
STYLE="font-size:85%; vertical-align:top">(2</SUP><SUP STYLE="font-size:85%; vertical-align:top">)</SUP> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">GAAP Cash Generated from Operations of $1,426M </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also continued to execute on our plans to pursue an initial public offering (&#147;IPO&#148;) of the Solta Medical business
and to pursue an IPO and full separation of the Bausch + Lomb (&#147;B+L&#148;) business (the &#147;B+L IPO&#148;). We made great progress in our efforts to unlock value by creating three great companies, substantially completing our preparations
and planning, including publicly filing the registration statements for the proposed IPOs of B+L and Solta. The launch of these IPOs are subject to market conditions, stock exchange and other approvals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Compensation Philosophy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Bausch Health&#146;s compensation philosophy is designed to attract, retain, and motivate talented executives, including our
NEOs, who are committed to the ongoing transformation of our company and to improving people&#146;s lives through our products. Our compensation program is designed to link executive compensation to long-term business performance, while providing
compensation opportunities that are competitive as compared to our peers and align the interests of our executives with those of our shareholders. Our programs also balance appropriate risk-taking and incorporate shareholder feedback. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A significant portion of total compensation is linked to satisfying our financial targets, including achieving positive total returns to
shareholders, and strategic initiatives. Our strategic initiatives focus on areas that are critical to our success, including an emphasis on fostering an inclusive work environment where everyone feels welcomed, supported and valued for their
talents and contributions through our Diversity, Equity&nbsp;&amp; Inclusion </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1</SUP><SUP STYLE="font-size:85%; vertical-align:top">)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Effective June&nbsp;1, 2021, Mr.&nbsp;Herendeen stepped down from his role and was appointed Advisor to the
Chairman and CEO. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2</SUP><SUP STYLE="font-size:85%; vertical-align:top">)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Adjusted EBITDA is a non-GAAP financial measure that may not be comparable to similar measures used by other
companies. Please see Appendix 1 for a reconciliation of our GAAP to <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures and related disclosures. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(&#147;DE&amp;I&#148;) strategy, and identifying and addressing current and emerging environmental, social, and governance (&#147;ESG&#148;) trends that help us understand the needs of our
patients and customers and provide us with the ability to enrich the communities and natural environments where we live and work. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In determining the appropriate mix of base salary and incentive pay (including annual cash incentives and long-term equity)
for our NEOs, the Talent and Compensation Committee seeks to balance: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attracting and retaining our executives with the stability of a competitive base salary;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">promoting <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">pay-for-performance,</FONT></FONT>
as we believe our compensation program should emphasize incentive pay that appropriately rewards executives for their contribution to our overall performance; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">aligning compensation with company performance and shareholder value creation through the use of
performance-based equity compensation awards. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In allocating between short-term and long-term
compensation, the Talent and Compensation Committee seeks to establish a balance between rewarding past performance and recognizing potential future contributions. In that respect, the Talent and Compensation Committee designs our annual incentive
program to reward executives for the achievement of <FONT STYLE="white-space:nowrap">pre-determined</FONT> financial metrics and strategic priorities, and it grants equity awards under our long-term incentive program to provide an opportunity for
additional compensation based on delivering on our long-term performance and shareholder value creation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The compensation
opportunity provided to our NEOs is primarily performance-based. In 2021, 92% of our CEO&#146;s and 85%, on average, of our other NEOs&#146; compensation opportunity was performance-based pay, subject to the achievement of annual and long-term
performance goals, including the growth of our Common Share price over time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Shareholder-Friendly Compensation Practices </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We maintain the following shareholder-friendly compensation practices which further align the interests of our executives with
those of our shareholders and balance appropriate risk taking. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>What We Do </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Share ownership guidelines</B> &#151; All NEOs are subject to significant share ownership guidelines.
Pursuant to our Share Ownership Guidelines, our CEO is required to hold 6 times base salary, and our other NEOs are required to hold 3 times base salary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Holding requirements</B> &#151; In connection with his hiring, our CEO was required to purchase $5,000,000
of Common Shares, and our other NEOs are required to hold 50% of their net shares that vest under our long-term incentive plans, until they satisfy our Share Ownership Guidelines. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Performance-based equity</B> &#151; We grant performance share units with rigorous absolute and relative
performance goals, which align the interests of our executives with our shareholders. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Capped award payouts</B> &#151; We set maximum award levels under our annual incentive program and
performance share units, with award payouts capped at 200%. In addition, payout for the portion of performance share units based on total shareholder return (&#147;TSR&#148;) performance is capped at 100% if absolute TSR is negative over the
performance period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Clawback</B> &#151; The Board may exercise its discretion to require any employee who receives equity-based
compensation to reimburse bonus, incentive or equity-based compensation awarded in the event of (1)&nbsp;a material restatement or adjustment to our financial statements or (2)&nbsp;detrimental conduct by the employee that has caused material
financial, operational, or reputational harm to us. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Double trigger acceleration following a change in control</B> &#151; No unvested equity awards accelerate
on a &#147;single-trigger&#148; basis in connection with a change in control. Instead, unvested equity awards accelerate on a &#147;double-trigger&#148; basis upon a qualifying termination of employment in connection with a change in control.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Limited severance</B> &#151; Our severance arrangements are modest, providing a cash severance payment for
our NEOs as follows: for our NEOs (other than our CEO, and the CEO of the Pharma Business), a cash severance payment equal to one and a half times annual base salary and annual target incentive and two times in the event of termination following a
change in control; and for our CEO and the CEO of the Pharma Business, a cash severance payment of two times annual base salary and annual target incentive. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Independent compensation consultant</B> &#151; The Talent and Compensation Committee has engaged an
independent compensation consultant that has no other ties to us or to our management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Shareholder engagement</B> &#151; We are committed to ongoing engagement with our shareholders through
structured, engaged investor outreach that enables us to obtain ongoing feedback on our compensation program. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>What We Don&#146;t
Do </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No hedging</B> &#151; Our anti-hedging policy prohibits officers, directors and employees from engaging in
hedging, short selling, or monetization transactions with our Common Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No pledging</B> &#151; Our anti-pledging policy prohibits officers, directors and employees from holding
our securities in a margin account where the securities are subject to margin sales or pledging our securities as loan collateral. The anti-pledging policy exempts any margin accounts in existence at the time the policy was adopted by the Company.
None of our NEOs or directors hold our securities in margin accounts subject to margin sales or pledging as loan collateral. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No repricing of underwater options</B> &#151; Repricing of stock options is expressly prohibited by our
Omnibus Incentive Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No excise tax <FONT STYLE="white-space:nowrap">gross-ups</FONT></B> &#151; We will not <FONT
STYLE="white-space:nowrap">gross-up</FONT> any excise tax that may be triggered as a result of a change in control severance payment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No single trigger vesting or payments</B> &#151; We do not provide for &#147;single trigger&#148; equity
award vesting or other &#147;single trigger&#148; payments or benefits upon a change in control. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No dividend or dividend equivalents on unearned incentive awards </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>No supplemental executive retirement plan</B> &#151; Executives are only eligible to participate in our <FONT
STYLE="white-space:nowrap">tax-qualified</FONT> Retirement Savings Plan that is provided on the same terms to all employees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No automatic or guaranteed annual salary increases </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2021 Shareholder Engagement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At our 2021 Annual Meeting of Shareholders, we held a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote with
respect to the compensation of our NEOs (commonly referred to as a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> vote) with approximately 93% of the total shareholders&#146; votes cast voted
in favor of our executive compensation program.&nbsp;We believe these favorable results indicate strong support for continuing our current executive compensation program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In recent years, we have had significant dialogue and engagement with our shareholders in order to solicit feedback on our
compensation philosophy and underlying programs through direct engagement with shareholders and during investor meetings and conferences. Members of our Talent and Compensation Committee directly engaged with 7 shareholders in April 2021
representing approximately 10% of our outstanding shares at that time. Consistent with our favorable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay&#148;</FONT></FONT> results, shareholders continued to provide
their support during these meetings for how our executive compensation program has evolved in recent years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee is committed to ongoing engagement
with our shareholders and will continue to solicit and consider the feedback received from shareholders regarding our executive compensation program. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Compensation Process </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of the Talent and
Compensation Committee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Board&#146;s Talent and Compensation Committee, which is comprised entirely of independent
directors, is responsible for implementing, monitoring, and evaluating our executive compensation philosophy and objectives and oversees the compensation program for senior executives. The Talent and Compensation Committee reviews and approves, or
recommends to the Board for approval, all components of executive pay and reports its decisions to the Board. The Board, with the assistance of the Talent and Compensation Committee, reviews or approves matters related to executive compensation on
an <FONT STYLE="white-space:nowrap">as-needed</FONT> basis. The Committee&#146;s responsibilities and authority are described fully in the Committee&#146;s charter, which is available on our website at <U>www.bauschhealth.com</U> (under the tab
&#147;Investors&#148; and under the subtab &#147;Corporate Governance &#151; Corporate Governance Documents&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of Management </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our CEO makes recommendations to the Talent and Compensation Committee for base salary, annual incentive awards and equity
grants for each NEO (other than the CEO, whose compensation is determined solely by the Talent and Compensation Committee, or recommended to the Board for approval). Our CEO and Chief Human Resources Officer also provide recommendations to the
Committee on other elements of our compensation program for senior executives, including, for example, the design and metrics under our annual and long-term incentive programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our CEO also leads a process each year to establish the collective strategic priorities of the senior executive team, and
then, with each executive, agrees on individual performance goals that tie to the achievement of these strategic priorities. These strategic priorities are shared with the Talent and Compensation Committee and their input is considered before they
are finalized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of the Independent Compensation Consultant </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In 2021, the Talent and Compensation Committee again engaged the services of Pay Governance as its independent consultant to
provide advice on executive compensation matters. Pay Governance reported directly to the Talent and Compensation Committee, which instructed the consultants to give it objective advice and without influence by management, and to provide such advice
for the benefit of the Board and our shareholders. Pay Governance did not provide any other services to the Company or its management. The Talent and Compensation Committee has evaluated Pay Governance&#146;s independence by considering the
requirements adopted by the NYSE and the SEC and has determined that no conflict of interest exists. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Peer Group </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each year, the Talent and Compensation Committee reviews its peer group to determine if any changes should be made in order to
ensure our peers reflect the businesses in which we compete for talent, and include relevant comparators, such as industry, business focus, and revenue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2021, the Talent and Compensation Committee reviewed the recommendation
of its independent compensation consultant, Pay Governance, and did not make any changes to the peer group, except to update our current peer from Mylan to Viatris, as a result of the combination of Mylan with Pfizer&#146;s Upjohn unit, as follows:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:31%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Alcon </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Alexion Pharmaceuticals, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Amgen Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Baxter International
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Biogen Inc.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:32%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CooperCompanies, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Eli Lilly and Company </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Endo
International plc </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Jazz Pharmaceuticals plc </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Perrigo Company plc
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:31%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Teva Pharmaceuticals </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">United Therapeutics Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Viatris </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Zimmer Biomet </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Zoetis Inc </P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent
and Compensation Committee will again review this peer group to determine what changes should be made in 2022 in order to establish peer groups for each of the three planned independent companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since we hire executives largely from within the pharmaceutical, medical device, and healthcare technology industries, we use
data from this peer group to benchmark pay levels, as well as pay practices. In addition to proxy data for the above companies, the Talent and Compensation Committee also utilizes the Willis Towers Watson&#146;s Pharmaceuticals and Health Sciences
Survey to supplement this data both in terms of pay levels as well as pay practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation
Committee references the median of the market data as a guide when making decisions. Market data is one element that the Talent and Compensation Committee uses to make pay decisions. Multiple factors are considered in determining total compensation
opportunity, including our compensation philosophy, the executive&#146;s role and responsibility, the executive&#146;s past performance, internal equity, and expected contributions and experience in the role. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Components of Executive Compensation </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The components of executive compensation for our NEOs, as described in more detail below, include (i)&nbsp;base salary;
(ii)&nbsp;incentive pay (including annual cash incentive and long-term equity incentives); (iii)&nbsp;retirement and welfare benefits; and (iv)&nbsp;executive benefits and perquisites. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base Salary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We set our
base salaries at competitive levels necessary to attract and retain top performing senior executives, including our NEOs. Base salaries provide an amount of fixed compensation to each senior executive for the performance of their core duties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Base salaries are periodically reviewed as part of our performance review process, as well as upon a promotion or other change
in job responsibilities. To the extent base salaries are adjusted, the amount of any such adjustment would reflect a review of competitive market data, consideration of relative levels of pay internally, individual performance of the executive, and
any other circumstances that the Talent and Compensation Committee determines are relevant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The NEOs Base Salaries are as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NEO</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020&nbsp;Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021&nbsp;Salary</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">No Change</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam A. Eldessouky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">No&nbsp;Change</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">775,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul S. Herendeen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During 2021, the changes to base salaries described above were all made in
connection with the promotions of our NEOs into new roles. As previously disclosed, Mr.&nbsp;Eldessouky, who previously served as the Controller and Chief Accounting Officer, was promoted to Chief Financial Officer, succeeding Mr.&nbsp;Herendeen
(who remained with the Company as Advisor to the Chairman and CEO, with a reduced salary commensurate with his new role). In addition, in connection with the&nbsp;separation of its B+L eye health business from the remainder of Bausch Health,
which&nbsp;is hereinafter being&nbsp;referred to as &#147;Bausch Pharma&#148;, Mr.&nbsp;Appio will be the CEO of Bausch Pharma and Mr.&nbsp;Spurr will be the&nbsp;U.S. President, Pharma Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In early 2022, the Talent and Compensation Committee determined that no annual increases would be made to any NEOs&#146;
salaries for 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Incentive Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our 2021 annual incentive program (the &#147;2021 AIP&#148;) provides an opportunity for our senior executives, including our
NEOs, to earn an annual incentive, paid in cash, based on the achievement of certain financial targets and strategic priorities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021
Annual Incentive Program Opportunity </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The NEOs annual incentive target, as a percentage of base salary, are as follows:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NEO</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incentive&nbsp;Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam A. Eldessouky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">%<SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">%<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul Herendeen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%<SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Eldessouky&#146;s target bonus opportunity reflects a change to his incentive target during fiscal
2021 in connection with a change in his role during the year. Mr.&nbsp;Eldessouky&#146;s target bonus opportunity for fiscal 2022 is 80% of base salary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Appio&#146;s target bonus opportunity reflects a change to his incentive target during fiscal 2021
in connection with a change in his role during the year. Mr.&nbsp;Appio&#146;s target bonus opportunity for fiscal 2022 is 120% of base salary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3.</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Herendeen&#146;s target bonus opportunity reflects a change to his incentive target during fiscal
2021 in connection with a change in his role during the year. Mr.&nbsp;Herendeen is not eligible for a bonus for fiscal 2022. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Annual Incentive Program Design </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For our senior executives, including our NEOs, the annual incentive program is based on performance against <FONT
STYLE="white-space:nowrap">pre-established</FONT> financial targets and strategic priorities approved by the Board. Performance against financial targets makes up 75% of the total payout, while performance against strategic priorities makes up 25%
of the total payout. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Adjusted EBITDA and Revenue are two of the key financial metrics our shareholders use to assess our
performance. We believe these metrics focus our NEOs on delivering both organic growth, as well as the Company&#146;s bottom line for our shareholders. The Company&#146;s strategic priorities are intended to focus the organization on the key
initiatives that will drive shareholder value over time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2021, the performance of our entire senior executive team,
including all of our NEOs, was measured against the Company&#146;s overall Adjusted EBITDA and Revenue performance for 75% of their total payout. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Adjusted EBITDA makes up 60% of this financial portion of their payout, and Revenue makes up 40% of this financial portion of their payout. Consistent with prior years, Company-wide strategic
priorities comprise the remaining 25% of their payout. This approach rewards our senior executive team for collectively working towards our mission of improving people&#146;s lives with our health care products, across all segments of our business.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2021, the threshold, target, and stretch performance and corresponding payouts were as follows, with award payouts
capped at 200% of incentive target. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EBITDA</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Revenue</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Performance&nbsp;versus&nbsp;Plan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payout</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Below Threshold</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&lt;90</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&lt;93</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Threshold</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Target</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Stretch</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Above Stretch</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&gt;110</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&gt;107</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee determines whether the financial metrics and strategic
priorities have been achieved. In addition, it retains the ability to reduce or eliminate payouts for individual executives, including the NEOs, even if financial metrics and strategic priorities are met, as well as to increase payouts based on
individual performance. In making these decisions, the Talent and Compensation Committee may consider factors such as the performance of the individual executive against their individual objectives in support of strategic priorities or additional
financial metrics applicable to the business or functional area for which the NEO is responsible. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Financial Objectives </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the beginning of 2021, the Board approved the Company&#146;s budget for the full year, including Adjusted EBITDA and Revenue
targets. These same financial metrics were reviewed and approved by the Talent and Compensation Committee to determine achievement under the Annual Incentive Program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For our NEOs, the financial targets are based on attaining budget (to receive a payout at target) or stretch targets (to
receive a payout above target) for Adjusted EBITDA and Revenue, as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Financial&nbsp;Metric<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighting</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stretch</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Achieved</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payout<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.067B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.408B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.749B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.501B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.057B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.663B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.269B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.446B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>102</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Adjusted EBITDA is a non-GAAP financial measure and may not be comparable to similar measures used by other
companies. Please see Appendix 1 for a reconciliation of our <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures to GAAP financial measures and related disclosures. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">In determining final payout versus the 2021 financial plan, the Talent and Compensation Committee reviewed
and approved external factors outside of management&#146;s control (e.g. foreign exchange, an earlier or later than anticipated loss of exclusivity, and other material adjustments). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Revenue for these purposes is the same as GAAP revenue, except that the exchange rates are those used for
the Annual Incentive Plan. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on the foregoing results, the Talent and Compensation Committee
certified that the total payout based on the Company&#146;s Adjusted EBITDA and Revenue was 102% for all NEOs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Strategic Priorities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the beginning of 2021, the Talent and Compensation Committee reviewed and approved the following strategic priorities, which
make up the remaining 25% of our NEOs&#146; payout: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Strategic&nbsp;Priority</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighting</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payout</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continue to cultivate a high-performance, results-oriented culture by recruiting, engaging,
developing, rewarding and retaining talent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Drive operational excellence across the enterprise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase size, breadth, and value of product pipeline</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Develop &#147;paths to win&#148; across the enterprise</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accomplish key milestones required to separate B+L into an independent company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>Total</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>102</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Achievement for each initiative was reviewed by the Talent and Compensation Committee, and
credit was determined based on results against each initiative, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We continued to cultivate a high-performance, results-oriented culture by: (i)&nbsp;launching a global
employee development framework focused on capability building, career development, and leadership growth to all employees, as well as global leadership programs to high-potential employees in support of our succession planning process;
(ii)&nbsp;continuing to foster connections amongst our workforce through employee resource groups and listening sessions, as well as online and <FONT STYLE="white-space:nowrap">facilitator-led</FONT> development programs for executives, managers,
and employees; (iii)&nbsp;introducing separation-related communication efforts in order to maintain a <FONT STYLE="white-space:nowrap">one-team</FONT> mindset during separation efforts; and (iv)&nbsp;ensuring employee retention, which, in line with
what most companies were experiencing in the industries and geographies in which we operate, trended higher than in 2020. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We drove operational excellence across the Company by: (i)&nbsp;delivering cost improvements across materials,
<FONT STYLE="white-space:nowrap">in-plant</FONT> efficiencies, and SKU reductions; (ii)&nbsp;executing on quality outcomes in support of business objectives; and (iii)&nbsp;achieving cash flow targets through management of payables, receivables, and
inventories. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We increased the size, breadth, and value of our product pipeline by: (i)&nbsp;meeting planned filings and
approvals; (ii)&nbsp;meeting expectations on phase III, early stage, and late stage projects; and (iii)&nbsp;launching four new products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We further developed &#147;paths to win&#148; by: (i)&nbsp;developing an environmental, social, and governance
scorecard and executing on these goals, and (ii)&nbsp;remaining agile and adaptable as new COVID variants emerged and regulations and guidelines changed, ensuring business continuity and the safety of our employees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We accomplished key milestones required to separate B+L and Solta into independent companies by
(i)&nbsp;completing all internal steps to ensure operations separation; (ii)&nbsp;establishing leadership teams for Bausch Pharma, B+L, and Solta and notified all employees globally which company they would work for post-separation;
(iii)&nbsp;completing financial segmentation; and (iv)&nbsp;filing the registration statements for the proposed IPOs of B+L and Solta. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our strong results and achievements for these Company-wide strategic priorities resulted in a payout of 102%. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Annual Incentive Program Payouts </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on this performance against <FONT STYLE="white-space:nowrap">pre-established</FONT> financial targets (102% payout,
comprising 75% of the total payout) and strategic priorities (102% payout, comprising 25% of the total payout) as approved by the Board, the following total payouts, were approved for our NEOs: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NEO</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incentive<BR>Target&nbsp;(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Incentive&nbsp;Target<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>Payout</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus&nbsp;Payout&nbsp;as<BR>%&nbsp;of&nbsp;Target<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,448,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam A. Eldessouky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">472,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 481,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 612,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">933,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 952,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">560,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 571,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul Herendeen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 510,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Bonus Payout as % of Target is shown at the nearest whole percent. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee did not make any further adjustments to the payouts as calculated above based on
performance against these <FONT STYLE="white-space:nowrap">pre-established</FONT> financial targets and strategic priorities approved by the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Long-Term Incentive Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This program provides an opportunity for our senior executives to be granted a balanced portfolio of Performance Share Units
(&#147;PSUs&#148;), Restricted Share Units (&#147;RSUs&#148;), and Stock Options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Grants to NEOs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2021, all of our NEOs received 2021 LTIP awards, which were granted for our CEO 70% in PSUs, 15% in RSUs and 15% in Stock
Options and for the other NEOs 40% in PSUs, 30% in RSUs, and 30% in Stock Options, with the following approximate values. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>NEO</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Approved&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam A. Eldessouky<SUP STYLE="font-size:85%; vertical-align:top">(2)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio<SUP STYLE="font-size:85%; vertical-align:top">(2)(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 7,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Spurr<SUP STYLE="font-size:85%; vertical-align:top">(2)(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul Herendeen<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 4,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="justify">Includes a PSU grant with an aggregate approved value of $4,000,000 for Mr.&nbsp;Papa, awarded in March 2021
as described below under B+L Separation Metrics. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="justify">Includes a <FONT STYLE="white-space:nowrap">one-time</FONT> RSU grant with an aggregate approved value of
$125,000 for Mr.&nbsp;Eldessouky, $500,000 for Ms.&nbsp;Ackermann, $450,000 for Mr.&nbsp;Appio, $350,000 for Mr.&nbsp;Spurr, and $875,000 for Mr.&nbsp;Herendeen, each of which were awarded in March 2021 in recognition of accomplishments related to
BHC&#146;s business recovery in connection with the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and efforts in connection with the separation of the B+L business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="justify">Includes a <FONT STYLE="white-space:nowrap">one-time</FONT> promotion equity grant with an aggregate approved
value of $2,000,000 for Mr.&nbsp;Eldessouky, which was awarded in June 2021 in connection with his appointment to CFO of BHC. This award was granted 50% in the form of RSUs and 50% in the form of stock options. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="justify">Includes a <FONT STYLE="white-space:nowrap">one-time</FONT> promotion equity grant with an aggregate approved
value of $5,000,000 for Mr.&nbsp;Appio, which was awarded in September 2021 in connection with his appointment to CEO of Bausch Pharma. This award was granted 50% in the form of PSUs and 50% in the form of stock options. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="justify">Includes a <FONT STYLE="white-space:nowrap">one-time</FONT> promotion equity grant with an aggregate approved
value of $500,000 for Mr.&nbsp;Spurr, which was awarded in September 2021 in connection with his appointment to U.S. President, Pharma Business. This award was granted 50% in the form of RSUs and 50% in the form of stock options.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2021 Performance Share Units </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">PSUs provide senior executives with the right to receive Common Shares at a future date, assuming performance against <FONT
STYLE="white-space:nowrap">pre-determined</FONT> metrics are achieved, specifically our Return on Tangible Capital (&#147;ROTC&#148;) and relative TSR, and, for our CEO, BHC&#146;s Separation of B+L (as described in more detail below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2021, for our CEO, ROTC and TSR metrics each comprised approximately 31% of the total PSU award, with the number of PSUs
that may be achieved capped at 200%, and B+L separation-related metrics comprised approximately 37% of the total PSU award (the &#147;B+L Separation PSUs&#148;), with the number of PSUs that may be achieved capped at 100%. For 2021, for all other
NEOs, ROTC and TSR each comprised 50% of the total PSU award, with the number of PSUs that may be achieved capped at 200%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The value ultimately received is based on our performance against these metrics, which are key measures of our long-term
performance, as well as the growth of our Common Share price over time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Return On Tangible Capital Metrics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ROTC is measured over three years, from 2021 through 2023. Starting in 2019, the Talent and Compensation Committee updated the
ROTC calculation by weighting the two components that comprise ROTC &#150; Net Operating Profit After Taxes (&#147;NOPAT&#148;) (75%) and Net Operating Assets (25%) &#150; with a higher weighting on the profitability component of this calculation.
The following ROTC goals were set at the beginning of 2021 and apply to the grants made to our NEOs in 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Financial&nbsp;Metric</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighting</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stretch</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Achieved</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payout</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NOPAT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.618B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.909B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.200B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.901B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Operating Assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.104B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.913B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.722B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.699B</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>123</B></TD>
<TD NOWRAP VALIGN="bottom"><B>%&nbsp;</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee has determined that, based on our combined NOPAT and Net
Operating Asset results, 123% of the ROTC PSUs were achieved for 2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Total Shareholder Return Metrics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The relative TSR performance period is three years, from January&nbsp;1, 2021 through December&nbsp;31, 2023, and is measured
as compared to the NYSE ARCA PHARMACEUTICAL INDEX peers. The following targets were set at the beginning of 2021 and apply to grants made in 2021: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentile</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payout</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Below Threshold</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&lt;30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Threshold</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Target</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Stretch</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Above Stretch</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&gt;80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">TSR is calculated as the stock price appreciation for the 20 days preceding the beginning of
the performance period as compared to the 20 days preceding the end of the performance period, plus dividends and distributions made or declared (assuming such dividends or distributions are reinvested in the Common Shares of the Company) during the
performance period. Further, if our absolute TSR is negative over the three-year period, any payout will in no event exceed 100%. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>B+L Separation Metrics </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B+L separation-related metrics for purposes of our CEO&#146;s B+L Separation PSUs are performance criteria related to the
separation of B+L from BHC. These PSUs will be earned based upon the achievement of (a)&nbsp;the operational separation of the B+L business from BHC and (b)&nbsp;the consummation of the <FONT STYLE="white-space:nowrap">spin-off</FONT> distribution
of B+L from BHC. The number of PSUs that may be achieved is capped at 100%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the first performance metric is achieved,
50% of these PSUs will vest upon the closing of the B+L IPO, subject to continued employment through such applicable date. The remaining 50% of these PSUs will vest on the date the second performance metric is achieved, subject to continued
employment through such applicable date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Restricted Share Units </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">RSUs provide senior executives with the right to receive Common Shares at a future date. The value ultimately received is based
on the growth of our Common Share price over time. RSUs vest <FONT STYLE="white-space:nowrap">one-third</FONT> per year, assuming continued employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2021 Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock options provide senior executives the opportunity to purchase our Common Shares at a price equal to the market price at
the time of the grant. The value ultimately received is based on the growth of our Common Share price over time. Stock options vest <FONT STYLE="white-space:nowrap">one-third</FONT> per year, and remain exercisable for a <FONT
STYLE="white-space:nowrap">ten-year</FONT> term, subject to continued employment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>2019 Performance Share Unit Vesting </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;27, 2022, the PSUs granted in 2019 to Mr.&nbsp;Papa, Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, Mr.&nbsp;Appio,
Mr.&nbsp;Spurr, and Mr.&nbsp;Herendeen vested based on their continued employment through the vesting date. ROTC comprised 50% of the total PSU award and TSR comprised 50% of the total PSU award, with the number of PSUs that could be achieved capped
at 200%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ROTC was measured over three years, from 2019 through 2021. 2019 ROTC was achieved at 117%, 2020 ROTC was
achieved at 65%, and, as disclosed above, 2021 ROTC was achieved at 123%. The average of these three years resulted in a final ROTC payout of 101% for the 2019 ROTC PSUs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">TSR was measured on both an absolute and relative basis. The relative TSR performance period was three years, from
January&nbsp;1, 2019 through December&nbsp;31, 2021, and was measured as compared to the NYSE ARCA PHARMACEUTICAL INDEX peers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentile</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payout</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Below Threshold</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&lt;30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Threshold</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Target</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Stretch</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Above Stretch</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&gt;80</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">TSR was calculated as the stock price appreciation for the 20 days preceding the beginning of
the performance period ($21.49) as compared to the 20 days preceding the end of the performance period ($25.93), plus dividends and distributions made or declared (assuming such dividends or distributions are reinvested in the Common Shares of the
Company) during the performance period. Based on our TSR ranking in the 38<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of our peers, the final payout was 70%. Further, since our absolute TSR was not negative over the three-year
period, and the payout was already below 100%, an absolute TSR cap was not applied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The total number of PSUs that were achieved for the combined ROTC and TSR
2019 PSU award was 85%. These 2019 PSUs were delivered in February 2022, as shown in the Outstanding Equity Awards at Fiscal Year End Table beginning on page 71. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>LTIP Program Changes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">BHC&#146;s Compensation Committee has determined that (i)&nbsp;ROTC performance in respect of the 2022 performance period and
the 2023 performance period applicable to the PSUs granted in each of 2020 and 2021, as applicable, will be deemed to be achieved at target at the closing of the B+L IPO, (ii)&nbsp;the last day of the TSR performance period applicable to such PSUs
will be the date of the closing of the B+L IPO, with actual achievement of the TSR performance metrics measured by the Talent and Compensation Committee through such date, and (iii)&nbsp;the 2021 ROTC PSUs will service vest on March&nbsp;3, 2023
(versus March&nbsp;3, 2024). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee also determined that 2022 LTIP awards should be
awarded 50% in RSU and 50% in Stock Options, in light of the pending B+L IPO and the challenge of setting new PSU metrics in the midst of this transformational time for our company. Mr.&nbsp;Appio and Mr.&nbsp;Spurr received grants in March 2022
under this program, based on their future roles with Bausch Pharma. We intend to <FONT STYLE="white-space:nowrap">re-introduce</FONT> PSUs in Bausch Pharma&#146;s future LTIP program. Specifically, following the B+L IPO, the Talent and Compensation
Committee will undertake a review of the LTIP for Bausch Pharma&#146;s senior executives, including the NEOs, to ensure the LTIP program continues to align with Bausch Pharma&#146;s future business strategy as well as pharmaceutical industry
practices. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Matching Share Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Starting in August&nbsp;2018, NEOs became eligible to participate in the Bausch Health Companies Matching Share Program. Under
this program, shares purchased on the open market by recipients are matched with one Matching Restricted Stock Unit (&#147;MRSU&#148;) issued under the 2014 Plan. Generally, MRSUs granted for a period of three years may not exceed the value of 50%
of the sum of the NEO&#146;s annual base salary and target annual cash bonus, less any shares sold within the past six months (excluding any shares sold to cover a tax obligation resulting from a vesting event). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the provisions of the 2014 Plan and applicable award agreements, MRSUs vest
<FONT STYLE="white-space:nowrap">pro-rata</FONT> over a three-year period, provided that the recipient is employed through the applicable vesting dates. Vesting ceases upon termination of employment (except in limited circumstances), and any MRSUs
that do not become vested prior to the recipient&#146;s termination of employment or that do not become vested according to the provisions of the terms of the award are forfeited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">None of our NEOs purchased shares under this program during 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>B+L Separation Bonus Opportunity </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October 2020, BHC&#146;s Compensation Committee approved Mr.&nbsp;Eldessouky&#146;s, Ms.&nbsp;Ackermann&#146;s,
Mr.&nbsp;Appio&#146;s, Mr.&nbsp;Spurr&#146;s and Mr.&nbsp;Herendeen&#146;s eligibility for a performance-based separation bonus, which requires the achievement of <FONT STYLE="white-space:nowrap">pre-determined</FONT> milestones related to the
separation transaction. Payment is made in cash, with 50% conditioned upon meeting internal readiness criteria for the separation of the two companies and the remaining 50% conditioned upon the successful close of the B+L separation transaction.
Payment is subject to continued employment, except in limited circumstances. The first 50% was paid in October 2021; additional details are shown below in the Summary Compensation Table on page 67. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Retirement and Welfare Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The retirement and welfare benefit programs are a necessary element of the total compensation package to ensure a competitive
position in attracting and maintaining a committed workforce. Participation in these programs is not tied to performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our specific contribution levels to these programs are adjusted annually to
maintain a competitive position while considering costs. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Retirement Savings Plan &#151; All employees in the United States, including our NEOs, are eligible to
participate in a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement savings plan under Section&nbsp;401(k) of the Code. Eligible employees are able to contribute to the Retirement Savings Plan, on a
<FONT STYLE="white-space:nowrap">before-tax</FONT> basis, up to 75% of their eligible compensation, subject to the limit prescribed by the Code. In 2021, we matched 100% of the first 3% of pay and 50% on the next 3% of pay that is contributed to the
Retirement Savings Plan. All employee contributions to the Retirement Savings Plan are fully vested upon contribution; matching contributions vest ratably over three years. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Welfare Plans &#151; Our executives are also eligible to participate in our broad-based welfare benefits plans
(including medical, dental, vision, life insurance and disability plans) upon the same terms and conditions as other employees. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Benefits and Perquisites </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We provide our NEOs with limited perquisites and other personal benefits that the Talent and Compensation Committee believes
are reasonable and consistent with our overall compensation program to better attract and retain superior employees for key positions. The Talent and Compensation Committee periodically reviews the levels of perquisites and other personal benefits
provided to our NEOs. The Talent and Compensation Committee intends to maintain only those perquisites and other benefits that it determines to be necessary components of total compensation and that are not inconsistent with shareholder interests.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee permits the Chairman and CEO to use our aircraft for his business travel and, on a
limited basis, for personal travel. Certain travel for immediate family members is also permitted, as reported on page 68 in footnote 4 to the Summary Compensation Table. We do not gross up the income tax incurred by Mr.&nbsp;Papa resulting from his
personal use of our aircraft. The Talent and Compensation Committee believes that making our aircraft available to our Chairman and CEO allows him to serve shareholder interests by efficiently and securely conducting business during and when
traveling. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Attributed costs of the personal benefits described above for our NEOs for the fiscal year ended
December&nbsp;31, 2021 are included in the column entitled &#147;All Other Compensation&#148; of the Summary Compensation Table on page 67. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Mr.&nbsp;Papa&#146;s Employment Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In April 2016, we entered into an employment agreement with Mr.&nbsp;Papa, which will be assigned to B+L upon, and subject to,
the closing of the B+L IPO. The initial term of Mr.&nbsp;Papa&#146;s agreement commenced on May&nbsp;2, 2016 and continues until the fifth anniversary of the commencement date. Beginning at the expiration of the initial term, the term will
automatically renew for successive <FONT STYLE="white-space:nowrap">one-year</FONT> periods unless either party gives notice of <FONT STYLE="white-space:nowrap">non-renewal.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to his agreement, Mr.&nbsp;Papa receives a base salary and a target annual incentive opportunity equal to 150% of his
base salary, with a maximum annual incentive opportunity equal to 200% of his annual target incentive. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with entering into his employment agreement, Mr.&nbsp;Papa received (i) 373,367 RSUs and (ii)&nbsp;an option to
acquire Common Shares with a grant-date fair value equal to $10,000,000 at an exercise price equal to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the fair market value of our Common Shares on the date of grant. Additionally, pursuant to his employment agreement, Mr.&nbsp;Papa was required to purchase $5,000,000 worth of Common Shares by no
later than the first anniversary of his commencement date. Mr.&nbsp;Papa satisfied this obligation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>RSUs</I>. As
provided for under the RSU award agreement, 50% (186,684) of these RSUs vested on May&nbsp;2, 2018, the second anniversary of his commencement date, based on <FONT STYLE="white-space:nowrap">pre-determined</FONT> individual goals relating to
(i)&nbsp;succession planning; (ii)&nbsp;government relations; (iii)&nbsp;employee relations; (iv)&nbsp;customer relations; and (v)&nbsp;shareholder relations being achieved. The remaining 50% vested on the fourth anniversary of his commencement
date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Options</I>. The options vest 25% on each of the first four anniversaries following the commencement date,
subject to Mr.&nbsp;Papa&#146;s continued employment with the Company through the applicable vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Future equity
grants for Mr.&nbsp;Papa are at the sole discretion of the Board or the Talent and Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination of Employment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consequences of Mr.&nbsp;Papa&#146;s termination of employment, whether or not in connection with a &#147;change in
control,&#148; are described in &#147;Potential Payments Upon Termination or Change in Control,&#148; beginning on page&nbsp;76. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Holding Requirements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to his employment agreement, Mr.&nbsp;Papa is restricted from selling, assigning, transferring or otherwise
disposing of Common Shares acquired pursuant to equity awards granted to him in accordance with the employment agreement (net of any shares sold or withheld by us in payment of the exercise price or tax withholding obligations) until the fourth
anniversary of his commencement date (or, if later, in the case of all of Mr.&nbsp;Papa&#146;s options, the first anniversary of the exercise date or vesting date and, in the case of 50% of Mr.&nbsp;Papa&#146;s options, the second anniversary of the
exercise date or vesting date). In addition, Mr.&nbsp;Papa is restricted from selling, assigning, transferring or otherwise disposing of Common Shares he purchases pursuant to his employment agreement until the fourth anniversary of the purchase
date. Notwithstanding the foregoing, all sales restrictions will lapse upon a &#147;change of control&#148; (excluding any change of control following which Mr.&nbsp;Papa serves as the chief executive officer of the ultimate parent company),
Mr.&nbsp;Papa&#146;s death, disability and involuntary termination of employment without &#147;cause&#148; or for &#147;good reason,&#148; or, in the case of the purchased shares, Mr.&nbsp;Papa&#146;s voluntary termination of employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrictive Covenants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Papa is subject to customary restrictive covenants, including <FONT STYLE="white-space:nowrap">non-competition</FONT>
and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants during his employment and for two years following termination of employment for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Mr.&nbsp;Eldessouky&#146;s Employment Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In May 2021, we entered into an employment agreement with Mr.&nbsp;Eldessouky upon his appointment as CFO, which will be
assigned to B+L upon, and subject to, the closing of the B+L IPO. The initial three-year term of Mr.&nbsp;Eldessouky&#146;s agreement commenced on June&nbsp;1, 2021. The term will automatically renew for successive
<FONT STYLE="white-space:nowrap">one-year</FONT> periods unless either party gives notice of <FONT STYLE="white-space:nowrap">non-renewal.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to his agreement, Mr.&nbsp;Eldessouky receives a base salary and a target annual incentive opportunity equal to 80%
of his base salary, with a maximum annual incentive opportunity equal to 200% of his annual target incentive. In connection with his promotion to Chief Financial Officer, Mr.&nbsp;Eldessouky received an equity grant with an aggregate value of
$2,000,000, 50% in the form of RSUs and 50% in the form of stock options. Ongoing equity grants are at the sole discretion of the Talent and Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consequences of Mr.&nbsp;Eldessouky&#146;s termination of employment,
whether or not in connection with a &#147;change in control,&#148; are described in &#147;Potential Payments Upon Termination or Change in Control,&#148; beginning on page&nbsp;76. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Eldessouky is subject to customary restrictive covenants, including
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants during his employment and for one year following termination of employment for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Ms.&nbsp;Ackermann&#146;s Employment Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In July 2016, we entered into an employment agreement with Ms.&nbsp;Ackermann, which will be assigned to B+L upon, and subject
to, the closing of the B+L IPO. Ms.&nbsp;Ackermann&#146;s agreement commenced on August&nbsp;8, 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to her
agreement, Ms.&nbsp;Ackermann receives a base salary and a target annual incentive opportunity equal to 80% of her base salary, with a maximum annual incentive opportunity equal to 200% of her annual target incentive. Ongoing equity grants are at
the sole discretion of the Talent and Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consequences of Ms.&nbsp;Ackermann&#146;s termination
of employment, whether or not in connection with a &#147;change in control,&#148; are described in &#147;Potential Payments Upon Termination or Change in Control,&#148; beginning on page&nbsp;76. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ms.&nbsp;Ackermann is subject to customary restrictive covenants, including
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants during her employment and for one year following termination of employment for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Mr.&nbsp;Appio&#146;s Employment Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2017, we entered into an employment agreement with Mr.&nbsp;Appio, which was amended in connection with his
appointment to CEO, Bausch Pharma in 2021. The initial three-year term of Mr.&nbsp;Appio&#146;s amended agreement commenced on September&nbsp;1, 2021. The term will continue to automatically renew for successive
<FONT STYLE="white-space:nowrap">one-year</FONT> periods unless either party gives notice of <FONT STYLE="white-space:nowrap">non-renewal.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to his agreement, Mr.&nbsp;Appio receives a base salary and a target annual incentive opportunity equal to 120% of
his base salary, with a maximum annual incentive opportunity equal to 200% of his annual target incentive. In connection with his promotion to CEO, Bausch Pharma, Mr.&nbsp;Appio received an equity grant with an aggregate approved value of
$5,000,000, 50% in the form of PSUs and 50% in the form of stock options. PSUs vest based on the achievement of absolute TSR, with 50% vesting if the stock price is $27.70, 100% vesting if the stock price is $30.47, 150% vesting if the stock price
is $31.86, and 200% vesting if the stock price is $33.24. Absolute TSR will be measured using the price at the time of the separation of B+L from the Company using a <FONT STYLE="white-space:nowrap">20-day</FONT> trail and straight-line
interpolation, and no shares will vest if the price at the time of measurement is less than $27.70. Ongoing equity grants are at the sole discretion of the Talent and Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Appio&#146;s expatriate assignment from New Jersey to China ended as of December&nbsp;31, 2021, in connection with
his appointment to CEO, Bausch Pharma. While on assignment in 2021, Mr.&nbsp;Appio received (i)&nbsp;Company-paid housing in China; (ii)&nbsp;tax equalization, with Mr.&nbsp;Appio responsible for actual taxes due in the United States and the Company
responsible for any taxes due in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions in which Mr.&nbsp;Appio earns taxable income; and (iii)&nbsp;tax preparation services. These benefits are reported in the &#147;All Other
Compensation&#148; column of the Summary Compensation Table on page&nbsp;67, including reimbursement related to the taxes on imputed income for these expatriate assignment benefits, as described on page&nbsp;68 in footnote 4 to such table. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consequences of Mr.&nbsp;Appio&#146;s termination of employment, whether or not in connection with a &#147;change in
control,&#148; are described in &#147;Potential Payments Upon Termination or Change in Control,&#148; beginning on page&nbsp;76. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Appio is subject to customary restrictive covenants, including <FONT
STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants during his employment and for two years following termination of employment for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Mr.&nbsp;Spurr&#146;s Employment Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In May 2020, we entered into an employment agreement with Mr.&nbsp;Spurr, which was amended in connection with his appointment
to U.S. President, Bausch Pharma in 2021. The initial three-year term of Mr.&nbsp;Spurr&#146;s amendment agreement commenced September&nbsp;1, 2021. The term will automatically renew for successive <FONT STYLE="white-space:nowrap">one-year</FONT>
periods unless either party gives notice of <FONT STYLE="white-space:nowrap">non-renewal.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to his
agreement, Mr.&nbsp;Spurr receives a base salary and a target annual incentive opportunity equal to 80% of his base salary, with a maximum annual incentive opportunity equal to 200% of his annual target incentive. In connection with his promotion to
U.S. President, Bausch Pharma, Mr.&nbsp;Spurr received an equity grant with an aggregate approved value of $500,000, 50% in the form of RSUs and 50% in the form of stock options. Ongoing equity grants are at the sole discretion of the Talent and
Compensation Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consequences of Mr.&nbsp;Spurr&#146;s termination of employment, whether or not in connection
with a &#147;change in control,&#148; are described in &#147;Potential Payments Upon Termination or Change in Control,&#148; beginning on page&nbsp;76. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Spurr is subject to customary restrictive covenants, including
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants during his employment and for one year following termination of employment for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Mr.&nbsp;Herendeen&#146;s Employment Agreement </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In August 2016, we entered into an employment agreement with Mr.&nbsp;Herendeen, which was amended effective June&nbsp;1, 2021
when he stepped down from his role as Chief Financial Officer and was appointed Advisor to the Chairman and CEO. Under this amended agreement, Mr.&nbsp;Herendeen&#146;s employment shall continue through May&nbsp;31, 2022 unless renewed by mutual
agreement by Mr.&nbsp;Herendeen and the Company. Under this amended agreement, Mr.&nbsp;Herendeen receives an annual base salary of $500,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consequences of Mr.&nbsp;Herendeen&#146;s termination of employment, whether or not in connection with a &#147;change in
control,&#148; are described in &#147;Potential Payments Upon Termination or Change in Control,&#148; beginning on page&nbsp;76. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mr.&nbsp;Herendeen is subject to customary restrictive covenants, including
<FONT STYLE="white-space:nowrap">non-competition</FONT> and <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenants during his employment and for one year following termination of employment for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Other Compensation Governance Practices </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Share
Ownership Guidelines </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee believes that purchasing and holding Common Shares with
one&#146;s own money should create an incentive to manage the Company prudently. When our CEO was hired in 2016, he was required to purchase at least $5,000,000 worth of Common Shares by no later than the first anniversary of his commencement date,
which he did. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee has also established minimum share ownership requirements for our
NEOs. Our CEO is required to hold 6 times base salary, and our other NEOs are required to hold 3 times base salary. Common Shares and unvested RSUs are included in the calculation of share ownership. NEOs have five years to achieve these guidelines
and must retain 50% of their net shares vesting until this requirement is met. Mr.&nbsp;Papa, Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, and Mr.&nbsp;Appio have satisfied this requirement; Mr.&nbsp;Spurr has until May 2025 to satisfy this requirement.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Pledging, Anti-Hedging and Clawback Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have adopted Anti-Hedging, Anti-Pledging, and recoupment (&#147;Clawback&#148;) Policies. The Anti-Hedging Policy generally
prohibits officers, directors and employees from engaging in new hedging or monetization transactions with Company stock. This prohibition prevents officers, directors and employees from owning securities without the full risks and rewards of
ownership and preserves the common interests and objectives of the Company and its officers, directors and employees. The Anti-Pledging Policy generally prohibits officers, directors and employees from holding our securities in a margin account
where the securities are subject to margin sales or pledging our securities as loan collateral. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Clawback Policy
provides that the Board may exercise its discretion to require any employee who receives equity-based compensation to reimburse bonus, incentive or equity-based compensation awarded to such employees beginning in 2017 in the event of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A material restatement or adjustment to our financial statements as a result of such employee&#146;s knowing
or intentional fraudulent or illegal misconduct; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Such employee&#146;s detrimental conduct that has caused material financial, operational or reputational harm
to us, including (i)&nbsp;acts of fraud or dishonesty during the course of employment; (ii)&nbsp;improper conduct that causes material harm to us or our affiliates; (iii)&nbsp;improper disclosure of confidential material that causes material harm to
us or our affiliates; (iv)&nbsp;the commission of a felony or crime of comparable magnitude that subjects us to material reputational harm; (v)&nbsp;commission of an act or omission that causes a violation of federal or other applicable securities
law; or (vi)&nbsp;gross negligence in exercising supervisory authority. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Following a material
restatement or adjustment of our financial statements, the compensation subject to clawback is the amount in excess of what would have been awarded based on the corrected performance measures, calculated on a
<FONT STYLE="white-space:nowrap">pre-tax</FONT> basis. If the financial reporting measure applicable to the incentive or equity-based compensation is a stock price or TSR measure, the Board has broad authority to estimate the effect of the financial
restatement on our share price in calculating recoverable compensation. In the case of detrimental conduct, the Board has the ability to recover all incentive compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may not indemnify any covered employee, directly or indirectly, for any losses incurred in connection with the recovery of
any compensation under the policy, including through the payment of insurance premiums, <FONT STYLE="white-space:nowrap">gross-up</FONT> payments or supplemental payments. The policy will continue to apply to covered employees even after they cease
to be employed by us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Risk Determination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee assesses the potential risks relating to our compensation policies and practices for our
employees, including those related to our executive compensation programs. Periodically, the Talent and Compensation Committee reviews and discusses with management the relationship between the Company&#146;s compensation policies and practices and
its risk management, including the extent to which those policies and practices create risks for the Company, to ensure that such policies and practices support not only economic performance, but also compliance with our risk management objectives,
and to ensure that they do not encourage excessive or unnecessary risk-taking and are not reasonably likely to have a material adverse effect on the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Tax and Accounting Implications </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax
Considerations of Our Executive Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;162(m) of the Code generally limits the tax deductibility of
annual compensation paid by public companies for certain executive officers to $1&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee may continue to approve compensation
that will not be fully-deductible in order to ensure competitive levels of total compensation for its executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounting for Our
Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We account for stock-based payments, including grants under each of our equity compensation
plans in accordance with the requirements of FASB ASC Topic 718. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_19"></A>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>The Report of the Talent and Compensation Committee of the Board shall not be deemed incorporated by reference by any
general statement incorporating by reference this Proxy Statement into any filing under the Securities Act of 1933, or the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates this information by
reference, and shall not otherwise be deemed filed under such Acts. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee of our
Board has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> with management and, based on such review and discussions, the Talent and Compensation
Committee recommended to the Board that the Compensation Discussion and Analysis be included in this&nbsp;Proxy&nbsp;Statement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talent&nbsp;and&nbsp;Compensation&nbsp;Committee</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Argeris (Jerry) N. Karabelas, Chairperson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard U. De Schutter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:25.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amy B. Wechsler, M.D.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_20"></A>2021 SUMMARY COMPENSATION TABLE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth the annual and long-term compensation awarded to or paid to the NEOs for services rendered to
the Company in all capacities during the years ended December&nbsp;31, 2021, 2020 and 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive&nbsp;
Plan<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Joseph C. Papa<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,561,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,250,054</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,448,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,889,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,526,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,127,907</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,251,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,160,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,119,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,286,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,999,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,240,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,141,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Sam A. Eldessouky</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">620,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,778,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,187,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">731,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,332,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive Vice President and Chief Financial Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">392,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,631</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,318,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Christina M. Ackermann</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,348,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">862,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,574,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive Vice President,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">743,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,692,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,541,028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:9pt; font-family:Times New Roman">General Counsel and Head of Commercial Operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">690,308</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,343,982</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">525,050</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">806,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">14,192</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,379,932</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Thomas J. Appio</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">854,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,752,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,202,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">839,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,188,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">President&nbsp;&amp; <FONT STYLE="white-space:nowrap">Co-Head</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">775,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">558,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">824,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,828,387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Bausch + Lomb/International</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">768,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,343,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">892,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">427,227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,958,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Robert A. Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">636,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,768,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">821,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,868,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">President, U.S. Pharma Business</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Paul S. Herendeen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">707,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,109,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,050,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,010,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,898,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Former Executive Vice President</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,815,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,050,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,966,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">and Chief Financial Officer<B><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,175,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,050,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,728,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,977,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This column represents the aggregate grant date fair value computed in accordance with FASB ASC Topic 718
for all stock awards granted in 2021, which includes PSUs and RSUs. The grant date fair value shown here differs from the approved value shown in the CD&amp;A because of the accounting methodology required in this table. The grant date fair value of
PSU awards was calculated based on the probable outcome of the performance conditions related to these awards in accordance with FASB ASC Topic 718 (excluding the effects of estimated forfeitures). For the 2021 amounts, the amount in the table
includes the following values: (i) PSUs ($14,146,781) and RSUs ($2,414,324) for Mr. Papa; (ii) PSUs ($364,944) and RSUs ($1,413,849) for Mr. Eldessouky; (iii) PSUs ($1,167,925) and RSUs ($1,180,300) for Ms. Ackermann; (iv) PSUs ($3,086,514) and RSUs
($3,666,304) for Mr. Appio; (v) PSUs ($729,887) and RSUs ($1,038,323) for Mr. Spurr; and (vi) PSUs ($2,043,914) and RSUs ($2,065,574) for Mr. Herendeen. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The number of PSUs that are ultimately distributed will be determined based on (i) TSR, and (ii) ROTC, and (iii), for Mr. Papa,
B+L separation-related metrics. The grant date fair value assuming a 200% payout, which is the maximum outcome of the performance conditions for TSR and ROTC, and a 100% payout, which is the maximum outcome of the performance for B+L
separation-related metrics, would be $24,001,405 for Mr. Papa, $729,888 for Mr. Eldessouky, $2,335,850 for Ms. Ackermann, $6,173,028 for Mr. Appio, $1,459,774 for Mr. Spurr and $4,087,828 for Mr. Herendeen. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For the 2021 amounts, this column represents the aggregate grant date fair value computed in accordance with
FASB ASC Topic 718, using Black-Scholes, excluding the effect of estimated forfeitures. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This column represents the NEO&#146;s 2021 AIP payouts as further described beginning on page 52 under
&#147;Components of Executive Compensation &#151; Annual Incentive Program&#148;. In addition, this column also represents the payout of 50% of the B+L separation bonus for our NEOs (other than Mr.&nbsp;Papa, who was not
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
eligible for such bonus) for the achievement of <FONT STYLE="white-space:nowrap">pre-determined</FONT> performance metrics related to the B+L separation transaction as further described under
&#147; &#150;B+L Separation Bonus Opportunity.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For 2021, amounts in this column for each NEO consist of the following: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Papa</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Eldessouky</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Ackermann</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Appio</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Spurr</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Herendeen</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">401(k) Match</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$<BR></TD>
<TD VALIGN="bottom" ALIGN="right">13,050<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of Company Aircraft<SUP STYLE="font-size:85%; vertical-align:top">(A)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 3,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of Company Car<SUP STYLE="font-size:85%; vertical-align:top">(B)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Physical<SUP STYLE="font-size:85%; vertical-align:top">(C)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Reimbursement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">51,983</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(D)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expat Program Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">774,051</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(A)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Amount includes the value of Mr.&nbsp;Papa and Mr.&nbsp;Herendeen&#146;s personal use of the Company&#146;s
aircraft (with the Company&#146;s incremental cost calculated based on all variable costs for the year, including the mileage charge for the flight, the fuel and allocable maintenance charge for the flight, as well as the ground transportation
charge, in accordance with the Company&#146;s policy on aircraft use). Beginning with 2020, the Company modified its methodology for calculating this incremental cost by limiting the maintenance charge to the portion allocable to the flight. There
was no income tax <FONT STYLE="white-space:nowrap">gross-up</FONT> related to the personal use of the Company aircraft and Mr.&nbsp;Papa and Mr.&nbsp;Herendeen are solely responsible for the income tax incurred. We did not include the incremental
cost of any portion of our monthly aircraft management fee, which we would have paid regardless of the personal use, or depreciation on the plane, which does not vary based on use. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(B)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This amount is the value of Mr.&nbsp;Eldessouky&#146;s and Ms.&nbsp;Ackermann&#146;s personal use of a
Company vehicle. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(C)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This amount represents the value of the executive physical benefit provided to Company executives.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(D)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Appio was on an expatriate assignment from New Jersey to China during 2021. This amount represents
the reimbursement related to the taxes on the imputed income from Mr.&nbsp;Appio&#146;s Expat Program Benefits as provided for pursuant to the Company&#146;s standard policy. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Papa is Chairman of the Board. He does not receive any additional compensation of any kind for his
services as a Board member. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Herendeen ceased serving as the Company&#146;s Chief Financial Officer on June&nbsp;1, 2021 and
transitioned to a new role as Advisor to the Chairman and CEO. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Grants of Plan-Based Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table provides information on the grants of plan-based awards to the NEOs during the year ended
December&nbsp;31, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Possible Payouts<BR>Under <FONT STYLE="white-space:nowrap">Non-Equity</FONT> Incentive<BR>Plan Awards<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated Future<BR>Payouts Under<BR>Equity Incentive Plan<BR>Awards<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other<BR>Stock<BR>Awards:<BR>Number<BR>of<BR>Shares&nbsp;of<BR>Stock
or<BR>Units<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP><BR>(#)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All
Other<BR>Option<BR>Awards:<BR>Number<BR>of<BR>Securities<BR>Underlying<BR>Options<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP><BR>(#)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>or Base<BR>Price of<BR>Option<BR>Awards<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP><BR>($/Sh)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date Fair<BR>Value<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP><BR>($)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Committee<BR>Action<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Threshold<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Joseph&nbsp;C.&nbsp;Papa</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 AIP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 TSR PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,233,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 ROTC PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,621,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 B+L Separation PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,292,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 RSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,414,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,250,054</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Sam A. Eldessouky</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 AIP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">560,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 TSR PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">230,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 ROTC PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 RSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Promotion RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/10/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,078,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Promotion Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/10/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Christina M. Ackermann</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 AIP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 TSR PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">738,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 ROTC PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">429,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 RSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,180,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600,033</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Thomas J. Appio</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 AIP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 TSR PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,932</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">664,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 ROTC PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">386,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 RSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,062,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Promotion PSUs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/30/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180,520</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,035,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Promotion RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/30/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,604,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Robert A. Spurr</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 AIP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">560,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 TSR PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">461,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 ROTC PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">268,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 RSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">777,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Promotion RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/30/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">260,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Promotion Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/30/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Paul Herendeen</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 AIP</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 TSR PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,292,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 ROTC PSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">751,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 RSU</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,065,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">2021 Options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,050,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">2021 AIP represents the threshold, target, and maximum awards set under the program. The actual amount paid
for 2021 is included in the Summary Compensation Table on page&nbsp;67 under the column titled <FONT STYLE="white-space:nowrap">&#147;Non-Equity</FONT> Incentive Plan Compensation.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Amounts shown are the threshold, target and maximum number of units that can be distributed under the 2021
PSUs awarded, based on the extent to which the metrics are achieved under these awards, as further described in the section titled &#147;Components of Executive Compensation &#151; Long-Term Incentive Program &#151; 2021 Performance Share
Units&#148; on page&nbsp;57. Earned PSUs, if any, can range from 0% to 100% of target for Mr.&nbsp;Papa&#146;s B+L separation-related metrics and 0% to 200% of target for our NEO&#146;s ROTC and TSR metrics. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This column shows the number of RSUs granted in 2021. The 2021 RSUs vest in three equal installments on the
first, second and third anniversaries of the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This column shows the number of <FONT STYLE="white-space:nowrap">non-qualified</FONT> Stock Options granted
in 2021. The aggregate number of Stock Options granted in 2021 expressed as a percentage of the total issued and outstanding shares of the Company as of December&nbsp;31, 2021 (otherwise known as the &#147;burn rate&#148;) was .45%.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The <FONT STYLE="white-space:nowrap">non-qualified</FONT> Stock Options vest
<FONT STYLE="white-space:nowrap">one-third</FONT> per year on the first, second and third anniversaries of the grant date and have a <FONT STYLE="white-space:nowrap">ten-year</FONT> term. The exercise price is the closing price of the Company&#146;s
Common Shares on the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">This column shows the grant date fair value of each equity award computed in accordance with FASB ASC Topic
718. The grant date fair value of the TSR PSU awards was calculated based on the probable outcome of the performance conditions related to these awards in accordance with FASB ASC 718. The grant date fair value of the Stock Options was determined
using Black-Scholes. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table provides information on the holdings of Stock Options and stock awards by the NEOs as of
December&nbsp;31, 2021. This table includes unexercised and unvested option awards and unvested RSUs and PSUs. Each equity grant is shown separately for each NEO. The market value of the stock awards is based on the closing market price of our
Common Shares on December&nbsp;31, 2021, which was $27.61. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Stock Awards</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date of<BR>Grant</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number<BR>of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Exercisable</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Options<BR>Exercise<BR>Price<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option<BR>Expiration<BR>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number<BR>of&nbsp;Shares<BR>or Units<BR>of
Stock<BR>That&nbsp;Have<BR>Not<BR>Vested<BR>(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That&nbsp;Have<BR>Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number<BR>of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have<BR>Not<BR>Vested<BR>(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market<BR>or<BR>Payout<BR>Value<BR>of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have<BR>Not<BR>Vested<BR>($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Joseph C. Papa</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/9/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">682,652</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.92</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/2/2026</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,058</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,455</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,728</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,990<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,395,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,241<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$2,353,504</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,061<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">747,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/28/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">276,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/13/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,083<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">195,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,704</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">227,410</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2030</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,177<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,103,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,520<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,118,757</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,780<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$1,678,136</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,027<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,491,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196,464</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,603<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,259,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,151<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$2,047,309</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">222,452<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$6,141,900</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,823<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$3,639,633</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,150<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,047,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Sam A. Eldessouky</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,430</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.38</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/2027</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.697</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,766</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,383</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,123<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">141,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,551<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$98,043</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,537<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">70,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,476</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,953</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2030</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,821<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">77,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,501<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$41,443</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,251<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$62,150</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,502<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">124,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,374</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,689<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 46,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,746<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 75,817</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,238<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 227,451</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,179 <SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">170,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,119 <SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">113,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/1/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,427</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.03</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/1/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6/1/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,673<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">929,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Christina&nbsp;M.&nbsp;Ackermann</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/10/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,469</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/10/2026</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,336</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,668</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,348<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">396,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Stock Awards</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date of<BR>Grant</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number<BR>of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Exercisable</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Options<BR>Exercise<BR>Price<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option<BR>Expiration<BR>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number<BR>of&nbsp;Shares<BR>or Units<BR>of
Stock<BR>That&nbsp;Have<BR>Not<BR>Vested<BR>(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That&nbsp;Have<BR>Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number<BR>of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have<BR>Not<BR>Vested<BR>(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market<BR>or<BR>Payout<BR>Value<BR>of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have<BR>Not<BR>Vested<BR>($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,944<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$274,554</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,104<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">196,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,291</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,582</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2030</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,125<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">224,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,322<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$119,330</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,483<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$178,996</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,966<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">357,991</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/10/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,927<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/28/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,781<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">518,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,392</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,405<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">149,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,788<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 242,637</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,364<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$727,910</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,773<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">545,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,477<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">454,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Thomas J. Appio</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/9/2013</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,350</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101.68</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/9/2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,174</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.38</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/2027</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="right">65,923</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,336</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,668</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,348<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">396,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,944<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$274,554</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,104<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">196,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,291</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,582</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2030</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,125<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">224,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,322<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$119,330</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,483<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$178,996</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,966<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">357,991</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,151</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,864<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">134,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,909<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 218,367</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,728<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 655,130</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,796<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">491,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,830<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">409,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,260<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,492,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1//2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,130<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$&nbsp;1,264,039</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Robert A. Spurr</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/27/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,576</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22.93</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/27/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,575</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,288</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,223<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,392<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$176,483</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,567<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">126,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/1/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">805<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 22,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,952</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,906</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2030</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,642<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">155,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,001<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$82,858</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,502<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$124,300</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,004<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">248,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,749</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,378<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 93,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,492<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 151,634</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,476<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 454,902</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,358<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">341,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Stock Awards</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date of<BR>Grant</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number<BR>of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Exercisable</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Options<BR>Exercise<BR>Price<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option<BR>Expiration<BR>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number<BR>of&nbsp;Shares<BR>or Units<BR>of
Stock<BR>That&nbsp;Have<BR>Not<BR>Vested<BR>(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock<BR>That&nbsp;Have<BR>Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number<BR>of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have<BR>Not<BR>Vested<BR>(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Market<BR>or<BR>Payout<BR>Value<BR>of<BR>Unearned<BR>Shares,<BR>Units
or<BR>Other<BR>Rights<BR>That<BR>Have<BR>Not<BR>Vested<BR>($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,534<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">318,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1//2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,026<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">249,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1//2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,400</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.85</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/1/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Paul S. Herendeen</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.74</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2026</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,387</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.32</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/7/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,668</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,334</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,697<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">792,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,889<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$549,135</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/27/2019</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,972<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">579,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,064</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,128</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.77</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2030</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,799<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">436,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,404<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$232,034</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,606<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$348,052</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/26/2020</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,020<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,160,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,684</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.56</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2031</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,458<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">261,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,379<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$ 424,614</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,138<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$&nbsp;1,273,870</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,603<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">955,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,836<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">796,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Options vest <FONT STYLE="white-space:nowrap">one-third</FONT> per year on the first, second and third
anniversary of the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the number of shares earned based on the average of the results of the 2019, 2020 and
2021 annual ROTC performance which was 101% of target. The shares were distributed to the NEOs on February&nbsp;28, 2022. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the number of shares earned based on the Company&#146;s TSR at the end of the
performance period. The Company&#146;s TSR was at the 38<SUP STYLE="font-size:85%; vertical-align:top">th </SUP>percentile of the Share Unit Peer Group&#146;s TSR, and the number of shares earned was 70% of target. The shares were distributed to the
NEOs on February&nbsp;28, 2022. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">RSUs and MRSUs vest <FONT STYLE="white-space:nowrap">one-third</FONT> per year on the first, second, and
third anniversary of the grant date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported reflects the first and second tranches of the award and is shown at achievement of 94%
of target. The award vests based on ROTC, measured over three <FONT STYLE="white-space:nowrap">one-year</FONT> periods, from 2020 through 2022. In connection with the B+L IPO, the Compensation Committee determined to adjust the terms of the PSUs
granted in 2020 to provide that ROTC performance in respect of the 2022 performance period will be deemed to be achieved at target as of the completion of the IPO. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the target number of shares for the third tranche of an award with three <FONT
STYLE="white-space:nowrap">one-year</FONT> periods. <FONT STYLE="white-space:nowrap">One-third</FONT> of such PSUs delivered will be based on ROTC for 2020 and <FONT STYLE="white-space:nowrap">one-third</FONT> of such PSUs delivered will be based on
ROTC for 2021, which were achieved at 65% and 123%, respectively, as described on page 58 and reflected in footnote 5 above. In connection with the B+L IPO, the Compensation Committee determined to adjust the terms of the PSUs granted 2020 to
provide that ROTC performance in </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
respect of the 2022 performance period will be deemed to be achieved at target as of the completion of this offering. The value shown above reflects target achievement for the 2022 measurement
period. The total number of PSUs delivered will be based on the average achievement with respect to each of the three <FONT STYLE="white-space:nowrap">one-year</FONT> periods. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the threshold number of shares for 2020 and the maximum number of shares for 2021.
The award vests as follows: If at the end of the TSR performance period, the Company&#146;s TSR equals or exceeds the 30th percentile of the Share Unit Peer Group&#146;s TSR, then 50% of the target shares will be delivered; equals or exceeds the
50th percentile of the Share Unit Peer Group&#146;s TSR, then 100% of the target shares will be delivered; equals or exceeds the 80th percentile of the Share Unit Peer Group&#146;s TSR, then 200% of the target shares will be delivered. However, if
the Company&#146;s TSR for the TSR performance period is negative, no more than 100% of the target shares will be delivered. In connection with B+L IPO, the Compensation Committee determined to adjust the terms of the PSUs granted in each of 2020
and 2021 to provide that the last day of the TSR performance period applicable to such PSUs will be the date of the completion of the IPO, with actual achievement of the TSR performance metrics measured by BHC&#146;s Compensation Committee through
such date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported reflects the first tranche of the award for the first year of the three-year measurement
periods and is shown at achievement of 123% of target. The award vests based on ROTC, measured over the three <FONT STYLE="white-space:nowrap">one-year</FONT> periods, from 2021 through 2023. In connection with the B+L IPO, the Compensation
Committee determined to adjust the terms of the PSUs granted in 2021 to provide that ROTC performance in respect of the 2022 performance period and the 2023 performance period will be deemed to be achieved at target as of the completion of the IPO.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the target number of shares for the second and third tranches of an award with three <FONT
STYLE="white-space:nowrap">one-year</FONT> periods. <FONT STYLE="white-space:nowrap">One-third</FONT> of such PSUs delivered will be based on ROTC for 2021, which were achieved at 123% as described on page 58 and reflected in footnote 8 above. In
connection with the B+L IPO, the Compensation Committee determined to adjust the terms of the PSUs granted 2021 to provide that ROTC performance in respect of the 2022 and 2023 performance periods will be deemed to be achieved at target as of the
completion of this offering. The value shown above reflects target achievement for the 2022 and 2023 measurement periods. The total number of PSUs delivered will be based on the average achievement with respect to each of the three <FONT
STYLE="white-space:nowrap">one-year</FONT> periods. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the target number of shares. These PSUs will be earned upon the achievement of
(a)&nbsp;the operational separation of B+L from BHC and (b)&nbsp;the consummation of the <FONT STYLE="white-space:nowrap">spin-off</FONT> distribution of B+L from BHC. The number of PSUs that may be achieved is capped at 100%. The earned PSUs will
generally vest on the date the performance metric is achieved (or otherwise certified by the BHC Compensation Committee, if applicable). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amount reported is the threshold number of shares; the actual amount earned will be determined upon the
full separation of B+L from the Company. The amount of shares that can be earned under the award is based on the value equal to the sum of (x)&nbsp;the average closing price of the Common Shares for the 20 trading days preceding (and not including)
the performance measurement date plus (y)&nbsp;the aggregate value of any dividends paid or declared on such Common Shares (excluding the Distribution) over the performance period (the &#147;Adjusted Share Price&#148;). If the Adjusted Share Price
equals or exceeds $27.70, 50% of target shares delivered; if the Adjusted Share Price equals or exceeds $30.47, 100% of target shares delivered; if the Adjusted Share Price equals or exceeds $31.86, 150% of target shares delivered; and if the
Adjusted Share Price equals or exceeds $33.24, 200% of target shares delivered. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Option Exercises and Stock Vested </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table provides information regarding option exercises by the NEOs during 2021 and Common Shares acquired on the
vesting of RSUs held by the NEOs during 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="justify"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on&nbsp;Exercise<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized<BR>on Exercise<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired&nbsp;on&nbsp;Vesting<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value&nbsp;Realized<BR>on Vesting<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">544,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,779,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sam A. Eldessouky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">858,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christina M. Ackermann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">121,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,057,581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,106,873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Appio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,759</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,108,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert A. Spurr</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul S. Herendeen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,425,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,362,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amounts reflected in this column represent the market value of the underlying Common Shares as of the
vesting date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_21"></A>POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth the expected benefits to be received by each NEO in each of the following termination
scenarios. This table assumes a termination date of December&nbsp;31, 2021 and a stock price of $27.61, which was the closing price of our Common Shares on December&nbsp;31, 2021, the last business day of the year. The receipt of benefits is
generally subject to executing and not revoking a release of claims. Other relevant assumptions and explanations are set forth in the footnotes following the table. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination&nbsp;without<BR>Cause or for<BR>Good Reason ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination&nbsp;within<BR>12 months of<BR>Change&nbsp;in&nbsp;Control&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination&nbsp;due&nbsp;to<BR>Death<BR>or Disability ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination&nbsp;due&nbsp;to<BR>Retirement ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Joseph C. Papa</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,448,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,448,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,448,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">RSUs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,177,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,757,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,757,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,238,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">PSUs<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,536,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,882,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,897,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,897,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock Options<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">996,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">996,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">996,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other Benefits<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Total Estimated Incremental Value</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>24,191,687</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>33,113,457</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>16,099,262</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,132,319</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Sam A. Eldessouky</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,621,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,330,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">RSUs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163,805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,408,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,408,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">PSUs<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">319,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">521,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">319,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock Options<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other Benefits<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Total Estimated Incremental Value</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,127,169</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,368,960</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,814,131</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Christina M. Ackermann</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,887,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,550,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">RSUs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">710,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,154,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,154,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">PSUs<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,503,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock Options<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other Benefits<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Total Estimated Incremental Value</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,530,195</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,488,499</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,301,162</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Thomas J. Appio</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,602,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,850,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">RSUs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">467,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,947,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,947,015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">554,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">PSUs<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,686,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">899,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock Options<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other Benefits<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Total Estimated Incremental Value</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,975,788</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>11,737,194</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,093,824</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,700,942</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Robert A. Spurr</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,711,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">RSUs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">321,377</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,305,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,305,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">PSUs<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">590,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">987,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">590,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock Options<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other Benefits<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Total Estimated Incremental Value</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,629,735</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>5,796,569</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,062,826</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#151;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Paul S. Herendeen</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,010,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,010,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">510,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">RSUs<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,466,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,490,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,490,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,739,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">PSUs<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,786,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,920,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,786,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,786,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stock Options<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">485,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other Benefits<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B><I>Total Estimated Incremental Value</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,283,334</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>7,927,393</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>6,273,072</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>4,011,521</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If Mr.&nbsp;Papa&#146;s employment is terminated by us without cause, or by Mr.&nbsp;Papa for good reason,
including within 12 months of our change in control (or during the <FONT STYLE="white-space:nowrap">six-month</FONT> period prior to a change in control if </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
such termination was in contemplation of, and directly related to, the change in control), or upon the expiration of his employment term, Mr.&nbsp;Papa will be entitled to receive a cash
severance payment equal to the sum of two times the sum of his annual base salary and annual target incentive payable in a lump sum and a prorated annual incentive based on actual performance, as shown above in &#147;Cash&#148; under
&#147;Termination without Cause or for Good Reason&#148; and &#147;Termination within 12 months of a Change in Control.&#148; Mr.&nbsp;Papa will also be entitled to receive continued health benefits for 24 months at active employee rates, as shown
above in &#147;Other Benefits&#148; under &#147;Termination without Cause or for Good Reason&#148; and &#147;Termination within 12 months of a Change in Control.&#148; For Mr.&nbsp;Papa, &#147;good reason&#148; includes (i)&nbsp;a diminution of
duties and responsibilities, including removing Mr.&nbsp;Papa from the position of CEO; (ii)&nbsp;any reduction in base salary or target incentive opportunity; (iii)&nbsp;any relocation of Mr.&nbsp;Papa&#146;s primary place of business that results
in an increase of his <FONT STYLE="white-space:nowrap">one-way</FONT> commute by 50 miles or more; and (iv)&nbsp;a material breach by the Company of a material provision of his employment agreement. If employment is terminated as a result of death
or disability, the Company will pay any bonus earned but unpaid in respect to the fiscal year preceding the termination date, as shown above under &#147;Termination due to Death or Disability.&#148; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If the employment of Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, Mr.&nbsp;Appio, or Mr.&nbsp;Spurr is
terminated by us without cause, or by Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, Mr.&nbsp;Appio, or Mr.&nbsp;Spurr for good reason, Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, and Mr.&nbsp;Spurr will be entitled to receive a cash severance payment equal
to the sum of one and a half times annual base salary and annual target incentive payable in a lump sum and Mr.&nbsp;Appio will be entitled to receive a cash severance payment equal to the sum of two times annual base salary and annual target
incentive payable in a lump sum, a prorated annual incentive for the year of termination equal to the lesser of the annual incentive based on our actual performance and annual target incentive, a cash payment equal to the remaining 50% of the B+L
separation bonus, continued health benefits at active employee rates for 12 months for Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, and Mr.&nbsp;Spurr and for 24 months for Mr.&nbsp;Appio, and, for Ms.&nbsp;Ackermann, outplacement support, as shown
above under &#147;Termination without Cause or for Good Reason.&#148; For Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann, Mr.&nbsp;Appio, and Mr.&nbsp;Spurr, &#147;good reason&#148; includes (i)&nbsp;a material reduction in duties and responsibilities,
including a removal from their current position; (ii)&nbsp;any reduction in base salary or target incentive opportunity which is not comparable to the reductions for other similarly situated executive officers; and (iii)&nbsp;a material breach by us
of a material provision of their employment agreement, and for Mr.&nbsp;Eldessouky, Mr.&nbsp;Appio, and Mr.&nbsp;Spurr, (iv)&nbsp;any relocation of their primary place of business that results in an increase of
<FONT STYLE="white-space:nowrap">one-way</FONT> commute by 50 miles or more. If such termination occurs in contemplation of our change in control or within 12 months following our change in control, Mr.&nbsp;Eldessouky, Ms.&nbsp;Ackermann,
Mr.&nbsp;Appio, and Mr.&nbsp;Spurr will be entitled to receive a cash severance payment equal to two times the sum of annual base salary and annual target incentive payable in a lump sum, a prorated annual target incentive for the year of
termination, continued health benefits for 12 months at active employee rates, and, for Ms.&nbsp;Ackermann, outplacement support, as shown above under &#147;Termination within 12 months of a Change in Control.&#148; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">If the employment of Mr.&nbsp;Herendeen is terminated for any reason, including the expiration of his
employment term, he will be entitled to any previous compensation earned. Under &#147;Termination without Cause or for Good Reason&#148; and &#147;Termination within 12 months of a Change in Control&#148; this includes Mr.&nbsp;Herendeen&#146;s
prorated annual incentive for 2021, as well as a cash payment equal to the remaining 50% of the B+L separation bonus. Under &#147;Termination due to Death or Disability,&#148; this includes Mr.&nbsp;Herendeen&#146;s prorated annual incentive for
2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Pursuant to the terms of the equity award agreements governing all of the NEOs&#146; 2019, 2020, and 2021
RSUs and MRSUs, if their employment is terminated by us without cause or by the NEOs for good reason, unvested RSUs will vest <FONT STYLE="white-space:nowrap">pro-rata</FONT> and if their employment is terminated due to death or disability, all
unvested RSUs will vest. Under these agreements, if an NEO is terminated without cause (or, in the case of the 2019, 2020 and 2021 RSUs, by the NEO for good reason) within 12 months of a change in control (or during the <FONT
STYLE="white-space:nowrap">six-month</FONT> period prior to a change in control if such termination was in contemplation of, and directly related to, the change in control), all unvested RSUs will vest. This vesting treatment applies beginning after
the first anniversary of the grant date if an NEO is terminated without cause or for good </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
reason. Therefore, no value is shown above for the 2021 RSUs and MRSUs under &#147;Termination without Cause or for Good Reason.&#148; For all of the NEOs&#146; 2019, 2020 and 2021 RSUs, if the
NEO voluntarily terminates his or her service with us on or after age 55, and age plus years of service total at least 65, all unvested RSUs will vest. This vesting treatment applies beginning after the first anniversary of the grant date.
Therefore, no value is shown for the 2021 RSUs separately above for &#147;Termination due to Retirement.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Pursuant to the terms of the equity award agreements governing all of the NEOs&#146; 2019, 2020 and 2021
PSUs, if their employment is terminated by us without cause, by the NEOs for good reason, or upon death or disability, they will be entitled to prorated vesting of unvested PSUs at actual performance as shown above under &#147;Termination without
Cause or for Good Reason&#148; and &#147;Termination due to Death or Disability.&#148; This vesting treatment for the PSUs applies beginning after the first anniversary of the grant date. Therefore, no value is shown above for the 2021 PSUs under
&#147;Termination without Cause or for Good Reason&#148; or &#147;Termination due to Death or Disability.&#148; If their employment is terminated by us without cause, or by the NEOs for good reason, in each case within 12 months of our change of
control (or during the <FONT STYLE="white-space:nowrap">six-month</FONT> period prior to a change in control if such termination was in contemplation of, and directly related to, the change in control), unvested PSUs will vest <FONT
STYLE="white-space:nowrap">pro-rata</FONT> based on target performance through the termination date (or, if later, the date of the change in control). In the event the PSUs are not assumed or substituted in connection with the change in control,
unvested PSUs will vest <FONT STYLE="white-space:nowrap">pro-rata</FONT> based on target performance on the date of such change in control. For all of the NEOs&#146; 2019, 2020 and 2021 PSUs, if the NEO voluntarily terminates his or her service with
us on or after age 55, and age plus years of service total at least 65, any unvested portion of the PSU will vest <FONT STYLE="white-space:nowrap">pro-rata</FONT> based on actual results. This vesting treatment applies beginning after the first
anniversary of the grant date. Therefore, no value is shown separately above for the 2021 PSUs for &#147;Termination due to Retirement.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Pursuant to the terms of the equity award agreements governing all of the NEOs&#146; 2019, 2020 and 2021
stock options, if their employment is terminated by us without cause, or terminated by the NEOs for good reason, in either case within 12 months of our change of control (or during the <FONT STYLE="white-space:nowrap">six-month</FONT> period prior
to a change in control if such termination was in contemplation of, and directly related to, the change in control), or in the case of death or disability, unvested options will vest in full. For all of the NEOs&#146; 2019, 2020 and 2021 stock
options, if the NEO voluntarily terminates his or her service with us on or after age 55, and such NEO&#146;s age plus years of service total at least 65, all unvested options will vest. This vesting treatment applies beginning after the first
anniversary of the grant date. Therefore, no value is shown separately above for the 2021 stock options for &#147;Termination due to Retirement.&#148; </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 Pay Ratio Disclosure </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Pay
Ratio </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with the requirements of Section&nbsp;953(b) of the Dodd-Frank Act and Item 402(u) of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> (which we collectively refer to as the &#147;Pay Ratio Rule&#148;), we are providing the following estimated information for 2021: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the median of the annual total compensation of all our employees (excluding our CEO) was $44,617;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the annual total compensation of our CEO was $22,889,137; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ratio of these two amounts was 513 to 1. We believe that this ratio is a reasonable estimate calculated in
a manner consistent with the requirements of the Pay Ratio Rule. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Methodology for Identifying Our Median Employee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Employee Population </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To identify the median of the annual total compensation of all of our employees (other than our CEO), we first identified our
total employee population from which we determined our median employee. We determined </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
that, as of December&nbsp;31, 2021, our employee population consisted of approximately 19,601 individuals (of which approximately 32% were located in the United States and 68% were located in
jurisdictions outside the United States). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As permitted by the Pay Ratio Rule, we adjusted our total employee population
(as described above) for purposes of identifying our median employee by excluding approximately 120 of our employees located in certain jurisdictions outside of the United States given the relatively small number of employees in those jurisdictions
(less than 25), as follows: Austria, Belgium, Bosnia&nbsp;&amp; Herzegovina, Croatia, Estonia, Indonesia, Lithuania, Montenegro, New Zealand, Panama, Peru, Philippines, and Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After taking into to account the above described adjustments to our employee population as permitted by the Pay Ratio Rule,
our total adjusted employee population for purposes of determining our median employee consisted of approximately 19,481 individuals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Determining our Median Employee </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To identify our median employee from our adjusted employee population, we compared the amount of base salary of our employees
as reflected in our payroll records and converted to U.S. Dollars. In making this determination, we annualized the compensation of our full-time employees, including those who were hired in 2021 (but did not work for us for the entire fiscal year)
and permanent part-time employees (reflecting what they would have earned if they had worked the entire year at their part-time schedule). We identified our median employee using this compensation measure, which was consistently applied to all our
employees included in the calculation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Determination of Annual Total Compensation of our Median Employee and our CEO </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Once we identified our median employee, we then calculated such employee&#146;s annual total compensation for 2021 by using the
same methodology we used for purposes of determining the annual total compensation of our NEOs for 2021 as set forth in the 2021 Summary Compensation Table on page 67. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our CEO&#146;s annual total compensation for 2021 for purposes of the Pay Ratio Rule is equal to the amount reported in the
&#147;Total&#148; column in the 2021 Summary Compensation Table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Please note that SEC rules for identifying the median
employee and calculating the pay ratio allow companies to apply various methodologies and apply various assumptions and, as result, the pay ratio reported by us may not be comparable to the pay ratio reported by other companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_22"></A>DIRECTOR COMPENSATION TABLE </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard U. De Schutter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">383,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">383,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D. Robert Hale<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brett Icahn<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">366,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Argeris (Jerry) N. Karabelas</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">392,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sarah B. Kavanagh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Miller<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">366,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John A. Paulson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert N. Power</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">392,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Russel C. Robertson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">397,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">397,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas W. Ross, Sr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">217,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">463,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrew C. von Eschenbach, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amy B. Wechsler, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">373,382</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The amounts shown in this column relate to the annual RSU grant made to each
<FONT STYLE="white-space:nowrap">non-employee</FONT> director in 2021, as further described below under the heading &#147;Director Compensation,&#148; and with respect to Mr.&nbsp;De Schutter, Mr.&nbsp;Paulson, Mr.&nbsp;Robertson and
Dr.&nbsp;Wechsler, also relate to RSUs granted in lieu of cash for annual Board and/or committee retainers, pursuant to their respective elections. These amounts are based upon the grant date fair value of awards calculated in accordance with FASB
ASC Topic 718. Fair value is calculated using the closing price of our Common Shares on the date of grant for purposes of determining the individual grant amounts. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Directors had aggregate outstanding RSUs at 2021 fiscal <FONT STYLE="white-space:nowrap">year-end</FONT> as
follows: Mr.&nbsp;De Schutter, 38,731, Mr.&nbsp;Hale, 7,645; Mr.&nbsp;Icahn, 11,023; Dr.&nbsp;Karabelas, 85,328; Ms.&nbsp;Kavanagh, 83,060; Mr.&nbsp;Miller, 11,045; Mr.&nbsp;Paulson, 85,289; Mr.&nbsp;Power, 94,823; Mr.&nbsp;Robertson, 126,585;
Mr.&nbsp;Ross, 86,424; Dr.&nbsp;von Eschenbach, 35,147; and Dr.&nbsp;Wechsler, 99,054. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">With respect to Mr.&nbsp;Hale, all Board compensation accrues to the benefit of the investors in ValueAct
Capital Master Fund, L.P., and not to any individual. Under an agreement with ValueAct Capital, Mr.&nbsp;Hale is deemed to hold the RSUs for the benefit of the limited partners of ValueAct Capital Master Fund, L.P and indirectly for VA Partners I,
LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management,
L.P., (iv) ValueAct Holdings, L.P. as the majority owner of the membership interests of VA Partners I, LLC, (v)&nbsp;ValueAct Holdings II, L.P. as the sole owner of the membership interests of ValueAct Capital Management, LLC and as the majority
owner of the limited partnership interests of ValueAct Capital Management, L.P., and (vi)&nbsp;ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P and ValueAct Holdings II, L.P. Each person disclaims beneficial ownership of any
securities deemed to be owned by the group that are not directly owned by such person. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Messrs. Icahn and Miller were appointed to the Board on March&nbsp;17, 2021. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In 2021, our directors&#146; fees consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Cash Compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board Retainer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Fee &#151; Lead Independent Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Retainers &#151; Committee Chairpersons</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit and Risk Committee Chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talent and Compensation Committee Chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee Chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Science and Technology Committee Chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance and Transactions Committee Chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special Transactions Committee Chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional Retainers &#151; Committee Members not serving as Chairpersons</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit and Risk Committee Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Talent and Compensation Committee Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Science and Technology Committee Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finance and Transactions Committee Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special Transactions Committee Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Equity Compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual RSU Grant</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our Nominating and Corporate Governance Committee is required by its charter to periodically
review, and make recommendations to the full Board regarding, the compensation of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. The Nominating and Corporate Governance Committee has sole authority under its charter to retain
and/or terminate compensation consultants or compensation consulting firms as the Nominating and Corporate Governance Committee may deem appropriate in recommending <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In 2021, the Nominating and Corporate Governance Committee engaged Pay Governance LLC to assist in its periodic assessment of
our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation. In their evaluation, which concluded in February 2021, the Nominating and Corporate Governance Committee considered, among other factors, (i)&nbsp;compensation data of
comparator groups; (ii)&nbsp;the high level of expertise and the time commitment that service on our Board and the Board committees require; and (iii)&nbsp;the workload of each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. The
Nominating and Corporate Governance Committee determined that, based on these factors, it was appropriate to recommend that the Board increase the annual retainers for the Chairpersons of the Nominating and Corporate Governance Committee and the
Finance and Transactions Committee from $15,000 to $20,000, and to increase the annual retainer for the <FONT STYLE="white-space:nowrap">non-Chairperson</FONT> members of the same committees from $10,000 to $12,500.&nbsp;The Board reviewed and
approved these changes on, and effective as of, February&nbsp;16, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our directors may elect to receive their fees in
cash, in RSUs, or in a combination of cash and RSUs. RSUs received pursuant to this election are paid in a lump sum of Common Shares at the end of such director&#146;s service with the Company. All fees, whether payable in cash or RSUs, are
delivered in quarterly installments, with the exception of the additional fee for the Lead Independent Director, which is paid once annually on the third day following each Annual Meeting of Shareholders. In addition to the above fees, directors are
also reimbursed for their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses in attending <FONT STYLE="white-space:nowrap">in-person</FONT> meetings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any director serving as
<FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairperson would be entitled to receive an annual payment of $400,000 (payable $220,000 in RSUs and $180,000 in cash). There is currently no <FONT STYLE="white-space:nowrap">Non-Executive</FONT>
Chairperson on the Board, and Mr.&nbsp;Papa, our Chairman and CEO, received compensation in 2021 only in his capacity as our CEO. See Summary Compensation Table on page 67. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company also grants each <FONT STYLE="white-space:nowrap">non-employee</FONT> director, on the third business day
following each Annual Meeting of Shareholders, a number of RSUs with a fair market value equal to $250,000. These annual grants of RSUs vest and are deliverable prior to the next Annual Meeting of Shareholders, unless the director elects to defer
issuance until the director&#146;s separation from the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors are also subject to minimum share ownership requirement. For further detail regarding the share ownership requirement for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, see the discussion in the section titled
&#147;Statement of Corporate Governance Practices &#151; Directors&#146; Share Ownership&#148; on page 30. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon his
appointment to the Board at the IPO Closing Date, Dr. Mulligan will be eligible to participate in our non-employee director compensation programs described above. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_23"></A>EQUITY COMPENSATION PLAN INFORMATION </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities<BR>to Be Issued Upon<BR>Exercise of<BR>Outstanding&nbsp;Options,<BR>Warrants and<BR>Rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-Average<BR>Exercise Price of<BR>Outstanding&nbsp;Options,<BR>Warrants and<BR>Rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities<BR>Remaining&nbsp;Available&nbsp;for<BR>Future Issuance Under<BR>Equity&nbsp;Compensation&nbsp;Plans<BR>(Excluding
Securities<BR>Reflected in Column (a))</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Approved By Shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,600,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Not Approved By Shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Included in this amount is the maximum number of Common Shares that may be issued under each of the PSUs and
annual RSUs outstanding as of December&nbsp;31, 2021. As of December&nbsp;31, 2021, the weighted average remaining contractual term of outstanding options was 6.6 years. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amended and Restated 2014 Omnibus Incentive Plan Summary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s 2014 Omnibus Incentive Plan was initially adopted by the Board on April&nbsp;7, 2014 and approved by our
shareholders effective as of May&nbsp;20, 2014, and was amended and restated effective as of each of April&nbsp;30, 2018 and April&nbsp;28, 2020, as approved by the Board and shareholders of the Company (the &#147;2014 Plan&#148;). For Information
about the 2014 Plan, please see Proposal No.&nbsp;3 starting on page 90. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2011 Omnibus Incentive Plan Summary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s 2011 Omnibus Incentive Plan (the &#147;2011 Plan&#148;) was adopted and approved by the Board and the
shareholders of the Company effective as of May&nbsp;16, 2011. The Company ceased granting new awards under the 2011 Plan upon the approval of the 2014 Plan in 2014. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Awards Under The 2011 Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards under the 2011 Plan may be granted as options (including both incentive stock options and nonqualified stock options),
SARs, share awards (including restricted shares, deferred shares and share units that may be settled either in Common Shares or cash) or cash awards. A SAR entitles the participant to receive an amount equal to the difference between the market
price of the Company&#146;s Common Shares on the exercise date and the exercise price of the SAR (which may not be less than 100% of the market price of a Common Share on the grant date), multiplied by the number of Common Shares subject to the SAR.
However, no SARs or deferred shares have been granted under the 2011 Plan. Awards may be granted singly, in combination or in tandem as determined by the Talent and Compensation Committee, in its sole discretion. A maximum of 328,923 Common Shares
(less than 1% of the issued and outstanding Common Shares as of December&nbsp;31, 2021) may be issued pursuant to the exercise of options or in connection with the vesting of share awards under the terms of the 2011 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Eligibility </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Persons eligible to receive awards are any employees, directors or individuals performing services for the Company or its
subsidiaries in the capacity of a consultant, agent or otherwise, as determined by the Talent and Compensation Committee. Unless otherwise determined by the Talent and Compensation Committee, members of the Board shall generally not be eligible to
receive SARs or options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Participation Limits </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to adjustments made to reflect a change in the Company&#146;s capital structure, including as a result of a stock
dividend, stock split, reverse consolidation, recapitalization, reorganization or divestiture or other similar event (&#147;capital structure adjustments&#148;), the aggregate number of Common Shares that may be granted to any &#147;covered
employee&#148; during a calendar year in the form of options, SARs, and/or share awards intended to qualify as &#147;performance-based compensation&#148; (such terms having the meanings given in Section&nbsp;162(m) of the Code, including any rules
and regulations thereunder) shall not exceed 1,000,000 Common Shares (computed based on maximum performance). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, (i)&nbsp;the number of Common Shares issuable to persons who are reporting insiders (as defined in National
Instrument <FONT STYLE="white-space:nowrap">55-104</FONT> &#151;<I> Insider Reporting Requirements and Exemptions</I> of the Canadian Securities Administrators), at any time, under all security-based compensation arrangements of the Company, cannot
exceed 10% of issued and outstanding Common Shares of the Company; and (ii)&nbsp;the number of Common Shares issued to such insiders, within any <FONT STYLE="white-space:nowrap">one-year</FONT> period, under all security-based compensation
arrangements of the Company, cannot exceed 10% of its issued and outstanding securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Expiration of Options and SARs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, options and SARs are granted for a term determined by the Talent and Compensation Committee but not to exceed 10
years (the &#147;Original Term&#148;). For options granted as incentive stock options to certain participants, the Original Term shall not exceed five years. If the Original Term of an option and SAR held by a participant expires during a Company
blackout period applicable to the participant which prohibits the participant from trading in Company securities, the term of such option shall be extended until the tenth business day following the end of the Company blackout period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Exercise Price of Options and SARs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The exercise price per share for each option and SAR is not less than 100% of the closing price of the Common Shares on the
trading day immediately preceding the date of grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Vesting </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards under the 2011 Plan are subject to such vesting provisions as the Talent and Compensation Committee may determine.
Options currently outstanding vest in equal installments over a period of three or four years after the date of grant or 100% on the third or fourth anniversary of the grant date. Share units generally vest 100% on the third anniversary of the date
of grant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dividend Equivalents </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee may provide that share awards earn dividends or dividend equivalents in the form of
additional share awards, subject to such terms, conditions, restrictions and limitations as it may establish from time to time. Notwithstanding the foregoing, dividends or dividend equivalents may not be paid with respect to any share award subject
to the achievement of performance criteria, unless and until the relevant performance criteria have been satisfied. Generally, holders of share units receive dividend equivalents which are subject to vesting in line with the underlying award to
which they relate<B>.</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Termination of Employment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as otherwise provided in a participant&#146;s employment agreement or letter, in the event that the optionholder&#146;s
employment is terminated by reason of death, disability, termination by the Company without cause or the participant voluntarily resigns, the right to exercise such option terminates on the date that is 90 days from the participant&#146;s
termination (but in no event beyond the Original Term). Any options or share units that are unvested and do not vest on the termination date are cancelled and forfeited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event that the optionholder&#146;s employment is terminated by the Company without cause within one year following a
change of control, all unvested options will vest on such termination and the optionholder will have one year following such a termination to exercise the option (but in no event beyond the Original Term). In the case of a holder of share units
whose employment is terminated by the Company within one year following a change of control, a number of the holder&#146;s share units will vest on such termination equal to the number of share units granted multiplied by a fraction, the numerator
of which is the number of completed months between the date of grant and the date of termination and the denominator of which is <FONT STYLE="white-space:nowrap">thirty-six</FONT> (36). Any remaining unvested share units which do not vest on the
termination date will be cancelled and forfeited on the date of termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event that the optionholder&#146;s
employment is terminated by the Company for cause prior to the exercise of the option, the option shall terminate and expire as of the date of termination of the employment. In the case of a holder of share units whose employment is terminated by
the Company for cause, all of the holder&#146;s share units shall terminate as of the date of termination of the employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Nontransferability </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards granted under the 2011 Plan, and during any period of restriction on transferability, Common Shares issued in connection
with the exercise of an option, may not be sold, pledged, hypothecated, assigned, margined or otherwise transferred in any manner other than by will or the laws of descent and distribution, unless and until the Common Shares underlying such award
have been issued, and all restrictions applicable to such Common Shares have lapsed or have been waived by the Talent and Compensation Committee. Notwithstanding the foregoing, the Talent and Compensation Committee may, in its sole discretion,
permit (on such terms, conditions and limitations as it may establish) nonqualified stock options and/or Common Shares issued in connection with an option exercise to be transferred to a member of a participant&#146;s immediate family or to a trust
or similar vehicle for the benefit of a participant&#146;s immediate family members. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Amendment and Termination </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2011 Plan and any award may be amended, suspended or terminated at any time by the Board, provided that no amendment shall
be made without shareholder approval if such shareholder approval is required in order </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to comply with applicable law or the rules of the NYSE, the rules of the TSX, or any other securities exchange on which the Common Shares are traded or quoted. Under the 2011 Plan, the Company
shall obtain shareholder approval for: (i)&nbsp;a reduction in the exercise price or purchase price of an award (or the cancellation and <FONT STYLE="white-space:nowrap">re-grant</FONT> of an award resulting in a lower exercise price or purchase
price), except where the reduction is made to reflect a change in the Company&#146;s capital structure, including as a result of a capital structure adjustment; (ii)&nbsp;the extension of the Original Term of an option; (iii)&nbsp;any amendment to
remove or to exceed the participation limits described above; (iv)&nbsp;an increase to the maximum number of Common Shares issuable under the 2011 Plan (other than adjustments made to reflect a change in the Company&#146;s capital structure,
including as a result of a capital structure adjustment); (v)&nbsp;amendments to the amendment provision of the 2011 Plan other than amendments of a clerical nature; and (vi)&nbsp;any amendment that permits awards to be transferable or assignable
other than for normal estate settlement purposes or for other purposes not involving the receipt of monetary consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Without shareholder approval, the Board has the discretion to make certain amendments to the 2011 Plan, including:
(i)&nbsp;amend the vesting provisions of an award; (ii)&nbsp;amend the payment provisions of an award; (iii)&nbsp;cancel or modify outstanding awards; (iv)&nbsp;waive any restrictions imposed with respect to awards or the Common Shares issued
pursuant to awards; (v)&nbsp;make amendments to the 2011 Plan to ensure compliance with applicable securities and tax law as well as the TSX and NYSE rules; (vi)&nbsp;make any amendment of a clerical nature as well as any amendment clarifying any
provision of the 2011 Plan; (vii)&nbsp;make any adjustment to reflect a change in the Company&#146;s capital structure, including as a result of capital structure adjustments; and (viii)&nbsp;suspend or terminate the 2011 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except for adjustments to awards made in connection with a change of control of the Company, no termination, suspension or
amendment of the 2011 Plan or any award shall adversely affect the right of any participant with respect to any award theretofore granted, as determined by the Talent and Compensation Committee, without such participant&#146;s written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No amendments were made to the 2011 Plan in 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option and RSU Plans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As
of April&nbsp;28, 2022, 425,124 Common Shares (less than 1% of the issued and outstanding Common Shares) had been issued upon the exercise of options granted under the 2011 Plan and 2,607,034 Common Shares (less than 1% of the issued and outstanding
Common Shares) had been issued in connection with the vesting of RSUs granted under the 2011 Plan. As of April&nbsp;28, 2022, a total of 325,173 Common Shares (less than 1% of the issued and outstanding Common Shares) remained reserved for issuance
under the 2011 Plan, representing (i)&nbsp;320,151 Common Shares (less than 1% of the issued and outstanding Common Shares) issuable in respect of options and (ii)&nbsp;5,022 Common Shares (less than 1% of the issued and outstanding Common Shares)
issuable in respect of RSUs granted and which remain outstanding under such plan. The Company ceased granting new awards under the 2011 Plan upon the approval of the 2014 Plan in 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of April&nbsp;28, 2022, 2,187,177 Common Shares (less than 1% of the issued and outstanding Common Shares) had been issued
upon the exercise of options granted under the 2014 Plan and 16,487,546 Common Shares (4.6% of the issued and outstanding Common Shares) had been issued in connection with the vesting of RSUs granted under the 2014 Plan. As of April&nbsp;28, 2022, a
total of 17,890,295 Common Shares (4.9% of the issued and outstanding Common Shares) remained reserved for issuance under the 2014 Plan, representing (i)&nbsp;10,865,199 Common Shares (3% of the issued and outstanding Common Shares) issuable in
respect of options and (ii)&nbsp;7,025,096 Common Shares (1.9% of the issued and outstanding Common Shares) issuable in respect of RSUs granted and which remain outstanding under such plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_24"></A>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>The Report of the Audit and Risk Committee of the Board shall not be deemed incorporated by reference by any general
statement incorporating by reference this Proxy Statement into any filing under the Securities Act or under the Exchange Act, except to the extent that we specifically incorporate this information by reference, and shall not otherwise be deemed
filed under such Acts. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee, comprised of independent directors, is delegated by the Board to
monitor the integrity of our financial statements, the auditor&#146;s qualifications and independence, the performance of the auditor and our internal auditor, and the Company&#146;s compliance with legal and regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Management has primary responsibility for our financial statements and the overall reporting process as well as establishing
and maintaining our internal controls. PricewaterhouseCoopers LLP, our auditor for fiscal year ended December&nbsp;31, 2021, had the responsibility for expressing an opinion as to whether the audited financial statements have been prepared in
accordance with generally accepted accounting principles in the United States in all material respects and on the effectiveness of our internal controls over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee met with management and the auditor to review and discuss the audited financial statements for
the year ended December&nbsp;31, 2021, as well as management&#146;s assessment of the effectiveness of our internal controls over financial reporting and the auditor&#146;s assessment of our internal controls over financial reporting. The auditor,
as well as the internal auditor, had full access to the Audit and Risk Committee, including regular meetings without management present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee received from and discussed with the auditor the written report and the letter from the auditor
required by applicable requirements of the Public Company Accounting Oversight Board regarding the auditor&#146;s communications with the Audit and Risk Committee concerning independence and has discussed with the auditor the auditor&#146;s
independence. Additionally, the committee discussed with the auditor the matters required by the Public Company Accounting Oversight Board and the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee acts only in an oversight capacity and must rely on the information provided to it and on the
representations made by management and the auditor. Based on the aforementioned reviews and discussions, and the report of the auditor, the Audit and Risk Committee recommended to the Board that the audited financial statements for the year ended
December&nbsp;31, 2021, be included in the Company&#146;s Annual Report filed with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Audit and Risk Committee
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Russel C. Robertson, Chairperson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Sarah B. Kavanagh </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Robert N. Power </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Thomas W. Ross, Sr. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_25"></A>CERTAIN TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Related-Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As described in the section titled &#147;Statement of Corporate Governance Practices &#151; Ethical Business Conduct &#151;
Bausch Health Code of Conduct&#148; beginning on page 29, the Board has adopted the Code of Conduct, which sets out the Company&#146;s expectations for the conduct of our employees and directors in their dealings on behalf of the Company. The
Conflict of Interest Policy set forth in our Code of Conduct requires that our employees and directors avoid situations in which they have a potential or actual conflict of interest with the Company. In accordance with our Conflict of Interest
Policy, any employee, including our officers, involved in any type of relationship described in the Conflict of Interest Policy is required to immediately and fully disclose the relevant circumstances to his or her immediate supervisor, the General
Counsel or the Chief Compliance&nbsp;&amp; Ethics Officer, and in accordance with the process set out in the Company&#146;s Conflicts of Interest Standard Operating Procedures. <FONT STYLE="white-space:nowrap">Non-employee</FONT> directors are
required to report their involvement in any type of relationship described in the Conflict of Interest Policy to the Audit and Risk Committee. In addition to reviewing cases where the conflict, or potential conflict, involves a member of the Board,
the Audit and Risk Committee reviews transactions or proposed transactions in which an executive officer has an interest that conflicts with the Company&#146;s interests and makes recommendations to the Board regarding any such transaction. Our
Conflict of Interest Policy states that the following are types of outside activities that can create conflicts: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ownership by a director or employee, or any member of the director&#146;s or employee&#146;s family, of a
substantial interest in any concern that does business with the Company, whether as a supplier, dealer or customer, or are a competitor (except in the case of a publicly owned corporation whose securities are traded on the open market).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Serving as a director, officer, employee, consultant, advisor, or in any other capacity for any business or
other organization with which the Company currently (or potentially) has a business relationship or which is, or can expect to become, a competitor of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Engaging in an outside activity with an individual, business or organization which currently (or potentially)
has a competitive or business relationship with the Company where such activity is likely to decrease the impartiality, judgment, effectiveness or productivity expected from an employee. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Performance by a director or employee or a member of the director&#146;s or employee&#146;s family of services
for any outside concern or individual that does business with the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Outside employment which conflicts or might be reasonably expected to conflict with the normal duties of the
director or employee. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since January&nbsp;1, 2021, the Company was involved in the following
related-party transactions, which have been approved or ratified by either the Audit and Risk Committee or the Board: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Employment Relationship </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Joseph C. Papa&#146;s son, Dr.&nbsp;Matthew Papa, has been employed by the Company since September 2016, and is currently the
Director, Strategy. In 2021, Dr.&nbsp;Papa received an aggregate of $355,043 in compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Director Appointment and Nomination Agreement </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On February&nbsp;24, 2021, the Company entered into a Director Appointment and Nomination Agreement (&#147;Nomination
Agreement&#148;) with Carl C. Icahn, Brett Icahn, Steven D. Miller, Icahn Partners, Icahn Master, Icahn Enterprises GP, Icahn Enterprises Holdings, IPH, Icahn Capital, Icahn Onshore, Icahn Offshore, and Beckton (collectively, the &#147;Icahn
Group&#148;). Pursuant to the Nomination Agreement, effective as of March&nbsp;17, 2021, the Board (i)&nbsp;increased its size to thirteen directors; (ii)&nbsp;appointed Brett Icahn and Steven Miller (collectively, the &#147;Icahn Designees&#148;)
to the Board to fill the resulting vacancies; (iii)&nbsp;appointed the Icahn Designees to serve on the Finance and Transactions Committee and the Special Transactions Committee; and (iv)&nbsp;nominated the Icahn Designees for election at the Annual
Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From and after the date of the Nomination Agreement, so long as an Icahn
Designee is a member of the Board, without the approval of the Icahn Designees who are then members of the Board, the Board will not increase its size above thirteen directors. In addition, the Icahn Group will be entitled, in the event any Icahn
Designee resigns or for any reason fails to serve or is not serving as a director (subject to exceptions set forth in the Nomination Agreement, including as a result of such director not being nominated by the Company to stand for election at an
annual meeting of shareholders subsequent to the 2021 Annual Meeting or the termination of the Icahn Group&#146;s designation rights with respect to such director in accordance with the Agreement), to designate a replacement for appointment to the
Board on the terms set forth in the Agreement. So long as an Icahn Designee is a member of the Board, the Icahn Group will also have certain rights with respect to newly created committees as set forth in the Nomination Agreement. In addition, any
Board consideration of appointment and employment of named executive officers, mergers, acquisitions of material assets, dispositions of material assets, or similar extraordinary transactions, such consideration, and voting with respect thereto,
will take place only at the full Board level or in committees of which one of the Icahn Designees is a member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If at any
time the Icahn Group ceases to hold a &#147;net long position,&#148; as defined in the Agreement, in at least (i) 17,757,550 Common Shares, one of the Icahn Designees will, and the Icahn Group will cause one Icahn Designee to, promptly resign from
the Board; and (ii) 10,654,530 Common Shares, each of the Icahn Designees will, and the Icahn Group will cause each such Icahn Designee to, promptly resign from the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">So long as the Icahn Group holds &#147;a net long position,&#148; as defined in the Nomination Agreement, in at least
17,757,550 of the Company&#146;s common shares, the Company will not adopt a Rights Plan, as defined in the Nomination Agreement, with an &#147;Acquiring Person&#148; beneficial ownership threshold below 20.0% of the then-outstanding common shares,
unless (x)&nbsp;such Rights Plan provides that, if such Rights Plan is not ratified by the Company&#146;s shareholders within 105 days of such Rights Plan being adopted, such Rights Plan shall automatically expire and (y)&nbsp;the &#147;Acquiring
Person&#148; definition of such Rights Plan exempts the Icahn Group up to a beneficial ownership of 19.95% of the then-outstanding common shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Nomination Agreement also includes other customary voting, standstill and
<FONT STYLE="white-space:nowrap">non-disparagement</FONT> provisions. Absent an uncured breach of the material provisions of the Nomination Agreement by the Company, the standstill restrictions on the Icahn Group will remain in effect until the
later of (i)&nbsp;the end of the Annual Meeting and (ii)&nbsp;such date as no Icahn Designee is on the Board and the Icahn Group no longer has any right to designate a replacement (including if the Icahn Group has irrevocably waived such right in
writing). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_26"></A>PROPOSAL NO. 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At our 2017 Annual Meeting of Shareholders, our Board recommended, and shareholders approved, in a <FONT
STYLE="white-space:nowrap">non-binding</FONT> advisory vote, that a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory vote on executive compensation
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(&#147;say-on-pay&#148;)</FONT></FONT> be held every year. The Board determined that our shareholders should vote on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> proposal every year, consistent with the preference expressed by our shareholders at the 2017 Annual Meeting of Shareholders. At our 2021 Annual Meeting,
approximately 93% of the total shareholders&#146; votes cast voted in favor of our executive compensation program.&nbsp;We believe these favorable results indicate strong support for continuing our current executive compensation
program.&nbsp;Proposal No.&nbsp;2 provides the Company&#146;s shareholders with an opportunity to provide an advisory vote related to compensation of the Company&#146;s named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company has a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;pay-for-performance&#148;</FONT></FONT> philosophy that forms the foundation of the executive compensation program for our Company&#146;s named executive officers. This
philosophy and the executive compensation program approved by the Talent and Compensation Committee have been central to the Company&#146;s ability to attract, retain and motivate individuals who are committed to the ongoing transformation of our
company and to improving people&#146;s lives through our products. Our compensation program is intended to link executive compensation to long-term business performance, while providing compensation opportunities that are competitive as compared to
our peers and align the interests of our executives with those of our shareholders. Our programs also balance appropriate risk taking and incorporate shareholder feedback. Please refer to &#147;Executive Compensation &#151; Compensation Discussion
and Analysis&#148; starting on page 48 for detailed information regarding our executive compensation program for the Company&#146;s named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to Schedule 14A of the Exchange Act, we are asking for shareholder approval, in an advisory resolution, of the
compensation of our named executive officers as disclosed in this Proxy Statement in accordance with SEC rules. This disclosure is provided in the section titled &#147;Executive Compensation&nbsp;&#151; Compensation Discussion and Analysis,&#148;
the compensation tables and the narrative discussion following the compensation tables. This vote is not intended to address any specific item of compensation, but rather the overall compensation program of our named executive officers and the
executive compensation policies and practices described in this Proxy Statement. The Board requests that shareholders endorse the compensation of our named executive officers through the following resolution: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Resolved, that the shareholders approve, in an advisory resolution, the compensation paid to the named
executive officers, as disclosed pursuant to Item 402 of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> including the Compensation Discussion and Analysis, compensation tables, and other narrative executive compensation disclosures,
contained in this Proxy Statement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This vote is advisory and therefore not binding on the Company, the Talent and
Compensation Committee, or the Board. The Board and the Talent and Compensation Committee value the opinions of our shareholders and will take the outcome of the vote into consideration in the design of our executive compensation program going
forward. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board recommends that the shareholders vote FOR Proposal No.&nbsp;2. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_27"></A>PROPOSAL NO. 3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY&#146;S AMENDED AND RESTATED 2014 OMNIBUS INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board originally adopted the 2014 Omnibus Incentive Plan (the &#147;2014 Plan&#148;) on April&nbsp;7, 2014, which was
approved by our shareholders effective as of May&nbsp;20, 2014. The 2014 Plan was amended and restated on April&nbsp;30, 2018 to increase the number of Common Shares available for issuance by an additional 11,900,000 Common Shares and on
April&nbsp;28, 2020 to increase the number of Common Shares available for issuance by an additional 13,500,000 Common Shares. As of December&nbsp;31, 2021, 11,593,059 Common Shares were available for future issuance under the 2014 Plan, representing
3.23% of the issued and outstanding Common Shares as of that date. On February 14, 2022, the Talent and Compensation Committee approved an amendment and restatement to the 2014 Plan, subject to approval by the shareholders at the Annual Meeting, to,
among other things, increase the number of Common Shares authorized for issuance under the 2014 Plan (the &#147;Amended Plan&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are asking our shareholders to approve at the Annual Meeting an amendment and restatement to the 2014 Plan, which will
result in an increase the number of Common Shares authorized for issuance under the 2014 Plan by 11,500,000 Common Shares. The proposed 11,500,000 additional Common Shares, which represents 3.20% of the 359,405,748 Common Shares outstanding as of
December&nbsp;31, 2021 and 3.18% of the 361,446,847 Common Shares outstanding as of our record date, April&nbsp;28, 2022, is expected to allow us to make grants under the Amended Plan for approximately three years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the adoption of the amendment and restatement of the 2014 Plan, the Board carefully considered our
anticipated future equity needs, our historical equity compensation practices (including our historical share usage and &#147;burn rate&#148;, as discussed in the section titled &#147;Historical Annual Common Share Usage&#148; beginning on page 91)
and the advice of the Talent and Compensation Committee&#146;s independent compensation consultant. We believe that increasing the number of Common Shares issuable under the 2014 Plan is necessary in order to allow Bausch Health to continue to align
the long-term financial interests of employees, members of the Board, consultants, members of our sales force and other service providers of the Company and its subsidiaries with those of the Company&#146;s shareholders, to attract and retain those
individuals by providing compensation opportunities that are competitive with other companies and provide incentives to those individuals who contribute significantly to the long-term performance and growth of the Company and its subsidiaries. As of
the filing of this Proxy Statement, the number of persons eligible to participate in the Amended Plan is approximately 4,000. A copy of the Amended Plan is attached to this Proxy Statement as Exhibit B. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the amendment increasing the number of Common Shares issuable under the 2014 Plan, the Amended Plan
incorporates additional changes into the 2014 Plan, as summarized in &#147;Summary of Amended Plan Terms&#148; below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As
a shareholder of the Company, you are invited to vote with respect to the Amended Plan through the following resolution: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Resolved, that the shareholders approve the amendment and restatement of the Company&#146;s Amended and
Restated 2014 Plan Omnibus Plan (which will increase the maximum number of Common Shares available for issuance pursuant to Awards under the plan by 11,500,000 additional Common Shares). </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board recommends that the shareholders vote &#147;FOR&#148; Proposal No.&nbsp;3. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Considerations for the Approval of the Amended Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board believes that the Amended Plan is in the best interest of shareholders and supports this proposal for the following
reasons: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Plan is administered by our Talent and Compensation Committee, which is composed entirely of independent
directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company strives to maximize employee and shareholder alignment through the use of equity awards, while
minimizing dilution. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the proposed amendments are not approved, the Company will not have sufficient Common Shares for grant
needs and will lose a critical tool for recruiting, retaining and motivating employees. The Company would thus be at a competitive disadvantage in attracting and retaining talent. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The terms of the Company&#146;s equity and other annual and long-term incentive compensation awards and
employee policies are all designed to protect shareholder interests and encourage employees to focus on the long-term success of the Company and shareholder value creation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Employees typically cannot fully monetize equity awards until three years after grant subject to certain
exceptions. For example, RSUs granted for 2021 generally vest <FONT STYLE="white-space:nowrap">in&nbsp;one-third&nbsp;increments</FONT> with the final third not converting to Common Shares until after the third year. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company does not permit &#147;liberal&#148; share recycling. Common Shares that are withheld to satisfy
any tax withholding obligations may not again be available for issuance under the Amended Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Amended Plan does not contain an &#147;evergreen&#148; feature pursuant to which the Common Shares
authorized for issuance under the Amended Plan can be increased automatically without shareholder approval. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Equity awards under the Amended Plan are generally double-trigger unless the outstanding awards are not
assumed or substituted in connection with a Change of Control (as defined in the Amended Plan). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company cannot, without shareholder approval, seek to effect any repricing of any previously granted
&#147;underwater&#148; stock option or SAR. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our NEOs are subject to share ownership guidelines to ensure that they face the same downside risk and upside
potential as our shareholders. For additional details regarding the share ownership guidelines applicable to our NEOs and directors, see pages&nbsp;63 and 30, respectively. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Amended Plan continues to provide the Talent and Compensation Committee with the authority to subject
awards granted under the Amended Plan to the Company&#146;s clawback policy. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No participant is entitled under the Amended Plan to any tax <FONT STYLE="white-space:nowrap">gross-up</FONT>
payments for any excise tax pursuant to Sections&nbsp;280G or 4999 of the IRC that may be incurred in connection with awards under the plan. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Historical Annual Common Share Usage </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2021, there were 8,885,000 Common Shares subject to outstanding options (2.47% of Common Shares
Outstanding) and 7,642,000 Common Shares subject to outstanding unit awards (2.13% of Common Shares Outstanding) under all of our equity incentive compensation plans, as well as 11,593,059 Common Shares available for future grant (3.23% of Common
Shares Outstanding). In total, the Company had 28,120,059 Common Shares subject to outstanding equity awards or available for future equity awards under the 2014 Plan and predecessor plans, which represented approximately 7.82% of fully diluted
Common Shares outstanding (or &#147;Overhang Percentage&#148;). The 11,500,000 new Common Shares proposed to be included in the Amended Plan share reserve would increase the overhang percentage by an additional 3.20% to approximately 11.02% as of
December&nbsp;31, 2021. The options outstanding as of December&nbsp;31, 2021 have a weighted average exercise price of $27.65 per share and a weighted average remaining life of 6.6&nbsp;years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s gross burn rate for the fiscal year 2021 was 1.93% and
average gross burn rate for fiscal year 2019 through fiscal year 2021 was 1.98%. Burn rate does not take into account equity awards that have been cancelled or forfeited. Burn rate with respect to each year is calculated by dividing the total number
of Common Shares subject to stock options and full value awards (such as restricted stock units) granted during the year (assuming achievement of the maximum performance levels for outstanding performance awards) by the total weighted-average number
of Common Shares outstanding during the period. Using the Institutional Shareholder Services (&#147;ISS&#148;) methodology for calculating burn rate, the Company&#146;s three-year average (ISS adjusted) burn rate for equity grants made in fiscal
years 2019, 2020 and 2021 was 2.72%, which was less than the allowable burn rate of 7.65% under ISS policy, based on the Company&#146;s industry group. The Company&#146;s burn rate calculation using the standard TSX methodology for the year ended
2021 was 1.66%, for the year ended 2020 was 1.82%, and for the year ended 2019 was 1.65%. This burn rate calculation assumes performance-based share units vest at target. Performance-based share units granted in 2019, 2020 and 2021 can pay out at a
maximum of 2&nbsp;times target. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of Amended Plan Terms </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a summary of the Amended Plan which is qualified in its entirety by the full text of the Amended Plan, a copy
of which is included as Exhibit B to this Proxy Statement. The capitalized terms not otherwise defined in this summary have the meaning assigned to them in the Amended Plan. For the avoidance of doubt, the changes to the 2014 Plan incorporated in
the Amended Plan and described below will only be applicable to equity awards granted after approval of the Amended Plan at the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purpose </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The purpose of
the Amended Plan is to align the long-term financial interests of our employees, directors, consultants and other service providers with our shareholders, attract and retain such service providers and provide incentives to those individuals who are
expected to contribute significantly to our long-term performance and growth. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Common Shares Subject to the Amended Plan </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Common Shares issued or to be issued under the Amended Plan consists of authorized but unissued Common Shares or issued
Common Shares that have been reacquired by the Company in any manner. Subject to adjustment made in connection with a recapitalization, Change of Control (as defined in the Amended Plan) and certain other events set forth in the Amended Plan, the
maximum number of Common Shares subject to Awards which may be issued pursuant to the Amended Plan will be equal to the sum of (i) 43,768,825 Common Shares, (ii) 11,500,000 Common Shares and (iii)&nbsp;the number of Common Shares becoming available
for reuse after awards are terminated, forfeited, cancelled, exchanged or surrendered following the Effective Date under the Company&#146;s 2011 Omnibus Incentive Plan. Shares underlying &#147;substitute awards&#148; (i.e., awards granted as
replacements for awards granted by a company that we or one of our subsidiaries acquires or with which we or one of our subsidiaries combines) will not reduce the number of Common Shares available for issuance under the Amended Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In determining the number of Common Shares to be reserved for issuance under the Amended Plan, the Company&#146;s management
and Talent and Compensation Committee evaluated the historic share usage and &#147;burn rate&#148; under the 2014 Plan and the existing terms of outstanding Awards under the 2014 Plan, as discussed in the section titled &#147;Historical Annual
Common Share Usage&#148; beginning on page 91. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The number of Common Shares authorized for grant under the Amended Plan is
subject to adjustment, as described in the section titled &#147;Types of Awards &#151; Adjustments&#148; on page 98. In addition, (i)&nbsp;the number of Common Shares issuable to Insiders, at any time, under all security-based compensation
arrangements of the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Company, cannot exceed 10% of issued and outstanding Common Shares; (ii)&nbsp;the number of Common Shares issued to
Insiders, within any one year period, under all security-based compensation arrangements of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Company, cannot exceed 10% of issued and outstanding securities; and (iii)&nbsp;the number of Common Shares issuable <FONT STYLE="white-space:nowrap">to&nbsp;non-employee&nbsp;members</FONT> of
the Board, at any time, under all security-based compensation arrangements of the Company, cannot exceed 1% of issued and outstanding Common Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In any calendar year, no Participant who is <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> of the
Company may be granted Awards, in either equity, cash or other compensation, with an aggregate fair market value as of the grant date or payment date, as applicable, in excess of $750,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any Common Shares subject to an Award (other than a substitute award) are forfeited, canceled, exchanged or surrendered, or
if an Award (other than a substitute award) terminates or expires without a distribution of Common Shares to the participant, the Common Shares with respect to such Award shall, to the extent of any such forfeiture, cancellation, exchange,
surrender, termination or expiration, again be available for Awards under the Amended Plan; however, the Common Shares surrendered or withheld as payment of either the exercise price of an option (including Common Shares otherwise underlying an
award of a SAR that are retained by the Company to account for the exercise price of the SAR) and/or withholding taxes in respect of an Award will no longer be available for Awards under the Amended Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The maximum number of Common Shares available for Awards under the Amended Plan shall not be affected by the payment of cash
dividends on outstanding Awards (to the extent permitted under the Amended Plan), the payment of share-denominated awards that must be settled in cash, the granting of cash awards or substitute awards. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Administration of the Amended Plan </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as otherwise required by law or as designated otherwise by the Board, the Amended Plan will be administered by our
Talent and Compensation Committee. The Talent and Compensation Committee will have full power and authority to administer the Amended Plan, including, among other things, to (i)&nbsp;interpret the Amended Plan, (ii)&nbsp;determine the types of
Awards to be granted, (iii)&nbsp;select Award recipients, (iv)&nbsp;establish the terms and conditions of awards, (v)&nbsp;determine the settlement or exercise method of Awards and (vi)&nbsp;adopt any administrative rules, regulations, procedures
and guidelines governing the Amended Plan or any Awards granted under the Amended Plan as it deems to be appropriate. The Board may, in its sole discretion, at any time and from time to time, grant Awards or administer the Amended Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Eligibility </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally,
all of our employees, directors, advisors and consultants will be eligible to receive Awards under the Amended Plan, as selected by our Talent and Compensation Committee in its discretion in furtherance of the purpose of the Amended Plan (as
described above). As of the date of this Proxy Statement, we expect that approximately 4,000 employees and 11 directors will be eligible to receive Awards under the Amended Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The basis for participation in the Amended Plan is the Talent and Compensation Committee&#146;s decision, in its sole
discretion, that an Award to an eligible participant will further the Amended Plan&#146;s purposes (as described above). In exercising such discretion, the Talent and Compensation Committee will consider the recommendations of management and the
purposes of the Amended Plan, which are to continue to align the long-term financial interests of employees, directors, consultants, members of our sales force and other service providers of the Company and its subsidiaries with those of the
Company&#146;s shareholders, to attract and retain those individuals by providing compensation opportunities that are competitive with other companies and provide incentives to those individuals who contribute significantly to the long-term
performance and growth of the Company and its subsidiaries. In recent years, all eligible directors have received Awards under the 2014 Plan (unless such compensation was waived) and approximately 18% of our employees have received Awards under the
2014 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Types of Awards </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following types of Awards may be made under the Amended Plan. All of the Awards described below are subject to the
conditions, limitations, restrictions, exercise price, vesting and forfeiture provisions determined by the Talent and Compensation Committee, in its sole discretion, subject to such limitations as are provided in the Amended Plan. In addition,
subject to the limitations provided in the Amended Plan and in accordance with applicable law, the Talent and Compensation Committee may accelerate or defer the vesting or payment of awards, cancel or modify outstanding Awards, and waive any
conditions or restrictions imposed with respect to Awards or the Common Shares issued pursuant to Awards. As of April 28, 2022, the equity awards outstanding under our equity compensation plans were held by a total of 4,186 current and former
employees <FONT STYLE="white-space:nowrap">and&nbsp;non-employee&nbsp;directors</FONT> (all of the 4,186 current and former employees <FONT STYLE="white-space:nowrap">and&nbsp;non-employee&nbsp;directors</FONT> held outstanding Awards granted under
the 2014 Plan).<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-qualified&nbsp;Stock</FONT>
Options </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">An award of <FONT STYLE="white-space:nowrap">a&nbsp;non-qualified&nbsp;stock</FONT> option grants a
participant the right to purchase a certain number of Common Shares during a specified term in the future, after a vesting period, at an exercise price equal to at least 100% of the Market Price (as defined below) of our Common Shares on the grant
date (except in the case of substitute awards). The &#147;Market Price&#148; of Common Shares as of a particular date shall generally mean the closing price per Common Share on the national securities exchange on which the Common Shares are
principally traded (subject to certain exceptions set forth in the Amended Plan in the event that the Company is no longer traded on a national securities exchange). Unless otherwise determined by the Talent and Compensation Committee, Directors
shall generally not be eligible to receive options. The term of <FONT STYLE="white-space:nowrap">a&nbsp;non-qualified&nbsp;stock</FONT> option may not exceed ten years from the date of grant. The exercise price may be paid with cash, Common Shares
already owned by the participant, or with the proceeds from a sale of the Common Shares subject to the option. The Talent and Compensation Committee may also provide that an option may be &#147;net exercised&#148;, meaning that the participant would
receive the number of whole Common Shares equal to (A)&nbsp;the difference between (x)&nbsp;the aggregate Market Price of the Common Shares subject to the portion of such option then being exercised and (y)&nbsp;the aggregate exercise price for all
such Common Shares under the portion thereof then being exercised plus (to the extent it would not give rise to adverse accounting consequences pursuant to applicable accounting principles or to adverse tax consequences to the Participants under
Canadian federal, provincial or territorial tax laws) the amount of withholding tax due upon exercise divided by (B)&nbsp;the Market Price of a Common Share on the date of exercise. Any fractional share that would result from such equation shall be
canceled. <FONT STYLE="white-space:nowrap">A&nbsp;non-qualified&nbsp;stock</FONT> option is an option that does not meet the qualifications of an incentive stock option as described below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Incentive Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">An incentive stock option is a stock option that meets the requirements of Section&nbsp;422 of the Code, which include an
exercise price of no less than 100% of Market Price on the grant date, a term of no more than ten years, and that the option be granted from a plan that has been approved by shareholders. The repricing of incentive stock options is prohibited.
Notwithstanding the foregoing, if granted to a participant who owns shares representing more than 10% of the voting power of all classes of shares of the Company, its parent or one of its subsidiaries, an incentive stock option must have a term of
not more than five years and have an exercise price which is at least 110% of the Market Price. In addition, if the aggregate Market Price of the Common Shares (as of the grant date) for which incentive stock options are exercisable for the first
time by a participant during any calendar year exceeds $100,000, such excess will be treated <FONT STYLE="white-space:nowrap">as&nbsp;non-qualified&nbsp;stock</FONT> options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to adjustment, as described in the section titled &#147;Types of Awards &#151; Adjustments&#148; below, the maximum
number of Common Shares available for issuance with respect to incentive stock options under the Amended Plan is 55,268,825 Common Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Share Appreciation Rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A share appreciation right (&#147;SAR&#148;) entitles the participant to receive an amount equal to the difference between the
Market Price of the Company&#146;s Common Shares on the exercise date and the exercise price of the SAR (which may not be less than 100% of the Market Price of a Common Share on the grant date, except for substitute awards), multiplied by the number
of Common Shares subject to the SAR. A SAR may be granted in substitution for a previously granted option, and if so, the exercise price of any such SAR may not be less than 100% of the Market Price of Common Shares as determined at the time the
option for which it is being substituted was granted. Payment to a participant upon the exercise of a SAR may be in cash or Common Shares (in which case, the number of Common Shares to be paid will be determined by dividing the amount calculated
above by the Market Price of a Common Share at the time of payment). Unless otherwise determined by the Talent and Compensation Committee, Directors shall generally not be eligible to receive SARs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Restricted Shares </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A restricted share award is an award of outstanding Common Shares that does not vest until after a specified period of time, or
satisfaction of other vesting conditions as determined by the Talent and Compensation Committee, and which may be forfeited if conditions to vesting are not met. Participants generally accrue (but are not paid) dividends or dividend equivalents on
the Common Shares subject to their award during the vesting period (unless the awards are subject to performance-vesting criteria) and are also generally entitled to provide voting instructions with respect to the Common Shares underlying their
awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Deferred Shares </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A deferred share award is an unfunded, unsecured promise to deliver Common Shares to the participant in the future, if the
participant satisfies the conditions to vesting, as determined by the Talent and Compensation Committee. Participants do not have voting rights, but generally accrue (but are not paid) dividend equivalent payments during the vesting period subject
to the same vesting conditions as the underlying award. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Share Units </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A Share Unit is an Award that represents the right to receive a Common Share or a cash payment equal to the Market Price of a
Common Share. Share Units shall be subject to such terms and conditions (including service-based and/or performance-based vesting conditions), restrictions and limitations, as determined by the Talent and Compensation Committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Share Payment </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to limits in the Amended Plan, the Talent and Compensation Committee may issue unrestricted Common Shares, alone or in
tandem with other Awards, in such amounts and subject to such terms and conditions as the Talent and Compensation Committee determines. A share payment may (but need not) be granted as, or in payment of, a bonus, or to provide incentives or
recognize special achievements or contributions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Cash Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee may issue awards that are payable in cash, as deemed by the Talent and Compensation
Committee to be consistent with the purposes of the Amended Plan. These cash awards will be subject to the terms, conditions, restrictions and limitations determined by the Talent and Compensation Committee from time to time. The payment of cash
awards may be subject to the achievement of specified performance criteria. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Performance Criteria </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards granted under the Amended Plan may be subject to specified performance criteria. Performance criteria are based on the
Company&#146;s attainment of performance <FONT STYLE="white-space:nowrap">measures&nbsp;pre-established&nbsp;by</FONT> the Talent and Compensation Committee, in its sole discretion, including, without limitation, on one or more of the following:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">revenues, income before taxes and extraordinary items, net income, operating income, earnings before income
tax, earnings before interest, taxes, depreciation and amortization, cash flow or a combination of any or all of the foregoing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
<P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">after-tax&nbsp;or&nbsp;pre-tax&nbsp;profits</FONT></FONT> including,
without limitation, those attributable to continuing and/or other operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of the Company&#146;s bank debt or other long-term or short-term public or private debt or other
similar financial obligations of the Company either in absolute terms or as it relates to a profitability ratio including operating income or EBITA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">return on capital employed, return on assets, or return on invested capital; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
<P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">after-tax&nbsp;or&nbsp;pre-tax&nbsp;return</FONT></FONT> on
shareholders&#146; equity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">economic value added targets based on a cash flow return on investment formula; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the market price of the Common Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the market capitalization or enterprise value of the Company, either in amount or relative to industry peers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the value of an investment in the Common Shares assuming the reinvestment of dividends; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the achievement of operating margin targets or other measures of improving profitability;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing of one or more new drug application(s) (&#147;NDA&#148;) or one or more new drug submission(s)
(&#147;NDS&#148;) or the approval of one or more NDA(s) or one or more NDS(s) by the U.S. Food and Drug Administration or the Canadian Therapeutic Products Directorate, as applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the achievement of, or progress toward, a launch of one or more new drug(s); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the achievement of research and development milestones; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the achievement of other strategic milestones including, without limitation, the achievement of specific
synergy capture and cost savings realization relating to integrations and the successful creation or execution of a restructuring plan for a specific business or function; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the successful completion of clinical trial phases; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">licensing or acquiring new products or product platforms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquisition or divestiture of products or business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the entering into new, or exiting from existing, geographic markets or industry segments; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the attainment of a certain level of, reduction of, or other specified objectives with regard to limiting the
level in or increase in, all or a portion of controllable expenses or costs or other expenses or costs </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of the first item above, &#147;extraordinary items&#148; includes all items of gain, loss or expense for the
fiscal year determined to be extraordinary or unusual in nature or infrequent in occurrence or related to a corporate transaction, restructuring, or related to a change in accounting principles. Each financial metric above may be on a business unit,
geographic segment, total company, <FONT STYLE="white-space:nowrap">or&nbsp;per-share&nbsp;basis,</FONT> and on a GAAP <FONT STYLE="white-space:nowrap">or&nbsp;non-GAAP&nbsp;adjusted</FONT> basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The performance criteria may be based upon the attainment of specified
levels of performance under one or more of the measures described above relative to the performance of other entities. The Talent and Compensation Committee may designate additional business criteria on which the performance criteria may be based or
adjust, modify or amend the previously mentioned business criteria, including to take into account actions approved by the Board or a committee thereof that affect the achievement of the original performance criteria. Performance criteria may
include a threshold level of performance below which no Award will be earned, a level of performance at which the target amount of an Award will be earned and a level of performance at which the maximum amount of the Award will be earned. The Talent
and Compensation Committee shall make appropriate equitable adjustments to the performance criteria in recognition of unusual <FONT STYLE="white-space:nowrap">or&nbsp;non-recurring&nbsp;events</FONT> affecting us or our financial statements, in
response to changes in applicable laws or regulations, including changes in generally accepted accounting principles, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or
related to the disposal of a segment of a business or related to a change in accounting principles, as applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Deferrals </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee may postpone the exercise of Awards, or the issuance or delivery of Common Shares or cash
pursuant to any Award for such periods and upon such terms and conditions as the Talent and Compensation Committee determines. In addition, the Talent and Compensation Committee may determine that all or a portion of a payment to a participant,
whether in cash and/or Common Shares, will be deferred in order to prevent the Company or any subsidiary from being denied a U.S. federal income tax deduction with respect to an award granted under the Amended Plan. Notwithstanding this authority,
the Talent and Compensation Committee will not postpone the exercise or delivery of shares or cash payable in respect of Awards constituting deferred compensation under Section&nbsp;409A of the Code, where such postponement will cause the imposition
of additional taxes under Section&nbsp;409A of the Code. Section&nbsp;409A of the Code provides rules that govern the manner in which compensation of various types may be deferred and imposes taxes upon compensation that is improperly deferred or
accelerated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Blackout Periods </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Amended Plan provides that, to the extent applicable, (i)&nbsp;if the expiration of the term of options or SARs awarded
under the Amended Plan occurs during a period self-imposed by the Company in accordance with TSX rules during which a participant is prohibited from trading in the Company&#146;s securities (a &#147;Blackout Period&#148;), such term will be extended
until the tenth business day after the end of such Blackout Period, and (ii)&nbsp;if share units are to be delivered during a Blackout Period, the Talent and Compensation Committee may, in its discretion, determine that Common Shares subject to such
share units will instead be delivered as soon as practicable after the end of such Blackout Period, in each case subject to compliance with Section&nbsp;409A of the Code, if applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Dividends and Dividends Equivalents </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Talent and Compensation Committee may provide that Share Units and/or Share Awards shall earn dividends or dividend
equivalents, as applicable, subject to such terms, conditions, restrictions and limitations as the Talent and Compensation Committee may establish. Notwithstanding the foregoing, dividends or dividend equivalents (i)&nbsp;shall have the same vesting
dates and shall be paid in accordance with the same terms as the Awards to which they relate, (ii)&nbsp;with respect to any Award subject to the achievement of performance criteria, shall not be paid unless and until the relevant performance
criteria have been satisfied. Stock options and SARs will not be eligible for dividends and dividend equivalents and (iii)&nbsp;no stock options will be eligible for the payment of dividends or dividend equivalents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Adjustments </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Amended Plan will provide that the Talent and Compensation Committee will make appropriate equitable adjustments to the
maximum number of Common Shares available for issuance under the Amended Plan and other limits stated in the Amended Plan, the number and kind of shares covered by outstanding Awards, and the exercise prices and performance measures applicable to
outstanding Awards. These changes will be made to reflect changes in our capital structure (including a change in the number of Common Shares outstanding) on account of any share dividend, share split, reverse share split or any similar equity
restructuring, or any combination or exchange of equity securities, merger, consolidation, recapitalization, reorganization or similar event, or to the extent necessary to prevent the enlargement or diminution of participants&#146; rights by reason
of any such transaction or event or any extraordinary dividend, divestiture or other distribution (other than ordinary cash dividends) of assets to shareholders, or on account of any change in applicable laws, regulations or accounting principles.
These adjustments will be made only to the extent they conform to the requirements of applicable provisions of the Code and other applicable laws and regulations. The Talent and Compensation Committee, in its discretion, may decline to adjust an
Award if it determines that the adjustment would violate applicable law or result in adverse tax consequences to the participant or to the Company. Adjustments described in this paragraph are subject to any applicable regulatory approvals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Termination of Service </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the applicable award agreement provides otherwise or the Talent and Compensation Committee determines otherwise, vesting
with respect to an Award will cease upon termination of a participant&#146;s employment or service with the Company, and unvested Awards shall be forfeited upon such termination. In the case of termination for cause, vested awards shall also be
forfeited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Change of Control </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Amended Plan provides that, unless otherwise set forth in a participant&#146;s award agreement, all Awards that are assumed
or substituted in connection with a Change of Control (as defined in the Amended Plan) transaction will become fully vested, exercisable and free of restrictions, and any performance conditions on those Awards will be deemed to be achieved at the
target performance level (or at such other level as determined by the Talent and Compensation Committee in its discretion or as specified in the definitive transaction documentation in connection with such Change of Control) if the
participant&#146;s employment or service is terminated by the Company without &#147;cause&#148; (as defined in the Amended Plan) or the participant resigns for &#147;good reason&#148; (as defined in the Amended Plan), in each case within 12 months
following the Change of Control. In addition, the Amended Plan provides that, unless otherwise set forth in a participant&#146;s award agreement, all Awards that are not assumed or substituted in connection with the Change of Control transaction
will become fully vested (on a pro rata basis), exercisable and free of restrictions and any performance conditions on those Awards will be deemed to be achieved at target (or at such other level as determined by the Talent and Compensation
Committee in its discretion or as specified in the definitive transaction documentation in connection with such Change of Control), on a pro rata basis, immediately upon the occurrence of the Change of Control transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, in the event of a Change of Control transaction, the Talent and Compensation Committee may, in its discretion,
(i)&nbsp;provide that each option and each SAR which may, by its terms, only be settled in Common Shares, will, immediately upon the occurrence of a Change in Control, be deemed to have been exercised on a &#147;net exercise&#148; basis, and
(ii)&nbsp;may, in its discretion, except as would otherwise result in adverse tax consequences under Section&nbsp;409A of the Code, provide that each Award, other than options and SARs will, immediately upon the occurrence of the Change of Control,
be cancelled in exchange for a payment in an amount equal to the excess of the consideration paid per Common Share in the Change of Control over the purchase price (if any) per Common Share subject to the Award, multiplied by the number of Common
Shares subject to the Award. Additionally, in the event of a Change of Control transaction, the Talent and Compensation Committee may, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
its sole discretion, terminate any option or SAR for which the exercise or purchase price is equal to or exceeds the per Common Share value of the consideration to be paid in the Change of
Control transaction without payment of consideration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Transferability </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except in specific circumstances described in the Amended Plan, Awards granted under the Amended Plan may not be sold, pledged,
hypothecated, assigned, margined or otherwise transferred in any manner other than by will or the laws of descent and distribution, unless and until the Common Shares underlying such Award have been issued, and all restrictions applicable to such
Common Shares have lapsed or have been waived by the Talent and Compensation Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Amendment and Termination </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the approval of shareholders that we are seeking at the Annual Meeting, the Amended Plan will be effective as of
June 21, 2022 and will remain in effect until the earlier of (i)&nbsp;the date all Common Shares subject to the Amended Plan have been purchased or acquired or (ii)&nbsp;June 21, 2032. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Amended Plan and any Award may be amended, suspended or terminated at any time by the Board, provided that no amendment
will be made without shareholder approval if such shareholder approval is required in order to comply with applicable law or the rules of the NYSE, the rules of the TSX, or any other securities exchange on which the Common Shares are traded or
quoted. For instance, the Board may, without shareholder approval but subject to applicable law and the provisions of the Amended Plan, (i)&nbsp;amend the vesting provisions of an Award or of the Amended Plan, (ii)&nbsp;amend the payment provisions
of an Award, (iii)&nbsp;cancel or modify outstanding Awards, (iv)&nbsp;waive any restrictions imposed with respect to Awards or the Common Shares issued pursuant to Awards or of the Amended Plan, (v)&nbsp;amend the provisions of the Amended Plan in
order to ensure its compliance with applicable securities and tax law as well as the TSX and NYSE rules, (vi)&nbsp;make any amendment of a clerical nature as well as any amendment clarifying any provision of the Amended Plan, (vii)&nbsp;make any
adjustment as described above under the heading &#147;Adjustments&#148;, and (viii)&nbsp;suspend or terminate the Amended Plan. Except as may be required to comply with applicable tax law, no termination, suspension or amendment of the plan may
adversely affect the right of any participant with respect to a previously granted Award without the participant&#146;s written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will obtain shareholder approval for: (i)&nbsp;subject to the Talent and Compensation Committee&#146;s right to
make equitable adjustments as mentioned above, a reduction in the exercise price or purchase price of an Award (or the cancellation <FONT STYLE="white-space:nowrap">and&nbsp;re-grant&nbsp;of</FONT> an Award resulting in a lower exercise price or
purchase price); (ii) the extension of the original term of an option over the maximum period of 10 years described above, except if such term occurs during a Blackout Period as described above; (iii)&nbsp;any amendment to remove or to exceed the
participation limits described in the Amended Plan or any amendment to the limit of the number of incentive stock options that may be granted under the Amended Plan; (iv)&nbsp;an increase to the maximum number of Common Shares issuable under the
Amended Plan (other than adjustments in accordance with the plan); (v) amendments to the amendment and termination section of the Amended Plan other than amendments of a clerical nature; and (vi)&nbsp;any amendment that permits Awards to be
transferable or assignable other than for normal estate settlement purposes or for other purposes not involving the receipt of monetary consideration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>No Option and SAR Repricing </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as provided in the section titled &#147;Types of Awards &#151; Adjustments&#148; on page 98 and without limiting the
section titled &#147;Types of Awards &#151; Amendment and Termination&#148; beginning on page 99, the Talent and Compensation Committee may not, without shareholder approval, seek to effect
<FONT STYLE="white-space:nowrap">any&nbsp;re-pricing&nbsp;of</FONT> any previously granted &#147;underwater&#148; stock option or SAR by: (i)&nbsp;amending or modifying the terms of the stock option or SAR to lower the exercise price;
(ii)&nbsp;cancelling the underwater stock option or SAR and granting either (A)&nbsp;replacement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
stock options or SARs having a lower exercise price or (B)&nbsp;restricted shares, share units, or other share awards in exchange; or (iii)&nbsp;cancelling or repurchasing the underwater stock
options or SARs for cash or other securities. A stock option or SAR will be deemed to be &#147;underwater&#148; at any time when the market value of the Common Shares covered by such Award is less than the exercise price of the Award. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Clawback </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards under
the Amended Plan are subject to our Clawback Policy (adopted February&nbsp;21, 2017), available on our website at ir.bauschhealth.com (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance - Governance Documents&#148;).
In addition, the Talent and Compensation Committee may specify in an award agreement that an Award will be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events, include a termination of
employment or service, violation of material policies, breach of <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> confidentiality or other restrictive covenants, or requirements to
comply with minimum share ownership requirements, that may apply to the participant, or other conduct by the participant that is detrimental to the business or reputation of the Company and/or its subsidiaries. The Committee will also have full
authority to implement any policies and procedures necessary to comply with Section&nbsp;10D of the Securities Exchange Act of 1934. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amended Plan
Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Amended Plan was designed by the Talent and Compensation Committee, as part of a comprehensive
compensation strategy to provide long-term broad-based incentives for employees to contribute to the growth of the Company and its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If approved by the shareholders, participants in the Amended Plan will be eligible for annual long-term awards which may
include performance shares, stock options, restricted stock and share payments (or other Awards permitted under the Amended Plan). The level and types of Awards will be fixed by the Talent and Compensation Committee in light of the
participants&#146; targeted long-term incentive level. The Talent and Compensation Committee may impose additional conditions or restrictions to the vesting of such Awards as it deems appropriate, including, but not limited to, the achievement of
performance goals based on one or more business criteria. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards under the Amended Plan are made at the discretion of the
Talent and Compensation Committee and are not determinable at this time. Moreover, the ultimate value of any grants that are made will depend on the value of the underlying Common Shares at the time of settlement, which likewise is not determinable
at this time. Please refer to the &#147;Grants of Plan-Based Awards Table&#148; on page 69 to review equity and equity-based awards made to our NEOs in 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax Consequences of Amended Plan Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following is a brief summary of the principal United States federal income tax consequences of transactions under the
Amended Plan, based on current United States federal income tax laws. This summary is not intended to be exhaustive, does not constitute tax advice and, among other things, does not describe state, local or foreign tax consequences, which may be
substantially different. In particular, this summary does not address Canadian federal, provincial or territorial income tax consequences, including those applicable to employees resident in or whose employment is exercised in Canada. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">Non-Qualified&nbsp;Stock</FONT> Options </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, a participant will not recognize taxable income on the grant or vesting of
<FONT STYLE="white-space:nowrap">a&nbsp;non-qualified&nbsp;stock</FONT> option. Upon the exercise of <FONT STYLE="white-space:nowrap">a&nbsp;non-qualified&nbsp;stock</FONT> option, a participant will recognize ordinary income in an amount equal to
the difference between the market value of our Common Shares received on the date of exercise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
and the option cost (number of Common Shares purchased multiplied by the exercise price per Common Share). The Company will ordinarily be entitled to a deduction on the exercise date equal to the
ordinary income recognized by the participant upon exercise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Incentive Stock Options </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No taxable income is recognized by a participant on the grant or vesting of an incentive stock option. If a participant
exercises an incentive stock option in accordance with its terms and does not dispose of the Common Shares acquired within two years after the date of the grant of the incentive stock option or within one year after the date of exercise, the
participant will be entitled to treat any gain related to the exercise of the incentive stock option as capital gain (instead of ordinary income). In this case, the Company will not be entitled to a deduction by reason of the grant or exercise of
the incentive stock option, however the excess of the market value over the exercise price of the Common Shares acquired is an item of adjustment in computing alternative minimum tax of the participant. If a participant holds the Common Shares
acquired for at least one year from the exercise date and does not sell or otherwise dispose of the Common Shares for at least two years from the grant date, the participant&#146;s gain or loss upon a subsequent sale will be long-term capital gain
or loss equal to the difference between the amount realized on the sale and the participant&#146;s basis in the Common Shares acquired. If a participant sells or otherwise disposes of the Common Shares acquired without satisfying the required
minimum holding period, such &#147;disqualifying disposition&#148; will give rise to ordinary income equal to the excess of the market value of the Common Shares acquired on the exercise date (or, if less, the amount realized upon disqualifying
disposition) over the participant&#146;s tax basis in the Common Shares acquired. The Company will ordinarily be entitled to a deduction equal to the amount of the ordinary income resulting from a disqualifying disposition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Share Appreciation Rights </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, a participant will not recognize taxable income upon the grant or vesting of a SAR, but will recognize ordinary
income upon the exercise of a SAR in an amount equal to the cash amount received upon exercise (if the SAR is cash-settled) or the difference between the market value of our Common Shares received from the exercise of the SAR and the amount, if any,
paid by the participant in connection with the exercise of the SAR. The participant will recognize ordinary income upon the exercise of a SAR regardless of whether our Common Shares acquired upon the exercise of the SAR are subject to further
restrictions on sale or transferability. The participant&#146;s basis in the Common Shares will be equal to the ordinary income attributable to the exercise and the amount, if any, paid in connection with the exercise of the SAR. The
participant&#146;s holding period for Common Shares acquired pursuant to the exercise of a SAR begins on the exercise date. Upon the exercise of a SAR, the Company will ordinarily be entitled to a deduction in the amount of the ordinary income
recognized by the participant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Restricted Shares </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant generally will not be taxed at the time of a restricted share award but will recognize taxable income when the
award vests or otherwise is no longer subject to a substantial risk of forfeiture. The amount of taxable income will be the market value of the Common Shares at that time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Participants may elect to be taxed at the time of grant by making an election under Section&nbsp;83(b) of the Code within 30
days of the award date. If a restricted share award subject to the Section&nbsp;83(b) election is subsequently canceled, no deduction will be allowed for the amount previously recognized as income, and no tax previously paid will be refunded. Unless
a participant makes a Section&nbsp;83(b) election, dividends paid to a participant on Common Shares of an unvested restricted share award will be taxable to the participant as ordinary income. If the participant made a Section&nbsp;83(b) election,
the dividends will be taxable to the participant as dividend income. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will ordinarily be entitled to a deduction at the same time and
in the same amounts as the ordinary income recognized by the participant. Unless a participant has made a Section&nbsp;83(b) election, the Company will also be entitled to a deduction, for federal income tax purposes, for dividends paid on
restricted share awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Deferred Shares </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant will generally not recognize taxable income on a deferred share award until Common Shares subject to the award
are distributed. The amount of this ordinary income will be the market value of our Common Shares at the time of distribution. Any dividend equivalents paid on deferred share awards are taxable as ordinary income when paid to the participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company will ordinarily be entitled to a deduction at the same time and in the same amounts as the ordinary income
recognized by the participant. The Company will also be entitled to a deduction, for federal income tax purposes, on any dividend equivalent payments made to the participant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Share Units </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards of
share units are treated, for federal income tax purposes, in substantially the same manner as deferred share awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Share Awards </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant will generally recognize taxable income on the grant of unrestricted Common Shares, in an amount equal to the
market value of the Common Shares on the grant date. The Company will ordinarily be entitled to a deduction at the same time and in the same amounts as the ordinary income recognized by the participant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Withholding </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the
extent required by law, the Company will withhold from any amount paid in settlement of an Award amounts of withholding and other taxes due or take other action as the Company deems advisable to enable the Company and the participant to satisfy
withholding and tax obligations related to any Awards (including by providing for tax withholding obligations due in respect of an Award to be satisfied by &#147;net settlement&#148; or by <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;sell-to-cover&#148;).</FONT></FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Cash Awards </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant will generally recognize taxable income upon the payment of a cash award, in an amount equal to the amount of the
cash received. The Company will ordinarily be entitled to a deduction at the same time and in the same amounts as the ordinary income recognized by the participant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration with the SEC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If our shareholders approve the amendment to the Amended Plan, we plan to file with the SEC, as soon as reasonably practicable
after such approval, an amendment to the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> relating to the additional shares available for issuance under the Amended Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation Plan Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the information required by Item 201(d) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities
Exchange Act of 1934, see &#147;Equity Compensation Plan Information&#148; on page 82. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_28"></A>PROPOSAL NO. 4 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPOINTMENT OF AUDITOR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee recommended to the Board that PwC be put before the shareholders at the Meeting for appointment
as our auditor to serve until the close of the 2023 Annual Meeting of Shareholders. The Board has accepted and endorsed this recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the BCBCA, at each annual meeting of shareholders, shareholders of a corporation appoint, by a majority of votes cast in
respect of that proposal, an auditor to hold office until the close of the next annual meeting of shareholders. Notwithstanding the foregoing, if an auditor is not appointed at a meeting of shareholders, the incumbent auditor continues in office
until a successor is appointed. PwC currently serves as auditor of the Company and, therefore, shall continue to serve as the Company&#146;s auditor in the event that this proposal is not adopted by the shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Representatives of PwC will be present at the Meeting and will have an opportunity to make a statement if desired. Further,
the representatives will be available to respond to appropriate shareholder questions submitted in the manner described under &#147;Attending the Meeting &#151; How do I ask a question at the Meeting?&#148; on page 3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A simple majority of votes cast at the Annual Meeting, whether virtually, or by proxy or otherwise, will be required to
appoint PwC. You may either vote &#147;For&#148; the appointment of PwC or &#147;Withhold&#148; your vote with respect to such appointment. If you vote &#147;For&#148; the appointment of PwC, your Common Shares will be voted accordingly. If you
select &#147;Withhold&#148; with respect to the appointment of PwC, your vote will not be counted as a vote cast for the purposes of appointing PwC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a shareholder of the Company, you are invited to vote with respect to the appointment of PwC as the auditor for the Company
to hold office until the close of the 2023 Annual Meeting of Shareholders and to authorize the Board to fix the auditor&#146;s remuneration through the following resolution: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Resolved, that the shareholders hereby appoint PwC as auditor for the Company to hold office until the close
of the 2023 Annual Meeting of Shareholders and the Board of Directors of the Company is hereby authorized to fix the auditor&#146;s remuneration. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>The Board recommends that the shareholders vote FOR Proposal No.&nbsp;4. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_29"></A>AUDITOR FEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For fiscal years ended December&nbsp;31, 2021 and December&nbsp;31, 2020, PwC was our appointed auditor. Principal Auditor fee
includes fees paid to PwC and affiliated PwC network firms through the world. The table below summarizes the fees (expressed in thousands of U.S. Dollars) paid by the Company and its consolidated subsidiaries to PwC during 2021 and 2020. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,977</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Less than 1%. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Audit-related services are generally related to audits of financial statements prepared for special
purposes, assignments relating to due diligence investigations, <FONT STYLE="white-space:nowrap">pre-implementation</FONT> review procedures and employee benefit plan audits and, in 2021, were primarily related to the audit of the carve-out
financials relating to the proposed B+L IPO and other strategic alternatives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Tax services are professional services rendered by our auditor for tax compliance and tax consulting
primarily related to international transfer pricing. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">All other fees are amounts paid for miscellaneous permissible products and services. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Audit Fees </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The aggregate fees for professional services rendered by PwC for the fiscal years ended December&nbsp;31, 2021 and
December&nbsp;31, 2020 for the audit of our consolidated annual financial statements and the reviews of the financial statements included in our <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> and Form
<FONT STYLE="white-space:nowrap">10-Q,&nbsp;the</FONT> audits of our internal control over financial reporting with the objective of obtaining reasonable assurance about whether effective internal control over financial reporting was maintained in
all material respects, and the audits that are normally provided by PwC in connection with statutory and regulatory filings as well as for services billed related to our financing activities, such as comfort letters and consents, were approximately
$14.1&nbsp;million and $14.0&nbsp;million, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Audit-Related Fees </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee believes that the provision of the <FONT STYLE="white-space:nowrap">non-audit</FONT> services
referenced above is compatible with maintaining PwC&#146;s independence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Audit-related services are generally related to
audits of financial statements prepared for special purposes, employee benefit plan audits, <FONT STYLE="white-space:nowrap">pre-implementation</FONT> review procedures and assignments relating to due diligence investigations and procedures.
Audit-related services primarily related to the aggregated fees billed in the respective calendar year for the special purpose financial statement audits for the years ended December&nbsp;31, 2018 through December&nbsp;31, 2021, including quarterly
financial statement reviews for the applicable periods, and registration statement filings, consents, due diligence procedures and comfort letters associated with <FONT STYLE="white-space:nowrap">our&nbsp;eye-health&nbsp;and</FONT> medical
aesthetics businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The aggregate fees billed for audit-related services rendered by PwC during the fiscal year ended
December&nbsp;31, 2021 and December&nbsp;31, 2020 that are traditionally performed by the principal accountant and are reasonably related to the performance of the audit or review of the Company&#146;s financial statements and are not included in
&#147;Audit Fees&#148; above were approximately $20.5&nbsp;million and $4.5&nbsp;million, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Tax Fees </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Tax services are professional services rendered by our auditor for tax compliance and tax consulting primarily related to
international transfer pricing. The aggregate fees billed for tax services rendered by PwC during the fiscal years ended December&nbsp;31, 2021 and December&nbsp;31, 2020 were approximately $1.6&nbsp;million and $2.0&nbsp;million, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>All Other Fees </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There were insignificant amounts billed for miscellaneous permissible products and services as reported above to PwC during the
fiscal years ended December&nbsp;31, 2021 and December&nbsp;31, 2020. PwC did not provide any financial information systems design or implementation services to the Company during 2021 or 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All fees described above were approved by the Audit and Risk Committee of our Board under its
<FONT STYLE="white-space:nowrap">pre-approval</FONT> policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit and Risk Committee&#146;s <FONT STYLE="white-space:nowrap">Pre-Approval</FONT> of <FONT
STYLE="white-space:nowrap">Non-Audit</FONT> Services </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Audit and Risk Committee chooses and appoints (through
nomination to the Company&#146;s shareholders) the Company&#146;s auditor to audit our financial statements. The Audit and Risk Committee <FONT STYLE="white-space:nowrap">pre-approves</FONT> <FONT STYLE="white-space:nowrap">non-audit</FONT> services
that may be provided to the Company and its subsidiaries by its auditor. The Audit and Risk Committee is not permitted to approve any engagement of the Company&#146;s auditor if the services to be performed either fall into a category of services
that are not permitted by applicable law or the services would be inconsistent with maintaining the auditor&#146;s independence. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_30">
</A>OTHER </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_31"></A>SHAREHOLDER PROPOSALS AND DIRECTOR NOMINATIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE 2023 ANNUAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A shareholder who is entitled to vote at the 2023 Annual Meeting of Shareholders may raise a proposal for consideration at
such Annual Meeting of Shareholders. We will consider such proposal for inclusion in the proxy materials for the 2023 Annual Meeting only if our Corporate Secretary receives such proposal (at 2150 Saint Elz&eacute;ar Blvd. West, Laval,
Qu&eacute;bec, H7L 4A8, Canada, or by facsimile <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">514-744-6272):</FONT></FONT> (i) submitted pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act, on or
before January&nbsp;2, 2023, or (ii)&nbsp;submitted pursuant to Part 5, Division 7 of the BCBCA on or before March&nbsp;14, 2023. The use of certified mail, return receipt, is advised. In addition, a proposal submitted pursuant to Rule 14a-8 can be
submitted by sending an <FONT STYLE="white-space:nowrap">e-mail</FONT> to <U>ir@bauschhealth.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the date of the
2023 Annual Meeting of Shareholders is advanced or delayed more than 30 days from the date of the Annual Meeting, shareholder proposals intended to be included in the proxy statement for the 2023 Annual Meeting of Shareholders must be received by us
within a reasonable time before we begin to print and mail the proxy statement, or provide a notice to you with respect to accessing such proxy statement on the internet, for the 2023 Annual Meeting of Shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s Articles provide that shareholders seeking to nominate candidates for election as directors must provide
timely notice in writing to the Company&#146;s secretary by personal delivery or facsimile transmission at the number shown on the Company&#146;s issuer profile on SEDAR at <U>www.sedar.com</U>. The purpose of this advance notice requirement is to:
(i)&nbsp;inform the Company of nominees for election at a shareholder meeting proposed by a shareholder sufficiently in advance of such meeting; (ii)&nbsp;provide an opportunity to inform all shareholders of any potential proxy contest and proposed
director nominees sufficiently in advance of the applicable meeting; and (iii)&nbsp;enable the Board to make informed recommendations or present alternatives to shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To be timely, a shareholder&#146;s notice must be received by the Company: (i)&nbsp;in the case of an annual general meeting,
not later than the close of business on the 50th day before the meeting date or, if the first public announcement of the date of such meeting is less than 60 days prior to the meeting date, the close of business on the 10th day following the day on
which public announcement of the date of such annual general meeting was first made by the Company; and (ii)&nbsp;in the case of a special meeting called for the purpose of electing directors, not later than the close of business on the 15th day
following the day on which public announcement of the date of the special meeting is first made by the Company. The Company&#146;s Articles also prescribe the proper written form for a shareholder&#146;s notice as well as additional requirements in
connection with nominations. Shareholders </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">who failed to comply with the advance notice requirements would not be entitled to make
nominations for directors at the Annual General or Special Meeting of Shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_32"></A>COMMUNICATION WITH THE BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Shareholders and other interested parties may contact the Company&#146;s directors or independent directors in writing, as a
group or individually, by directing their correspondence to the attention of Bausch Health Investor Relations, Bausch Health Companies Inc., 2150&nbsp;Saint Elz&eacute;ar Blvd. West, Laval, Qu&eacute;bec, H7L 4A8, Canada. Shareholders and other
interested parties may also contact the Company&#146;s directors by calling the Company&#146;s helpline in the United States and Canada at <FONT STYLE="white-space:nowrap">(888)&nbsp;451-4510.</FONT> Additional international telephone numbers are
included in our Business Ethics Reporting Policy, which is available on our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Corporate Governance&nbsp;&#150; Governance Documents&#148;). The
Corporate Secretary will log incoming information and forward appropriate messages promptly to the director(s). Communications are distributed to the Board or to any individual director or directors as appropriate, depending on the facts and
circumstances outlined in the communication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain items that are unrelated to the duties and responsibilities of the
Board will not be distributed to the Board, such as mass mailings, product complaints, product inquiries, new product suggestions, resumes and other forms of job inquiries, surveys and business solicitations or advertisements. In addition, material
that is inappropriate or unsuitable will be excluded, with the provision that any communication that is excluded must be made available to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director upon request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Communications that include information better addressed by the Audit and Risk Committee will be addressed directly by that
Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company has specifically consulted with its stakeholders in recent years on matters including executive
compensation. See &#147;Compensation Discussion&nbsp;&amp; Analysis&nbsp;&#150; Shareholder-Friendly Compensation Practices&nbsp;&#150; 2021 Shareholder Engagement&#148; beginning on page 50 for additional information. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_33"></A>ANNUAL REPORT AND ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our financial information is contained in the Company&#146;s consolidated annual financial statements and related MD&amp;A for
the fiscal year ended December&nbsp;31, 2021. Our Annual Report is available on the internet at our website at <U>www.bauschhealth.com</U> (under the tab &#147;Investors&#148; and under the subtab &#147;Annual Reports Archive&#148;) or on SEDAR at
<U>www.sedar.com</U> or through the SEC&#146;s electronic data system, EDGAR, at <U>www.sec.gov</U>. To request a printed copy of our Annual Report or consolidated financial statements and related MD&amp;A as of and for the year ended
December&nbsp;31, 2021, which we will provide to you without charge, either write to Bausch Health Investor Relations at Bausch Health Companies Inc., 2150&nbsp;Saint Elz&eacute;ar Blvd. West, Laval, Qu&eacute;bec H7L 4A8, Canada, or send an email
to Bausch Health Investor Relations at <U>ir@bauschhealth.com</U>. Neither the Annual Report nor the consolidated financial statements and related MD&amp;A as of and for the year ended December&nbsp;31, 2021 form part of the material for the
solicitation of proxies. Additional information relating to the Company may be found on SEDAR at <U>www.sedar.com</U> or on EDGAR at <U>www.sec.gov</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_34"></A>PROXY SOLICITATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will bear the entire cost of solicitation, including the preparation, assembly, internet hosting, maintaining a dedicated
call line and printing and mailing the Proxy Materials, including the management proxy circular and proxy statement and form of proxy card. In addition to soliciting proxies by telephone, internet and mail, directors, officers or employees of the
Company may, without special compensation, solicit proxies in person, by telephone, telegraph, courier service, advertisement, telecopier or other electronic means. We have retained D.F. King to assist in the solicitation of proxies. We will pay
fees to D.F. King of $10,000, plus reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by them. We will pay those entities holding Common Shares in the names of their beneficial
owners, such as brokers, nominees, fiduciaries and other custodians for their reasonable fees and expenses in forwarding solicitation material to their beneficial owners and for obtaining their instructions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_35"></A>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Companies and intermediaries (e.g., brokers) are permitted under the SEC&#146;s rules to satisfy the delivery requirements for
proxy materials and annual reports with respect to two or more shareholders sharing the same address by delivering a single management proxy circular and proxy statement addressed to those shareholders. This process, which is commonly referred to as
&#147;householding,&#148; potentially means extra convenience for shareholders and cost savings for companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A number
of brokers with account holders who are our shareholders &#147;household&#148; our proxy materials. A single management proxy circular and proxy statement or Notice Regarding Internet Availability of Proxy Materials, as applicable, will be delivered
to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address,
&#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If you prefer to receive multiple copies of the separate management proxy circular and proxy statement, as applicable, at the same address for
the Meeting or for any future Annual Meetings of Shareholders, additional copies will be provided promptly upon written or oral request to your broker, or by contacting us at Bausch Health Companies Inc., Attn: Investor Relations, 2150 Saint
Elz&eacute;ar Blvd. West, Laval, Qu&eacute;bec H7L 4A8, Canada, telephone <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">514-856-3855</FONT></FONT> or toll-free at 877-281-6642. Shareholders who currently receive multiple copies
of the Proxy Statement at their address and would like to request &#147;householding&#148; of their communications should contact their broker. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_36"></A>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any other matters are properly presented for consideration at the Meeting, including, among other things, consideration of
a motion to adjourn the Meeting to another time or place in order to solicit additional proxies in favor of the recommendation of the Board, the designated proxyholders intend to vote the Common Shares represented by the Proxies appointing them on
such matters in accordance with the recommendation of the Board and the authority to do so is included in the Proxy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As
of the date this Proxy Statement, the Board knows of no other matters which are likely to come before the Meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g296110g10v55.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph C. Papa</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board and Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Laval, Qu&eacute;bec </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;2, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>WE WILL
MAIL WITHOUT CHARGE UPON WRITTEN REQUEST A COPY OF OUR MOST RECENT ANNUAL REPORT, INCLUDING THE FINANCIAL STATEMENTS, SCHEDULES AND A LIST OF EXHIBITS. REQUESTS SHOULD BE SENT TO: CORPORATE SECRETARY, BAUSCH HEALTH COMPANIES INC., 2150 SAINT
ELZ&Eacute;AR BLVD. WEST, LAVAL, QU&Eacute;BEC H7L 4A8, CANADA. THE ANNUAL REPORT IS ALSO AVAILABLE FREE OF CHARGE ON THE COMPANY WEBSITE: <U>WWW.BAUSCHHEALTH.COM</U>. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="tx296110_37"></A>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BAUSCH HEALTH COMPANIES INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHARTER OF THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BOARD OF
DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The board of directors (the &#147;<B>Board</B>&#148;) of Bausch Health Companies Inc. (the
&#147;<B></B><B><I>Company</I></B><B></B>&#148;) is elected by shareholders and is responsible for the stewardship of the activities and affairs of the Company. The Board seeks to discharge such responsibility by reviewing, discussing and approving
the Company&#146;s strategic planning and organizational structure and supervising management to oversee that the strategic planning and organizational structure preserve and enhance the business of the Company and the Company&#146;s underlying
value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DUTIES OF DIRECTORS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board discharges its responsibility for overseeing the management of the Company&#146;s business by delegating to the
Company&#146;s senior officers the responsibility for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of the Company. The Board discharges its responsibilities both directly and by delegation
through its committees. In addition to these regular committees, the Board may appoint <I>ad hoc</I> committees periodically to address certain issues of a more short-term nature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board&#146;s primary roles are overseeing the Company&#146;s performance and the quality, depth and continuity of
management needed to meet the Company&#146;s strategic objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Other principal duties, which may be carried out
directly or via one or more committees, include, but are not limited to the following categories: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Appointment of Management </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for approving the appointment of the chief executive officer (the
&#147;<B><I>CEO</I></B>&#148;) and all other senior management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">In approving the appointment of the CEO and all other senior management, the Board will, to the extent
feasible, satisfy itself as to the integrity of these individuals and that they create a culture of integrity throughout the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board from time to time delegates to senior management the authority to enter into certain types of
transactions, including financial transactions, subject to specified limits. Investments and other expenditures above the specified limits, and material transactions outside the ordinary course of business are reviewed by and are subject to the
prior approval of the Board. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board oversees that succession planning programs are in place, including programs to train and develop
management. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board assesses and revises the Company&#146;s executive compensation policy to, among other things,
better align management&#146;s interests with those of the shareholders. This includes establishing minimum shareholding requirements for senior management. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Board Organization </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board will receive recommendations from the Nominating and Corporate Governance Committee (the
&#147;<B><I>NCG Committee</I></B>&#148;), but retains responsibility for managing its own affairs by giving its approval for its composition and size, the selection of the Chairperson of the Board, the selection of the Lead Independent Director of
the Board, if applicable, candidates nominated for election to the Board, committee and committee chairperson appointments, committee charters and director compensation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Board may establish committees of the Board, where required or prudent, and define their
mandate. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board may delegate to Board committees matters it is responsible for, including the approval of
compensation of the Board and management, the conduct of performance evaluations and oversight of internal controls systems, but the Board retains its oversight function and ultimate responsibility for these matters and all other delegated
responsibilities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board will oversee orientation and education program for new directors and ongoing educational
opportunities for continuing directors. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Strategic Planning </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board has oversight responsibility to participate directly, and through its committees, in reviewing,
questioning and approving the mission of the Company and its objectives and goals. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for participating in the development of, and reviewing and approving, the business,
financial and strategic plans by which it is proposed that the Company may reach those goals. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Monitoring of Financial Performance
and Other Financial Reporting Matters </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for enhancing congruence between shareholder expectations, the Company&#146;s plans
and management performance. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for adopting processes for monitoring the Company&#146;s progress toward its
strategic and operational goals, and to revise and alter its direction to management in light of changing circumstances affecting the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for approving the audited financial statements, management&#146;s discussion and
analysis accompanying such financial statements and the annual earnings press release. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for reviewing the quarterly financial statements, management&#146;s discussion and
analysis accompanying such financial statements and the quarterly earnings press release. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for reviewing and approving material transactions outside the ordinary course of
business and those matters which the Board is required to approve under the Articles, including the payment of dividends, purchase and redemptions of securities, acquisitions and dispositions. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Risk Management </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for overseeing the identification of the principal risks of the Company&#146;s
business, including cybersecurity risks, and the implementation of appropriate systems to effectively monitor and manage such risks with a view to the long-term viability of the Company and achieving a proper balance between the risks incurred and
the potential return to the Company&#146;s shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Policies and Procedures </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">approving and assessing compliance with all significant policies and procedures by which Bausch Health is
operated; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">approving policies and procedures designed to ensure that Bausch Health operates at all times within
applicable laws and regulations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for supporting a corporate culture of integrity and responsible stewardship.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board shall enforce its policy respecting confidential treatment of the Company&#146;s proprietary
information and the confidentiality of Board deliberations. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Communications and Reporting </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board is responsible for: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">overseeing the accurate reporting of the financial performance and condition of the Company to shareholders,
other securityholders and regulators on a timely and regular basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">encouraging effective and adequate communication with shareholders, other stakeholders and the public; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">ensuring the integrity and adequacy of internal controls and management information systems.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Certain Individual Responsibilities of the Members of the Board </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Each member of the Board is expected to attend all meetings of the Board, unless adequate notification of
absence is provided. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Each member of the Board is expected to have reviewed all materials provided in connection with a meeting in
advance of such meeting and be prepared to discuss such materials at the meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. REVIEW AND DISCLOSURE </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board shall review and reassess the adequacy of this Charter for the Board of Directors (the
&#147;<B><I>Charter</I></B>&#148;) periodically and otherwise as it deems appropriate and amend it accordingly. The performance of the Board shall be evaluated with reference to this Charter. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Board shall ensure that this Charter is disclosed on the Company&#146;s website and that this Charter or
a summary of it which has been approved by the NCG Committee is disclosed in accordance with all applicable securities laws or regulatory requirements. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: July&nbsp;27, 2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx296110_38"></A>Bausch Health Companies Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 OMNIBUS INCENTIVE PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(As Amended and Restated, Effective as of June 21, 2022) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purpose and Background</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The purposes of the Amended and Restated 2014 Omnibus Incentive Plan (as amended from time to time, the
&#147;<B>Plan</B>&#148;) are to (i)&nbsp;align the long-term financial interests of employees, directors, consultants, agents and other service providers of the Company and its Subsidiaries with those of the Company&#146;s shareholders;
(ii)&nbsp;attract and retain those individuals by providing compensation opportunities that are competitive with other companies; and (iii)&nbsp;provide incentives to those individuals who contribute significantly to the long-term performance and
growth of the Company and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Bausch Health Companies Inc., a British Columbia corporation, adopted the
2014 Omnibus Incentive Plan (the &#147;<B>2014 Plan</B>&#148;) effective as of April&nbsp;7, 2014, which was approved by the shareholders at the 2014 annual meeting. The 2014 Plan reserved approximately 18&nbsp;million Common Shares for the issuance
of Awards. On April&nbsp;30, 2018, the shareholders approved an amendment to the 2014 Plan to increase the number of Common Shares authorized under the 2014 Plan by an additional 11,900,000 Common Shares. On April&nbsp;28, 2020, the shareholders
approved an amendment and restatement of the 2014 Plan to increase the number of authorized Common Shares by an additional 13,500,000 Common Shares. As of December&nbsp;31, 2021, 11,593,059 Common Shares were available for further issuance. On
February 14, 2022, the Talent and Compensation Committee of the Board of Directors approved an amendment and restatement of the 2014 Plan to increase the number of authorized Common Shares by an additional 11,500,000 Common Shares. The Plan, as
amended and restated, has been adopted and approved by the Board (defined below) and shall be effective as of June 21, 2022 (the &#147;<B>Effective Date</B>&#148;), subject to the approval of shareholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the right of the Board to amend or terminate the Plan at any time pursuant to Section&nbsp;19 hereof, the Plan shall remain in
effect until the earlier of (i)&nbsp;the date all Common Shares subject to the Plan have been purchased or acquired according to the Plan&#146;s provisions or (ii)&nbsp;the tenth anniversary of the Effective Date. No Awards shall be granted under
the Plan after such termination date, but Awards granted prior to such termination date shall remain outstanding in accordance with their terms, and the authority of the Committee to amend, alter, adjust, suspend, discontinue or terminate any such
Award, or to waive any conditions or rights under any such Award shall extend beyond such date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Award</B>&#148; shall mean an Option, SAR, Share Unit, Share Award or Cash Award granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Award Agreement</B>&#148; shall mean any written agreement, contract, or other instrument or document evidencing an Award, which may,
but need not, be executed or acknowledged by a Participant, as determined in the discretion of the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Board</B>&#148;
shall mean the Board of Directors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Blackout Period</B>&#148; means a period self-imposed by the Company (within
the meaning of Section&nbsp;613(m) of the TSX Company Manual) when the Participant is prohibited from trading in the Company&#146;s securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Business Day</B>&#148; means any day, other than a Saturday, Sunday or statutory or civic holiday, on which banks in Toronto, Ontario
are open for business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Cash Award</B>&#148; means cash awarded under Section&nbsp;7(d) of the Plan,
including cash awarded as a bonus or upon the attainment of Performance Criteria or otherwise as permitted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Cause</B>&#148; shall have the meaning set forth in the Participant&#146;s Service Agreement; provided that if no such agreement or
definition exists, &#147;Cause&#148; shall mean, unless otherwise specified in the Award Agreement: (i)&nbsp;conviction of any felony or indictable offense (other than one related to a vehicular offense) or other criminal act involving fraud;
(ii)&nbsp;willful misconduct that results in a material economic detriment to the Company; (iii)&nbsp;material violation of Company policies and directives, which is not cured after written notice and an opportunity for cure; (iv)&nbsp;continued
refusal by the Participant to perform the Participant&#146;s duties after written notice identifying the deficiencies and an opportunity for cure; (v)&nbsp;a material violation by the Participant of any material covenants to the Company and
(vi)&nbsp;such other actions constituting cause under applicable common law. No action or inaction shall be deemed willful if (x)&nbsp;not demonstrably willful and (y)&nbsp;taken or not taken by the Participant in good faith and with the
understanding that such action or inaction was not adverse to the best interests of the Company. Reference in this definition to the Company shall also include direct and indirect Subsidiaries of the Company, and materiality shall be measured based
on the action or inaction and the impact upon the Company taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Change of Control</B>&#148; shall have the meaning
set forth in Section&nbsp;11. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Code</B>&#148; shall mean the U.S. Internal Revenue Code of 1986, as amended, including any rules
and regulations promulgated thereunder and any successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Committee</B>&#148; shall mean the Board or a committee
designated by the Board to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Common Shares</B>&#148; shall mean the common shares of the Company, no par
value per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Company</B>&#148; shall mean Bausch Health Companies Inc., a corporation incorporated under the British
Columbia Business Corporations Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Consultant</B>&#148; means any individual, including an advisor, consultant or agent, who is
providing services to the Company or any Subsidiary under a written agreement, other than services provided in relation to a distribution, including, without limitation, any <FONT STYLE="white-space:nowrap">non-employee</FONT> director serving on
the Board of Directors of any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Deferred Shares</B>&#148; shall mean an Award payable in Common Shares at the end of a
specified deferral period that is subject to the terms, conditions and limitations described or referred to in Section&nbsp;7(d)(iv). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Director</B>&#148; means any member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Disability</B>&#148; shall mean, unless otherwise provided in an applicable Service Agreement or Award Agreement, that the
Participant is (i)&nbsp;unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less
than twelve (12)&nbsp;months or (ii)&nbsp;by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12)&nbsp;months,
receiving income replacement benefits for a period of not less than three (3)&nbsp;months under an accident and health plan covering employees of the Company; provided, that, if applicable to the Award, &#147;Disability&#148; shall be determined in
a manner consistent with Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Eligible Recipient</B>&#148; shall mean (i)&nbsp;any Employee,
(ii)&nbsp;any Director or (iii)&nbsp;any Consultant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Exchange Act</B>&#148; shall mean the Securities Exchange Act of 1934, as
amended, including the rules and regulations promulgated thereunder and any successor thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Good Reason</B>&#148; shall have the meaning set forth in the Participant&#146;s
applicable Service Agreement; provided that if no such agreement or definition exists, &#147;Good Reason&#148; shall mean, unless otherwise specified in the Award Agreement, the occurrence of any of the events or conditions described in clauses
(i)&nbsp;and (ii) immediately below without the Participant&#146;s consent, which are not cured by the Company (if susceptible to cure by the Company) within thirty (30)&nbsp;days after the Company has received written notice from the Participant
which notice must be provided by the Participant within ninety (90)&nbsp;days of the initial existence of the event or condition constituting Good Reason specifying the particular events or conditions which constitute Good Reason and the specific
cure requested by the Participant: (i)&nbsp;any material reduction in the Participant&#146;s duties or responsibilities as in effect immediately prior thereto; provided that diminution of responsibility shall not include any such diminution
resulting from a promotion, death or Disability, the Participant&#146;s Termination of Service for Cause, or the Participant&#146;s Termination of Service other than for Good Reason; and (ii)&nbsp;any reduction in the Participant&#146;s base salary
or target bonus opportunity which is not comparable to reductions in the base salary or target bonus opportunity of other similarly-situated employees at the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Insider</B>&#148; shall mean a reporting insider, as defined in National Instrument <FONT STYLE="white-space:nowrap">55-104</FONT>
-<I> Insider Reporting Requirements and Exemptions</I> of the Canadian Securities Administrators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>ISO</B>&#148; shall mean an
Option intended to be and designated as an incentive stock option within the meaning of Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Intrinsic
Value</B>&#148; with respect to an Option or SAR means (i)&nbsp;the excess, if any, of the price or implied price per Common Share in a Change of Control or other event over (ii)&nbsp;the exercise or price of such Award multiplied by (iii)&nbsp;the
number of Shares covered by such Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Market Price</B>&#148; shall mean, with respect to Common Shares, (i)&nbsp;the closing
price per Common Share on the national securities exchange on which the Common Shares are principally traded (as of the Effective Date, the New York Stock Exchange), or (ii)&nbsp;if the Common Shares are not then listed on a national securities
exchange but are then traded in an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, the average of the closing bid and asked prices for the Common Shares in such
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or (iii)&nbsp;if the Common Shares are not then listed on a national securities exchange or traded in an <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, such value as the Committee, using any reasonable method of valuation, shall determine. With respect to property other than Common Shares, the Market Price shall mean the fair market
value of such other property determined by such methods or procedures as shall be established from time to time by the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Nonqualified Stock Option</B>&#148; shall mean an Option that is granted to a Participant that is not designated as an ISO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Option</B>&#148; shall mean the right to purchase a specified number of Common Shares at a stated exercise price for a specified
period of time subject to the terms, conditions and limitations described or referred to in Section&nbsp;7(a). The term &#147;Option&#148; as used in the Plan includes the terms &#147;Nonqualified Stock Option&#148; and &#147;ISO.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Original Term</B>&#148; shall have the meaning set forth in Section&nbsp;7(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Participant</B>&#148; shall mean an Eligible Recipient who has been granted an Award under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Performance Criteria</B>&#148; shall mean performance criteria based on the attainment by the Company or any Subsidiary (or any
division or business unit of such entity) of performance measures <FONT STYLE="white-space:nowrap">pre-established</FONT> by the Committee in its sole discretion, including, but not limited to, one or more of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">revenues, income before taxes and extraordinary items, net income, operating income, earnings before income
tax, earnings before interest, taxes, depreciation and amortization, cash flow or a combination of any or all of the foregoing; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><FONT STYLE="white-space:nowrap">after-tax</FONT> or <FONT STYLE="white-space:nowrap">pre-tax</FONT> profits
including, without limitation, that attributable to continuing and/or other operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the level of the Company&#146;s bank debt or other long-term or short-term public or private debt or other
similar financial obligations of the Company either in absolute terms or as it relates to a profitability ratio including operating income or EBITA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">return on capital employed, return on assets, or return on invested capital; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><FONT STYLE="white-space:nowrap">after-tax</FONT> or <FONT STYLE="white-space:nowrap">pre-tax</FONT> return
on stockholders&#146; equity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">economic value added targets based on a cash flow return on investment formula; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the Market Price of the Common Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the market capitalization or enterprise value of the Company, either in amount or relative to industry
peers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the value of an investment in the Common Shares assuming the reinvestment of dividends;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the achievement of operating margin targets or other measures of improving profitability;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the filing of one or more new drug application(s) (&#147;NDA&#148;) or one or more new drug submission(s)
(&#147;NDS&#148;) or the approval of one or more NDA(s) or one or more NDS(s) by the U.S. Food and Drug Administration or the Canadian Therapeutic Products Directorate, as applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the achievement of, or progress toward, a launch of one or more new drug(s); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xiii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the achievement of research and development milestones; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xiv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the achievement of other strategic milestones including, without limitation, the achievement of specific
synergy capture and cost savings realization relating to integrations and the successful creation or execution of a restructuring plan for a specific business or function; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the successful completion of clinical trial phases; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xvi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">licensing or acquiring new products or product platforms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xvii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">acquisition or divestiture of products or business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xviii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the entering into new, or exiting from existing, geographic markets or industry segments; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="7%" VALIGN="top" ALIGN="left">(xix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the attainment of a certain level of, reduction of, or other specified objectives with regard to limiting
the level in or increase in, all or a portion of controllable expenses or costs or other expenses or costs. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For
purposes of item (i)&nbsp;above, &#147;extraordinary items&#148; shall mean all items of gain, loss or expense for the fiscal year determined to be extraordinary or unusual in nature or infrequent in occurrence or related to a corporate transaction
(including, without limitation, a disposition or acquisition) or restructuring or related to a change in accounting principles, all as determined in accordance with standards established by Opinion No.&nbsp;30 of the Accounting Principles Board.
Each financial metric described in item (i)&nbsp;above may be on a business unit, geographic segment, total company or <FONT STYLE="white-space:nowrap">per-share</FONT> basis, and on a GAAP or <FONT STYLE="white-space:nowrap">non-GAAP</FONT>
adjusted basis. The Performance Criteria may be based upon the attainment of specified levels of performance under one or more of the measures described above relative to the performance of other entities. The Committee may designate additional
business criteria on which the Performance Criteria may be based or adjust, modify or amend the aforementioned business criteria, including to take into account actions approved by the Board or a committee thereof that affect the achievement of the
original performance criteria. Performance Criteria may include a threshold level of performance below which no Award will be earned, a level of performance at which the target amount of an Award will be earned and a level of performance at which
the maximum amount of the Award will be earned. The Committee, in its sole discretion, shall make equitable adjustments to the Performance Criteria in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
recognition of unusual or <FONT STYLE="white-space:nowrap">non-recurring</FONT> events affecting the Company or any Subsidiary or the financial statements of the Company or any Subsidiary, in
response to changes in applicable laws or regulations, including changes in generally accepted accounting principles, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or
related to the disposal of a segment of a business or related to a change in accounting principles, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Person</B>&#148; shall have the meaning set forth in Section&nbsp;14(d)(2) of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Restricted Shares</B>&#148; shall mean an Award of Common Shares that is subject to the terms, conditions, restrictions and
limitations described or referred to in Section&nbsp;7(d)(iii). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>SAR</B>&#148; shall mean a share appreciation right that is
subject to the terms, conditions, restrictions and limitations described or referred to in Section&nbsp;7(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Section</B><B></B><B>&nbsp;16(a) Insider</B>&#148; shall mean an Eligible Recipient who is subject to the reporting requirements of
Section&nbsp;16(a) of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Separation from Service</B>&#148; shall have the meaning set forth in <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h)</FONT> of the Treasury Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Service Agreement</B>&#148; means any
employment, severance, consulting or similar agreement between the applicable Participant and the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Specified Employee</B>&#148; shall have the meaning set forth in Section&nbsp;409A of the Code and the Treasury Regulations
promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Share Award</B>&#148; shall have the meaning set forth in Section&nbsp;7(d)(i). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Share Payment</B>&#148; shall mean a share payment that is subject to the terms, conditions, and limitations described or referred to
in Section&nbsp;7(d)(ii). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Share Unit</B>&#148; shall mean a share unit that is subject to the terms, conditions and limitations
described or referred to in Section&nbsp;7(c). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Subsidiary</B>&#148; means any corporation (other than the Company) in an
unbroken chain of corporations beginning with the Company, if each of the corporations (other than the last corporation) in the unbroken chain owns shares possessing fifty percent (50%) or more of the total combined voting power of all classes of
shares in one of the other corporations in the chain (or such lesser percent as is permitted by <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(b)(5)(iii)(E)</FONT> of the Treasury Regulations). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Substitute Award</B>&#148; means an Award granted in connection with a transaction between the Company (or a Subsidiary) and another
entity or business acquired by the Company (or a Subsidiary), or with which the Company or a Subsidiary combines, in substitution or exchange for, or conversion, adjustment, assumption or replacement of, awards previously granted by such other
entity or business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Termination of Service</B>&#148; means, unless as otherwise provided in an Award Agreement, in the case of a
Participant who is an Employee, cessation of the employment relationship such that the Participant is no longer an employee of the Company or any Subsidiary, or, in the case of a Participant who is a Consultant or
<FONT STYLE="white-space:nowrap">non-employee</FONT> Director, the date the performance of services for the Company or any Subsidiary has ended; <I>provided</I>, <I>however</I>, that in the case of a Participant who is an Employee, the transfer of
employment from the Company to a Subsidiary, from a Subsidiary to the Company, from one Subsidiary to another Subsidiary or, unless the Committee determines otherwise, the cessation of employee status but the continuation of the performance of
services for the Company or a Subsidiary as a Director or Consultant shall not be deemed a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
cessation of service that would constitute a Termination of Service; <I>provided</I>, <I>further</I>, that a Termination of Service shall be deemed to occur for a Participant employed by, or
performing services for, a Subsidiary when such Subsidiary ceases to be a Subsidiary unless such Participant&#146;s employment or service continues with the Company or another Subsidiary. Notwithstanding the foregoing, with respect to any Award
subject to Section&nbsp;409A of the Code (and not exempt therefrom), a Termination of Service occurs when a Participant experiences a Separation of Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Transferred Shares</B>&#148; shall have the meaning set forth in Section&nbsp;6(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>Treasury Regulations</B>&#148; shall mean the regulations promulgated under the Code by the United States Internal Revenue Service,
as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;<B>TSX</B>&#148; means the Toronto Stock Exchange. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>4<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Administration</U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Committee Authority</I></B>. Subject to applicable law, the Committee shall have full and exclusive
power to administer and interpret the Plan, to grant Awards and to adopt such administrative rules, regulations, procedures and guidelines governing the Plan and the Awards as it deems appropriate, in its sole discretion, from time to time. The
Committee&#146;s authority shall include, but not be limited to, the authority to (i)&nbsp;determine the type of Awards (including Substitute Awards) to be granted under the Plan; (ii)&nbsp;select Award recipients and determine the extent of their
participation; (iii)&nbsp;determine Performance Criteria; (iv)&nbsp;establish all other terms, conditions, and limitations applicable to Awards, Award programs and, if applicable, the Common Shares issued pursuant thereto; (v)&nbsp;determine
whether, to what extent, under what circumstances and by which methods Awards may be settled or exercised in cash, Common Shares, other Awards, other property, net settlement (including broker-assisted cashless exercise), or any combination thereof,
or canceled, forfeited or suspended; and (vi)&nbsp;establish, amend, suspend or waive such rules and regulations and appoint such agents, trustees, brokers, depositories and advisors and determine such terms of their engagement as it shall deem
appropriate for the proper administration of the Plan and due compliance with applicable law, stock market or exchange rules and regulations or accounting or tax rules and regulations. The Committee may accelerate or defer the vesting or payment of
Awards, cancel or modify outstanding Awards, waive any conditions or restrictions imposed with respect to Awards or the Common Shares issued pursuant to Awards and make any and all other determinations that it deems appropriate with respect to the
administration of the Plan, subject to the limitations contained in Sections 6(d) and 19 of the Plan and applicable law and listing rules with respect to all Participants. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Administration of the Plan</I></B>. The administration of the Plan shall be managed by the Committee.
All determinations of the Committee shall be made by a majority of its members either present in person or participating by conference telephone at a meeting or by written consent. The Committee shall have the power to prescribe and modify the forms
of Award Agreement, correct any defect, supply any omission or clarify any inconsistency in the Plan and/or in any Award Agreement and take such actions and make such administrative determinations that the Committee deems appropriate in its sole
discretion. Any decision of the Committee in the administration of the Plan, as described herein, shall be final, binding and conclusive on all parties concerned, including the Company, its shareholders and Subsidiaries and all Participants.
Notwithstanding anything to the contrary contained herein, the Board may, in its sole discretion, at any time and from time to time, grant Awards or administer the Plan. In any such case, the Board shall have all of the authority and responsibility
granted to the Committee herein. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Delegation of Authority</I></B>. To the extent permitted by applicable law, the Committee may at any
time delegate to one or more officers or Directors of the Company some or all of its authority over the administration of the Plan (including the authority to grant Awards under the Plan), with respect to individuals who are not Section&nbsp;16(a)
Insiders. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Indemnification</I></B>. No member of the Committee or any other Person to whom any duty or power
relating to the administration or interpretation of the Plan has been delegated shall be personally liable for any action or determination made with respect to the Plan, except for his or her own willful misconduct or as expressly provided by
statute. The members of the Committee and its delegates, including any employee with responsibilities relating to the administration of the Plan, shall be entitled to indemnification and reimbursement from the Company, to the extent permitted by
applicable law and the <FONT STYLE="white-space:nowrap">by-laws</FONT> and policies of the Company. To the fullest extent permitted by the law, in the performance of its functions under the Plan, the Committee (and each member of the Committee and
its delegates) shall be entitled to rely upon information and advice furnished by the Company&#146;s officers, accountants, counsel and any other party they deem appropriate, and neither the Committee nor any such Person shall be liable for any
action taken or not taken in reliance upon any such advice. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>5<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Participation</U></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Eligible Recipients</I></B>. Subject to applicable law and Section&nbsp;7 hereof, the Committee shall
determine, in its sole discretion, which Eligible Recipients shall be granted Awards under the Plan. Holders of equity compensation awards granted by an entity or business that is acquired by the Company or a Subsidiary (or whose business is
acquired by the Company or a Subsidiary) or with which the Company or a Subsidiary combines are eligible for grants of Substitute Awards under the Plan to the extent permitted under applicable law and the applicable regulations of any stock exchange
on which the Company is then listed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Participation outside of the United States</I></B>. In order to facilitate the granting of Awards to
Employees who are foreign nationals or who are employed outside of the U.S., the Committee may provide for such special terms and conditions, including, without limitation, substitutes for Awards, as the Committee may consider necessary or
appropriate to accommodate differences in local law, tax policy or custom. The Committee may approve any supplements to, or amendments, restatements or alternative versions of, this Plan (including <FONT STYLE="white-space:nowrap">sub-plans)</FONT>
as it may consider necessary or appropriate for the purposes of this Section&nbsp;5(b) without thereby affecting the terms of this Plan as in effect for any other purpose, and the appropriate officer of the Company may certify any such documents as
having been approved and adopted pursuant to properly delegated authority; <I>provided</I>, that no such supplements, amendments, restatements or alternative versions shall include any provisions that are inconsistent with the intent and purpose of
this Plan, as then in effect; <I>further provided</I> that any such action taken with respect to an Employee who is subject to Section&nbsp;409A of the Code shall be taken in compliance with Section&nbsp;409A of the Code. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>6<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Available Shares of Common Shares</U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Shares Subject to the Plan</I></B>. Subject to the following provisions of this Section&nbsp;6, the
maximum number of Common Shares that may be issued to Participants pursuant to Awards (all of which may be granted as ISOs) shall be equal to the sum of (i) 43,768,825 Common Shares, (ii) 11,500,000 Common Shares and (iii)&nbsp;the number of Common
Shares becoming available for reuse after awards are terminated, forfeited, cancelled, exchanged or surrendered following the Effective Date under the Company&#146;s 2011 Omnibus Incentive Plan (the &#147;<B>Transferred Shares</B>&#148;). For the
avoidance of doubt, the Transferred Shares shall no longer be available under the Company&#146;s 2011 Omnibus Incentive Plan. Common Shares issued pursuant to Awards granted under the Plan may be shares that have been authorized but unissued, or
have been purchased in open market transactions or otherwise. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Forfeited and Expired Awards</I></B>. If any shares subject to an Award (other than a Substitute
Award) are forfeited, canceled, exchanged or surrendered, or if an Award (other than a Substitute Award) terminates or expires without a distribution of Common Shares to the Participant, the Common Shares with respect to such Award shall, to the
extent of any such forfeiture, cancellation, exchange, surrender, termination or expiration, again be available for Awards under the Plan. Notwithstanding the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
foregoing, (i)&nbsp;the Common Shares surrendered or withheld as payment of either the exercise price of an Option (including shares otherwise underlying an Award of a SAR that are retained by
the Company to account for the exercise price of such SAR) and/or withholding taxes in respect of an Award shall no longer be available for Awards under the Plan and (ii)&nbsp;any Common Shares subject to any Substitute Award that is
(A)&nbsp;forfeited, cancelled, exchanged, surrendered, cancelled or otherwise terminates or expires without a distribution of Common Shares or (B)&nbsp;surrendered or withheld as payment of either the exercise price of a Substitute Award and/or
withholding taxes in respect of a Substitute Award, in each case, will not again become available for distribution in connection with Awards under the Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Other Items Not Included in Allocation</I></B>. The maximum number of Common Shares that may be issued
under the Plan as set forth in Section&nbsp;6(a) shall not be affected by (i)&nbsp;the payment in cash of dividends or dividend equivalents in connection with outstanding Awards to the extent such cash dividends or dividend equivalents are permitted
in accordance with Section&nbsp;8; (ii) the granting or payment of share-denominated Awards that by their terms may be settled only in cash, (iii)&nbsp;the granting of Cash Awards; or (iv)&nbsp;the grant of, or issuance of Common Shares pursuant to,
Substitute Awards. For the avoidance of doubt, Common Shares underlying Substitute Awards and Common Shares remaining available for grant under a plan of an acquired company or of a company with which the Company or a Subsidiary combines (whether by
way of amalgamation, merger, sale and purchase of shares or other securities or otherwise), appropriately adjusted to reflect the acquisition or combination transaction, shall not reduce the number of Common Shares remaining available for grant
hereunder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>ISO Limit.</I></B><I> </I>Subject to Section&nbsp;6(f), the maximum number of Common Shares available
for issuance with respect to ISOs shall be 55,268,825. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Other Limitations on Shares that May be Granted under the Plan</I></B>. Subject to Section&nbsp;6(f),
(i) the number of Common Shares issuable to Insiders, at any time, under all security-based compensation arrangements of the Company, cannot exceed 10% of issued and outstanding Common Shares of the Company; (ii)&nbsp;the number of Common Shares
issued to Insiders, within any one year period, under all security-based compensation arrangements of the Company, cannot exceed 10% of issued and outstanding securities; and (iii)&nbsp;the number of Common Shares issuable to <FONT
STYLE="white-space:nowrap">non-employee</FONT> members of the Board, at any time, under all security-based compensation arrangements of the Company, cannot exceed 1% of issued and outstanding Common Shares of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Adjustments</I></B>. In the event of any change in the Company&#146;s capital structure, including,
but not limited to, a change in the number of Common Shares outstanding, on account of (i)&nbsp;any stock dividend, stock split, reverse stock split or any similar equity restructuring or (ii)&nbsp;any combination or exchange of equity securities,
merger, consolidation, recapitalization, reorganization, or divesture or any other similar event affecting the Company&#146;s capital structure, or change in applicable laws, regulations or accounting principles, to reflect such change in the
Company&#146;s capital structure, the Committee shall make appropriate equitable adjustments to the maximum number of Common Shares that may be issued under the Plan as set forth in Section&nbsp;6(a) and the limits set forth in Section&nbsp;6(d) and
Section&nbsp;6(e). In the event of any extraordinary dividend, divestiture or other distribution (other than ordinary cash dividends) of assets to shareholders, or any transaction or event described above, to the extent necessary to prevent the
enlargement or diminution of the rights of Participants, the Committee shall make appropriate equitable adjustments to the number or kind of shares subject to an outstanding Award (including the identity of the issuer), the exercise or hurdle price
applicable to an outstanding Award, and/or any measure of performance that relates to an outstanding Award, including any applicable Performance Criteria. Any adjustment to ISOs under this Section&nbsp;6(f) shall be made only to the extent not
constituting a &#147;modification&#148; within the meaning of Section&nbsp;424(h)(3) of the Code. With respect to Awards subject to Section&nbsp;409A of the Code, any adjustments under this Section&nbsp;6(f) shall conform to the requirements of
Section&nbsp;409A of the Code. Notwithstanding anything set forth herein to the contrary, the Committee may, in its discretion, decline to adjust any Award made to a Participant, if it determines that such adjustment would violate applicable law or
result in adverse tax consequences to the Participant or to the Company. If, as a result of any adjustment under this section 6(f), a </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Participant would become entitled to a fractional Common Share, the Participant has the right to acquire only the adjusted number of full Common Shares and no payment or other adjustment will be
made with respect to the fractional Common Shares so disregarded. Adjustments under this Section&nbsp;6(f) are subject to any applicable regulatory approvals. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Limitations. </I></B>In any calendar
year, no Participant who is a <FONT STYLE="white-space:nowrap">non-employee</FONT> Director shall be granted Options, SARs, Share Units, Share Awards, Cash Awards or any other compensation with an aggregate fair market value as of the grant date (as
determined in accordance with applicable accounting standards) or payment date, as applicable, in excess of $750,000. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>7<B>.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Awards Under The Plan</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards under the Plan may be granted in the form of Options, SARs, Share Units,
Share Awards or Cash Awards as described below. Awards may be granted singly, in combination or in tandem as determined by the Committee, in its sole discretion. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Options</I></B>. Options granted under the Plan shall be designated as Nonqualified Stock Options or
ISOs. Options shall expire after such period, not to exceed a maximum of ten years, as may be determined by the Committee (the &#147;<B>Original Term</B>&#148;). If an Option is exercisable in installments, such installments or portions thereof that
become exercisable shall remain exercisable until the Option expires or is otherwise canceled pursuant to its terms. Notwithstanding anything to the contrary in this Section&nbsp;7(a), except as otherwise determined by the Committee, and subject to
compliance with Section&nbsp;409A of the Code (including <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(v)(C)(1)</FONT> of the Treasury Regulations), if the Original Term of an Option held by a Participant expires during a Blackout Period,
the term of such Option shall be extended until the tenth Business Day following the end of the Blackout Period, at which time any unexercised portion of the Option shall expire; <I>provided, however, </I>that in no event shall such extension
pursuant to this provision result in the term of such Option being extended beyond the latest date which would not result in an extension within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(v)(C)(1)</FONT> of the Treasury
Regulations. Except as otherwise provided in this Section&nbsp;7(a), Options shall be subject to the terms, conditions, restrictions, and limitations determined by the Committee, in its sole discretion, from time to time. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Exercise Price</I></B>. The Committee shall determine the exercise price per share for each Option,
which, except with respect to Substitute Awards, shall not be less than 100% of the Market Price (as of the date of grant) of the Common Shares subject to the Option. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Exercise of Options</I></B>. Upon satisfaction of the applicable conditions relating to vesting and
exercisability, as determined by the Committee, and upon provision for the payment in full of the exercise price and applicable taxes due, the Participant shall be entitled to exercise the Option and receive the number of Common Shares issuable in
connection with the Option exercise. The Common Shares issued in connection with the Option exercise may be subject to such conditions and restrictions as the Committee may determine, from time to time. The exercise price of an Option and applicable
withholding taxes relating to an Option exercise may be paid by methods permitted by the Committee from time to time including, but not limited to, (1)&nbsp;a cash payment; (2)&nbsp;tendering (either actually or by attestation) Common Shares owned
by the Participant (for any minimum period of time that the Committee, in its discretion, may specify), valued at the Market Price at the time of exercise; (3)&nbsp;arranging to have the appropriate number of Common Shares issuable upon the exercise
of an Option withheld or sold (including pursuant to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;sell-to-cover&#148;</FONT></FONT> method) pursuant to such procedures as determined by the Committee in its discretion; or
(4)&nbsp;any combination of the above. Additionally, the Committee may provide that an Option may be &#147;net exercised,&#148; meaning that upon the exercise of an Option or any portion thereof, the Company shall deliver the number of whole Common
Shares equal to (A)&nbsp;the difference between (x)&nbsp;the aggregate Market Price of the Common Shares subject to the Option (or the portion of such </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Option then being exercised) and (y)&nbsp;the aggregate exercise price for all such Common Shares under the Option (or the portion thereof then being exercised) plus (to the extent it would not
give rise to adverse accounting consequences pursuant to applicable accounting principles or to adverse tax consequences to the Participants under Canadian federal, provincial or territorial tax laws) the amount of withholding tax due upon exercise
divided by (B)&nbsp;the Market Price of a Common Share on the date of exercise. Any fractional share that would result from such equation shall be canceled. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>ISOs</I></B>. The terms and conditions of ISOs granted hereunder shall be subject to the provisions of
Section&nbsp;422 of the Code and the terms, conditions, limitations and administrative procedures established by the Committee from time to time in accordance with the Plan. At the discretion of the Committee, ISOs may be granted only to an employee
of the Company, its &#147;parent corporation&#148; (as such term is defined in Section&nbsp;424(e) of the Code) or a Subsidiary. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>ISO Grants to 10% Shareholders</I></B>. Notwithstanding anything to the contrary in this
Section&nbsp;7(a), if an ISO is granted to a Participant who owns shares representing more than ten percent of the voting power of all classes of shares of the Company, its &#147;parent corporation&#148; (as such term is defined in Section&nbsp;424
(e) of the Code) or a Subsidiary, the term of the Option shall not exceed five years from the time of grant of such Option and the exercise price shall be at least 110&nbsp;percent of the Market Price (as of the date of grant) of the Common Shares
subject to the Option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>$100,000 Per Year Limitation for ISOs</I></B>. To the extent the aggregate Market Price (determined as
of the date of grant) of the Common Shares for which ISOs are exercisable for the first time by any Participant during any calendar year (under all plans of the Company) exceeds $100,000, such excess ISOs shall be treated as Nonqualified Stock
Options. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Disqualifying Dispositions</I></B>. Each Participant awarded an ISO under the Plan shall notify the
Company in writing immediately after the date he or she makes a &#147;disqualifying disposition&#148; of any Common Shares acquired pursuant to the exercise of such ISO. A &#147;disqualifying disposition&#148; is any disposition (including any sale)
of such Common Shares before the later of (i)&nbsp;two years after the date of grant of the ISO and (ii)&nbsp;one year after the date the Participant acquired the Common Shares by exercising the ISO. The Company may, if determined by the Committee
and in accordance with procedures established by it, retain possession of any Common Shares acquired pursuant to the exercise of an ISO as agent for the applicable Participant until the end of the period described in the preceding sentence, subject
to complying with any instructions from such Participant as to the sale of such shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>No Dividends or Dividend Equivalents</I></B>. No Option will be eligible for the payment of dividends
or dividend equivalents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Subject to applicable laws and Company policies, the Committee may provide in any applicable Award Agreement
that, if, as of the last day of the Original Term of the Option, (i)&nbsp;the Market Price of the Common Shares subject to the Option exceeds the aggregate exercise price of the Option and (ii)&nbsp;the Participant has not previously exercised such
Option, then the Option shall be deemed to have been automatically exercised by the Participant on such date (the &#147;<B>Automatic Exercise Date</B>&#148;), which such automatic exercise shall be made on a &#147;net exercise&#148; basis (pursuant
to such terms and procedures as determined by the Committee) to cover the applicable exercise price applicable to such Option and any applicable tax withholding obligations; <I>provided</I> that, unless otherwise determined by the Committee, this
Section&nbsp;7(a)(v) shall not apply to any Option held by a Participant who has incurred a Termination of Service on or before the Automatic Exercise Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Share Appreciation Rights</I></B>. A SAR represents the right to receive a payment in cash, Common
Shares, or a combination thereof, in an amount equal to the product of (1)&nbsp;the excess of the Market Price per </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Common Share on the date the SAR is exercised over the exercise price per Common Share of such SAR (which exercise price shall be no less than 100% of the Market Price of the Common Shares
subject to the SAR as of the date the SAR was granted, except in the case of Substitute Awards) and (2)&nbsp;the number of Common Shares subject to the portion of the SAR being exercised. If a SAR is paid in Common Shares, the number of Common
Shares to be delivered will equal the amount determined to be payable in accordance with the prior sentence divided by the Market Price of a Common Share at the time of payment. The Committee shall establish the Original Term of a SAR, which shall
not exceed a maximum of ten years. Notwithstanding anything to the contrary in this Section&nbsp;7(b), except as otherwise determined by the Committee, and subject to compliance with Section&nbsp;409A of the Code (including <FONT
STYLE="white-space:nowrap">Section&nbsp;1.409A-1(v)(C)(1)</FONT> of the Treasury Regulations) if the Original Term of a SAR held by the Participant expires during a Blackout Period, the term of such SAR shall be extended until the tenth Business Day
following the end of the Blackout Period, at which time any unexercised portion of the SAR shall expire; <I>provided, however, </I>that in no event shall such extension pursuant to this provision result in the term of such SAR being extended beyond
the latest date which would not result in an extension within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(v)(C)(1)</FONT> of the Treasury Regulations. Except as otherwise provided in this Section&nbsp;7(b), SARs shall be
subject to the terms, conditions, restrictions and limitations determined by the Committee, in its sole discretion, from time to time. A SAR may only be granted to an Eligible Recipient to whom an Option could be granted under the Plan. No SAR will
be eligible for the payment of dividends or dividend equivalents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Share Units. </I></B>A Share Unit is an Award that represents the right to receive a Common Share or a
cash payment equal to the Market Price of a Common Share. Share Units shall be subject to such terms and conditions (including, without limitation, service-based and/or performance-based vesting conditions, including Performance Criteria),
restrictions and limitations as the Committee may determine to be applicable to such Share Units, in its sole discretion, from time to time and set forth in the applicable Award Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Blackout Period.</I></B><I> </I>In the event that any Share Unit is scheduled by its terms to be
settled in Common Shares (the &#147;<B>Original Distribution Date</B>&#148;) during a Blackout Period, then, if the Participant is restricted from selling Common Shares during the Blackout Period, the Committee, in its discretion, may determine that
such Common Shares subject to the Share Unit shall not be delivered on such Original Distribution Date and shall instead be delivered as soon as practicable following the expiration of the Blackout Period; <I>provided, however,</I> that in no event
shall the delivery of the Common Shares be delayed pursuant to this provision beyond the latest date on which such delivery could be made without violating Section&nbsp;409A of the Code. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Share Awards</I></B>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Form of Awards</I></B>. The Committee may grant Awards that are payable in Common Shares or
denominated in units equivalent in value to Common Shares or are otherwise based on or related to Common Shares (&#147;<B>Share Awards</B>&#148;), including, but not limited to, Share Payments, Restricted Shares and Deferred Shares. Share Awards
shall be subject to such terms, conditions (including, without limitation, service-based and performance-based vesting conditions, including Performance Criteria), restrictions and limitations as the Committee may determine to be applicable to such
Share Awards, in its sole discretion, from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Share Payment</I></B>. If not prohibited by applicable law, the Committee may issue unrestricted
Common Shares in such amounts and subject to such terms and conditions as the Committee shall from time to time in its sole discretion determine. A Share Payment may (but need not) be granted as, or in payment of, a bonus, or to provide incentives
or recognize special achievements or contributions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Restricted Shares</I></B>. Restricted Shares shall be subject to the terms, conditions, restrictions,
and limitations determined by the Committee, in its sole discretion, from time to time. The number of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Restricted Shares allocable to an Award under the Plan shall be determined by the Committee in its sole discretion. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Deferred Shares</I></B>. Subject to Section&nbsp;409A of the Code (to the extent applicable), Deferred
Shares shall be subject to the terms, conditions, restrictions and limitations determined by the Committee, in its sole discretion, from time to time. A Participant who receives an Award of Deferred Shares shall be entitled to receive the number of
Common Shares allocable to his or her Award, as determined by the Committee in its sole discretion, from time to time, at the end of a specified deferral period determined by the Committee. Awards of Deferred Shares represent only an unfunded,
unsecured promise to deliver shares in the future and shall not give Participants any greater rights than those of an unsecured general creditor of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B><I>Cash Awards</I></B>. The Committee may grant Awards that are payable to Participants solely in cash,
as deemed by the Committee to be consistent with the purposes of the Plan, and, except as otherwise provided in this Section&nbsp;7(e), such Cash Awards shall be subject to the terms, conditions, restrictions, and limitations determined by the
Committee, in its sole discretion, from time to time. Awards granted pursuant to this Section&nbsp;7(e) may be granted with value and payment contingent upon the achievement of Performance Criteria. Payments earned hereunder may be decreased or
increased in the sole discretion of the Committee based on such factors as it deems appropriate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Unless the applicable Award Agreement provides otherwise or the Committee determines otherwise,
(i)&nbsp;vesting with respect to an Award will cease upon a Termination of Service, and unvested Awards shall be forfeited upon such termination and (ii)&nbsp;in the case of a Termination of Service for Cause, vested Awards shall also be forfeited.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>8<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends and Dividend Equivalents</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Committee may, in its sole discretion, provide that Share Units and/or Share Awards shall earn dividends or dividend equivalents, as
applicable. Such dividends or dividend equivalents may be credited to an account maintained on the books of the Company. Any payment or crediting of dividends or dividend equivalents will be subject to such terms, conditions, restrictions and
limitations as the Committee may establish, from time to time, in its sole discretion, including, without limitation, reinvestment in additional Common Shares or common share equivalents; provided, however, if the payment or crediting of dividends
or dividend equivalents is in respect of a Share Unit or Share Award that is subject to Section&nbsp;409A of the Code, then the payment or crediting of such dividends or dividend equivalents shall conform to the requirements of Code
Section&nbsp;409A of the Code and such requirements shall be specified in writing. Notwithstanding the foregoing, dividends or dividend equivalents (i)&nbsp;shall have the same vesting dates and shall be paid in accordance with the same terms as the
Award to which they relate and (ii)&nbsp;with respect to any Award subject to the achievement of Performance Criteria, shall not be paid unless and until the relevant Performance Criteria have been satisfied, and then only to the extent determined
by the Committee, as specified in the Award Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>9<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Nontransferability</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as may be permitted by the Committee or as specifically provided in an Award Agreement, Awards granted under the Plan, and during any
period of restriction on transferability, Common Shares issued in connection with the exercise of an Option or a SAR, may not be sold, pledged, hypothecated, assigned, margined or otherwise transferred in any manner other than by will or the laws of
descent and distribution, unless and until the shares underlying such Award have been issued, and all restrictions applicable to such shares have lapsed or have been waived by the Committee. No Award or interest or right therein shall be subject to
the debts, contracts or engagements of a Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be
voluntary or involuntary or by operation of law, by judgment, lien, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy and divorce), and any attempted disposition thereof shall be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
null and void, of no effect, and not binding on the Company in any way. Notwithstanding the foregoing, the Committee may, in its sole discretion, permit (on such terms, conditions and limitations
as it may establish) Nonqualified Stock Options and/or shares issued in connection with an Option or a SAR exercise that are subject to restrictions on transferability, to be transferred to a member of a Participant&#146;s immediate family or to a
trust or similar vehicle for the benefit of a Participant&#146;s immediate family members. During the lifetime of a Participant, all rights with respect to Awards shall be exercisable only by such Participant or, if applicable pursuant to the
preceding sentence, a permitted transferee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <B>&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of a Termination of Service</U></B> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Committee may provide, by rule&nbsp;or regulation or in any applicable Award Agreement, or may determine
in any individual case, the circumstances in which, and the extent to which, an Award may be exercised, settled, vested, paid or forfeited in the event of a Participant&#146;s Termination of Service. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Subject to Section&nbsp;409A of the Code, the Committee may determine, in its discretion, whether, and the
extent to which, (i)&nbsp;an Award will vest during a leave of absence, (ii)&nbsp;a reduction in service level (for example, from full-time to part-time employment) will cause a reduction, or other change, to an Award and (iii)&nbsp;a leave of
absence or reduction in service will be deemed a Termination of Service. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>11<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Change of
Control</U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Unless otherwise determined in an Award Agreement, in the event of a Change of Control:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">With respect to each outstanding Award that is assumed or substituted in connection with a Change of
Control, in the event of a Termination of Service without Cause or by the Participant for Good Reason during the <FONT STYLE="white-space:nowrap">12-month</FONT> period following such Change of Control (i) such Award shall become fully vested and
exercisable, (ii)&nbsp;the restrictions, payment conditions, and forfeiture conditions applicable to any such Award granted shall lapse, and (iii)&nbsp;any performance conditions (including any Performance Criteria) imposed with respect to Awards
shall be deemed to be achieved at target performance levels or at such other level as determined by the Committee in its discretion or specified in the applicable Award Agreement or the definitive transaction documentation in connection with such
Change of Control. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">With respect to each outstanding Award that is not assumed or substituted in connection with a Change of
Control immediately upon the occurrence of the Change of Control, (x)&nbsp;such Award (including both time-based and performance-based Awards) shall become fully vested and exercisable based on a fraction, the numerator of which is the number of
days between the grant date and the date of the Change of Control and the denominator of which is the number of days during the period beginning on the grant date of the Award and ending on the date of vesting of the Award or such other period
determined by the Committee in its discretion or as set forth in the applicable Award Agreement, (y) the restrictions, payment conditions, and forfeiture conditions applicable to any such Award granted shall lapse, and (z)&nbsp;any performance
conditions (including any Performance Criteria) imposed with respect to performance-based Awards shall be deemed to be achieved at target performance levels (for the avoidance of doubt, prorated in accordance with clause (x)) or at such other level
as determined by the Committee in its discretion or specified in the applicable Award Agreement or the definitive transaction documentation in connection with such Change of Control. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For purposes of this Section&nbsp;10, an Award shall be considered assumed or substituted for if, following
the Change of Control, the Award remains subject to the same terms and conditions that were applicable to the Award immediately prior to the Change of Control except that, if the Award related to Common Shares, the Award instead confers the right to
receive common shares of the acquiring entity (or its parent). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding any other provision of the Plan, in the event of a Change of Control, the Committee
(a)&nbsp;may, in its discretion provide that each Option and each SAR which may, by its terms, only be settled in shares shall, immediately prior to the occurrence of a Change of Control, be deemed to have been exercised on a &#147;net
exercise&#148; basis; and (b)&nbsp;may, in its discretion, except as would otherwise result in adverse tax consequences under Code Section&nbsp;409A, provide that each Award, other than Options and SARs which may, by their terms, only be settled in
shares, shall, immediately upon the occurrence of a Change of Control, be cancelled in exchange for a payment in cash or securities in an amount equal to (i)&nbsp;the excess of the consideration paid per Common Share in the Change of Control over
the exercise or purchase price (if any) per Common Share subject to the Award multiplied by (ii)&nbsp;the number of Common Shares then outstanding under the Award; <I>provided</I> that, if the Intrinsic Value of an Option or SAR is equal to or less
than zero, the Committee may, in its sole discretion, provide for the cancellation of such Award without payment of any consideration therefor (for the avoidance of doubt, in the event of a Change of Control, the Committee may, in its sole
discretion, terminate any Option or SAR for which the exercise or purchase price is equal to or exceeds the per Common Share value of the consideration to be paid in the Change of Control transaction without payment of consideration therefor).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">For purposes of this Agreement and, except to the extent as would result in a violation of Code
Section&nbsp;409A, a &#147;Change of Control&#148; shall be deemed to occur if and when the first of the following occurs: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the acquisition (other than from the Company), by any person (as such term is defined in Section&nbsp;13(d)
or 14(d) of the Exchange Act, including a &#147;group&#148; as defined in Section&nbsp;13(d) thereof) of beneficial ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of fifty
percent (50%) or more of the combined voting power of the Company&#146;s then outstanding voting securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the individuals who, as of the date hereof, are members of the Board (the &#147;Incumbent Board&#148;),
cease for any reason to constitute at least a majority of the Board, unless the election, or nomination for election by the Company&#146;s shareholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, and
such new director shall be considered as a member of the Incumbent Board; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">the closing of an amalgamation or similar business combination (each, an &#147;Amalgamation&#148;) involving
the Company if (i)&nbsp;the shareholders of the Company, immediately before such Amalgamation, do not, as a result of such Amalgamation, own, directly or indirectly, more than fifty percent (50%) of the combined voting power of the then outstanding
voting securities of the entity resulting from such Amalgamation in substantially the same proportion as their ownership of the combined voting power of the voting securities of the Company outstanding immediately before such Amalgamation or
(ii)&nbsp;immediately following the Amalgamation, the individuals who comprised the Board immediately prior thereto do not constitute at least a majority of the board of directors of the entity resulting from such Amalgamation (or, if the entity
resulting from such Amalgamation is then a subsidiary, the ultimate parent thereof); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">a complete liquidation or dissolution of the Company or the consummation of the sale or other disposition of
all or substantially all of the assets of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding the foregoing, a Change of Control shall not be deemed to occur solely because fifty percent
(50%) or more of the combined voting power of the Company&#146;s then outstanding securities is acquired by (i)&nbsp;a trustee or other fiduciary holding securities under one or more employee benefit plans maintained by the Company or any of its
subsidiaries or (ii)&nbsp;any corporation which, immediately prior to such acquisition, is owned directly or indirectly by the shareholders of the Company in the same proportion as their ownership of shares in the Company immediately prior to such
acquisition. In addition, notwithstanding the foregoing, solely to the extent required by Section&nbsp;409A of the Code, a </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Change of Control shall be deemed to have occurred only if a change in the ownership or effective control of the Company or a change in ownership of a substantial portion of the assets of the
Company shall also be deemed to have occurred under Section&nbsp;409A of the Code and the Treasury Regulations thereunder. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>12<B>.&nbsp;&nbsp;&nbsp;&nbsp;<U>Clawback</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Committee may specify in an Award Agreement that a Participant&#146;s rights, payments and benefits with respect to an Award shall be
subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include a Termination of Service,
violation of material policies, breach of <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> confidentiality or other restrictive covenants, or requirements to comply with minimum share
ownership requirements, that may apply to the Participant, or other conduct by the Participant that is detrimental to the business or reputation of the Company and/or its Subsidiaries. The Committee shall have full authority to implement any
policies and procedures necessary to comply with Section&nbsp;10D of the Exchange Act and any rules promulgated thereunder and any other regulatory regimes. Notwithstanding anything to the contrary contained herein, any Awards granted under the Plan
(including any amounts or benefits arising from such Awards) shall be subject to any clawback or recoupment arrangements or policies the Company has in place from time to time, and the Committee may, to the extent permitted by applicable law and
stock exchange rules or by any applicable Company policy or arrangement, and shall, to the extent required, cancel or require reimbursement of any Awards granted to the Participant or any Common Shares issued or cash received upon vesting, exercise
or settlement of any such Awards or sale of Common Shares underlying such Awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Award Agreements</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each Award under the Plan shall be evidenced by an Award Agreement (as such may be amended from time to time) that sets forth the terms,
conditions, restrictions and limitations applicable to the Award, including, but not limited to, the provisions governing vesting, exercisability, payment, forfeiture, and Termination of Service, all or some of which may be incorporated by reference
into one or more other documents delivered or otherwise made available to a Participant in connection with an Award. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>14<B>.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Withholding</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Participants shall be solely responsible for any applicable taxes (including, without
limitation, income, payroll and excise taxes) and penalties, and any interest that accrues thereon, which they incur in connection with the receipt, vesting or exercise of an Award. The Company and its Subsidiaries shall have the right to require
payment of, or may deduct from any payment made under the Plan or otherwise to a Participant, or may permit shares to be tendered or sold, including Common Shares delivered or vested in connection with an Award, in an amount sufficient to cover
withholding of any federal, state, provincial, territorial, local, foreign or other governmental taxes or charges required by law or such greater amount of withholding as the Committee shall determine from time to time and to take such other action
as may be necessary to satisfy any such withholding obligations. It shall be a condition to the obligation of the Company to issue Common Shares upon the exercise of an Option, or SAR, or upon settlement of a Share Award, that the Participant pay to
the Company, on demand, such amount as may be requested by the Company for the purpose of satisfying any tax withholding liability. If the amount is not paid, the Company may refuse to issue shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>15<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Other Benefit and Compensation Programs</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Awards received by Participants under the Plan shall not be deemed a part of a Participant&#146;s regular, recurring compensation for purposes
of calculating payments or benefits from any Company benefit plan or severance program unless specifically provided for under the plan or program. Unless specifically set forth in an Award Agreement, Awards under the Plan are not intended as payment
for compensation that otherwise would have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
been delivered in cash, and even if so intended, such Awards shall be subject to such vesting requirements and other terms, conditions and restrictions as may be provided in the Award Agreement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>16.<B> &nbsp;&nbsp;&nbsp;&nbsp;<U>Unfunded Plan</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan is intended to constitute an &#147;unfunded&#148; plan for incentive and deferred compensation. The Plan shall not establish any
fiduciary relationship between the Company and any Participant or other Person. To the extent any Participant holds any rights by virtue of an Award granted under the Plan, such rights shall constitute general unsecured liabilities of the Company
and shall not confer upon any Participant or any other Person any right, title, or interest in any assets of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>17<B>.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights as a Shareholder</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the Committee determines otherwise, a Participant shall not have any
rights as a shareholder with respect to Common Shares covered by an Award until the date the Participant becomes the holder of record with respect to such Common Shares. No adjustment will be made for dividends or other rights for which the record
date is prior to such date, except as provided in Section&nbsp;8. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>18<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Future Rights</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No Eligible Recipient shall have any claim or right to be granted an Award under the Plan. There shall be no obligation of uniformity of
treatment of Eligible Recipients under the Plan. Further, the Company and its Subsidiaries may adopt other compensation programs, plans or arrangements as deemed appropriate or necessary. The adoption of the Plan, or grant of an Award, shall not
confer upon any Eligible Recipient any right to continued employment or service in any particular position or at any particular rate of compensation, nor shall it interfere in any way with the right of the Company or a Subsidiary to terminate the
employment or service of Eligible Recipients at any time, free from any claim or liability under the Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>19<B>.
&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Termination</U></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">The Plan and any Award may be amended, suspended or terminated at any time by the Board, provided that no
amendment shall be made without shareholder approval if such shareholder approval is required in order to comply with applicable law or the rules of the New York Stock Exchange, the rules of the TSX, or any other securities exchange on which the
Common Shares are traded or quoted. Except as otherwise provided in Section&nbsp;11(a), no termination, suspension or amendment of the Plan or any Award shall materially adversely affect the right of any Participant with respect to any Award
theretofore granted, as determined by the Committee, without such Participant&#146;s written consent. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding Section&nbsp;19(a), the Company shall obtain shareholder approval for: (i)&nbsp;except as
provided in Section&nbsp;6(f), a reduction in the exercise price or purchase price of an Award (or the cancellation and <FONT STYLE="white-space:nowrap">re-grant</FONT> of an Award resulting in a lower exercise price or purchase price); (ii) the
extension of the Original Term of an Option; (iii)&nbsp;any amendment to the ISO limits described in Section&nbsp;6(d); (iv) any amendment to remove or to exceed the participation limits described in Section&nbsp;6(e), including but not limited to
those applicable to Insiders; (v)&nbsp;an increase to the maximum number of Common Shares issuable under the Plan pursuant to Section&nbsp;6(a) (other than adjustments in accordance with Section&nbsp;6(f)); (vi) amendments to this Section&nbsp;19
other than amendments of a clerical nature; and (vii)&nbsp;any amendment that permits Awards to be transferable or assignable other than for normal estate settlement purposes or for other purposes not involving the receipt of monetary consideration.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>20<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Option and SAR Repricing</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as provided in Section&nbsp;6(f) and without limiting Section&nbsp;19(b)(i), the Committee may not, without shareholder approval, seek
to effect any <FONT STYLE="white-space:nowrap">re-pricing</FONT> of any previously granted &#147;underwater&#148; Option or SAR by: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(i)&nbsp;amending or modifying the terms of the Option or SAR to lower the exercise price; (ii)&nbsp;cancelling the underwater Option or SAR and granting either (A)&nbsp;replacement Options or
SARs having a lower exercise price or (B)&nbsp;Restricted Shares, Share Units, or Other Share Awards in exchange; or (iii)&nbsp;cancelling or repurchasing the underwater Options or SARs for cash or other securities. An Option or SAR will be deemed
to be &#147;underwater&#148; at any time when the Market Value of the Common Shares covered by such Award is less than the exercise price of the Award. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>21<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan and any applicable Award Agreement shall be binding on all successors and assigns of a Participant, including, without limitation, the
estate of such Participant and the executor, administrator or trustee of such estate, or any receiver or trustee in bankruptcy or representative of the Participant&#146;s creditors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>22<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any provision of the Plan or any Award Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction, or
as to any Participant or Award, or would disqualify the Plan or any Award under any law deemed applicable by the Committee, such provision shall be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed
amended without, in the determination of the Committee, materially altering the intent of the Plan or the Award Agreement, such provision shall be stricken as to such jurisdiction, Participant or Award, and the remainder of the Plan and any such
Award Agreement shall remain in full force and effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>23<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan and all agreements entered into under the Plan shall be governed, construed and administered in accordance with the laws of the
Province of Ontario and the laws of Canada applicable therein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>24<B>.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation</U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Plan is designed and intended, to the extent applicable, to provide for grants and other transactions which are exempt under Rule <FONT
STYLE="white-space:nowrap">16b-3,</FONT> and all provisions hereof shall be construed in a manner to so comply. Awards under the Plan are also intended to be exempt from, or otherwise comply with Section&nbsp;409A of the Code to the extent subject
thereto, and the Plan and all Awards shall be interpreted in accordance with Section&nbsp;409A of the Code and Treasury Regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other
guidance that may be issued after the effective date of the Plan. If any provision of the Plan or any term or condition of any Award would otherwise frustrate or conflict with this intent, the provision, term or condition shall be interpreted and
deemed amended so as to avoid this conflict. Notwithstanding any provision in the Plan to the contrary, no payment or distribution under this Plan that constitutes an item of deferred compensation under Section&nbsp;409A of the Code and becomes
payable by reason of a Participant&#146;s Termination of Service with the Company shall be made to such Participant until such Participant&#146;s Termination of Service constitutes a Separation from Service. For purposes of this Plan and any Award
granted hereunder, each amount to be paid or benefit to be provided shall be construed as a separate identified payment for purposes of Section&nbsp;409A of the Code. If a participant is a Specified Employee, then to the extent necessary to avoid
the imposition of taxes under Section&nbsp;409A of the Code, such Participant shall not be entitled to any payments upon a termination of his or her employment or service until the earlier of: (i)&nbsp;the expiration of the six (6)-month period
measured from the date of such Participant&#146;s Separation from Service or (ii)&nbsp;the date of such Participant&#146;s death. Upon the expiration of the applicable waiting period set forth in the preceding sentence, all payments and benefits
deferred pursuant to this Section&nbsp;24 (whether they would have otherwise been payable in a single lump sum or in installments in the absence of such deferral) shall be paid to such Participant in a lump sum as soon as practicable, but in no
event later than sixty (60)&nbsp;calendar days, following such expired period, and any remaining payments due under this Plan will be paid in accordance with the normal payment dates specified for them herein
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
or the terms of the applicable Award. If an Award includes a &#147;series of installment payments&#148; (within the meaning of
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(iii)</FONT> of the Treasury Regulations), a Participant&#146;s right to such series of installment payments shall be treated as a right to a series of separate payments and not as a right
to a single payment, and if an Award includes &#147;dividend equivalents&#148; (within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(e)</FONT> of the Treasury Regulations), a Participant&#146;s right to such dividend
equivalents shall be treated separately from the right to other amounts under the Award. Notwithstanding any provision of the Plan to the contrary, in no event shall the Company or any affiliate be liable to a Participant on account of an
Award&#146;s failure to (i)&nbsp;qualify for favorable U.S. or foreign tax treatment or (ii)&nbsp;avoid adverse tax treatment under U.S. or foreign law, including, without limitation, Section&nbsp;409A, 4999 or 457A of the Code. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>24<B>. &nbsp;&nbsp;&nbsp;&nbsp;<U>Data Protection</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the Plan, the Company or its Subsidiaries, as applicable, may need to process personal data (as such term, &#147;personal
information,&#148; &#147;personally identifiable information,&#148; or any other term of comparable intent, is defined under applicable laws or regulations, in each case to the extent applicable) provided by the Participant to, or otherwise obtained
by, the Company or its Subsidiaries, their respective third party service providers or others acting on the Company&#146;s or its Subsidiaries&#146; behalf. Examples of such personal data may include, without limitation, the Participant&#146;s name,
account information, social security number, tax number and contact information. The Company or its Subsidiaries may process such personal data for the performance of the contract with the Participant in connection with the Plan and in its
legitimate business interests for all purposes relating to the operation and performance of the Plan, including but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering and maintaining Participant records; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing the services described in the Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing information to future purchasers or merger partners of the Company or any Subsidiary, or the
business in which such Participant works; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">responding to public authorities, court orders and legal investigations and complying with law, as applicable.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company or its Subsidiaries may share the Participant&#146;s personal data with (i)&nbsp;Subsidiaries,
(ii)&nbsp;trustees of any employee benefit trust, (iii)&nbsp;registrars, (iv) brokers, (v)&nbsp;third party administrators of the Plan, (vi)&nbsp;third party service providers acting on the Company&#146;s or its Subsidiaries&#146; behalf to provide
the services described above, (vii)&nbsp;future purchasers or merger partners (as described above) or (viii)&nbsp;regulators and others, as required by law or in order to provide the services described in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If necessary, the Company or its Subsidiaries may transfer the Participant&#146;s personal data to any of the parties mentioned above in a
country or territory that may not provide the same protection for the information as the Participant&#146;s home country. Any transfer of the Participant&#146;s personal data to recipients in a third country will be made subject to appropriate
safeguards or applicable derogations provided for, and to the extent required, under applicable law. Further information on those safeguards or derogations can be obtained through, and other questions regarding this Section&nbsp;25&nbsp;may be
directed to, the contact set forth in the applicable employee privacy notice or other privacy policy that previously has been made available by the Company or its applicable Subsidiary to the Participant (as applicable, and as updated from time to
time by the Company or its applicable Subsidiary upon notice to the Participant, the &#147;<B>Employee Privacy Notice</B>&#148;). The terms set forth in this Section&nbsp;25 are supplementary to the terms set forth in the Employee Privacy Notice
(which, among other things, further describes the Company&#146;s and its Subsidiaries&#146; processing activities, and the rights of the Participant, with respect to the Participant&#146;s personal data); <I>provided</I> that, in the event of any
conflict between the terms of this Section&nbsp;25 and the terms of the Employee Privacy Notice, the terms of this Section&nbsp;25 shall govern and control in relation to the processing of such personal data in connection with the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company and its Subsidiaries will keep personal data collected in connection with the
Plan for as long as necessary to operate the Plan or as necessary to comply with any legal or regulatory requirements and in accordance with the Company&#146;s and its Subsidiaries&#146; backup and archival policies and procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain Participants may have a right, as further described in the Employee Privacy Notice, to (i)&nbsp;request access to and rectification or
erasure of the personal data provided, (ii)&nbsp;request the restriction of the processing of his or her personal data, (iii)&nbsp;object to the processing of his or her personal data, (iv)&nbsp;receive the personal data provided to the Company or
its Subsidiaries and transmit such data to another party, and (v)&nbsp;to lodge a complaint with a supervisory authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bausch Health Companies Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-GAAP</FONT> Information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B><A NAME="tx296110_39"></A>Appendix 1</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use of Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), in this
Proxy Statement, the Company uses certain <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures, including, Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP),</FONT> which does not have any standardized meaning under GAAP.
Management uses this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure as a key metric in the evaluation of our Company&#146;s performance and consolidated financial results and to forecast results as part of its guidance. Adjusted EBITDA <FONT
STYLE="white-space:nowrap">(non-GAAP)</FONT> is intended to show our unleveraged, <FONT STYLE="white-space:nowrap">pre-tax</FONT> operating results and therefore reflects our financial performance based on operational factors. In addition, cash
bonuses for the Company&#146;s executive officers and other key employees are based, in part, on the achievement of certain Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT> targets. The Company believes this <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> measure is useful to investors in their assessment of our operating performance and the valuation of our Company. In addition, this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure addresses
questions the Company routinely receives from analysts and investors and, in order to assure that all investors have access to similar data, the Company has determined that it is appropriate to make this data available to all investors. Other
companies may use similarly titled <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures that are calculated differently from the way we calculate such measures and accordingly, our calculation of Adjusted EBITDA <FONT
STYLE="white-space:nowrap">(non-GAAP)</FONT> may not be comparable to such similarly titled <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The reconciliation of net loss, the most directly comparable financial measure calculated and presented in accordance with GAAP
to Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP),</FONT> is shown in the table below. Readers are encouraged to review this reconciliation and should consider this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure as a
supplement to, not a substitute for, or superior to, the corresponding measure calculated in accordance with GAAP. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adjusted EBITDA <FONT
STYLE="white-space:nowrap">(non-GAAP)</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT> is net loss
attributable to the Company, the most directly comparable financial measure calculated and presented in accordance with GAAP, adjusted for: interest expense, net, benefit from income taxes, and depreciation and amortization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT> is EBITDA
<FONT STYLE="white-space:nowrap">(non-GAAP)</FONT> adjusted for the following items: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Asset impairments, including loss on assets held for sale</B>: The Company has excluded the impact of
impairments of finite-lived and indefinite-lived intangible assets, as well as impairments of assets held for sale, as such amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions and
divestitures. The Company believes that the adjustments of these items correlate with the sustainability of the Company&#146;s operating performance. Although the Company excludes impairments of intangible assets and assets held for sale from
measuring the performance of the Company and the business, the Company believes that it is important for investors to understand that intangible assets contribute to revenue generation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Goodwill impairments</B>: The Company excludes the impact of goodwill impairments. When the Company has
made acquisitions where the consideration paid was in excess of the fair value of the net assets acquired, the remaining purchase price is recorded as goodwill. For assets that we developed ourselves, no goodwill is recorded. Goodwill is not
amortized but is tested for impairment. The amount of goodwill impairment is measured as the excess of a reporting unit&#146;s carrying value over its fair value. Management excludes these charges in measuring the performance of the Company and the
business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Restructuring and integration costs:</B> The Company has incurred restructuring costs as it implemented
certain strategies, which involved, among other things, improvements to its infrastructure and operations, internal reorganizations and impacts from the divestiture of assets and businesses. With regard to infrastructure and operational improvements
which the Company has taken to improve efficiencies in the businesses and facilities, these tend to be costs intended to right size the business or organization that fluctuate significantly between periods in amount, size and timing, depending on
the improvement </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
project, reorganization or transaction. The Company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the Company&#146;s operating
performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Acquisition-related costs and adjustments (excluding amortization of intangible assets)</B>: The Company
has excluded the impact of acquisition-related contingent consideration <FONT STYLE="white-space:nowrap">non-cash</FONT> adjustments due to the inherent uncertainty and volatility associated with such amounts based on changes in assumptions with
respect to fair value estimates, and the amount and frequency of such adjustments is not consistent and is significantly impacted by the timing and size of the Company&#146;s acquisitions, as well as the nature of the agreed-upon consideration. In
addition, the Company excludes the impact of acquisition-related costs and fair value inventory <FONT STYLE="white-space:nowrap">step-up</FONT> resulting from acquisitions as the amounts and frequency of such costs and adjustments are not consistent
and are impacted by the timing and size of its acquisitions. There were no acquisition-related costs or fair value inventory <FONT STYLE="white-space:nowrap">step-up</FONT> for the periods presented. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Loss on extinguishment of debt</B>: The Company has excluded loss on extinguishment of debt as this
represents a cost of refinancing our existing debt and is not a reflection of our operations for the period. Further, the amount and frequency of such charges are not consistent and are significantly impacted by the timing and size of debt financing
transactions and other factors in the debt market out of management&#146;s control. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Share-based compensation</B>: The Company has excluded costs relating to share-based compensation. The
Company believes that the exclusion of share-based compensation expense assists investors in the comparisons of operating results to peer companies. Share-based compensation expense can vary significantly based on the timing, size and nature of
awards granted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Separation and IPO costs and separation-related and <FONT STYLE="white-space:nowrap">IPO-related</FONT>
costs</B>: The Company has excluded certain costs incurred in connection with activities taken to: (i)&nbsp;separate the <FONT STYLE="white-space:nowrap">eye-health</FONT> and the Solta aesthetic medical device businesses from the remainder of the
Company and (ii)&nbsp;register the <FONT STYLE="white-space:nowrap">eye-health</FONT> and the Solta aesthetic medical device businesses as independent publicly traded entities. Separation and IPO costs are incremental costs directly related to
effectuating the separation of the <FONT STYLE="white-space:nowrap">eye-health</FONT> business and the IPO of the Solta aesthetic medical device business (the &#147;Solta IPO&#148;) and include, but are not limited to, legal, audit and advisory
fees, talent acquisition costs and costs associated with establishing a new board of directors and related board committees. Separation-related and <FONT STYLE="white-space:nowrap">IPO-related</FONT> costs are incremental costs indirectly related to
the separation of the <FONT STYLE="white-space:nowrap">eye-health</FONT> business and the Solta IPO and include, but are not limited to, IT infrastructure and software licensing costs, rebranding costs and costs associated with facility relocation
and/or modification. As these costs arise from events outside of the ordinary course of continuing operations, the Company believes that the adjustments of these items provide supplemental information with regard to the sustainability of the
Company&#146;s operating performance, allow for a comparison of the financial results to historical operations and forward-looking guidance and, as a result, provide useful supplemental information to investors. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Other <FONT STYLE="white-space:nowrap">non-GAAP</FONT> adjustments</B>: The Company has excluded certain
other amounts including: legal and other professional fees incurred in connection with legal and governmental proceedings, investigations and information requests regarding certain of our legacy distribution, marketing, pricing, disclosure and
accounting practices, litigation and other matters, and net gain on sales of assets. Given the unique nature of the matters relating to these costs, the Company believes these items are not normal operating expenses. For example, legal settlements
and judgments vary significantly, in their nature, size and frequency, and, due to this volatility, the Company believes the costs associated with legal settlements and judgments are not normal operating expenses. In addition, as opposed to more
ordinary course matters, the Company considers that each of the recent proceedings, investigations and information requests, given their nature and frequency, are outside of the ordinary course and relate to unique circumstances. The Company has
also excluded expenses associated with acquired <FONT STYLE="white-space:nowrap">in-process</FONT> research and development, as these amounts are inconsistent in amount and frequency and are significantly impacted by the timing, size and nature of
acquisitions. Furthermore, as these amounts are associated with research and development acquired, the Company does not believe that they are a representation of the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Company&#146;s research and development efforts during any given period. The Company has also excluded IT infrastructure investment, that are the result of other,
<FONT STYLE="white-space:nowrap">non-comparable</FONT> events to measure operating performance. These events arise outside of the ordinary course of continuing operations. The Company has also excluded certain other costs, including settlement costs
associated with the conversion of a portion of the Company&#146;s defined benefit plan in Ireland to a defined contribution plan. The Company excluded these costs as this event is outside of the ordinary course of continuing operations and is
infrequent in nature. The Company believes that the exclusion of such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-the-ordinary-course</FONT></FONT></FONT> amounts provides supplemental
information to assist in the comparison of the financial results of the Company from period to period and, therefore, provides useful supplemental information to investors. However, investors should understand that many of these costs could recur
and that companies in our industry often face litigation. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bausch Health Companies Inc. (unaudited) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended,<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss attributable to Bausch Health Companies Inc.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(948</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>(560</B></TD>
<TD NOWRAP VALIGN="bottom"><B>)&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(375</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,552</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>1,936</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>2,411</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset impairments, including loss on assets held for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill impairments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restructuring and integration costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition-related costs and adjustments (excluding amortization of intangible assets)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on extinguishment of debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Separation costs, separation-related costs, IPO costs and
<FONT STYLE="white-space:nowrap">IPO-related</FONT> costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other adjustments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Litigation and other matters<SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IT infrastructure investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal and other professional fees<SUP STYLE="font-size:85%; vertical-align:top">(b)</SUP></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net gain on sale of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired <FONT STYLE="white-space:nowrap">in-process</FONT> research and development
costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Adjusted EBITDA <FONT STYLE="white-space:nowrap">(non-GAAP)</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,472</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>$</B></TD>
<TD VALIGN="bottom" ALIGN="right"><B>3,294</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(a)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">In 2021, Litigation and other matters of $356&nbsp;million includes adjustments related to a Glumetza
antitrust litigation matter, partially offset by insurance recoveries related to certain litigation matters. In 2020, Litigation and other matters of $422&nbsp;million includes net charges related to a legacy U.S. securities class action matter
(which is subject to an objector&#146;s appeal of the final court approval), a SEC investigation matter and a Canadian securities litigation and related <FONT STYLE="white-space:nowrap">opt-outs</FONT> matter. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(b)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Legal and other professional fees are incurred in connection with legacy legal and governmental proceedings,
investigations and information requests related to, among other matters, our distribution, marketing, pricing, disclosure and accounting practices. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g296110g11i11.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">BAUSCH HEALTH COMPANIES INC. ATTN: CHRISTINA M. ACKERMANN 2150 SAINT ELZEAR BLVD. WEST LAVAL, QUEBEC H7L 4A8 CANADA SCAN TO VIEW
MATERIALS&nbsp;&amp; VOTE VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. (Eastern
Daylight Time) on June&nbsp;16, 2022. Have your proxy card in hand when you access the website and then follow the instructions. When voting online, you may not appoint a person as proxyholder other than the nominees specified in this proxy card.
During The Meeting - Go to www.virtualshareholdermeeting.com/BHC2022 You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.
VOTE BY TELEPHONE - <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT> Use any touch-tone telephone to transmit your instructions up until 11:59 p.m. (Eastern
Daylight Time) on June&nbsp;16, 2022. Have your proxy card in hand when you call and then follow the instructions. When voting by telephone, you may not appoint a person as proxyholder other than the nominees specified in this proxy card. VOTE BY
MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717, United States. To be effective, your proxy card must be
received by Broadridge not later than 11:59 p.m. (Eastern Daylight Time) on June&nbsp;16, 2022. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D85311-P70089 KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS
PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. BAUSCH HEALTH COMPANIES INC. The Board of Directors recommends you vote FOR proposals 1, 2, 3 and 4. Election of Directors For Withhold 1a. Thomas J. Appio 1b. Richard U. De Schutter 1c. Brett Icahn
1d. Dr.&nbsp;Argeris (Jerry) N. Karabelas 1e. Sarah B. Kavanagh 1f. Steven D. Miller 1g. Dr.&nbsp;Richard&nbsp;C. Mulligan 1h. Joseph C. Papa 1i. Robert N. Power 1j. Russel C. Robertson 1k. Thomas W. Ross, Sr. 1l. Amy B. Wechsler, M.D. 2. The
approval, in an advisory vote, of the compensation of our Named Executive Officers. For Against Abstain 3. The approval of an amendment and restatement of the Company&#146;s Amended and Restated 2014 Omnibus Incentive Plan. For Withhold 4. The
appointment of PricewaterhouseCoopers LLP to serve as the Company&#146;s auditor until the close of the 2023 Annual Meeting of Shareholders and to authorize the Board to fix the auditor&#146;s remuneration. Without limiting the general powers hereby
conferred, the undersigned hereby directs the proxyholder to vote or withhold from voting the Common Shares represented by this proxy in the manner set forth above. THIS PROXY IS SOLICITED ON BEHALF OF THE MANAGEMENT OF THE COMPANY. THE COMMON
SHARES REPRESENTED BY THIS PROXY WILL BE VOTED, WHERE THE SHAREHOLDER HAS GIVEN A CHOICE, AS DIRECTED OR, IF NO DIRECTION IS GIVEN, FOR EACH OF 1, 2, 3 AND 4. THE PERSON OR PERSONS APPOINTED UNDER THIS PROXY ARE CONFERRED WITH DISCRETIONARY
AUTHORITY WITH RESPECT TO AMENDMENTS OR VARIATIONS OF THOSE MATTERS SPECIFIED IN THIS PROXY AND THE NOTICE OF MEETING AND WITH RESPECT TO ANY OTHER MATTERS WHICH MAY BE PROPERLY BROUGHT BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF WHETHER OR NOT
THE AMENDMENT, VARIATION OR OTHER MATTER IS OR IS NOT ROUTINE OR CONTESTED. THIS FORM OF PROXY SHOULD BE READ IN CONJUNCTION WITH THE ACCOMPANYING NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND MANAGEMENT PROXY CIRCULAR AND PROXY STATEMENT. The
undersigned hereby revokes any prior proxies. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g296110g22i22.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting To Be Held on June&nbsp;21, 2022: The Notice of
Annual Meeting of Shareholders and Management Proxy Circular, Proxy Statement and Annual Report are available at www.proxyvote.com. BAUSCH HEALTH COMPANIES INC. INSTRUMENT OF PROXY FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON TUESDAY,
JUNE&nbsp;21, 2022 The undersigned hereby appoints Joseph C. Papa and Christina M. Ackermann, or each of them, or instead of either of the foregoing, __, as proxyholder of the undersigned, with full power of substitution, to attend, vote and act for
and on behalf of the undersigned at the Annual Meeting (the virtual&#147;Meeting&#148;) of the Shareholders (the &#147;Shareholders&#148;) of Bausch Health Companies Inc. (the &#147;Company&#148;) to be held virtually via live audio webcast at
www.virtualshareholdermeeting.com/BHC2022 on June&nbsp;21, 2022, at 9:00 a.m. (Eastern Daylight Time) and at any adjournment of the virtual Meeting, and on every ballot that may take place in consequence thereof to the same extent and with the same
powers as if the undersigned were personally present at the virtual Meeting, with authority to vote at the proxyholder&#146;s discretion except as otherwise specified on the reverse side. NOTES: 1. A SHAREHOLDER HAS THE RIGHT TO APPOINT A PERSON OR
COMPANY, WHO NEED NOT BE A SHAREHOLDER, TO ATTEND AND ACT ON ITS, HIS OR HER BEHALF AT THE MEETING OTHER THAN THE PERSONS DESIGNATED IN THIS FORM OF PROXY. THIS RIGHT MAY BE EXERCISED BY INSERTING SUCH PERSON&#146;S NAME IN THE SPACE PROVIDED ABOVE
AND SIGNING AND RETURNING THIS FORM OF PROXY IN ACCORDANCE WITH THE INSTRUCTIONS PROVIDED BELOW. YOU SHOULD ENSURE THAT THE PERSON YOU HAVE APPOINTED WILL BE ATTENDING THE VIRTUAL MEETING AND HAS YOUR CONTROL NUMBER AND OTHER INFORMATION REQUIRED IN
ORDER TO VOTE YOUR COMMON SHARES. 2. This form of proxy must be dated and executed by the Shareholder (using exactly the same name in which the shares are registered) or by his or her attorney authorized in writing or, if the Shareholder is a
corporate body, by a duly authorized officer or attorney thereof. A copy of any such authorization should accompany this form of proxy. Persons signing as executors, administrators, trustees, etc. should so indicate. If the Common Shares are
registered in the name of more than one owner, then all these registered owners should sign this form of proxy. If this form of proxy is not dated, it will be deemed to bear the date on which it was mailed to the Shareholder by the Company. 3. In
order for this form of proxy to be effective, it must be signed and deposited with Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717, United States, so that it arrives prior to 11:59 p.m. (Eastern Daylight Time) on June&nbsp;16,
2022, or, in the case of any adjournment of the Meeting, not less than 48 hours (excluding Saturdays, Sundays and applicable holidays) prior to the rescheduled Meeting. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g296110g10v55.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g296110g10v55.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[2!^4&AO=&]S:&]P(#,N,  X0DE-!"4
M     !                      .$))300Z      &-    $     $
M  MP<FEN=$]U='!U=     <     0VQR4V5N=6T     0VQR4P    !21T)#
M     $YM("!415A4    $0!! &0 ;P!B &4 ( !2 $< 0@ @ "@ ,0 Y #D
M.  I        26YT965N=6T     26YT90    !#;')M     $UP0FQB;V]L
M 0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   N %P 7 !0 $@ 6 !& $( 50 M $T 5P!% "T 1@!0 #$ ,  N &8 :0!N
M &, ;P!A &0 +@!C &\ ;0!< $$ 6@ P #$ -0 Q "T 6 !% %( 3P!8 "T
M,0 X       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "
M4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,
M8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M 0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B
M;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M  !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L("!D
M;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD(%5N
M=$8C4FQT                4G-L=%5N=$8C4'AL0(P@           *=F5C
M=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,
M969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M  !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O
M;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L
M;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14
M;W!L;VYG       X0DE- ^T      ! #P     $  0/      0 !.$))300F
M       .             #^    X0DE-! T       0    >.$))3009
M   $    'CA"24T#\P      "0           0 X0DE-)Q        H  0
M       !.$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      S4    &              -Q   $L0         !
M                          $             !+$   -Q
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   -Q     %)G:'1L
M;VYG   $L0    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   #<0    !29VAT;&]N9P  !+$    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!0       0    ".$))300,     !:I     0   *
M  !U   !X   VV   !:- !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !U * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M'M;7_,XGZ/\ 1/\ M&5V:K]/Z?A=-PJ<# I;CXN.W;54W@#GO[G/<[WV6/\
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MW4?69C[.H_S*[+IGU4^K?2;&W=/Z=CT7,C9<&!UC88W&]E]F^UF^IGZ3:_\
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M!"(      2Y-30 J    "  ' 1(  P    $  0   1H !0    $   !B 1L
M!0    $   !J 2@  P    $  @   3$  @   !X   !R 3(  @   !0   "0
MAVD !     $   "D    T ")5$   "<0 (E40   )Q!!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*0 R,#$W.C S.C(Q(#$T.C Q.C$T   #H $  P
M  '__P  H ( !     $   2QH , !     $   -Q          8! P #
M 0 &   !&@ %     0   1X!&P %     0   28!*  #     0 "   " 0 $
M     0   2X" @ $     0              2     $   !(     3A"24T#
M_0      "      !    _^$!,$U- "H    (  <!$@ #     0     !&@ %
M     0   &(!&P %     0   &H!*  #     0 "   !,0 "    '@   '(!
M,@ "    %    )"':0 $     0   *0   #0   #P     $   /      4%D
M;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3<Z,#,Z,C$@,30Z,#$Z
M,30   .@ 0 #     ?__  "@ @ $     0  !+&@ P $     0   W$
M    !@$#  ,    !  8   $:  4    !   !'@$;  4    !   !)@$H  ,
M   !  (   (!  0    !   !+@("  0    !              /      0
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M 0$! 0$! 0$! 0$! 0$! 0$!_\  "P@ 7@"  0$1 /_$ !T  0 #  ,! 0$
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FC.<H;6Y4N0MC-KV9A2ZNJ9"[O"QZ_*+D05:I4!-OJXXXXXY__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g296110g11i11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g296110g11i11.jpg
M_]C_X1"#17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,CHP-#HS," P.3HR.3HP-    Z !
M  ,    !__\  * "  0    !   "YJ #  0    !   #P          & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0 "/_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M#A3_ #)GC^9=\/\ 1I*;22222G__T?54DDDE*22224I))))2DDDDE.,'9>T
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M0/S^_N:I?;;RT.%V.&&"'>XZ'\Z/;N24GO8[UK+/39M]!S?6_/F9]/\ XO\
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M[?+]*_\ ])IQA=8W2;6D2);ZUFOB-PK_ #DE.KN/[A_#_P DF+R/S3KIV_\
M)*A]FZC^XS_V)O\ _(*+\3JCFD,V5NTAXR+G1_9?7M24Z0?J 6D3Q,?P*DLZ
MNGJE9#@RIS@(E]]K@?Y6QU>U%W=7_P!'C_\ ;C__ $DDIL7_ ,Q9_5=^14O_
M %G?_0/_ -%*;_VN]CF>GC#<")WOTD?\4B_8_P#)WV'?_@?1WQ_)]/?M24__
MV?_M&'Q0:&]T;W-H;W @,RXP #A"24T$!       #QP!6@ #&R5'' (   +^
MSP X0DE-!"4      !"41BV97+'UF@= [A>W<6'=.$))300Z      #E
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M<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M    0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T
M=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT
M;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !
M+     $  @$L     0 ".$))300F       .             #^    X0DE-
M! T       0   !X.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ !
M &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M   ! #4    ! "T    &       !.$))30/X      !P  #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z     #_____________________
M________ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      -;    !@             #P    N8    3
M #( .0 V #$ ,0 P "  4@!E '8 :0!S &4 9  @ %  0P M #$    !
M                      $              N8   /
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   /      %)G:'1L;VYG
M   "Y@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   #P     !29VAT;&]N9P   N8    #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!$       $! #A"24T$%       !     (X0DE-! P
M#VD    !    ?    *    %T  #H@   #TT &  !_]C_[0 ,061O8F5?0TT
M ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( *  ? ,!(@ "$0$#$0'_W0 $  C_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M]553*Q[;;06ANPM#222"-9X;]-6TDE--O3Q(WO#FZ[@ 1,CM[_:K5=;*V!C
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M[:T,;_T56KJL.2Y@ZA:]U1:^RDMIC:XES6$MH:[:[^OO24UATG-$Q>!/;?=
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\
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MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
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MX**.*&MW)U_@NB_[Q8;;67E6,25M#B\QGJV:G61F$+U4A0 L3[]YCJRBJ/\
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MIR >/14/CS_/UZ=^3?>'P8^/_6_Q^[AH]^_*>GW32=X0[WHLILRA^(N]=O\
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MOGBQ'9'RKW=CI*>LBIJFCBQNSZ?)4T/W-?4TDX)]U:@'Q?ZO]7^H]&)^+/\
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MV<B-S;\Q?361$&/RLD25%)64T$BWBB6#W[KVK)KT&'2O\E[X$_&_?WQW[,Z
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M,5M>K&QEJILE-U?N#9M;US)-&M+O/-YC)X\24W\%JIF]UO3\^F7'_P W'O\
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MN9.N9\SWGEAG^I(MU+\>J&JWQE<1!2T..K^PTRFS,J]9M^EI&,M+OKVD>O\
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M'C\A7RO0^_=:&FC5&>L4&$_F2YG^6_WWO#?'8/8F.^;LN0WQ5=3;<ZHVKL+
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MPW3.9K:RCZKK^NL_G,WVM3[[PU$U=GZ+9O9"4=!)A:21PU)).D-.*D>==]>
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MZ)MM_P"=G1&X\+69FE'8E ST..RFS<-G.M]U87/=JXK-[TH>NL%D>J\=D*&
M[RARN]LK1T 2%DGI6KJ::KCIZ:HAF?W5M)Z5G7GRTZM[6W)BMM=?4._]S35F
MU*+=N;RE%L;-1X78\&1DWM24>#WM6U44#X7=$N5Z]RM":!8YIDK(%B;29H=?
MNM4ZP8WY@]-5=+M<Y5]\[1SFZ^ZL+\?:79N[>O-W8G>.)[2W)M3^_6 PVY\&
MN+JI=MXS+[+>+)0Y2K:+&&"HA4SB:18O?NO4/0K;%[@V%V1NGM39NT<G6U^?
MZ8W;0;([ IJK!YO$0XS<>2VSA]W4M+CZS+X^BI=P4C87.T[&KH'J*03%X?)Y
M8I$3W7B"*?/HMY^?_1<FT-S;YH,5VUEMO;/2LRNX)<?U=N5JZBV-3R;LI:/M
M"+%5,-+DJ_KK.9/8N7HL?D*>*5JNNH7ITB\K1J_NMZ36G2JS/S7Z*P6<W9MR
MNK]WG+;;JY\+B:>FV-N6H7LK>./R^(VYG.O>J)HZ$Q;_ -_;9W1N"AQF3Q="
M6J*&LJ"LH58*IX/=>TGJ$?G5\<XZ[:M-5;HRV.H=S8[&U=9G\GMK+X[ ;'R6
M9BW@^'VIV+D*RGA.SMWY*?K[.4ZX^J0315.,DBF\3O )O=:TGH7NF>]-B=ZX
M;+Y;9G]XJ"HV_DZ?&9[;>\]MY;9N[\,V2Q5#N' 5N2VSG:>ERE+B]S[;RM+D
M,=4,GCJ::<6(D26./W7B".AC]^ZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=);([YV3B*MZ#*[PVOC*Z+(T^'EHJ_/XJCJX\M5X:LW'2XN
M2FJ*N.9,A4[>QU17QPE1(]%!). 8D9A[KU.DQCN[^E\Q'M*;$]N]892'?U76
M8_8DN.W]M6MCWI7XZ>CILA1;3>FRLJ[CJZ&IR%/'-'1^9XGGC5@"Z@^Z]3J1
M1]R=09#:F:WY0=J];UVQMM5DV.W'O.CWQMBIVI@,A3O31U%#FMQ0Y1\1BJR"
M2LA5XIYHW4RH"!J6_NO4/IU/P?9_6FY\2V?VUV'L;<."0XL/FL'NW 9;$J<W
M6MC<*&R-!D*BC7^+Y%33TMW_ ,HF&B/4W'OW7J'TZD4/8G7^3W!1[3QN^MG9
M#=.0P1W10;:H=SX2KW!7;9%7)0'<5'AH*Z3(U."%=$\/W:1M3^52FO4"/?NO
M4Z9SW+U *+>.2/:O6PQW7>0CQ/8%>=\[8%%L7*35CXZ'&[QJCE/!MFOER$;0
M+#6M!(TRE -0(]^Z]0^G7*'N+J.HKMIXR#M/KB?);]Q4^=V-CX=[[9DK=YX2
MFAFJ:G,[3I4R;3[BQ5/3T\DCU%&LT*)&S%@%)'NMT/IU&V_W?TONRBR&2VKV
M[UAN7'8F+)U&5K\!O[:F8HL;!A*./(YF;(56.RU1!1Q8C'S)/5-(RBGA</)I
M4@^_=:H?3J?@>VNJMU1[=EVOV9U]N2+>!SPVE)@=Y[<S$>Z#M94?<XVZ^/R5
M0N;.W$E4U_VWE^S# RZ+CW[K=#Z=2,KV?UK@8]IS9SL+8^&BW]4T]'L67*[L
MP./CWI5U44,]+2[3>KKX5W%45,-1&\:49F9UD4@$,+^Z]0^G37+W5TW -Z--
MVUUG"O6[:.Q&EWYM:,;"?[V;&Z=YE\J!M=OXC3R4]J[P'SHR?J4@>Z]0^G2G
MH=Z[-R=#MC*8W=NV<AC-[,B;,R-#G<75T&[GDQM7F(TVS64]5)3YYY,1CYZI
M12M*33022CT(S#W6NF!^X.I8\QM[;TG:'7<>?W=/74NU,')O7;29C<]3C,E5
MX?)4^WL8V3%;FI\?E\?/2SK3)*T53!)&P#HRCW6Z'TZGY#LOKG$80;FRN_\
M9.,VV<=E<P-P9#=6"H\(<1@JFGH\WE!E:FOCH#CL/5U<455/Y/%3R2HLC*S
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M*&+"FDJ6C6FJAE9)UH33U#2H$?R:7+"Q-Q[]U6AX>?2:_P!*W5W_ #\G8/\
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M]DY#'U&WHL9MB3#TC4$"TXCI#31&,+H6WNM D&H.>BR_\-1_RQ_^]??PW_\
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ML72YVCRN'I\ACZ"NJH$JH@'BBED0, S#W[JH)!P<]%.R/\MC^4CC BY7X4_
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MO__5W^/?NO=>]^Z]UQ9E16=V5452S,Q"JJJ+LS,; * .3[]U[JC3N'_A2/\
MR:.DM_YSK7<_S&P>XMR;:JZG'9RHZQV!V?VCM>CR-'4/35-#!O78NSLYM'+R
MPRQD,]#6U4(((UZ@0/=7$;M6@_P=!C_T%._R3/\ O*7<W_I/_??_ -KKWJO6
M_!D_A_F.O?\ 04[_ "3/^\I=S?\ I/\ WW_]KKWZO7O!D_A_F.O?]!3O\DS_
M +REW-_Z3_WW_P#:Z]^KU[P9/X?YCKW_ $%._P DS_O*7<W_ *3_ -]__:Z]
M^KU[P9/X?YCKW_04[_),_P"\I=S?^D_]]_\ VNO?J]>\&3^'^8Z]_P!!3O\
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M&3^'^8Z]_P!!3O\ ),_[REW-_P"D_P#??_VNO?J]>\&3^'^8Z]_T%._R3/\
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M_P DS_O*7<W_ *3_ -]__:Z]^KU[P9/X?YCKW_04[_),_P"\I=S?^D_]]_\
MVNO?J]>\&3^'^8Z]_P!!3O\ ),_[REW-_P"D_P#??_VNO?J]>\&3^'^8Z]_T
M%._R3/\ O*7<W_I/_??_ -KKWZO7O!D_A_F.O?\ 04[_ "3/^\I=S?\ I/\
MWW_]KKWZO7O!D_A_F.O?]!3O\DS_ +REW-_Z3_WW_P#:Z]^KU[P9/X?YCKW_
M $%._P DS_O*7<W_ *3_ -]__:Z]^KU[P9/X?YCKW_04[_),_P"\I=S?^D_]
M]_\ VNO?J]>\&3^'^8Z]_P!!3O\ ),_[REW-_P"D_P#??_VNO?J]>\&3^'^8
MZ]_T%._R3/\ O*7<W_I/_??_ -KKWZO7O!D_A_F.O?\ 04[_ "3/^\I=S?\
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M?_VNO?J]>\&3^'^8Z]_T%._R3/\ O*7<W_I/_??_ -KKWZO7O!D_A_F.O?\
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MMFINJLS)A9*&JDPU?6555!'D$CF:*JAJ:>'U>O,*8U5/1P/]%?6'_/N-A?\
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M_H'[>_\ K=[]UZIZ]_HKZP_Y]QL+_P! _;W_ -;O?NO5/7O]%?6'_/N-A?\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUT_\ A53_ -N6_D%_XD;XY?\
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M^;IZN5Y_=>JOIUQRGP8_F4Q8K.[=VU\^]UQ8NL.[<GALQF]]YFNW?CLWB_\
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MY*S<^Z=L[T^*79O46^'WMWYV;T/L_9VS</MGL.M^2D<WV62JLO+@LS4M O\
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ME[]U7K73_P"%5/\ VY;^07_B1OCE_P"_TV+[T>G8?[0?8>K_ /8/_'B[+_\
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M^X*G9^TNQ,#)E-KYU$K(\3NSKW?N%S>,JE+15-!D8[Z)DFAB]UHJ5X]4T?\
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M?865JMNR9'$M7;6V_3?9X>BG2CK8HC64%* B5P45Y51>8Z1;W7B2>)Z9MO\
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M[K>IL9Z.5L'ISK7J_.]E;EV'M:EV[G.W]SX#>79%?3UN4JI-T;FVOUSLKJ7
MY6IBR%=64]'+CNN^NL+C%2E2")HZ%9'5IGED?W6JDTZH?_X54_\ ;EOY!?\
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MT]'[WTR>/2M]^Z]U[W[KW7__T-_CW[KW7O?NO=:\G_"IW_MR7\I__#DZ _\
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M]^Z]UKR?\*G?^W)?RG_\.3H#_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\
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M1Z61F]UH@C!Z&SW[K76NG_PJI_[<M_(+_P 2-\<O_?Z;%]Z/3L/]H/L/5_\
ML'_CQ=E_^&EMS_W3T?O?31X]*WW[KW7O?NO=?__6W^/?NO=>]^Z]UKR?\*G?
M^W)?RG_\.3H#_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\ >>QWOW39XGI?
M>_=:Z][]U[KWOW7NO>_=>Z([W&WR8D[5K,/LK.Y\]9Y'?WP^JE3';0IHAA=G
MS;_[(7Y!8O';OQ=10YF0Y/!;;P;Y"HJ))/X71UFB) *DM[]U84I\\]'7Q];#
MDJ"BR-,M2E/7TE-6P)64=7CZM8:J%)XEJJ"OAIJZAJ C@/#-''+&UU=58$#W
M5>@^[FFWA3]4]@U&P-PTNT]Z4^U,O/MK<=9M',;\IL/E8:5Y::LEVAM^.?-Y
MT(5L(J6&IF!(=8)ROA?W7AQ'1!L?\@?FY%E]OXG!]%Q96CWK2; ?!CM>FRVV
MY^OHZWJ+!UF1QO8N]-E8W)XO<FX=S=D?Q6<UU'A\52XJDHDHJRAI*JJC\/NK
MT7UZF;;^3?S?WQF<A1XWXM8GKS"YBEV/5[,R?92;Q;<.+Q^[<MM[#9'+;RV9
MA%1"^S\BN:7*8X97'5,%'#0UR/+!4,J>ZU1?7IV["[2^5=3OGI>HVEMO>NWZ
MK<O475FYJOKF'8O\0V#6]D9[M#:M#VYM3L??=7M7*5NSZ39?5];7U5*SY'#S
M+-")$6MF_P B?W7@!0]*3Y$]F_*G =B;?RG0NU,[N_K;-=(9_"G G8(-5!W=
MV/O_ &7M7J7?E?D\U%C,IA-N]6TK9#(;HQU4%3^!54E4T1EI%!]UX >9\^BX
M4_;7SVVQC\+NBHZY[!WMFMN5?]V=P8O+;?\ [N[0W3]EUN]%D^X\QAZ'%29O
M%X*JW=-_%&VWAGDF22,4E&[ 'W[K=%]>K&NAMV]Q[SPF\<IW+LS;VP\E1[^S
M6#VI@=OR9RNCFVCB*/%TU-GJK.9R''/G1G\O]Y44L\%!01"@:!&C,JR,?=5-
M/+H=/?NM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54W\U?=FWNLL9\"
M^Y-^UR[<ZJZ=_F)=,[T[8["R%-4G:G5^R\CU3WQU_#O??F9AAEI=I[-AW?O?
M%8^IRU:T-!1RY"(U$L49+CW5TSJ XTZ#O:WR>^/GR^_FB_&/,?%[MG9/?^!Z
M7^(OR[G[5W1U7EZ;>6U>MZCL[L3XP8SK_%;KW3B348/#;DWO+L;,/CL6]0,C
M54F,J*E8?MHC+[]UZA5""*&HZN=]^ZIU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M5O\ \WW;F?W7_++^:.&VQMW-;LS3]([AR-/M_;F*J\[G,A38*IH,[DQB\+CX
M:C(96KIL7C9IEIZ>.6HE\>F)'D*J?=60T8'HE_RP^<OQ!^8V\?Y>G5OQ4^0G
M5_R,[&G_ )A/QJ[1EV/T[N.CW]N7$];]>T>[]Y;X[!W%B<":RKVQL_9F!B$V
M1R.06FIJ.=XJ=V6IEBA?W5E4KJ+"@IU?A[]TWU[W[KW7O?NO=$L^+>4^3J[L
M[L@^26U,[B/[R]A4&=ZX^VW%M7=^Q]N[='7>T(\QMG:>3V_CL-EJ':V-S\4J
MP-FZ?^)U^4EKI1: 1!/=6-,4/1T_?NJ] ]\@MO[MW1T?VOA=@97=.%W[5;!W
M1)L;);*S$6!W/!O*CP]76[73$Y2I(HX)JC.4\$;+4?Y-*CLDW[;-[]UL<17H
MC6<7YS=3XCL2CZ^&9WYB,IN_"IM7*[XHX^P-W['P%)C>K\7FMQP11[EAK>P*
M?.9&MRT[8A(:"2BBI:F:!G?Q13>ZMVXKT.OR&[)^2VPJ7JZLZWV119Z6FPF;
MW/VUDH\5#D=AO'@]O1OE=NB6ISV+W=MAUFJ9\MCJL1U(JH\8<>R/55<(]^ZT
M ,UZ*=L?Y%?/7<>:Z]PV.V'39S(YKJ3$]FTU%N;KJEV-1[D?<3S4V7I^P\Q!
MO7+1=4TNV*V*H3;E+3)D:_.K3Q&M-,LS2#W6Z+GH2<5O3Y^9'$8?)X_:4:3P
MQYW(R9#=VS\7ALQN[!;3_OIE]NX/.[$@[!3&=>[I[%R%/0XJIDII:TT=%)%4
MK('D*4WNO47IV^\^?*53T&*S%)+CL/O/MF+)Y;<?6^U:K)Y[#U?9W<>7V#%@
MOL=V;=H8\)M_K3 ;/Q=%.:5IZZ3.5$]6_P!Q T<.NO=O6+9^^/Y@^>Q=/EMR
M;.VGM7+T>]<QD]Q[(CVM#7I28C&IM6&BZZPV\JK==!0;FV_FZ;,5=;3[GI*;
M[E9J*>EF@B98S)OK7;TM*K/?+7:?Q4VE,%SV\.\*'>.2P78FXGV+M3([QCVG
M1[UW71+NS:W7.+S. VCN2MJ<;28M::!*RGCDQE4]80)8S$?=>Q7Y=1L'MSY3
MTO0WRWR>:FRW^G??>8W5F.JL=BLGAUAVPM7U%L7&;<VMLS*FJEHHL%@=Z09-
M:6LG2&J+,\SAY+32>Z\:57TZ2==3?.;KC%9?'8VK'9M/LO;0Q&VLC_#8Z[,Y
M>NJME9'<>=W9-59'>-#5]B5VV\UDH\%@L=DH*&7)/BHI*VH-15RUB^Z]VGJ'
M)V%_,&J&W['MS9FW:GR;PH-C]=_WNV.V+?'8;=./KL?M/NK=-=!NK%4V6VG@
M(THLSNK"TE-%FZ.NFJ<=3P+'%$S^ZWVXZ@9;L?Y^[JBM2=<Y?K!*SK[KG?N3
MHZ7;VR-RY3;>X:GMOK[.9SK?;^:DW-DL3N'(GJ?)YS 9T3THEIZ[%OD,>X6H
MI(Y?=> 7KE2UG\P3LO!TN,SDN/ZN>JS%/4UV1V]LV&#.;:S,7>?5M!-AGFR6
M]$I-R[*V;L;^\.0IJND#)NW#QQ+4M3S&:DG]U[M'3IA^VOGEC]T4E7NSJ"*H
MVWB\-MS([TP6#P6/R,S[>H<KM>')9?K_ #%-N*-MQ]H[OAES9JMLS&*DP5)3
M4SQ555*R+5^ZU1?(]8(.SOGU65VQJ%^OJ'#/F=Z;'?>N<K]B0S[8V7@\ML_&
M5T^QWQ.*WIF=S;@F&X36IN'==%.<7BVEHH:.!_%7./=;HO3=3;A^7FU-MX]]
MM;=[;SW8V1[*K*3N"HW_ $&*W1MQ<I#2Y"HVE0]/XNERF&VSA>C-U9*2*CR6
M9HW%=@L<L4\U+)6FH9?=:QTG<CWM\],?O#9.U*G8$=-E-W;PWN9*&/8%'7X^
M#+;4IJ2KI=@T&X_[VT%,.C:BFK:5INP*J&/+R25$B08P/$T:>ZW1>E7#OK^8
M15[/W;GLEA,#MW*8/'=GY:EV[B.KGW/GLAN+'[BV?C-K=:X U.]<50YBDJ<=
M69>7!;F"-05L:T]3E(Z98*BGF]U[MZ'/O7<G>U+4;938&V.QXI=Z?'SO;#)2
M[=I]JY>+9'>-1@-EYCJVIWED4JY<;CZBFJ:++T-+7P/48C[V33,?%)%)[]UH
M 9STG.A<9\C=V=W[@[4WMG-];0ZAFZSZNH-N]:[TIJ>GR.7W+6[*II-[?Q+;
M:RO3[0R.U=X13--5Q!ZK)SU#QB5J"&FU^Z\:4IY])+KC=?SAQ?876FT=Y86?
M=6V&WEV51[XW7EMJ[>PE'D=J-V7VC+1Y6JS.!R AV]+LS8<6SX-KP4]%.VZ(
MZVL>M>">GE,'NO'3FG3]V1OWYB4';<FV=@;:AK^OINU]H05&_:[K]CMW;FPZ
MK;M#(=J0XB'<M1O+=]9E=RBJ_C^[*=*?&86BGHTI:62>&NM[KPTTSQZ#S=G8
M'\Q/#;?6DQFR,!D,E48;;N\LUNVFV;CJ]]LTFY\]E-L;@Z]VWLO&;WR%5NW>
M'6/@HL\#)*E/F<+43Q).*V..)O=;HOKT/W=N]/D]M^@Z/INK=G4><W/FJFBG
M[2R%+@(\OL*A\4.!H\[BJJDK]R87=^#HS'F,AF,?4Q22O(,'_#Y3]S74]_=:
M%,UZ3V=S/R<SOQLZEW!CDW?M[M6/?FQ3VS0TFSMGQ;JW%L"#>51A-\2XC:55
MEJZCVE2;KV\R9*D@6M?.X7'RHDKG(02@^Z]BI].@ZZIS'SRV]OOH_KG?.,P^
M3Z^H-L;?;??965P!RF2W-D9-G8&LW+M3-5&'W-E*K;&9VA63SQ4&?G:IIMPY
M"&5)UB]#RZZV=-"?/JR?WOJG7O?NO=:]GQ_^>?PW^+/5'SGZ6^1GR)ZPZ*[?
MV[\Q?YAVXJ[JKLO/P[1["FV_V%W3V/V5U[G\%L[*)!G=SX?L796Z\?D-OU.,
M@JX<X*M(Z)IY]42^Z<*L2I J*#JSO^6QMO/[/_EZ?!W:VZMO9?:>Y<#\3N@,
M9G=L9_'3X?/;?RM+U=MB.MQ&;P]6D59B<OCYPT532SHD]/,K1R*KJRCW56^)
MOMZ.Q[]U7KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZH\Q7RB^.WP]_F?_P PJ3Y4
M=O;"^/%+W;UQ\)-T]0YCM[.T6Q,)VE@]E;,[2V;O.NV/GL\]'B=RMLW<DT-'
ME8:>:2HQS3P-.D<<\+O[J]"RK05I7H:_Y2.:QF]^I_E1VWM8S9'K?NO^8/\
M+[M/J;>2T5328;LGK;.;^@QNW^PMI5%5# V:V=N.;"U#8W(QJ:;(4T:SP/)
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MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_P"%5/\
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MT?O"BAQ^4K?LNN*/:NT,C%61A9Z?,UN*PLDDDK/D&;?7M0].HV%^"&[^MZ'
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M:>/9X^Q,#38_=E/BJR.EJ*5TB#547F65:==^G7J_+SZ%/:/7N-R_1?9W7O\
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M*_.93X;X[97?6R4[7WAM[!=Y]GGNW>^X]M8K<F&JMY;@RC=8Y/.]==;;PQN
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M"[P&(V7%F\;25L$6W!'"^+R5;'5>&-W>IC]U[N]>L.;J?BQE^IMJYM?C?O\
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M^0>+^-GRF^(&7^+&_-]]8;R[7Z>RV.[MV'WWLSL'!=9;@V=MWLO"9#,;-QF
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M*W:6U*K=E)A\KGMYX[<F]O\ 2AMOJ;-=^=@4%;'5Q9W)9.+(;(["W*:?</\
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M#&4^'KZJJPV)Q^X\P369*&CIZ>/(U?[]2)9?7[]UZIZA]>?'GI?JB:BJM@;
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MTMM[L."_O'B*7,#;.XL;NW!)6!WCQ^Y,,*@8K+Q1*ZQR56.:I=X2X=8Y=,@
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MY([PR^:I.XJOK=NPM^_QK&;DP5,VPUZFR&T]@0]+-U=14M)#D1NV'>-;6ME
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M.N_^5+<W_HQ.Q?\ [*_?NO5Z]_H0Z[_Y4MS?^C$[%_\ LK]^Z]7KW^A#KO\
MY4MS?^C$[%_^ROW[KU>O?Z$.N_\ E2W-_P"C$[%_^ROW[KU>O?Z$.N_^5+<W
M_HQ.Q?\ [*_?NO5Z]_H0Z[_Y4MS?^C$[%_\ LK]^Z]7KW^A#KO\ Y4MS?^C$
M[%_^ROW[KU>O?Z$.N_\ E2W-_P"C$[%_^ROW[KU>O?Z$.N_^5+<W_HQ.Q?\
M[*_?NO5Z]_H0Z[_Y4MS?^C$[%_\ LK]^Z]7KW^A#KO\ Y4MS?^C$[%_^ROW[
MKU>O?Z$.N_\ E2W-_P"C$[%_^ROW[KU>O?Z$.N_^5+<W_HQ.Q?\ [*_?NO5Z
M]_H0Z[_Y4MS?^C$[%_\ LK]^Z]7KW^A#KO\ Y4MS?^C$[%_^ROW[KU>O?Z$.
MN_\ E2W-_P"C$[%_^ROW[KU>O?Z$.N_^5+<W_HQ.Q?\ [*_?NO5Z]_H0Z[_Y
M4MS?^C$[%_\ LK]^Z]7KW^A#KO\ Y4MS?^C$[%_^ROW[KU>@K[1ZMVEA)>L8
M\2^[:!<UVQM?"Y44_8G82FOQ%5C\]+4XVH9MT,S4=3)3QM(@(#E%O>P]^Z\#
MQZ%'_09US_RI[J_]&5V5_P#9=[]UZIZ]_H,ZY_Y4]U?^C*[*_P#LN]^Z]4]>
M_P!!G7/_ "I[J_\ 1E=E?_9=[]UZIZ]_H,ZY_P"5/=7_ *,KLK_[+O?NO5/7
MAT;UR"#]GNDV-[-V1V2P-OP5;=I5A_@>#[]UZIZA_'J:JEZDVTM97Y+)R4E=
MN_&Q5F7R-;ELB]%BMZ[BQF.AJ<ED9ZFOK#28^DBA5YI'D*(-3$\^_=>/'H:?
M?NM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=,.Z:B>DVQN.KI97IZFEP.7J*:>.PDAGAQ]1)#*A((#QR*"+@
MBX]^Z]T"'7'46R<SUYL/,91-U5V4RNS-KY/)5TW8G87FK<A7X2AJJVLG\>Z4
M0S553*SN0 "S$^_=;/2S_P!"'7?_ "I;F_\ 1B=B_P#V5^_=>KU[_0AUW_RI
M;F_]&)V+_P#97[]UZO7O]"'7?_*EN;_T8G8O_P!E?OW7J]>_T(==_P#*EN;_
M -&)V+_]E?OW7J]>_P!"'7?_ "I;F_\ 1B=B_P#V5^_=>KU[_0AUW_RI;F_]
M&)V+_P#97[]UZO7O]"'7?_*EN;_T8G8O_P!E?OW7J]>_T(==_P#*EN;_ -&)
MV+_]E?OW7J]>_P!"'7?_ "I;F_\ 1B=B_P#V5^_=>KU[_0AUW_RI;F_]&)V+
M_P#97[]UZO7O]"'7?_*EN;_T8G8O_P!E?OW7J]>_T(==_P#*EN;_ -&)V+_]
ME?OW7J]>_P!"'7?_ "I;F_\ 1B=B_P#V5^_=>KU[_0AUW_RI;F_]&)V+_P#9
M7[]UZO7O]"'7?_*EN;_T8G8O_P!E?OW7J]>_T(==_P#*EN;_ -&)V+_]E?OW
M7J]>_P!"'7?_ "I;F_\ 1B=B_P#V5^_=>KU[_0AUW_RI;F_]&)V+_P#97[]U
MZO7O]"'7?_*EN;_T8G8O_P!E?OW7J]>_T(==_P#*EN;_ -&)V+_]E?OW7J]>
M_P!"'7?_ "I;F_\ 1B=B_P#V5^_=>KT&77O4^SLQD>T8LFV[ZR/"]FY'#XF.
M7LCL8+C\7'M;:-;'04PCW6FBFCJZZ:0+S9I6/Y]^ZV213H2O]!G7/_*GNK_T
M9797_P!EWOW6JGKW^@SKG_E3W5_Z,KLK_P"R[W[KU3U[_09US_RI[J_]&5V5
M_P#9=[]UZIZ]_H,ZY_Y4]U?^C*[*_P#LN]^Z]4](C<^P\#L+=/464VI/N;&U
M>1[,@P61$^]]YYBDR&'K=E[TJ*G'UN.SF?R6.J()*FAAE&J(LDD2,I5E!]^Z
M]QK7HRGOW6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NM=/\ X54_]N6_D%_XD;XY?^_TV+[T>G8?[0?8>K_]
M@_\ 'B[+_P##2VY_[IZ/WOIH\>E;[]U[KWOW7NO_T-_CW[KW7O?NO=:\G_"I
MW_MR7\I__#DZ _\ ?]]=>_>1Z=A_M%ZO=ZI_YE=UM_X8.S__ 'GL=[]TV>)Z
M7WOW6N@=A_[* R/_ (AW"_\ O:Y[W[K?ET,7OW6NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H%>Y?\ @1T]_P")JVC_ .ZO<GOW
M6QY]#5[]UKKWOW7NO>_=>Z][]U[KWOW7N@4^/'_,I\'_ -KS?_\ [\/=7OW6
MSQZ&OW[K77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW2;WE_QZ&ZO_  V\Y_[K*KW[K8XCIBZE_P"95=9_^(^V
M9_[SF-]^Z\>)Z$'W[K77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]T$/57_%U[D_\2]E/_>,V-[]UL^70O>_=:Z][]U[KWOW7NO>_
M=>Z![M?_ (O'2W_B8<;_ .\-O[W[K8\^AA]^ZUU[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UKI_\ "JG_ +<M
M_(+_ ,2-\<O_ '^FQ?>CT[#_ &@^P]7_ .P?^/%V7_X:6W/_ '3T?O?31X]*
MWW[KW7O?NO=?_]'?X]^Z]U[W[KW6O)_PJ=_[<E_*?_PY.@/_ '_?77OWD>G8
M?[1>KW>J?^97=;?^&#L__P!Y['>_=-GB>E][]UKH'8?^R@,C_P"(=PO_ +VN
M>]^ZWY=#%[]UKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z!7N7_ ($=/?\ B:MH_P#NKW)[]UL>?0U>_=:Z][]U[KWOW7NO>_=>
MZ][]U[H%/CQ_S*?!_P#:\W__ ._#W5[]UL\>AK]^ZUU[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TF]Y?\>ANK
M_P -O.?^ZRJ]^ZV.(Z8NI?\ F576?_B/MF?^\YC??NO'B>A!]^ZUU[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!#U5_Q=>Y/_$O9
M3_WC-C>_=;/ET+WOW6NO>_=>Z][]U[KWOW7N@>[7_P"+QTM_XF'&_P#O#;^]
M^ZV//H8??NM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=:Z?_  JI_P"W+?R"_P#$C?'+_P!_IL7WH].P_P!H
M/L/5_P#L'_CQ=E_^&EMS_P!T]'[WTT>/2M]^Z]U[W[KW7__2W^/?NO=>]^Z]
MUKR?\*G?^W)?RG_\.3H#_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\ >>QW
MOW39XGI?>_=:ZJM^=VR_D)G.\.@D^.7SBW]\5=X;\V]NO95?LK8GQ1ZE^2LF
M^,+A=Q[3KZKL//5O9Q1MB[9ZOFW1%%7R498U"9E&:*0PKI]U=:4-17HOF/Z!
M_F,U=70XBN_GU+@-SU^$J-RQ;.SGP;^#=/NI-O4PR,LN=;$4F5K7DPOVN)J)
M_NXFDIQ!"[EP$?3[K=5_WW_,]3:/X\?S$,C2[;KL?_PH!Q%=0[RJ,K2;0K*/
MX0_"2JI=U5>!6I?.4NVZB"J>'.5&&2CF-6E*96IQ$YD"Z6M[KU5_WW_,]0-B
M]$_S!^S=H;=W_L#^?_1[KV9NW'8O+;:W'A_@A\-*C&9G'9M:UL1544UU,D>2
M&.J/#P&D^WDL#H:WNO$J.,?\ST\;=^-?\QS=]73T&T_Y^U#NBOJ\#3;JI:+;
MOP9^%.:JZG:]9524-'N2GIL;45,TV!JJZ%X8ZQ5-.\JE%<L"/?NO57_??\ST
M5A]Q?.2F7"U.0_G9]V8S$9?%;KSD^X*O^5G\7'P.W\3MO?>\NM\55[DR-'%5
MQXINP-W;$R%-@(2'J:PB+RQP&:(-KK?;_OO^9Z&*'JG^9=7=C[(ZQPG\YKN;
M<&8WQU_A^SXLSB/Y8/Q2EVGMC9FX:C(T>!R6\,_5K1T^&J,M68JHBBI0LU4&
MC)>-$LWO?6JK2OA_S/0=X]_G5N#9XWALK^>)VKOZ.K[FWOT+@=N[1_E@_%NM
MW7NSL7KR/.Y#<])M;#UU-C?XQA(-M;;J\U2Y-)!0Y##(E52RS1S0^3W6^T&A
MC_F>A0V)T[_,P[#W-VAM_ _SHNV:?'=29W+;7W-O?-?RS?B7B-CUFX]NB ;E
MQ&WLU5Z9\Q/MZ2<)4RI3K3:U<1R2:&M[K54%/T_YGH.<?3?/*IV/C.Q<G_._
M[8VSM'<>WMS[QV;DMQ?RO?B]22;[V;MR38,%)NC9U#24==7YNAWI5=FX2#;]
M.D:Y',5%:(8*8RJR#W6^WAX8_;TX1;;_ )B5)GNI=I;R_G.]Y]9[N[MJ>S:+
MKW;/8/\ *N^,6&R.4KNJ,/0[@W'0U=31TN3PV+KLEA*X5&(AGJDERZPS+2K)
M)#(B^Z]VY[!^WJ=N7:WSYVCLA>Q<Y_/-['IMI2_'3=/RFI,C%_+"^-%5)D.I
M-FXW;N6W#58ZAI\3)6UVZJ.BW;C2N$CC;*3/61)'"SM;W[K55K3P_P"9Z2>X
MYOG9@<=ELC1?SO.W]X#"=;XKMS(4>S?Y6_QAS-;'U_D]L8S>LF<A22CHX*M\
M3M'-4F0K*2*1ZV*"IB"Q/(ZQG76^W_?8_;TK,#M#^83G,359.7^=QVK@)\=D
M>I,3E\'N#^6)\6:3.8;(]WP8ZJZ[I,E24E-7012Y*DR]-)4Z97&.$NFJ\4BN
MB[Z]V_[[_GTP[/7YM;[K,ACMN?SX.P*G(8KL7JCJZOH:G^5_\;J"HAW/W9LK
M#[^ZXE5:S"0I/M_.X',JC9*-GHZ6NIJJDFDCJ:::-/=>[?\ ??\ /J1F,?\
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M $,-O?\ UQ]^Z]0]>_TJ=8?\_'V%_P"AAM[_ .N/OW7J'KW^E3K#_GX^PO\
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MKWC2?Q?R'7O^@6+^29_WBUN;_P!* [[_ /MB^_4Z]XTG\7\AU[_H%B_DF?\
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M?R'7O^@6+^29_P!XM;F_]* [[_\ MB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_\
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M8OY)G_>+6YO_ $H#OO\ ^V+[]3KWC2?Q?R'7O^@6+^29_P!XM;F_]* [[_\
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M%B_DF?\ >+6YO_2@.^__ +8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_ $H#OO\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g296110g16f81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g296110g16f81.jpg
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M:ALE1[11UC@;%2;8>LKS&#)P&2)_XD8Q2R(2I!(;A"/^%]H+_N_<'_O]+_\
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MR\K?LB=XF5)I+^6=E@$<,16,&5MA(TK; ;N3N2&72NA1= ]0IN.E-K;LU?\
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'1OX;$>?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g296110g22i22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g296110g22i22.jpg
M_]C_X1%U17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,CHP-#HS," P.3HR.3HU,    Z !
M  ,    !__\  * "  0    !   "YJ #  0    !   #P          & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0 "/_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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MP&D['L<1^\[\_P#PGYZM?:Q^SOMNS3T?6].?Y/J;-R+?_,6?U7?D5+_UG?\
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M NZG>  2<5H (D'WV_2;[53LOIQK7TW8=60]A8 *V55PYX:&?SUSOIN/I_\
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MBS NK+'5NQB0(M:;Q#VN(W;S]E=MW6;Z/;_H_6_GTQZ9DM#'BZ@V5@;'&U@
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M[VQ%?3U$N.RS:USB?IMT'YNW=BO_ .DDI'518SUGNK<P"HM:7$'GW:;;[O\
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M ,G?8=_^!]'?'\GT]^U)3__9_^T9;E!H;W1O<VAO<" S+C  .$))300$
M   /' %:  ,;)4<< @   O[/ #A"24T$)0      $)1&+9E<L?6:!T#N%[=Q
M8=TX0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0
M  !0<W138F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R
M:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $
M  ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U
M '        IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN
M4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2
M<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O
M;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B
M;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U
M8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M          !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M              !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A
M8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&
M(U)L=                %1O<"!5;G1&(U)L=                %-C;"!5
M;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC
M<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M    #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M     #A"24T#[0      $ $L     0 " 2P    !  (X0DE-!"8       X
M            /X   #A"24T$#0      !    '@X0DE-!!D       0    >
M.$))30/S       )           ! #A"24TG$       "@ !          (X
M0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M  $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M     '   /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z   .$))300(       0     0
M D    )      #A"24T$'@      !      X0DE-!!H      UL    &
M          /    "Y@   !, ,@ Y #8 ,0 Q #  ( !2 &4 =@!I ', 90!D
M "  4 !# "T ,@    $                          0             "
MY@   \                       0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   \      4F=H=&QO;F<   +F    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   "Y@    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
M A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R
M@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]522224I))))2DDD
MDE*22224I))))2DDDDE*22224I))))3_ /_0]522224I))))2DDDDE*22224
MI))))2DDDDE*22224I))))3_ /_1]5220[KFTM#G->X$P=C2\CSVL#G)*2)+
M/RK,;+86/^UU&O<=U3;ZS(#AHZEK6V_R/IL0?LV#)87YY)FLM+\J#(=6X[YV
M_1/\YO\ ^$24ZR2QAC]/<V#9U ;HC<[+!W#W>W^5[$FXV'66DV]1-C2WW%V2
MZ8+;/<UNZCW_ $+/8DIV4ESGV?)+"UIM]-@>QDOZ@'2YP->\:N=6ZBOW^[]!
M;_-6?IO33"G(KDN];U(<TQ9GD$DN:UGN8_V;'N?ZU?\ A=GI_HV)*>D27/>C
M>&%X]9CPUP#6NSG,+_<UA>QPW>CL#=_IL_G/YNW]^>/AULHVY=F6'';L]"W-
M< W\WW6$OW?O_P A)3O)+*->$+"9S0^NPVP'9,3N:QVW_!VT[O?Z/O9L_P &
MHUX_3QMVOS]K1.USLN( _.]1)3KI+&;BX%8:6V]0&S:6DORW:-=.UPLW[MVS
M:_U?S%H-SZ76>GLN#I UIL UX=OV;-J2FRDDDDI__]+U5))))2DDDDE*4+:F
M75NKL&YCQ#AQ(^2FDDIJ/Z7@6?3J#M(U)X #?'^0U2/3\,\U^?)[@-\?W6-5
ME))34/2\ S-4S(,N=K/[WN1:L3'JL]2MFUY&W=).GAJ?Y*,DDI22222E))))
M*4DDDDI__]/U5)1<]C?I.#="=3&@Y2]2O]]OWCPW?]2DIDDH>K6?SVZQW'?Z
M/^<EZM7[[=8[COH$E,TE#U:N=[?O'8[4C;6.7MTF=1V^E_FI*9I*/JU\;V^'
M(\-W_4IA;6>'MUB-1W^C_G)*9I*'JU<[V^/([G;_ -4EZM7[[=)[CMH4E,TE
M#U:QR]NDSJ.WTO\ -2]6OC>W[QX;O^I24S24!;4>'MUB-1W^C_G)>K5SO;X\
MCQV_]4DIFDH>K4.7MTF=1V^E_FJ4B)[)*?_4]'R7Y%N9]FH;2-E6]S[FE\A[
MBSTVM:6;?YOW^Y-]GZE,SBSS_-.\-O\ I?W5-O\ RQ9_X79_U=JN)*: Q^I#
M@XND1^B=VT;_ (7\U+[-U$:3B:1'Z)W8[F_X57TDE-#[-U'B<2./YIW<[C_A
M?WDCC]2,R<4S,_HG?G?2_P +^<KZ%DY-6+2;[MVQI .QCK#+B&-_1TM?9])W
M[J2FK]GZE,SBSS_-.\-O^E_=2&/U(1!Q=(C]$[\WZ/\ A?S4XZS@N#BTVG:"
M3%%QX&X_X).SK&"_Z)M.A,^A=&D?\%_*24Q^S=1B)Q(X_FG=CN_TO[R7V;J)
MY.)K,_HG=S+O\*H_M_IHG^?T[_9LB/[)]#W(U/4\2^]M%9L]1S=XW56,$?\
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M(X@$:B9;SE;7M^E_72./DD!WI..FM9#=LM.]GM^U?2_,^E_X&IFS,W&#:!S
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M &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "
M4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))300&       '  @
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ME.O-T=B[F:G:G6NK*';6+J,@F'Q2U4U/3S9K.U<<=%0Q.Z":KJ(TN-5_?NO
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MN'KJA[(Z0[:^+6R.\]E?)+L;X_=R]P9_J2MZG[0V;\1MPUVW_D'6U^?V=O\
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MLO18?;BU\G3F])JRHVW+G5-3-#BS''_#:F*/PR>ZV' H*8K_ ).E!NG^5O\
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M'V!$E5M^?M//]Q[-P77NUMIT>TYJW=F8I-S]-5L\]=53X>C_ ()505(M5L:
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M]D-U74[LWGMS?=!W!08R!Z3;:U&*SM/4T]9$(H3.WNJZ0*FN.H]#_,QW#O\
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M]9;UVE5[_P!F]B[$W;L2@&6-=O7;.[MOY[:5$,#Y?XZ:O<F*R%7AJ887P/\
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M67@I<G0P5$:5$$BI/"DB@.BD>Z\"1D'/16/^&R_Y;O\ WKZ^$/\ Z2CT/_\
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MCW4^2V5MS#8W;5<VY8Y77(&6F<UBL1-K!/OW6JGC7/1>8?Y8W\MBGBBIZ?\
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ML+UA)A6V2-O4D\"/%1?8_;1NBE4! /OW5>@ _P"&R_Y;O_>OKX0_^DH]#_\
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M?_VNO?J]>\&3^'^8Z]_T%._R3/\ O*7<W_I/_??_ -KKWZO7O!D_A_F.O?\
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M^KU[P9/X?YCKW_04[_),_P"\I=S?^D_]]_\ VNO?J]>\&3^'^8Z]_P!!3O\
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M&3^'^8Z]_P!!3O\ ),_[REW-_P"D_P#??_VNO?J]>\&3^'^8Z]_T%._R3/\
MO*7<W_I/_??_ -KKWZO7O!D_A_F.O?\ 04[_ "3/^\I=S?\ I/\ WW_]KKWZ
MO7O!D_A_F.O?]!3O\DS_ +REW-_Z3_WW_P#:Z]^KU[P9/X?YCKW_ $%._P D
MS_O*7<W_ *3_ -]__:Z]^KU[P9/X?YCKW_04[_),_P"\I=S?^D_]]_\ VNO?
MJ]>\&3^'^8Z]_P!!3O\ ),_[REW-_P"D_P#??_VNO?J]>\&3^'^8Z]_T%._R
M3/\ O*7<W_I/_??_ -KKWZO7O!D_A_F.O?\ 04[_ "3/^\I=S?\ I/\ WW_]
MKKWZO7O!D_A_F.O?]!3O\DS_ +REW-_Z3_WW_P#:Z]^KU[P9/X?YCKW_ $%.
M_P DS_O*7<W_ *3_ -]__:Z]^KU[P9/X?YCKW_04[_),_P"\I=S?^D_]]_\
MVNO?J]>\&3^'^8ZCU7_"I/\ DA5U-/15OR<SU91U44D%5257QY[WJ*:I@E4I
M+#/!-UP\4T4B$AE8$$&Q]^KU[PI/3^8ZP2?\*B?Y',RT"2_)3+RIBI8I\6LG
MQS[S=<;/!"]/#-0*W6Q%'+#!(R*T>DJC$#@V]^KU[PI/3^8ZBR?\*>_Y%DL-
M13R_(BMD@J\DN8JH)/C7W<\-3ET>.5<K41MUF4FR2R0HPG8&4,H.JX'OU>M^
M%)Z?S'3G-_PJ6_DBU$;Q5'R?W!/%*ACECF^/7?$L<D9-RCH_7#*Z$_@BWOU>
MM>%)_#_,=1L?_P *B/Y'&)I!08KY)Y;&4*O)(M%C_CGWG1TBR32&6604]-UK
M'"'EE8LQM=F-SS[]7KWA2?P_S'4T?\*FOY)(=I!\HMQB1U56<?'WOH.RH6**
MS?Z.=15"YL#]+G^OOU>O>#)_#_,=-Z?\*A/Y&D<%%2I\D,FE-CJK[['TZ?'#
MO)8*"M!F85E%".M1'2U0:ID/D0*]Y&Y]1OZO7O"D_A_F.L,W_"GW^1;4"J%1
M\BJZ<5U;39*M$WQL[OE%9D:/Q?9Y"J#]9M]Q6TOV\?CE>\B:%TD6%O5'6_"D
M]/YCIX_Z"G?Y)G_>4NYO_2?^^_\ [77OU>M>#)_#_,=>_P"@IW^29_WE+N;_
M -)_[[_^UU[]7KW@R?P_S'1T_A?_ #HOY:?\P#>\_6'QA^3VV-W=H1TM=7TO
M6VYL#O#K7>V;H,; :K(5FUL%V'M_;-1NU*&C1YZA,8:N:GIXWFE1(E+^]]5*
MLO$=6D>_=5Z][]U[KWOW7NO_UM_CW[KW7O?NO=48_P#"DCM_?W2O\F?YB[FZ
MWSM9MG<6X<'U_P!9U.<QM54T62H]K=G]H;-V-O2GH:JDEAEAER^TLW64+F_,
M%2XX)!'NKQKJ8#H\GP@^$?Q<^+7Q7Z4Z=Z?Z7Z]P.UL#U[M*>KJ7VGA*O.;J
MW#6X&AJLYO#=N9JZ.?(Y_=&X,C-)45554RR/J?0FF)(XU]U4DU/IT:W_ $5]
M8?\ /N-A?^@?M[_ZW>_=:J>O?Z*^L/\ GW&PO_0/V]_];O?NO5/7O]%?6'_/
MN-A?^@?M[_ZW>_=>J>O?Z*^L/^?<;"_] _;W_P!;O?NO5/7O]%?6'_/N-A?^
M@?M[_P"MWOW7JGKW^BOK#_GW&PO_ $#]O?\ UN]^Z]4]>_T5]8?\^XV%_P"@
M?M[_ .MWOW7JGKW^BOK#_GW&PO\ T#]O?_6[W[KU3U[_ $5]8?\ /N-A?^@?
MM[_ZW>_=>J>O?Z*^L/\ GW&PO_0/V]_];O?NO5/7O]%?6'_/N-A?^@?M[_ZW
M>_=>J>O?Z*^L/^?<;"_] _;W_P!;O?NO5/7O]%?6'_/N-A?^@?M[_P"MWOW7
MJGKW^BOK#_GW&PO_ $#]O?\ UN]^Z]4]>_T5]8?\^XV%_P"@?M[_ .MWOW7J
MGKW^BOK#_GW&PO\ T#]O?_6[W[KU3U[_ $5]8?\ /N-A?^@?M[_ZW>_=>J>O
M?Z*^L/\ GW&PO_0/V]_];O?NO5/7O]%?6'_/N-A?^@?M[_ZW>_=>J>O?Z*^L
M/^?<;"_] _;W_P!;O?NO5/7O]%?6'_/N-A?^@?M[_P"MWOW7JGKW^BOK#_GW
M&PO_ $#]O?\ UN]^Z]4]>_T5]8?\^XV%_P"@?M[_ .MWOW7JGKW^BOK#_GW&
MPO\ T#]O?_6[W[KU3U[_ $5]8?\ /N-A?^@?M[_ZW>_=>J>O?Z*^L/\ GW&P
MO_0/V]_];O?NO5/7O]%?6'_/N-A?^@?M[_ZW>_=>J>O?Z*^L/^?<;"_] _;W
M_P!;O?NO5/7O]%?6'_/N-A?^@?M[_P"MWOW7JGKW^BOK#_GW&PO_ $#]O?\
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M_P!;O?NO5/7O]%?6'_/N-A?^@?M[_P"MWOW7JGKW^BOK#_GW&PO_ $#]O?\
MUN]^Z]4]>_T5]8?\^XV%_P"@?M[_ .MWOW7JGKW^BOK#_GW&PO\ T#]O?_6[
MW[KU3U[_ $5]8?\ /N-A?^@?M[_ZW>_=>J>O?Z*^L/\ GW&PO_0/V]_];O?N
MO5/7O]%?6'_/N-A?^@?M[_ZW>_=>J>O?Z*^L/^?<;"_] _;W_P!;O?NO5/7O
M]%?6'_/N-A?^@?M[_P"MWOW7JGKW^BOK#_GW&PO_ $#]O?\ UN]^Z]4]>_T5
M]8?\^XV%_P"@?M[_ .MWOW7JGKW^BOK#_GW&PO\ T#]O?_6[W[KU3U[_ $5]
M8?\ /N-A?^@?M[_ZW>_=>J>O?Z*^L/\ GW&PO_0/V]_];O?NO5/7O]%?6'_/
MN-A?^@?M[_ZW>_=>J>O?Z*^L/^?<;"_] _;W_P!;O?NO5/7O]%?6'_/N-A?^
M@?M[_P"MWOW7JGK6O_X4\="=3];_  9V[\\>L]D[=ZX^5WP\[YZ#WETKW+L7
M$T>U=YXELKVEMS;V0VUD<S@XJ&JRNV*@91*I:2H,L<-53(\877,)/=.1C4P4
MG'6SEMG)S9K;>W\S4QQ15&6PF*R=1%!K\,<U?04]5+'#Y&9_$DDI"ZB38<GW
M[IOI[]^Z]U[W[KW7_]??X]^Z]U[W[KW6O)_PJ=_[<E_*?_PY.@/_ '_?77OW
MD>G8?[1>KW>J?^97=;?^&#L__P!Y['>_=-GB>E][]UKKWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_X54_]N6_D%_XD;XY?
M^_TV+[T>G8?[0?8>K_\ 8/\ QXNR_P#PTMN?^Z>C][Z:/'I6^_=>Z][]U[K_
MT-_CW[KW7O?NO=:\G_"IW_MR7\I__#DZ _\ ?]]=>_>1Z=A_M%ZO=ZI_YE=U
MM_X8.S__ 'GL=[]TV>)Z7WOW6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NM=/_A53_VY;^07_B1OCE_[_38OO1Z=A_M!]AZO
M_P!@_P#'B[+_ /#2VY_[IZ/WOIH\>E;[]U[KWOW7NO_1W^/?NO=>]^Z]UKR?
M\*G?^W)?RG_\.3H#_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\ >>QWOW39
MXGI?>_=:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>ZUT_^%5/_;EOY!?^)&^.7_O]-B^]'IV'^T'V'J__ &#_ ,>+LO\ \-+;
MG_NGH_>^FCQZ5OOW7NO>_=>Z_]+?X]^Z]U[W[KW6O)_PJ=_[<E_*?_PY.@/_
M '_?77OWD>G8?[1>KW>J?^97=;?^&#L__P!Y['>_=-GB>E][]UKKWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_X54_]N6_D
M%_XD;XY?^_TV+[T>G8?[0?8>K_\ 8/\ QXNR_P#PTMN?^Z>C][Z:/'I6^_=>
MZ][]U[K_T]_CW[KW7O?NO=:\G_"IW_MR7\I__#DZ _\ ?]]=>_>1Z=A_M%ZO
M=ZI_YE=UM_X8.S__ 'GL=[]TV>)Z7WOW6NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM=/_A53_VY;^07_B1OCE_[_38OO1Z=
MA_M!]AZO_P!@_P#'B[+_ /#2VY_[IZ/WOIH\>E;[]U[KWOW7NO_4W^/?NO=>
M]^Z]UKR?\*G?^W)?RG_\.3H#_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\
M>>QWOW39XGI?>_=:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>ZUT_^%5/_;EOY!?^)&^.7_O]-B^]'IV'^T'V'J__ &#_ ,>+
MLO\ \-+;G_NGH_>^FCQZ5OOW7NO>_=>Z_]7?X]^Z]U[W[KW6O)_PJ=_[<E_*
M?_PY.@/_ '_?77OWD>G8?[1>KW>J?^97=;?^&#L__P!Y['>_=-GB>E][]UKK
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI/\ Y@/\VW?7PO[^
MWSTMLCXJX+N[&=0_"Q_G/VQO+<7R6VYT;44'5M#V;N;KC,;8Z\VYN#K;=U-V
M%V-3OMMJRDQTF3Q*Y S)2Q2?</$LONG%34*U\Z<.I_S*_G.]<?$>B^&F;DZ0
M[!WS@/DQLS!][=NFJKX]C[F^)'Q1K<EU9MO<??O;&UZ[!YN::+9N\.YL'C:W
M"M48^7R"M850-&R/[JH6II7/1SZ/YA05G\PS+_ E.O*GR8OX9;=^7R]MKNBE
M?'U4&X.Z]Q=.)U\FSEPXJTJ:8X#^)?Q3^(-%(DP@%."OD;W7M/;J\JTZK'V7
M_/#WOW9M?XB8;X[_  L@WY\BOEOMOY8[\V_U!V#\GMH=.;+V]LCXI=X;JZ-R
MXINXLYUQG(]Z]@[\S>WHJO&[>QF >2DI:B26MJ(*6F:J?W6] !(8T ^71K^X
M?YB7<\'?V<^)OQ#^&U7\I?D3U7U+LCMKY)XG/]][2Z(ZGZ%B[,QF6K^N>N\M
MVID]H;_JMV]G[W.!JWH:''X/[$4"I63UL$1<1^ZT%'$F@ZA5'\U##8#-_P R
MO:N_.I*'8V[?Y=/4W6?8U7M_+]P[8:J[IS>__BU+\C\CLC;<IP5/%@JC:^1I
MWVT:Y/XM#6SK]Y&BH1![]UL(3I^9Z5_>W\Q^'I'^570_S.9NE<EN2"K^//1?
M?DG1L>^J'$9.FC[JCZ[E;:DF_P"?;=;0&;::[^_=K?X6$JA1L1%%Y!H]UX)5
M]%?/I/?)+^:?LKH3N'M;J[ ]?T7;N.ZJ_EI?)K^8O7;MVAV;A=&6I?CCN+;>
M"DZ<IL31X'-Q4F3WFF?::+,R5OCHS $^RJ-;/'XXZ\$)I\S3IU^-?\PG?._O
MB_V[\NOE!TKU9\<NH.MNE\#WYCJSK_Y0XCY'YBOZ\KNMLGVAN'^^N-QO5O63
M==[FV_@8*6./'NV1;(3U#B)U$2F7WY=>90" #_DZ+9M#^=@F<_EF_*OY[[K^
M*FZ^M^T_B#6U>/[6^(F[.R**GW=C9Z_%[!WIL"HJ-_#8R0TF,WYU;V?AL[3U
M(P<R1&::D43R4[R'W6BM#2N.AB^<W\PWY0?$?L+X_8#9'PDV;W;U_P#)[M#J
MOH#J7?E?\L:+JW*2]\=HX+>NY*/:^[-ES]&;WEP&RL3B=E3-)GHLA6R2RRJB
MT M<^ZVJAJ]W =<<9_-47$S?S%-L=O=+X#K'L[^7ATSU?V3N;9H[UP.>Q_;.
M[-__ !CKOD3EM@[%W#7;+VM41TNV:VB.WX\L^/G%?*PJQ20 ?;^_=>T?#0X/
M^?H?]P?S!^K.MOY<NU/YD'<V!W!L;KO.?'3J/OO*[ PAAWIO*CR?<>VMH9+:
M?5.W'2+ TFZMY9;=N]:';^/=EH*:KKYXWD--$S-'[K6DZBHZ+!NW^9U\C^A.
MF,YW1\O?Y?&<Z1AW7ENHNO\ XO=7;-^2?7O<G</?7>_>.\*K9^PNA\[MJDVE
MLK;?5&]O(:6NR-4^9S>(HZ*2HTU4U12F"7W6](--)KU.P/\ -,[ V3N3Y"=0
M_+WXBUWQM^0_3GQ![!^;FP]D8+N_;W='6'>W2_6M%/#O"EV=W'B=D[..$W_M
M#=8I\9FL-D, LU)%60U]*U?0MYO?NO:1BAP3T5NK_P"% ^&IOY8$/SZ'Q*W6
MW<K]Y3?'6?X<OVK019ZF[.I=JU';E52/VM_H^DI#@XOCM3_WY^]_N^ <8P30
M ?-[]UOPSJI_J_P_Y>IG:7\^G)=6YC?FZZWX;Y/.?&WHCHKX)]^?)+MW%=][
M?AWQUMM3YX4LR[(39_3V3Z[H4[3DV=F(#2UR4^XL=6U8(>FI2Q$1]UK14TKW
M=&^VI_-<V3N?^9QNO^7=_HGSU!MS%4N?V5M'Y.G<])4[&WU\G-B=9;+[R[-^
M->.VR,%!-2;HV-TKOVBSDU<,I4"22"LI6IHGIB[^ZUIQ7HI>4_G_ &R\-L7^
M9]F\E\:]Q4._?Y=6[=WT^VNOJWLRCI8OE#U=LGN^;X_;C[4V)NR78@HMN4NV
M.QZ*:BS>/%-F&Q$LU%'+4,]8JQ^ZMX9JHKQZ%+Y$_P Y',=+9+Y [9VM\8:/
M?N[>G_YA/QM_E^;5I<]WWC>MML[WW+\D.IMF]EX?LG<V[,AUGN"GZWV[MBLW
M<,?5TS4^6UQ0BJ^YCUM!%[K2KJ\_+IX[/_FE?(/K_,?$WHS#_#/K3?GS+^6&
M"[[WMMSJ#$?-C9^)Z.P>Q^B<M2XZ>2D^3><Z>I*??F_MZIEZ%J';N$VK53T;
M25!KYZ:"E:HD]U[2M2-6/LZ./\WOF5E/A)\*=U?+?=/3U5N[.[,7I&FS_3U!
MOK&8JHI<UV[VOUMU3DL5%OP83,8JI79>0[ >I:HCHFCR"4!2/Q^973W6E74V
MFO5=^7_GN;5PF5_FN[4R'QOW'2;V_EK;:[4W[LG#U?8/@PORPV!TO7T>V^S=
MQ;4W.O7LU+L&JV#O/,XJ@SE$8<])CH<YCIR\AJ&AB]UXK2A)P>C!;W_F2]Y;
MI[[[ ^-_PM^#N:^4&_\ H78/6.\?DKN'>??.T_CIU;U=N3N'9E-V#L#IO;F\
M=P;-WWE.RNV<GLZJCR-53TV)H<-BZ2II369*"6H$2>Z\ /Q&G5M5!-4U-#15
M%;1-C:RHI*::KQ[SPU3T%3+"CST35-,S4]0U+*Q0R1DHY6ZFQ'OW5>I?OW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_ .%5/_;EOY!?
M^)&^.7_O]-B^]'IV'^T'V'J__8/_ !XNR_\ PTMN?^Z>C][Z:/'I6^_=>Z][
M]U[K_];?X]^Z]U[W[KW6O)_PJ=_[<E_*?_PY.@/_ '_?77OWD>G8?[1>KW>J
M?^97=;?^&#L__P!Y['>_=-GB>E][]UKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>ZUX?YG_\ *;^07S)^6N9[YZTPGP;WUM'=WP=C^(\5#\N=
MN]B[AW3T5O67MK>._P!OD7T='LS;63BI.Q]OXC<D,.*GBRF!KH:VG605J1KI
M?W3BL M#7C7INW3_ "-NS?D%V#W]NCY0_.'NZMH]U_#CICX!];YKJG/;:CWA
MV3\?]D]:T_\ I<SWRAG[*ZPW><EO/N_O_)9/<U=3;8K:#P4HAC;)332R&/W6
MM0 I3'3UL?X)?S.OC[O?XM?)_KK=?Q$[X^3>POY>^/\ Y>_R"VMVQO3M[KOK
M3=&-Z][%R.^>H>^MD[^VUU=O;=M?NC[FK1MV82OPE!#D%>=*.LAD,,T?NMEE
M((/"M>@A[2_DY_(\?RX_C_\ R]]N]>_!GY,3[3V-W)7[@^1?R$W%VYUIV%\?
M/DKW/V=G^TZ[N?XW0=>=<[TS$F$V?F=Z9%:2B7,;8R%>U!CUJI_MWJH1[KVH
M%BQZ,[A/@W_, ^'_ 'OG?D/\1>Q>A/D_N#OKXV?&?J'Y:[?^7FZ.R>JL_OSN
M[XM]<3]8;,^3&TNR>NMF=O/%5;VP5:QW-MNOQ \TD7GI\D99 D?NM:@10^72
M?[%_DU47?_8G\TWN3Y$]>_$+LWL_YJ=.]3;6^-6>WAUP.R,E\:^Q-G_$E^F=
MT9.@W5O79;[@V]MZ3MTQYO'38'PUST=-%43)'6HB)JG6Q(0% )H.AX^2G\O;
MN+NW^2_1_P MW#=@==T/=(^+/QUZ)R?8F?3=$O6M=N7J6#JZ#>67>.DH:C=<
MF W%'LFM6E#TYJ"*F/S(/6!OK6H:RU,= IW7_)@VO+W/W[O/X@[/^,WQ9Z^[
MM_E/_+/X)U6V^M>N:7K2IE[R[YW#M2OV/VSN?%=<;5QN'SNW]IXC"305%7),
MV9BU+'!')&Y,?J=>UDZ:DFAZ +$_R?OE+NCX(;@^ NX-E_R[OBSL/M7>'Q5V
MM\A^ROA5A]^[;[#[LZ#ZFCB?NW(;H?.=1;;H)^\.Q7VWC*7&UM2:VDAI<EE#
M632LR+-[K98$UJ2?GUR[V_D<?(?,C^8;L_J7Y<Y'L;KC^8+\+MB=4[ZRORLR
M<&7[2QGR;Z3WE04G4.]6RO4?5>S]H5'5D?24U5M^N'\+;/0U-)1REZV.Z0ZZ
MUJ!I4='&[$^)/S[^4.$^&4OR.R'P_P!C;J^)7\Q'HOY/I'TEN/NC<^W]W=(]
M7=7;]VMGL&TN^]C[=R-#VIE-U;W9Z.,(<0F/B!DJ/-=6WUZJK736A'0?]R?R
M:=J=^=S?S9^X^X=A_%CM?<GS0ZUZWVE\1-R=H=74._-X_'/<6R_BU6]-5^9K
M\]N3:V3KMJ057934V<@;;,YG$5,DS$5<<87U.MB0@( 30=&&[:_EQ9GOK^4G
ML/\ EU;\[1IMK]E;0^.GQMV%2]T[3QM7G,3@N\/C?C^M\YM7L/&X+.2XVNSV
MUAV7UQ354M#5O3SUF,D>%VBE?6ONJU[B?GT ?=GQ/_F<?-/HO#[)^1TWPIZ<
M[V^-?:?Q[^3?Q7[DZ7WIW5V1LG>7R>Z#WA5[@CR7;/5F[NM^O<ILOI_>NWYY
M,;/CL;G\WE<=-7S3+-5I3115'NM@JI[2:$=0MP_ 'YK?*_L/Y#?(GY<9CXV=
M7]GYS^7YWW\%/C-U!T?NKL?L[K;9M9W]CH*G?O=G:G96\NO.L]U9C+9C<>$Q
MU+1X?&8-:7&8&-]<M77.95]UZH%*5Z*S5?R'>^*K+YV67OWKJ7:&0_EHUG4>
M/Z]>FW2-K47\S3(_"*A^ E9\IO#_  %JM>O'Z&QRTOID.8,\K3?:B8>1_=;U
MCR&:_P"K_5_/HQ?0G\E/:^WOD[7_ "3^3VTNA/D'F=A_%7X&]4_';'99-Y55
M#L/N;XH]:[GVOO/>V4P&5QJ[9J,5G]U5F,K<#6S4^3R./CIFD6&FG0&;W6BW
MIT7W9W\B3Y)[)ZLZ5[3I/FGN7/?.;87S5H?Y@.^=N9G,X^#X6;D^0>]^PZJL
M[YDP^.H.GD[W@Q>[^G<[7[7IIZS+3I*BH[4=*)F\/NMZQP(Q_/\ P]0_E1_(
M>[Y[O^.7<>SNO>\^M]@][;Q^<OS<[CVIN.IEWD^P,Q\/OG!VYC^PNR?CKV;3
MT^WJO*UF29]NX+,))24TD-+N# TYIJB-99*H>Z\'HRFG #H4OEQ_)\^0G><_
MRKRFUL[\8=V1]T?S.?BK\Y]L];=XP;ZR766[^MOC_P!';%ZUW-U#W/0XG9N:
M=UWOG=JRAX*6FR=%+C'!D=9)#%%KK2L!^SI1?*G^75\FN^O@OU;\2:3X4?RC
M%DH,-W;C'PN)S_=?6?5WQ/WGN;<LM3U)V]\5AL[HW^]T>6Q^)RM?D-RT5,=G
MU53FW2.GKGI)JAO>^O56M:G_ %?ZL=&T^6/P%[H[Z_E08GX#X_N_%[R[MQVP
M?B=M/,]]]NP9O[3?FX.@NSNF-[[VWKNB#"+FL_\ Q3?%)UO7/$&DJY_O:R,U
M-1*?+.WNM*VEM75=?RP_D6=Z=]_'SYF[<V1W?UEL'Y&=Q_.[Y6?(?HSL%4WG
M'MG'_&OY?=<]>]4]S?'+MWQ8?(9"6CW[MG:AK,B<;1U<$>7Q.'J('5X'=?=6
MUBJXQ3HX\WQ._F$_%WY0?(?Y!?#*N^*O<VT?F)A.G,WW)U%\D-X=G]0S=9]\
M=1]4[=Z<A['ZOWYUOUKVK+NG8>]=K[:I)LU@<KCJ.MBJZ5)*&MC622$^ZT"I
MH#7JT_K+_3]_>CN4]RGI\[+/85*?CVO62[T&Z$ZI.RMJFMC[E;=3'%2]A)V*
M<XL3X0)C7P@H695JC4*/=5-/+H8/?NM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW6NG_ ,*J?^W+?R"_\2-\<O\ W^FQ?>CT[#_:#[#U?_L'
M_CQ=E_\ AI;<_P#=/1^]]-'CTK??NO=>]^Z]U__7W^/?NO=>]^Z]UKR?\*G?
M^W)?RG_\.3H#_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\ >>QWOW39XGI?
M>_=:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[HHGSY^3F0^&'PR^27RKQ6SZ/L#(]#=5;D['I-EY#,S;=HMR38&!
M)ABZG-T^.R\^-BG#&\JTTQ%OT\^_=>'5=R_SDY<;\Y/DC\-]U=%?P:GZS^/=
M%V=TGVA#NO(5N![@[AH?C%@?E-N[X_Y6!=K(FT=VT?6N8J<KCI%EK/OL1AJZ
MH"+)$81KJ^C@:\>D_P!5?S?NX_D'VG\1^E>E?COT@O8G=GP<^*WSN[0PW<_R
M>JNIL@NP/DE%'4UFROC+@DZBW;F.]]R=;8ZEKZK+9"H7!8FF--%2R2I45"A=
M]: '0G9/YP?S Z?^8]%\#*#XQ_$RHQF0ZZS?R:Q79]7\FNUJ6L/Q5PO?6,Z:
M?)Y3:</QMJHZ7O2JHLM#D5V_!7U.$21C"<S8&3W[K>E=&JIZ+]\,?YV/;'R0
M[6^,FT]^?&'K/;/7_P SL1\O<OTGN?K'Y"5?8._^MT^(V0W529IODYU=E>KM
MIOUS@-_)M9XL7F,;E<Q21Y&JI:.9%EJ4*^ZVR4KGA3^?0Y[,_FR;HW9\-?Y5
M?RH/1N"I<A_,;^3O1'Q^S^S%[ KGH^I<9W)0]HUE3N[$YL[2$^\:S _Z/(A'
M0S4V.2H^[:\\?B&OW6@M=6> KT!/1O\ /EI-]=:_S+M[=L=#4G6>:^#!WIE^
MJ=LX[?T^XV^2^T<3VKVIT#LZNPM9)M?&OM[,;E[XZP;;%12K%6FCK<E3V,FH
M!M=;\,]N>/20H_YWWR W'U)\ ,]C_C[\7.INTOF1%\_(]\TGR9^5N<ZHZ6Z1
MS/P4[0H>M<OMJM[3Q_3FZYLWG=\5E1,(8Y,=1PTU33O'Y9(@9QO/7M&6&33T
MZ--M[^;5EL?_ #(-H?R^^T^G]LX6+>WQUZGWE@N]]B=BU&[NM:[Y+=E["WMV
M5C.BJ7(9':^W8WP.\-H]7;GJ-J9R1H9\XV'\2T233A(_=:*XKY=%QJ?YP?S3
MW-\?OY<'R/ZJ^)'QKRVQ_P"8UN/J3IG9F.WW\E^R-K[AZ^^079M-VGE),?NB
MFP?QYW915?4N)PW6K.N8I)I<M+/4^/\ A@"AV]UY5!K4G KU9K\M/FON3X5?
M%'8/;G:74$?8?R,[(W3T[T=L/XZ=.[SCJ<;V-\I>YLA1[=VWU?L_LS>^"VO#
M1[0&X7JIIMP9/%TLD&&H9JHT+SA*1_=5 J33AT3K>O\ -5^0?QYH?EKUU\K_
M (E[)V-\DN@_@UVI\^>H\-U-WGE^T>COD%U-U)3)!OO;E#V/G>I>N=V[(["V
M%N;(T%!E<=4[>JQ-2U(R-')/3<#W6Z#&<='-_E[?*+MCY8]5Y/LCM.B^*6.>
MI.SJ[;F-^+7R(R_R$I\/CMU;+Q&[)L%VC6Y?K?K>39>_L.^72*7&I#5HR#R+
M*4*%O=>84-,]5)]<_P _7M2NV93[][6^)&Q\!M?M[I/^91VS\7ZKKWOO(;QW
M!G\M_+6EW[%V'L_O'9^7ZLVO5=:8O?:[#F?$Y_%UFX:199X::>".>4!==6T9
MI7H4.FOYY]=CL/W7EOF/T5LCKG$=2?R^]@_S&HMZ?&KN:K^0&TJ[K+L>JCQF
MV^EMW?WCZ[ZGK>O/D5E,S504V-P]6U1C\LK2U$5;'2P-,^^M,E.'0^]>?S'?
ME7@^U/C7UM\Q_AKLOXUTGSDP^YJ7XN[IVM\@:GN>GVGV_B=D9'L+"]#?)_&+
MU5U^=B[UW#M+$U-5!7[;J-S8EZJ"2A$@E0R^_=:H/(])OXM?S9>ROE+W5UC\
M4,#\:AL_Y1[(KN]H/YB.S\_N+<4FT/AE1]2Y";:G7E93;I?:.-I>T#\GMTY#
M&Y#8B4;P&NVJ*_*->&DO)[KQ%.F#HC^<5O/OOL;H'XH;>^.^*Q7SKK^^^W^M
M/FUT;7[]R$^W_B!U/\=ZVGB[([XKMQTNU#E=V[5[(IMR[83K3ST.+H-VU.X=
M,=>L=!4.WNMZ:9/#H4OG?_,>[?\ C7\M>E_B?U'LCXJS97M;H3LCO.?L?Y;_
M "7S7QPZ]QJ=>[WVCLP[*QF8P_5?9C97=&?EW=%-21,D(9(922JH6]^Z\J@\
M:_ETFNQ/YG/R=R^__EQ1_$?X4[;^0O4OP!RD&T/DMOO<OR"/5>Y=_P#:F)V7
MA^P>T.IOBULI.K-ZIO?<G4^T\_235E5NBOVI1Y2NE%#1%V*5#^ZUIX5\_P#5
M_J_U4+W\B/YZF\MDY2LWW\>.@NH>U?CGMS^6]TW_ #,\UN7MOY#Y#HOM+=G4
M';N[M\;8@V'UIL^#JGL?;N4[5PZ[-;_<9D,K1+59&3^'QR?<M"LWNMA00>->
MK2_DE\C>_=I_$+'?*#XT].[!W?D:;KJ'NW>77?R+W[N_I;)8#JREZRR_8N=Q
M\4FT>M^U:X]J4+4M+CTQ%52TM$*F67S5L(B]7NM "M#T0CKK^;;V_0=-?RZ.
M\/DYTWT!TYLO^8UV[LS$[$R.#^0.=S&)ZPZ/WS\9MT=]8;>G9>X-[=7]>X?'
M]@#,8.#$R8BGDGQOCJ?*,B9 L3>Z\5R0*](?O3^>-7[)H_E56=.]9])=F8;H
MSYR_$/X9;![%S'?_ /!.H]Y#Y1[%VEN2L[-WCO\ V]LS=V.VAMOK?/;F:CR!
MI5R2+!2RRN\;H8O?NMA?7_5P_P _5Q'Q/[0['[CZ5P6_^TU^/QW1E\ON:G6I
M^,'<62[WZ=KL3B<[78K&U>W^R<KLO8%7EJYXJ,K70G&QBCJUDAU.4)]^ZJ10
MTZK_ /A#_-LQ?S$^47R5Z$/4LNQ=F;*QV_\ >WQ)[;;=,68P_P MNJ.E>X-T
M_'CN_?V H!C:*3;U+L?N?;D5!'%KJFJZ*OBJ/0H!D]ULK0 UZ*E\8OY^==\A
M_CKT1V;6?&^BV-W!V+\\?B9\3^P>H<AV%DJFEVKU'\P]PST_4?R8V?N5]DTL
MN\MI;JVS2U4N-IY*2B2JR>*R%&\\1IM;>ZL8R"1\C_+KCN7^?I7;7V3_ #5Z
MG*?&^BH>S/Y?6\NR7Z=VKD.P<E3;<^5'3G5WR#/QPWMV+A=S)LF:3;.1V!V"
MD=)N+'QTV0&-GR>.42R)4B1?=>$9)4>O^;H\.Z/YDF?V]MS^<1G8NH\36O\
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M_:<N[JE*G'0JM4XH:'PRJ87+ZZVSUH:FO\NC@_&/X ?(/KCX6?*;XH=BX+X
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M>]G[O^;F\-CY_LS:L&*KJ-L#V'5;%BBH_OJ:6FK)J)$C\H58V3W7HP#0?/\
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M_E._"#=G5.SNH,AL+LNGP?7F_=]]E;"WE1?)3Y*+W7LW=/:F(K=N=I-MWO\
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M3,9P5S87%55?2T^2S"XN&.HR;8NAEE2JR QU/*CSF)7\*,&>P(/OW7NG*X!
M) )O87Y-N38?FP]^Z]TVYC-8;;V/ERV?RV,P>*IY*6&?)YBOI<9CX9:ZK@H*
M**6LK98*:.2LKZJ*")2P,DTBHMV8 ^Z]TY^_=>Z][]U[IJFSN%I\U0;<J,OC
M8-P97'Y/+XS!RUU-'E\CBL+/C*7,9*AQSR"KJJ'%U.:HXZB5$:.%ZJ%7(,B
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MV_N>3"9?&QTC4LF'3$LE3"/=>Q\NE72]!_*AL1U7CI^TODY%-MCK#X2XK/Y
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MNM&E:^71>>J>O_E/NWL?IVBJ,G\LMB?'_%[EV5E^U:+M7LNA/:>8[*V?U#V
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M@-[&;_0HFSGCFFHJ6:GP]5D8J:7"8^$0SE_=>J!Z>?0T_)#X[;^WM\G=Q9?
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M[&S4.]-[X_)8^"I>NPE=O'=FVXLA42R&&:7*T2S:Q40ZE]U[..D;U]O/XO\
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M>P.HMJX:JS%-G]U[OW,V_L)#)/#!'B<;/EJ=:NKC J33^Z\%X9X]!]F/Y@.
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M&AP^1SK8W%YO[?(34<\D5!,WOW7M)QTZ]4?+K-3]?=U]D=Q[7RFW<3U_\O\
M+= KC5H,)C\AL?:E3O'8FP<'N'=U4NYLAA\MA\7F-VK7UN4H:F1&P\@J%A'C
MD0>Z\5X4].D[DOYFO2%#AL?DEVOV%%6YOLS?W56%Q>:HMN[>=\]M;L+'=<;-
MW'G:W(;B^UVGUQW'D<M!D=MY_(&&BGPODJZCP>)XQ[KVDUZZ?^9AU ^*I<[2
M[([&CP=?M+I7*4&<S]'@MI8JIWY\@]T9S:'6'5CMN/-T&3H<]593:^2JLGE*
MFEAV[C,-3QY%J^2FJ:9I?=>TGAT)]1\U-GU/2G2/<>T^NNS=Y-\@>PL=U5U_
MLG'8?'8G<";VKCO**8[DJ=RY3#8G#;0QT^Q,@TN:6:>DFI%BJJ45$$\3-[KV
MG)'IT&>#_F;=%9[=^WMF4V"WY2Y>LQ]+%O*AK,32?Q?K?>E?BNQLI3;'W+A:
M*NK:VKJ*!>JLK%E<O0_<X##M-0/5UL<-:DJ>Z]H/7>)_F/["JL4<UN#J/MO8
M\$G4.Q>W\1@]V4>UJ3>V[\?VSDL%BNK-O["VM1;DKWWKEMQ9/<M#C\I44%1+
MC-JY:JCI,Q4TA8R#W7M/SZ<LU_,$V]MRNW3MC,=(]M)V%U;@-W[U[QV1CY=A
MY"IZGV!L9>O<CF-XUF87=\.)W?1Y?:W9=#E\+2X5ZVNR=+35L1B@JJ5Z<^Z]
MI\ZXZ]VY\VZ'";QWSU!L2DHH^Q-JS]<9F@S$N6VCO/;^0VO5]Y=+]9=DT>9Q
MFU]T569V1N;&47;%,**BS,='63K-]TL)2%D;W7@OGY=3/C7\SZ7LNBZUV)O;
M$Y8]S[LW1N[ 9:DQF&HL=A8<#@MIU_8>)[-CA&<R-32]?[@VU+CZ"DJ'_P H
MDS=0U,T,?CE=/=>(IU#W7_,2ZZV56=G5FXNK>WZ/8?66]^V^J9-_)B-LST&\
M>V.G=@U/9>9V+LW"1[H.X*V7=.VL=6PX*OJH*.AK\M0S43R0.8'F]U[0<9ST
MR[F_F6=:;.S^Y=I;@ZR[2.[=FXCP[KVIMK'8C?6X\!V(NR,-V16==U^,V7D\
MZ[IM_9>X*6HR^Y(&FVKBZDR4LV0\L,@'NO:32M>GF;^8YTW1;ZQ'7]9A\_69
MF;9FW=S;CJMJ5>"WIB,!D]W]7[L[AVUAL?D]O9"JI-Y82MV-LVHJ*C<N*:HV
MUCY:W'155;$]9:+W7M)Z9L+\_LKO7</2NW]E?'S?$=9V3VQUCM3>&/WMN':&
MV\ML3K#N#I;>G<^Q.SHXJ3+9C%[@JJO$[-JJ:MPE/5_?X^IHZF.0$_;-4>Z]
MIXYZ5F[^POCI\:.Z]K]>8_K';R;O[\W3BH1D\-F-HY'/2]D97^_.YNO\9E-I
MUF:K-\X+;^5S&"RSTV76@@V_C,E6Z_(CSU,D7NO4)%>F[$?,/M?*?$+X]_(Y
M?CI*^^NY]\=(;5S?4<'96TP-H8OMSLS#[$FS]-O*HEAPV;7'4&7AJZ>G412S
M23)%((@LKI[KVD:B*XZ0VS?YAM)M/K3<.Z._-F;JQM1B)>X:O;&ZL'B<#%MW
ML^GV!\H*OX]4F#VMBZ?=.4S.'R5-EMQ[9B^XR\=!3UT%=+D$*4L$QC]ULKF@
MZ.WT/W7MKO[KVF[!VQ19/&TPSNZ-J93'9.-'^SW%LS/5^VL_%B\S1M/@]V;>
M?)8YY,=F<7/58S*43QU%/*R/Q[JI%#3H9/?NM=:Z?_"JG_MRW\@O_$C?'+_W
M^FQ?>CT[#_:#[#U?_L'_ (\79?\ X:6W/_=/1^]]-'CTK??NO=>]^Z]U_]+?
MX]^Z]U[W[KW6O)_PJ=_[<E_*?_PY.@/_ '_?77OWD>G8?[1>KW>J?^97=;?^
M&#L__P!Y['>_=-GB>E][]UKH$.XN@>H^\CA_])>&K*ZLVYC-T8RAR&%W;NC9
M>8CVKO:BI<9OC;%;EMH9O!9*MV;O&@QU/%E,?/*]%5_;0NZ&2&)T]UL$CATA
MSM[XN];;<Q7:6:Q&VNI=O83L:#?^+R&\)<CU[0X#?U?M:C^.F*R<.%SE7C*3
M$15VT*FDP./I!!'0-3ST[00AGCD/NMY..E56_'#IEJSMK(5&%R=#B^Z\)N7&
M]K[7I-\;SP^P-TKNG!TNWMW;CK=D8_<5'M+'[LSN HHH*W-4M)3Y*54\C3^5
MGD;W6JG'09[3ZW^,&V^VNN^M-A4.=V_N[9?QTVJFV\/M+=G8=!LG<'0>QZVL
MV#L;#;R..SXVGV52;6J,]4IC8LW_ !&KA6LFF5BLLC-[K=6I4^O18<%V%\(*
M+'].?S!Z'L3:]'\=_C_L++_#7H9Z/8>_HMT;2W5OCNO9G0VZ-M92"O2IWUF:
MW^^/7>$V[B\?-AE>AA-=D))YJ>K\\7NMT;*TSQZ-CO#X??%+?.[NQ]Y;TV'A
ML_D=X5C[B[2PV6W9N.?9F6W'+UK3=9TN^-T;#DW"-G0;QQ_5M&F,HLP]#'74
M= -4$J.!(/=5U$>?2<INF?B#2;BKMCPX\[[[!H<IMG=FZ:-]\;[[%[)I)>R7
MV#AMN[[WM6/N3+[GI\)E8.AL!#%DZUUHZ>EV_&%=(A(']UNK=.M;\.OB?)C>
MQ(:S:M-'A=P8W.;:SU,>PMWTV(V#C=P[TQ?:>?Q.PH$W3%1].QY+L*AH,_+'
M@ABC_$*:DF%A3TXC]UJIQT+O9O0O4W<"[7J.Q]O'<9V;C-Y8K$5LV<S5!*=O
M]A;/K=C[[PF6JL9DJ)LU@MU[8KFBK::K,T,DD<-0 M1!#+'[KP)'#H,NP/B#
M\8MUR;DW/N;KR2?(9':U1M[=E7MS<F]L9F=S[&EV11;%K=A91=M9^DR&;VGG
M]I86DHZC#C539)Z6%I(I9E5O?NMACC/3!69GXD8[)=H;'JJVG_B'R,W+M/8'
M=/77\6W,9*#<W8?1V1JL+#OW9RY!6ZDR>\NG-GE*NK>#%RUHI(#,[U C;W[K
MW=@^G0C[Q^-/QOW#@-Q4F^>O]KY';&Y,I0YW<L.?R61_@N3R4'5;=$X^JR J
MLJE&Z?Z+ZO\ @R1FT3HXDTFITR^_=:J>@JW9\,^I%SG46Y*BJAQVR^E>Z*CY
M3;GKMX9S=^[=Z[H[?VKU0>K=E[LS78^Z]Y5=3087:NQO^!L-1#5+51XW'HK4
M\5/()O=;J<^O4O-;?^(WS WC5)5+3;]SFVNNMBRT>YL%F]Q8?$9W8G:]7C^W
MNNLAMS<>!R..Q6[_ +'.]8T6Y</54\E148/(T$593/3R.7?W7LJ.EC1?%CXS
M4IQV7HMJ8ULOL?.U64HMY2;NW!D-TX#=0[-R/<N?RD^ZZW/U>6I]P9OL'/5U
M;F99I_-DJ?(5-%6>6@J):9_=:J>D[M/87151U_VE\:^L-U9;:&1WCUKFX&ZX
MW5N7=>X<SU?LO>-/NG8&W:_;?56_\]42;+Z]CK,;6#$XVC@H,3/!3A(5$ BT
M^ZV2:@GI 1?#SX5=4]3['ZL[3QNU\SA=S5'4?3>/K>R]Y;DJVWYN[:G7^<ZH
MZXV1A1N?=V6J(DCPF9S*8;;=+4/1T517U,E-")R9??NO58GH6\=\3OCQ!5T.
M2P]'N"'=^SM]9??%3OS']L]B?Z25W?N/ ;1PFZSNK?,6[VW3E*'=FU]EX6FR
M>+KZF3'UE+CJ0O3GPPLONM:CT)'7?5?5O1M)GH]D-4[3VUF\H,F-M5>]=P56
MQ=M5&;RM?6_:;%VGF\W5;7V!B\OG,O/(M%AZ:BI9)I B1Z4B1/=>))X]!;M/
MJ/XA83*Y38VT\=L:FS?1.Z.J=_[@V[3;OR$V2ZWW-A>M?[D]29W<=+4Y^6HQ
M3'K2B-/0+6?L5=-&96622\GOW6ZMQ]>E%O\ ^,GQ\W=GM][PWWMJ%CVM@L7M
M#LR@J=V[BPNS>PTHZ>GPVTZ_=>UJ7.4.V,QO3;D*0083,O3_ ,9QS14_VM0C
MT],8O=:!/ =)/:?1WQ(%9W!M'$0X#=&Z,;MW=VQ._:C-]@Y_=N_/X)W9@-J9
MS<N.[5W#F-R5^Y7FW5M+:^(>FGR$XGI<71PQT;PTZZ/?NMU;'2"VWUI\+^[]
MZ[FR.T\CD-W[WR>V.H=\X?M+!=F]@MFL=LS+MV+ENL:/I+M*@W2E=M[:E,:;
M<50^(VW6T]%''63"I@,4X4^Z]W#I5]A_#3I[LG>^T-^8JNJ<7N'9?;&S-][W
M@FS>X-YX+?E5L_K'<O4]5B=[[3S.Z)ML5FZMQ=8;O_A%=G:^CK,Q+C(H8I'D
M4(5]U[40*=9<!\+?BSMG"Y6/;&)SF"J(MS[:S=;OG#]R=FT6^<)N+K[9%7U5
MMF*C["I]\+N?;R;<ZUR4NW!105D$!Q$S4TT3JQO[KU3TOZOXV_&[<+9J&NV'
MM?.+D]V=EY7<5'597(Y.FR.[>V-AR;![/3-4,N6FIJRLW;L.H>DKJ6=&0PR-
M*(UD8R'W6JGH/=T=7?&_H/;6UNYLQ7]B4M/U+'BML8S>M%V?VWNG=59MG<N^
ML+C\)L3=64IMU9#/]B=?8G=^3I6IL3F),ACL8&F9(XXY:KR^ZW4G'0I]A=%]
M$]E[MP^^]^8+%Y?<53@J/85%62;BR>.IMP8?%[VPG9N%P5508_+4>/W!/M_?
M&T*?*8\R1RU%%/'/XF2.>I23W6@2.'0#9"/X@[/H=R?)2D@W-M&7KCMKL[$[
MLS^T<MV7@,UG]YS]PT&V>P\5N+;^"RU+4]A;,F[5A@J/LJNGK,-$TCS01)#4
MS^7W6^[AT,>W/C-T#M;.[,RNR,)4[0RW5>*39V,BV=O_ 'E@4.VZG-UF\*+9
M>^*#$[F@AWEMZ+<&=GR%)CLVE;!#)62F)%CJ)5D]UJIS7H*NFOC[\+=W;;J\
MOUCMBBW#MW-+38#$1Y/<>]JW^";5Z@[ER&9P^W.O<9N/--7[)ZMP?<&TI:VA
MH<1'1X2LDI86C2:D2F ]ULEO/I<=W[=^./96_=O;'[4VW6[YW>>N.SJ6GV[B
M(-UY.&OZYW%E^L-J]@[?W1B]KSBCRN/ER^Y=MY..DKXY9**?'PY:E$,F/^YB
M]UH5&1TL=J=/=&;,V7O[:E'%29C =H9;)XKM#)[UWKF-\YWL#-Y?"T>Q:S%;
MSWCO#.9G<.=R']W:&GP\-+45;-34D$=-$B*JK[]UZI/3/@_C-\<=OT6"VW3;
M4QE=_"=Q;6RN/BS^Z<]N'+9#<W7?6 ZQV[+EJC-9RMK]QUV'ZJ(QTT5::@5%
M!ZZE)6)D/NO5/3=TQCN@X>L:C9O3>[=UYOJ+)[<S<V(WAB^S^QMT[1V[@=O5
MU7L&OVYL/M:NW-DH]F?W)JL!+308W%Y*EDQ7VID1(RI?W[K9K6IX])K&_"+X
MC8K+XW-TFPZ(9;.Y*AW%5U<F]]VO+V7O'%2[ESV-W_O;_?RC_2?O_'2;MRU7
M#F<I]_D(A6R2+* L9C]U[4W2\A^,?QNP53B8UV%@*"IBJ.KZK$T]3F\T&FEZ
M$VW6[?ZV\5-59MA70[+VO73P&-EDCGIY&-6LWU]^ZU4]/>T>H.F^M>NLQUC0
MM-4]8YK'Q[:GVCOS?VX]\[:H=KYO%IMO'[%PM'OO<&<I\%LR?#D45'AZ3PT7
M@;QQQ6L/?NO5)-?/I 5GQ*^-.0VS0[:W%BLENG"==8C-X'!R[S[4W_NO(];T
M&7FVGFYQM_<&XMWY#,;*K\3!L[%&@JZ:HIJO'4D!6"2..>H\WNMZCU[&],_&
M5NV)L?MK,2XKN##9+,=Z5>&VEVYO+"[JI,/VWN:CR&YZJLQ&#W92U)ZG[*WW
MLH9&NPDD9VY7YN":K-*:F6:1_=:J:?+K)F/BO\3Z[:.:VCDMD;6I]KT.RMR=
M5Y6FCW1F,>NW]K;[WKC>S,QA170Y^&IV_7UF^H:/+4E4DD-?1U20M2RQ (/?
MNO5/3WVK\8/CWVAE]N;E[5VQ!F<QBMOX[KF#+9+=6X<15;HVU_>;";KQ>R]V
MU5!F\;)O?%/O7;]%DHJ'(M51R9&'R:&9Y _NO D<.@PW/B?A3NC,T'365H]M
M[FKMP9_Y!]93T.*RN=RE/M;=V>KML?)KN["[BSN-RDB;&W7)G*##[FBFJ9Z:
MNQ]8E,]"].= ]^ZV-7'H2:'XI?&ZAZJ[:^.LNRJ++; [[;?V?[CVKN+=6Y]P
MYOL>M[.IHL/O_<^X<[F<_6[NDR6X0(T>N@JH7IIE1J=H9$0K[K53QZD8CXM_
M&^GW'F]\X;8>(;.[OR/2-?E\O2[AW%4Q9/(_&<3ITM)'3_QZ7'1/U_Z_&D$:
M+4LMZL3E!;W7JGI%8+XN_$Z7%;FVK%UM%18G/U&=Z[GQ&X<AO#$Q9?%1]B5W
M=-9MW9J9/+TLE3L^E[!R]7E*)<6?LX"TL-.5IH_"ONO5/KT*W971'2O>M529
M;?NWZ7=<F(P.[MA3RT>X<UCJ:LVUN2OP59NG:.X4V]E\?#F,8<YM''59I:SR
M_:5U!'+&(Y%8GW7@2.F.MZ#Z%SN[\9V3CXJG#;USFY<MN>FW?L7LO>.T<ONV
MLR>.VC3;BQ%5D-I[IQC[FVGE*'K?#R5F&<S8MY,7'.T E#R-[KU32GEUR[D^
M/_Q^[YDBR?=&&H-^X'9L60I9MN;EW9F)^NL/E3C,E1ON#*[+_C46SX-ZX;#[
MCJHZ7+STHR=!#57BFCM$R>Z]4CAT7S*[/^'NT]T4O6.4Z_W]N_>_:.-[\&37
M)?Z4]\;SW7M'*;!ZYV1W-OG-9?+YNLW)N':^XMKX+:^ I\I ]49Y8Z>#'V*3
M,GNM]W&O0_[B^.G06;S53N.?&3;>W9M[.4>\J[=>T>P=W;(W9AJI=B;>Z_<U
M>XML;FQ&8QNWLSL#9&.H:RA:6/'UT..BFFB>>%9E]UJIZ"C<O2/27RN['?N_
M/9_.97:.P]C=V?&;.[8@K=V;"HLD(^T]M-V=#FL_@MP[=JMP[&RE7U@,=6XR
MKBJL-EZ!O*2T?Z_=;J5%.EL/B/\ %I:W,YB39>+FH^P,+O\ VS1X>IW=N.79
MU%C^Z\<(>S8NL]K/N#^[6QJ_LW'4^K)5&WJ>AJJQ?(X?]V8R>ZU4]!/V)T[\
M!NG,=O2@W5M;;>(RN*^*O7NU\_MW$Y_=N1[%3XR_&K<['K:MPF*QV>J-W+!U
MEO+<D346>H@N7CR34S-6/+!3F/W6P6-#\^C"2=&]0/@,O1KE]UP3[XP^S]@9
MO?--W%V#3[^W10[$S.Z:W;6#JNQ(MWKNK(5M'D]TY>*15K#-4QU,M-+KB1(T
M]UJIZ:MZ_$OXW;QVEU=U]G^O\5C]L=3[>R>P^K\3@,SFMG3;;V;GMFOL7<.Q
M</7[<RN)RK;9W+L> X_(4'F:*LI8AY QC5E]UX$C/2AZSZ*Z2ZYW'D>Q=A8>
MF7/9G9^V=A4VXJK<V7W.,+UMMB>I?:W7^SILUELI3[5V#C<E53ST^+QOV]":
MN5Y-!>Q'NO$D\>G?K3JCIKJ9<E5=:X/"[;CEPFR.OLI/19BMK8UQ/5V/J-L;
M*V[4/D<G7)!-MNBR+TJCTU#M):8N]C[]UXU/09T'Q5^+%/1Y^FI=GX.2@WDF
M[-DUL"[NSS4II-S]BUO:NY=DX%(MPK'A*1NQQ591<?0>#[.H,J0K%%JC'NO5
M/0A;6Z[ZQZ+DW?D=J)N+%Q;FFW+O"38E+NS>6Y<0M8:S)[MW7)UKU?5YG)XK
M"5>8S.7J:RJI<#CX/N:NI_02RK[]UZI/1><1T+\,NJ>U-C[<QVQ9\?V!VR5;
M9=!)DM^9/'X#'])[RB^26,VQC:*HS%1@^M=O;5WYG#GJ/$Q145+)55#1B)XK
M1#W6ZL03Y="/F/A[\9=]U=-N.?92U<-=G*+=]>VWM[;RQ6#WGFL9V[4]];>R
MV[J3;VY:/';U_NQV_6SYW$C("JAQM542I3+'!(\)]U[41TKL#\8^F-N5-/+C
M-M9+[+&=CIVUMG;U;O#>62VGLC?P.ZY)LUL':=?GZC;VR8:VHWQE9:BCQE-3
M4,TE82\)$<(C]UJIZ06Y/A5T7E\7V'-!LO&YS>O8%/N9LCNOLW,[_P"PZBNK
M,_MAMI4M+GJFKWOC=RY/;FWL'II\70Q9.E&'0:\<])/^[[]U[4>DWTS\&NL=
M@;7[&HM^PIV1NGN"H[9'8F:JJ_>24U7M_N@;/BWILS'U&>W?N7=M5AZNCV#B
M4>NR>5K\Q--3-+]S&LGA3W6RW"G0JY3XJ](YF/L^CR&VLO+A.X*ULSOC:L>]
M][TVS:C=3YC&;BEWS@=HTVX8MN[0W_)N/"TF2.<Q--19,9* 5:S"H>25_=:U
M''7+#_%/H7"=2=I=&T^Q16=:]W5G8F3[<PN:W%NK.U_8&8[9@FI^Q<WN#<N7
MSE9N:3,[I6H=IJF*LBEAD(: Q,J%?=>))(/3')\+_C67W-54O6Z8O+;KVUTE
MM3([AQ&Y]Y8O<M'B_C@^5DZ/GV[N&CW#%E]JYOKN7-U+4F2QLU+7S&2U3-.%
M4#W7JGI29CXO]*;@H-P4N8VM7U^0W13]8IFMV3[NWD=]U&2Z9:67K#=-/OI<
M^N[,=O;9]5.\]/FJ:KARCSL7EGD8W]^Z]J/2?[F^+6TNYMK]([-S.X-UT^#Z
M5[;V?VO0U=1N;=^3WGF<ALK ;IQ&*B;L4[IHM]8O-+7;D2L_BR5\M9JIO&0R
M2O;W7@2*]3,!\1^A-J2TC;7V=7;<HH]@'K++X/![QWKC-N;TV@*#<6.@I>Q-
MO4FX8L/V%E:2#=V3>+)YF&MR:3ULDWW'E".GNO:B>H>XOAM\=-WG"0[KV ^Y
M<3M?KI^K=H[:SNZ=X97:VS=J2X*FVQ-)LW;U;GYL7M3=$VWZ&GI6S>/CI\QH
M@C85(D77[]UZIZGX?XD] X:AW+2)LB;*U6]ML;]V?O?<&XMT[OW#NW>F![.?
M;K;XIMU;KR^>J]P9RIS,6TL9"M3/4/4T5+0PT]*\$""/W[KVH]1J+X>_'>@R
M^5S,&P"9<K79S(KC9=S[ODV[A*O='8VT.W]UOM7;+9[^ ;5&Z^TMAXG/Y,8^
MGIQ7Y*D$DVL,ZM[KU3TS=7_$O8W6'?6X>[\+3XVAECZ9VK\?^N=OXFGSD2[3
MZQPV[]Q=EYRDS60R^XLT-QYC/=A[JJ:B.>."B2CH((*<)(PEFD]UXFHZ26UO
M@/T?09SN3<.^L;-V/7=Q=G=P=BY"CRN0W/C-O84=R;:PNR=PTF.VI2;IFVS3
M[ECV5A5Q)W%2TE%EYJ*:6/R()9-?NMZCCH<<C\>^N:[=F^=ZTC;YVUN#LC%K
M0;SFV5V?V-LK'YFNAQ6,P5'NR3";6W1BL+!OO'X/#4E'!G(J=,FE+311>8I%
M&%]UJIQTC]M_#CX\;.@6@VELBKVQA)^OZKK+.[9P&\-ZX?:N]-IU=%N*@>+?
MVV<?N&GPF^<W'3[NR>C*Y2"JR:25;2"HUQPM'[KVH].[_%/H;[_"9:DV.<5E
M]N9;JC-X3+8?<F[,7DL=7])8+-;5ZW\-71YR*0TN%VKN3(XN>!M4&2Q]?/!6
MK41R,/?NO5/7+/?%;H?<O:\?=>9V+#5=AIG-D[JGR<6:W#18W);NZVQ^7P^P
M-W9O;M!E:;;^=W-L[#9ZLH\?65E-/-3TT^A39(]'NO5(%.I]%\;>H<=U#0]%
M4& RE'UIA\M09S;F&IMW;NBR.T\GA=YT_8&VJC:>YUS@W1MP;1W71P5.(2DK
M(DQB4\4%.(X(TB'NO5-:]0,E\5.@<MMI-HUW7=#+@H<'OG;]+3+E]Q05%#0=
MC]@X+M?=T^/R,&8CR-!F*_LG;&/S<&0AE2OQ^0HXI:2: J/?NO5/&O0R;4VU
M1;/V]B]M8ZNW!DJ/$P-!#7[JW-G]X[AJ@\TD[RY3<NZ,CEL[E:AI)39ZBHD*
M)9%THJJ/=:Z4/OW7NM=/_A53_P!N6_D%_P")&^.7_O\ 38OO1Z=A_M!]AZO_
M -@_\>+LO_PTMN?^Z>C][Z:/'I6^_=>Z][]U[K__T]_CW[KW7O?NO=:\G_"I
MW_MR7\I__#DZ _\ ?]]=>_>1Z=A_M%ZO=ZI_YE=UM_X8.S__ 'GL=[]TV>)Z
M7WOW6NB4?*3XS[L[IWWTONO9.9VUAJ#'Y2KZ\^0./SQRM/4[X^-^?R^W=][A
MVUMRLP\$TJ;O3??7.$BI34-#2C$9'+H9%:8))[K8-*]%-SG\N3=^<ZY[B@W1
MC.C>P^R=S[3Z/Q>Q6W71Y;)8"F;J7Y ]C=XYK:M16YK;64FVM@-Y1;NIZ U%
M%1U#"5=51#-%2T\9]U;7D=*W<WQ3^4LV?W)+L[*=.X_$X#_9Q,AL+([FJLUN
M.JW0?E3V%L/>U'MC/;%R.W<ALO#46Q]LT>X, 9*Y]P8Z:J?&UW\.DI4JL:_N
MO!A_@_ET)WQ.^)O8W1^]\;N[=N:VG48R#9G>6W:; X:KJ:RMV]#V?\C\EW)M
M/;M%-3;7VGMLX/:6V*_[%TQ^/Q=##5W2BHHZ4*??NM%@13HJ6/\ Y:_>=#UQ
M0]3-N7I:JV%!LO![]JMO33[P^QK/F!0;NQN*R78\@7;.IMGUO5./^[4L#DAO
M*1JNPA/OW5M0K7S_ ,G3]F_Y>/;U;+V]D:?<\51N7-=LQ;[I,Q5]E4T> [UV
M%+\E\EW_ #=9]F;0_P!"572X6LI<--2[>CR.9FWS10TM$E)3T,.'J*C'CW6M
M0QTL=D_ /=NR-W[#R^VJ#9F+HZ2E^*N5W-N;<6[Z[=?:%!-T+W%V5V%N;K^?
M>&/Z]VN^]]M9C"]BPTN%8QXF@Q<>'AH5H5HTIC#[KVKB/+H-,A\&ZGX^[2Z=
MW'D(NN<OLOKG:GQSQW;/6E/M[M3<VU.[^S]A9?M&AS>\]]4FS-@[XW'E)\<O
M8M%DL1E\AB<FTV1Q-/!D84ACI)Z;W6]52?7HS?P'ZX[#VK\7=B?&_N'IF':F
MS\7T=1',R5.<K#15V1[5W?VC5YSJ/';:K#/N/%T'7^Q7Q:54];5Q3*V6CI$B
M62DJ"GNJL16H/1<ME?RZOD#M^;!R9[L#K3<$FY,5N#:'==4V3WM3C=FS/CY0
M;HP'\O2EQU"</+!+DMI8?.BI[!>9HUR5>[M3_<>.-C[JQ<>G^KSZ5NV?Y=.X
MO[]86I[ Q73FZMJR[J^(&_\ L#(3P92MRG8&4^/7QJWCT5GML;JQU;@5&[:"
M+<-;CLSAZC*5$\,M/)/#/30RPH\_NM:\8^?0MYOXO=Z+\/.E?CO%F^O-YY39
MT]'@>SH-Q+292FW)L.BQFZ\?@L;LC=/9'7_9='MO([:KJW"/]U5[;KJHXO'U
M%+1R4=3)3UD7NM BI/2"V!\,^_<#'U9UUO7-=:[TZ\P&\>O.QNR=YY7<.[\M
MN+<E9@?A3/\ %K<VQ*/:&8P-329O'U.[*"CS<>1R>3"5F*FFIIZ1*M%G?W6R
MPR?/_9Z1VP/Y<F_,+M3%>5NINO.PMM[%^'O7.Q-V;#.5FR'65#\=J?>VWM^;
MGV)5#;.$BP];O3$[QJ:^CH(XHX:J6J>CR<DD*B0^Z\6'S\^L&S?Y=F^Z@]=4
M&\-M='[7VIL>N^)]#O79VULON/,[?[MR7QTW1O'=6XN\=WT<^SL$L^_MZU>9
MH8H*')?Q*:6):D97)UP%*(_=>U\<GSZ1787PW[8Z8ZRW]OW$8SKS<G<6*Z:V
MQ#U!O;:VW-S[NWY!\ENL?E)V?W#\?MNU5!3[2FS^9ZOW>W:M!A=P325M+3XG
M&T-6LT;T$GGIO=;U5Q7'1P]U_#RLF^/WQ9ZXQ&)V1NO<WQ\[KZ>[NRT&^6FR
M%!G]U8#<60SW9N;P><K\9EZK%;HKLMNK*Y3&5,E,RFJ"0.88Y6EB]U4-D])?
MXM?#??756\J>M["H>M(<!B.A<]T?O7(;/R6Z,OFOE/N#.[UH]QU'=G<M#N&E
M@@H=T/C::M,D4U3FZ\Y'<N649#[-8$F]UXM7UZ!/"?R_>[-MXO;-;NQ>E?D/
M/LW<&^]CTO6?8F4W7B=B;LZ/P6P_]$OQ=SFY*R3;FY((^TNL-DQU,N:C;%UE
M+4U>Y,Q-15$=3X)I/=;U?;TWYS^73W+24]0<=G=B;PRTV/\ AEF=\[DJJ\;?
MW)W[F?C;U9O#JK<^S.T:[<VR.R<5FL'4568QFYL'4YZ@W+3S5F,2DKZ0.JY$
M^ZWJ'G\^C =_?$ON'=7Q;ZE^-O4^=VS4;=V]LG+[)WNO;^93?V]6-1U?F]I;
M*S."[9W1L'<[PU6Q]U92.IK,A#MVDS==CX0N/J,7+</[JH(J3TO_ (U?%S</
M4>[N]JO?N-ZYW53]U;)Z&I-R[YQ\%15;JWON7872V&ZEW]1=A4N=Q,E9N''Y
M&MV\V3HZRKR-=+51Y::*HBCDB:2H]UXM6G0 ]1?R^,_M' [)GRVW>E=K;UZS
MVI\)=B;"R>S(JYX]K8_XP]Q;KW1V9N7:LXVGAUVU6=Q['W).&I(:=O/45T]#
MDIJBD'D?W6RU?Y]==.?#/L+H3I'Y30;ARFYMV[_W/T?OO8&+S.V]\U>XXNUI
M43M#<V)WU5=?4FQMH97&]KY7(;V^WEJ\AFMSYF<L**/(BCI:0'W7B:D=!UTE
M_+VWKF-D]+S;[V?U)UO@L-AOB)DL_P!8;;J=V9.@JMT]'=%]L[?KNW,UB=T;
M6QT%1V\-\]EX18Z#+4U9#X-H4[Y*LR$Z4_A]ULMQH?7IOF_EM=Y;DV*^QX-T
M=?=#95^KNI^H\EVAU'F\WE-XYG>O76Y,QNO+_,A8\KM/#F'O3-Q.V'I(ZFHJ
M,B*7=&<:OS=7&M/#/[KVH?;_ *N'33)\*.S.XMU_(G8:4.R-G==4'7?3^)QF
MTHL'OK!]78KY"]D3=8UOS Q_766KZ&+*;AZP'7'4&"H\/44U.(H\GN;,02,L
MAJ1%[KP:E#T(^_OY?':E;5]DX_;D'3VX=K[Y/=&W>JL?N/+[MQ%-\3J;LKL#
M$[\PO:G4.)QN"J:2FWAC:X5-544&/;$2Q93'8XTN3CII:I(O=:U#Y]<>QOY?
MO<&X<YO">%>F^QEWSO[;&Y,'N+L?*[CHLCTAC]J?,&O^0V;K=ET>&VC5QU^=
M[?VK6Q?QI*7^%0+N7'P+,U9BM,4'NO!A_J^SKO:G\MO=S[C$W8^5Q.]J2B^1
MNU.RMRY#=&]:[/[=[EV+M[M7N'M[&UNY>MZ/K[ K2]F;?S6_<92)49W+[JCD
MHZ.2C@J*7'QP4[^Z]J_P=')V9T7O;:7R^['[CPM%M/"=:;^VDM-NTY/*-O3>
M>[=X04.QL;MRMV=+5[8PV8Z?VWA<;MFJAR^%3-YO!9>H-)74M!CJTU]15>ZK
M7M Z(QM_^71W309;(Q5-1TVM11;(WGL[)]OG<'8*]H=]Y'=7RZZA^0T.\.RE
MHL5&<'D(-E;$K\3,XR&6KX\K5*:6IBH L<?NKZAT)'67PU[=V)O+K'<F8V3T
MSO?KCKW=F]J':/26Z-PODJ_KS";MJ^M*G&=SU'8_^C6GQ_;G=NSZG9V1IJ*O
MRV$I,X=OU\,-1G*K)K6UU=[K6H4.37I%=>_RV-[; WIT+DJK+XG+[?VECL9-
MOU]G;^RFRLOCNRL9\A]R=[9KM?&9+.=?;UW!N7(=H4^2Q^(W$E)D-LY2MH,6
MF,FR$^)J)(8?=>+ UZX87^7?VKMK;>)P>*HNE/[L[$RT4E-U702Y?;/7W;NW
M\1\MM\=_-MS<^'QVUZO$[6Q&]=J;LI4JZ=J7*PPY_$0)4)78\LWOW6R]?6O^
MQTH-O_R[=]P4VZ=SUU9UAB=_5>;ZQW)T]#CJK<-3COC=0[>^5.\N\=P]9]7Y
M>+;^.FQ>UL7L7<:8>AJZ&CQ[5TLU5224M)B/!3)[K6H<.AP[S^)N]NR?E?L?
MN^/(RY[96"VOUU1TF#B[!CV'E=B;HZLWYN?L456))ZPWU59;;7:\^2H,5N*#
M'U^ K*S'T1HZR>NQLYI8/=:!H*=%^Z@^"'=/5&4V'DMVX7I+O?$;:W_O3=M7
MLC=.=W-C\'B(>T,?L0;=AVBF;VSNRB%/\,J/:53LSK>#(4]2[[!R&A9\;D8I
MC6>ZWJ&:5Z!G+_ CN/KB@Z_I\GA4^0&YZSY:=/5NY<INK>NX<OL7M?86VM]=
MY=J5W87:VUL)UY%7[(W5!-O2&CJ,MGJW?P>8PX]I1C(X$/NMAA_+HZ_Q-^(.
M\?C_ -FX;>VX<+U5D'R/Q_FZWS&=VY)DVW+L.LH>]>S.TML]8;6K\WA9,MN#
MJ3;.T>S*? XUYZZCDI(=L4P%$(9HHZ/W52U13Y]%BW7\#/E5O#<7:N_MT97I
MC,[UW3C**FVU!@JF+9G7\W9>![;WOO#9';V[>M(>L<OM?>FW=O[(W@N*RF!W
M7_>K-9DFJ:/,T<JT53'[K>H8'1K?E-\8>T.Y*KKW-T^)Z@[2J,-TIVAU3F]B
M]ASY_:/7FW-_]D8_:,&/[YV)1X_%;WRE)FMH3;?JZ..DDF&2AQ&2=:')4U0)
MFJ_=:!I7H$L;_+?S)WA#3;KINI][[+HM\[N[#S^XMP8VH7<O;FZMZ_#3;7QR
MK=Q[]V[3X.>@K-U4N^,-D,O-6UF0R$E13Y;S*PKHF9O=;U8\_P#4>D#N#^6O
MW1N<;YHMQ[[I<SF-V=&[6V=B=^1]H;AQ<&(S^,^-^VNAMU=<[DQ$76]1OW=7
M5FX\G1Y7-H8MST$$M5E#65F,FRM-'62^ZWJ&,>?0D=Q_ SN?_2/NO>/QKW%U
M'U_@-DKM[N?XJ[.R-/G]M;?ZW^5U9LRLZ-[*R^Z<)M'!U6*R?4^>Z+AB^VHH
MHY)O[QY/(U,D%Y!,_NM!A3/6.'X =E[.SNSJ?K'/;6P5-@=[=PT^)WYE,[E\
M]5["ZD[&V]LO&RMB]BUVW8!4]Z5VX=O2YREW9A\SMZMQ&2_:>6NQM144+^Z]
MJ!X]"%\;OA3F>J_CEW1U9OB@R&9W#VAL/#; W!B,7WIFZ7:^[O[I]84_7?\
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MS[>\6WJ[HRG^2>W,EG,-5F>LJ,;7TD\;1K4M]O[K>@X^?1LOD[\V-]]6]];
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M]G= MU;V#V5U5MK);@ZSZ?WOV9W#D.VZ79LD>#W5/EI:C=&6ERU;3@8:GH*
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M'[^7)\;_ )8[<^$_R]^,3;4W5\:]@U&RJWISX$=B]Q[,Z.ZW^7F'VM+T%3[
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M!M/X7_'BGW[\7MY=L;RRVU<CG?G%NCL3;G9^-[&Z2@V=%FDKMR]5;3Z/QVU
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MNK=W7O361H^D]M97"]:TN2SB0;?D_=2*.6*+[V0Q>]]5J Q)I3JI#<O\MO\
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M*C69*>H?&10,V^O&A4Y_P]"/\YOB=VQ7?)C^8'N[-_!.K^?F ^<OQ#ZL^/\
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M\>MS=F;>R.Y]VYG(43YG:O6&V,C#G94RE0^4CH9HQ)5M(HDV>JJ:-GAU6_\
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M/0;.[KZJ^-W5'8U2^W?FEUOOC+;UW;U;TWF\5T!]AMS:>%GSC4='4TIS>.H
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M5G^\]A5^ WY2UD#T=+D</2U[F4SPU<<S2'7GUYF&D <<]5X]\?R?N^NVJ/\
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MZ&78W1=+78+-MU3M_*5FX:#(;CJL9@L@VW,3D-Q2T=-,T<18[ZI5=2D\!T!
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MMX=D] 9WX^?(S;>7P.)Q[4F%[*Z)[*JXZS$8]:/&4.X*;(P-1Q/2P@>Z\R@
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MAU_G=?S).V?AYD^C.K/C9V'AMF=N2;:[1^6G8M+7=>5W:$N\>D?CG18RHAZ
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MQNRWP(^&%?\ ';?>Z^I>KZ+?O7?RF^372&1[BZ>[0[&VQ08!L138GY"# Y7
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M79V^>P\MM?IG:DHW0=M=]9?#'*/5T.,H* ),*9:P)51^ZU133 X?/IT^:_\
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MVED.H^Z(NO<1M[;B[9SN$RE/7YF&>B^YJ&CHJGW6E ID#)_9\^E'N_\ G/\
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M[P[C;OWMSHCLKIZMW7NO;.^\CLS%;4WR_47=]+VQM2+:NVNQ:[;F+R5;29[
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M_'7:N:^/7<G2'R![4F[2Z#_TP=:?*;>W6O2>[^G*VI[ZZS/9.V,_N'$;S3<
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M^^>9FC;WKKP<TC!;ATBOFA\1OFCD]Q_-ZM[2VMF?DO5;IW?_ "*\OC]_=?\
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MVR,=1_ G.=O_ !-W%M*; =88?K[>/1LV;RVX:BLKI(X^QS+5(K!%I]]5)4*
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MYC=1[XQ.P<%V?F,E44$V-Q6.R69Q?6.&B@;'TU%3XX4K?:Q0^235[K>H]/\
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M_P *J?\ MRW\@O\ Q(WQR_\ ?Z;%]Z/3L/\ :#[#U?\ [!_X\79?_AI;<_\
M=/1^]]-'CTK??NO=>]^Z]U__T-_CW[KW7O?NO=:\G_"IW_MR7\I__#DZ _\
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M8CK6@FVGF=F==[*VIM[(8CL_ O7Y;';5Q.)H31Y62>F::JA=:GW7M0Z<]\_
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M\;=?8S/9C=NY<SV#F*OJ;.'>'8=+BZ':FX,93SY&GDI:W&Y7)&6LI,?[K1&
M0.H/R^^9$WQXWGU_LW;*XO+;CKYMB;CW;M?.;8KA39'KO>?=&Q.G):S";\GW
MEMF@Q>X,=6;KJ*E*/'XO=F0?[9&J*&DI'%4WNO*M:]$ISGSE[OK>S7W3ALQU
M#_>/$]3]UT6)Z%EKM_4-?USGF^;OQ]^.^"/?V*ILO6IF=Q8W;>9GKH9H:?!3
MPU<U9200R4C&NE]U8**9_P!6.ARH?EKWI/NC:^S^Q,7UK68O=G>>\>H\;7=?
MGL+9>5IZKI#YA])]'97=]=6G=V1J/L^PMO\ 8D]>,!&6AQ=10BCJ:[,4=7,T
M7NM:1_+I,[(^:_=N]I.KAO?;'78'964Z]WGLZCV/F^R-HKM_'Y#Y&;MZ6.W-
MY9B'*Y*3=--6XREQ.4J*@T<./AD:M@GQU9#'!*_NO:1FG2/J?GIW=4X78?85
M-O;J*#(;7Z<^:E1V;U,NT:F'9N^N_NF=@]4[_P!B;%Z_[;H>QMWTN[=KX[%[
MLGFBS> ^].8QRU<LE#25M-48_'>ZWI&13TZ7W:7S8[KP&]LCT5M^MV/D^R%Z
MK[KV?NC<6 Z[S.+IMB?(W8/QHK^^,7N'9FW-Q]E9W>'8G78>:AHTBGP5%C*F
M:H2.'.U%6D] GNM  Y\NDWMC^8!VWC-K[1KLAF>F.Q:[$;8Z*Q&2VMC*/-T7
M:?>;]A_&O']P[E^1/7=)C<_4[?PO5N'SM?-&]&*7(4IH=N9UY<K13P1TT?NO
M:1T,O1_S*[(KNQ.M=H_(W,=';5H>Q/CIMSN7&UO7%/GLE019:?8=#V%V'3;[
MR>9WK49'I3;NP\;6Z,;7[@QCXS=5(OW,5?05I_A ]UXJ/('CT,GR<[5[(ZS[
MG^(L.VMXX';G6^\=X]Q8CM#"9K:ZY23?DF%Z1W?O'8NUL+N:3,8M=JYN?.[=
MDEIPJ5,M<\801LD<D<GNM  AO7HL5-\_^T-I=8[5S':U+T=0]F]@=*?$WM_8
M^W<54;PP>"SU9\D>ZI^O,WLO#+F,CEMP[D_T;[?K<7+6Y*E@1H:BO6HJ:*"E
M:-7]UO2":"OGTC,Q\XN^HLIU?NR/*;(R"[+?YAXGN?IK9&U#F,5VIV'UA\=<
M3WAU5U=U#VY0;QWK3;KJJG#U;5=/E<92FJKXQ/!6X;'5])5XZF]UO2,BGIUR
M;^8'\EOX)UQ!1;$Z2S.6[$J-ZY39F]*7?'75+U[V/3[3V3UGN"EZWH*U_D+5
M[=Z^WWF]S[[K:&.3(;BR&0;#XG^*PX2=I*B@H?=>TBIX]'/^/GR=KM][V[;Z
M_P"V\MUSM;>^S=\8S!X7;.TJZ#,;:AQFZLIOBAV3A*7M==U9#$;^[#RM)L6N
M.3PAQ6VLYA:VCJ8WQDU$:+(U?NJD<*=!+W)\K.^Z'Y-;J^.O5VR-JT%-A-K;
M&J*?/;MJ,1%N;<=-V+M?LS(Y/LOK?"9;?FV<IOZ@ZARNSZ*"HV]AL+G*G-U,
ME3!)6XHQ1O+[KP I4])KXC?,7?79;;"P':7:G26+I]L?'#I#L;=^Z,WB9ML9
MWOW);VZSS&[.P]_]<K/OREVWM/9?6&8P<V.S)BASH7*T&42H&)2GBC;W6V6E
M: \>C)?*/Y#Y_HQ^D-PXFHV(.M-X=@X_"]E;@R$\VY=[4FV,D*&'#3]7=:XO
M-[?RO8M1E<K7Q0UTN,J<AD,11RK608C*J)(4]U4"M>J^>K?F#WOU'U)MK![G
MK]A;F&YX=RU^U^P-\5^[,D_6.*JOG#6]%U^\>[]Q5VXJ>/=.R-G;)WACLC45
M-$V$CHZBC^R9UHI/XE3>ZN5%?]7ITMLQ_,HWMM##[Z?<5'U)7O@*;,XOK7>=
M&NZL5L_OO/X3Y-8#I"7+=;TS9C-U&1Q$V&W51BHHZ&LRDE#G(YU%74T7CF/N
MM::TX]!7V)\F^S]OX7>_2\'9F#VO2;0^0W6^,Q&9WEG-SQ=S=V8[LK^8[O78
M^9QW4F?H]RT2+B.L=L;;@V]5T@H,I#4-42TM0^,HH8I*CW6PHXT\O\G1Y_E5
M\L]]_'3M#:F)I-L;9W7LO<'6V\LI@ML8)ZW<O<._NX,9BMSY3:O7\.U\3DX<
MQL'8N;I=OECO%<1N7'PU234U;#CU$%3/[JH%0>L_QX^3.\>UJ?NS$YW.=0]D
M4_7G6G6F_,7VAT3-N6CZ_K\AV3L[<N=R?752^6S>=KH=T;,DV_%5FII:\RS8
M;-8Z>>FQ]0_A?W7B*4Z+ULWYL=]P['P_8$6P]D;IV)2FAZ^Q'7V(GW_FNVMQ
M[JI_@-B_EI39+^^F:RV53)FJW53U.WC2RXZLR-91SQUYJ7K$:CG]UO2/7/\
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MZ>C][Z:/'I6^_=>Z][]U[K__TM_CW[KW7O?NO=:\G_"IW_MR7\I__#DZ _\
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MBJLW5[>VYO/<E+AL;A=O5M1*<=ALM72/$D45,YDNONM 5ZK9[[^67RLJ]O\
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MP]ULUX]&EQFQOB/NKL3M[#X?']+;D[*WW@:[$]V[3QN4VUF<_G,&)Z7"Y?\
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M/$_/>EJ]D;@WUAI=HXJBVKO6LZBB7,UU4,11UV,H8X\R*2CJ',,7NO&E"/\
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MOW7NO>_=>Z][]U[K73_X54_]N6_D%_XD;XY?^_TV+[T>G8?[0?8>K_\ 8/\
MQXNR_P#PTMN?^Z>C][Z:/'I6^_=>Z][]U[K_UM_CW[KW7O?NO=:\G_"IW_MR
M7\I__#DZ _\ ?]]=>_>1Z=A_M%ZO=ZI_YE=UM_X8.S__ 'GL=[]TV>)Z7WOW
M6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM=
M/_A53_VY;^07_B1OCE_[_38OO1Z=A_M!]AZO_P!@_P#'B[+_ /#2VY_[IZ/W
MOIH\>E;[]U[KWOW7NO_7W^/?NO=>]^Z]UKR?\*G?^W)?RG_\.3H#_P!_WUU[
M]Y'IV'^T7J]WJG_F5W6W_A@[/_\ >>QWOW39XGI?>_=:Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUT_^%5/_;EOY!?^)&^.
M7_O]-B^]'IV'^T'V'J__ &#_ ,>+LO\ \-+;G_NGH_>^FCQZ5OOW7NO>_=>Z
M_]#?X]^Z]U[W[KW6O)_PJ=_[<E_*?_PY.@/_ '_?77OWD>G8?[1>KW>J?^97
M=;?^&#L__P!Y['>_=-GB>E][]UKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[K73_X54_]N6_D%_XD;XY?^_TV+[T>G8?[0?8>
MK_\ 8/\ QXNR_P#PTMN?^Z>C][Z:/'I6^_=>Z][]U[K_T=_CW[KW7O?NO=:\
MG_"IW_MR7\I__#DZ _\ ?]]=>_>1Z=A_M%ZO=ZI_YE=UM_X8.S__ 'GL=[]T
MV>)Z7WOW6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NM=/_A53_VY;^07_B1OCE_[_38OO1Z=A_M!]AZO_P!@_P#'B[+_ /#2
MVY_[IZ/WOIH\>E;[]U[KWOW7NO_2W^/?NO=>]^Z]UKR?\*G?^W)?RG_\.3H#
M_P!_WUU[]Y'IV'^T7J]WJG_F5W6W_A@[/_\ >>QWOW39XGI?>_=:Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUT_^%5/_;EO
MY!?^)&^.7_O]-B^]'IV'^T'V'J__ &#_ ,>+LO\ \-+;G_NGH_>^FCQZ5OOW
M7NO>_=>Z_]/?X]^Z]U[W[KW5&/\ PI(Z@W]W5_)G^8NV>M\%6;FW%M[!]?\
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M,-O?_7'W[KU#U[_2IUA_S\?87_H8;>_^N/OW7J'KW^E3K#_GX^PO_0PV]_\
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M,-O?_7'W[KU#U[_2IUA_S\?87_H8;>_^N/OW7J'KW^E3K#_GX^PO_0PV]_\
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M?R'7O^@6+^29_P!XM;F_]* [[_\ MB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_\
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M8OY)G_>+6YO_ $H#OO\ ^V+[]3KWC2?Q?R'7O^@6+^29_P!XM;F_]* [[_\
MMB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_\ 2@.^_P#[8OOU.O>-)_%_(=>_Z!8O
MY)G_ 'BUN;_TH#OO_P"V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_P!* [[_ /MB
M^_4Z]XTG\7\AU[_H%B_DF?\ >+6YO_2@.^__ +8OOU.O>-)_%_(=>_Z!8OY)
MG_>+6YO_ $H#OO\ ^V+[]3KWC2?Q?R'7O^@6+^29_P!XM;F_]* [[_\ MB^_
M4Z]XTG\7\AU[_H%B_DF?]XM;F_\ 2@.^_P#[8OOU.O>-)_%_(=>_Z!8OY)G_
M 'BUN;_TH#OO_P"V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_P!* [[_ /MB^_4Z
M]XTG\7\AU[_H%B_DF?\ >+6YO_2@.^__ +8OOU.O>-)_%_(=>_Z!8OY)G_>+
M6YO_ $H#OO\ ^V+[]3KWC2?Q?R'7O^@6+^29_P!XM;F_]* [[_\ MB^_4Z]X
MTG\7\AU[_H%B_DF?]XM;F_\ 2@.^_P#[8OOU.O>-)_%_(=>_Z!8OY)G_ 'BU
MN;_TH#OO_P"V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_P!* [[_ /MB^_4Z]XTG
M\7\AU[_H%B_DF?\ >+6YO_2@.^__ +8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_
M $H#OO\ ^V+[]3KWC2?Q?R'7O^@6+^29_P!XM;F_]* [[_\ MB^_4Z]XTG\7
M\AU[_H%B_DF?]XM;F_\ 2@.^_P#[8OOU.O>-)_%_(=>_Z!8OY)G_ 'BUN;_T
MH#OO_P"V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_P!* [[_ /MB^_4Z]XTG\7\A
MU[_H%B_DF?\ >+6YO_2@.^__ +8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_ $H#
MOO\ ^V+[]3KWC2?Q?R'7O^@6+^29_P!XM;F_]* [[_\ MB^_4Z]XTG\7\AU[
M_H%B_DF?]XM;F_\ 2@.^_P#[8OOU.O>-)_%_(=>_Z!8OY)G_ 'BUN;_TH#OO
M_P"V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_P!* [[_ /MB^_4Z]XTG\7\AU[_H
M%B_DF?\ >+6YO_2@.^__ +8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_ $H#OO\
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L?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g296110g69b62.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g296110g69b62.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[39*4&AO=&]S:&]P(#,N,  X0DE-! 0
M     !<< 5H  QLE1QP!6@ #&R5'' (   (    X0DE-!"4      !#'71?E
M=+5N]=N^.93 Z7E<.$))300]     !OD @   "!N:5<     7 !< %  2 !8
M $8 0@!5 "T 30!7 $4 +0!& %  ,0 P %P 00!: #  ,0 U #$ +0!8 $4
M4@!/ %@       $$  ;< -@:4_\  @$  0#J"F\(9  !  \ 6 (!  $ 6 (#
M  $ 3 !E '0 = !E '( (  H #@ +@ U "  >  @ #$ ,0 B "D
M                                                 0         !
M     @    $                              %!225;B,
M
M                                       8       0)Q G$"<  ! G
M          #  )0#                                 P        !$
M%Q  7$L# &A#!             $  0                      S#ZV\ 4
M  #_  $ _P    ,
M
M
M
M
M
M
M
M
M
M
M                          $                   #     4TU42@
M   0 +  6 !E '( ;P!X "  4 !H &$ <P!E '( (  U #4 -0 P $0 3@ @
M %  4P   $QE861I;F=%9&=E  !086=E4VEZ90!,971T97( 4&%G95)E9VEO
M;@  1'5P;&5X $YO;F4 4F5S;VQU=&EO;@ V,#!X-C P9'!I
M
M  !$%P  ,4Y26 $    ,%P
M                 &D=;X<%  $ RP80     0 '(,(3Z ,     35-#1@
M  "N!@       "P          P$!  $    Y,   4@    $  0 ;'P
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M7%=]QDS9F88-ZZM>A:LZ162U%"&QV$H]_@>'MC\2Q^TWQ?_G>_X! O____\
M !\;0T]--0( &@!P &@ ;P!T &\ <P!H &\ <  N &4 > !E  0 $ !R '(
M,0 Y #( ,0 P #0 #  $       -  8  0!O".H*
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         0 !
M            .$))300Z      %U    $     $       MP<FEN=$]U='!U
M=     <     0VQR4V5N=6T     0VQR4P    !21T)#     $YM("!415A4
M    $0!! &0 ;P!B &4 ( !2 $< 0@ @ "@ ,0 Y #D .  I        26YT
M965N=6T     26YT90    !#;')M     $UP0FQB;V]L 0    ]P<FEN=%-I
M>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    B %P 7 !0 $@
M6 !& $( 50 M $T 5P!% "T 1@!0 #$ , !< $$ 6@ P #$ -0 Q "T 6 !%
M %( 3P!8 "T ,0 X       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R
M &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT
M;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T
M;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M     $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M
M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="
M0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M     $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M    0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0(D
M       *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M4&=00P    !,969T56YT1B-2;'1 ;             !4;W @56YT1B-2;'1
M=:            !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R
M:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG   "^P    QC<F]P
M4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P   D8    +
M8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #P     $  0/
M 0 !.$))300F       .  ! 1QQR0)G''#^    X0DE- _(       H  /__
M_____P  .$))300-       $    'CA"24T$&0      !    !XX0DE- _,
M      D           $ .$))32<0       *  $          3A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             #$@  !<X          0
M       !              7.   #$@                     !
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M;&]N9P   Q(     4F=H=&QO;F<   7.     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %,
M-@    $ .$))300B      %^34T *@    @ # $   ,    !!X    $!  ,
M   ! Z,   $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5
M  ,    !  ,   $:  4    !    I $;  4    !    K $H  ,    !  (
M  $Q  (    >    M $R  (    4    TH=I  0    !    Z    2  "  (
M  @ >A(    G$ !Z$@   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD ,C Q-SHP,SHR," Q-CHT,SHP-      $D   !P    0P,C(QH $  P
M  '__P  H ( !     $   7.H , !     $   ,2          8! P #
M 0 &   !&@ %     0   6X!&P %     0   78!*  #     0 "   " 0 $
M     0   7X" @ $     0              2     $   !(     3A"24T#
M_0      "           _^$!@$U- "H    (  P!   #     0>    ! 0 #
M     0.C   ! @ #     P   )X!!@ #     0 "   !$@ #     0     !
M%0 #     0 #   !&@ %     0   *0!&P %     0   *P!*  #     0 "
M   !,0 "    '@   +0!,@ "    %    -*':0 $     0   .@   $@  @
M"  (   #P     $   /      4%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O
M=W,I #(P,3<Z,#,Z,C @,38Z-#,Z,#0     !)    <    $,#(R,: !  ,
M   !__\  * "  0    !   %SJ #  0    !   #$@         & 0,  P
M  $ !@   1H !0    $   %N 1L !0    $   %V 2@  P    $  @   @$
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F!%=R4-%G;TL4=NB#QRX5"5/ \#P/ \#P/ \#P/ \#P/ \#P?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
